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Abstract 
Our knowledge and understanding of how bacterial pathogens have evolved has been limited 
by inadequate information on the full ecology of these organisms. Large-scale population 
genomic analyses have enabled a high-resolution view of variation at the core and accessory 
genome level, within and between bacterial populations, revealing previously hidden patterns 
of variation among microorganisms. This sheds light on the evolution and maintenance of 
ecologically distinct populations of bacteria and has raised the question of whether the same 
approach can uncover novel information on the ecology of established, clinically important 
pathogens. Yersinia pseudotuberculosis and Escherichia coli represent ‘model’ organisms in the 
study of microbial evolution, but given the high degree of niche overlap in both species, their 
ecology is largely unknown.  
In this study, genomic analyses of Y. pseudotuberculosis strains, obtained from various habitats 
worldwide, revealed a phylogeographic split within the population, with an Asian ancestry and 
subsequent dispersal of successful clonal lineages across the rest of the world. These lineages 
were differentiated by CRISPR arrays and we demonstrated that genetic exchange between 
lineages is restricted. Despite the coexistence of these lineages for thousands of years, the 
discrete lineage structure of the population is maintained due to the restriction of inter-lineage 
genetic exchange. The analyses did not identify a role for ecological barriers in defining the 
distinct lineage structure of the species, suggesting that Y. pseudotuberculosis is a host generalist 
able to succeed in multiple habitats.  
The relative abundance of multidrug-resistant extraintestinal pathogenic E. coli (ExPEC) among 
E. coli inhabiting non-human niches is undetermined, owing to many studies selectively isolating 
resistant bacteria. To compare the population structure of E. coli from non-human environments 
with the well-defined population structure of human-clinical E. coli, unbiased sampling of E. coli 
isolates from river water and retail poultry samples was undertaken. Genomic analysis of 
isolates revealed a low prevalence of clinically-associated sequence types and potential ExPEC 
strains among non-human E. coli when contrasted with human-clinical E. coli, suggesting two 
distinct populations. Comparative genomic analyses further supported this, revealing a 
noticeable difference in accessory genome content between the two populations and low levels 
of genetic exchange between closely related strains. This suggests ecological barriers, resulting 
in gradual genetic isolation, may have contributed to the divergence of these niche-associated 
populations of E. coli. The investigation concluded that the non-human population of E. coli is 
unlikely to contribute significantly to the weight of hospital- and community-acquired 
extraintestinal infections in humans. 
 iv 
 
Table of Contents 
Copyright Statement ............................................................................................................ i 
Acknowledgements ............................................................................................................. ii 
Abstract ............................................................................................................................. iii 
Table of Contents ............................................................................................................... iv 
List of Tables ...................................................................................................................... ix 
List of Figures ...................................................................................................................... x 
List of Abbreviations ......................................................................................................... xiii 
List of Publications ............................................................................................................ xvi 
1. Introduction ................................................................................................................ 1 
1.1. Unravelling microbial ecology ....................................................................................... 2 
1.1.1. 16S ribosomal RNA sequencing ............................................................................ 3 
1.1.2. Metagenomics ...................................................................................................... 3 
1.1.3. Combining a culture-based approach with whole-genome sequencing .............. 4 
1.1.4. Advancements in whole-genome sequencing technologies ................................ 5 
1.1.5. Using population genomics to uncover patterns of microbial ecology ................ 6 
1.2. Yersinia pseudotuberculosis .......................................................................................... 9 
1.2.1. The pathogenic Yersiniae ...................................................................................... 9 
1.2.2. Hidden ecological patterns in the pathogenic Yersiniae..................................... 10 
1.2.3. An introduction to the Y. pseudotuberculosis species ........................................ 11 
1.2.4. Pathogenesis of Y. pseudotuberculosis ............................................................... 12 
1.2.4.1. Transmission of the bacteria to humans..................................................... 12 
1.2.4.2. Epidemiology of Y. pseudotuberculosis-associated yersiniosis ................... 13 
1.2.4.3. Virulence factors of Y. pseudotuberculosis ................................................. 14 
1.2.4.4. Pathophysiology of Y. pseudotuberculosis infection................................... 15 
1.2.5. Clinical manifestations of Y. pseudotuberculosis infection ................................. 18 
1.2.6. Treatment and prevention .................................................................................. 18 
1.2.7. Identification and typing of Y. pseudotuberculosis ............................................. 19 
 v 
 
1.2.7.1. Serological characterisation of Y. pseudotuberculosis ................................ 19 
1.2.7.2. Y. pseudotuberculosis multilocus sequence typing (MLST) ........................ 20 
1.3. Escherichia coli ............................................................................................................ 21 
1.3.1. An introduction to the E. coli species ................................................................. 21 
1.3.2. Commensal E. coli ............................................................................................... 22 
1.3.3. Intestinal pathogenic E. coli (IPEC) ...................................................................... 23 
1.3.4. Extraintestinal pathogenic E. coli (ExPEC) ........................................................... 25 
1.3.4.1. Avian pathogenic E. coli (APEC)................................................................... 26 
1.3.4.2. Neonatal meningitis E. coli (NMEC) ............................................................ 26 
1.3.4.3. Uropathogenic E. coli (UPEC) ...................................................................... 27 
1.3.5. Antibiotic resistance in extraintestinal pathogenic E. coli .................................. 30 
1.3.6. Source attribution ............................................................................................... 33 
1.3.6.1. Surface waters as an environmental reservoir for ExPEC ........................... 35 
1.3.6.2. Retail poultry meat as a reservoir for ExPEC .............................................. 36 
1.3.7. Population structure of extraintestinal pathogenic E. coli ................................. 37 
1.3.7.1. E. coli phylo-typing ...................................................................................... 37 
1.3.7.2. ExPEC genotyping ........................................................................................ 38 
1.4. Aims and objectives .................................................................................................... 41 
2. Materials and methods .............................................................................................. 43 
2.1. Media and reagents .................................................................................................... 44 
2.1.1. Growth and storage media ................................................................................. 44 
2.1.2. API identification kit ............................................................................................ 44 
2.1.3. Molecular microbiology reagents ....................................................................... 45 
2.1.4. NGS reagents and sequencing kits ...................................................................... 45 
2.1.5. Buffers and reagents ........................................................................................... 46 
2.2. Y. pseudotuberculosis phylogenomics ........................................................................ 46 
2.2.1. Determining phylogenetic relationships ............................................................. 46 
2.2.2. Analysis of CRISPR loci ........................................................................................ 47 
2.2.3. Pan-genome and accessory genome analyses .................................................... 47 
 vi 
 
2.2.4. Detection of core genome recombination events .............................................. 48 
2.2.5. Dating analysis .................................................................................................... 48 
2.3. Non-human E. coli strain collection ............................................................................ 49 
2.3.1 River water sampling .......................................................................................... 49 
2.3.2. Retail poultry sampling ....................................................................................... 52 
2.3.3. Isolation and identification of E. coli from non-human samples ........................ 53 
2.4. Molecular characterisation of non-human E. coli ....................................................... 56 
2.4.1. Preparation of genomic DNA .............................................................................. 56 
2.4.2. Detection of β-lactamase genes ......................................................................... 56 
2.4.3. Agarose gel electrophoresis ................................................................................ 57 
2.5. Whole-genome sequencing ........................................................................................ 59 
2.5.1. Quality assessment of genomic DNA .................................................................. 59 
2.5.2. Illumina Nextera XT library preparation ............................................................. 59 
2.5.3. Sequencing on the MiSeq ................................................................................... 61 
2.6. Analysis of E. coli sequence data ................................................................................ 64 
2.6.1. Genome assembly, annotation, and quality assessment ................................... 64 
2.6.2. Sequence-typing and clonal complex assignment .............................................. 64 
2.6.3. Detecting antibiotic resistance genes and ExPEC virulence determinants ......... 64 
2.6.4. Reconstructing phylogenetic trees ..................................................................... 65 
2.6.5. Pan-genome analysis .......................................................................................... 65 
2.6.6. Detection of recombinant genomic regions ....................................................... 66 
2.6.7. Statistical analyses .............................................................................................. 66 
3. Ecology and evolution of a global population of Yersinia pseudotuberculosis ............... 67 
3.1. Introduction ................................................................................................................ 68 
3.1.1. Aim and objectives .............................................................................................. 70 
3.2. Materials and Methods ............................................................................................... 71 
3.3. Results and Discussion ................................................................................................ 78 
3.3.1. Phylogeographic structure of Y. pseudotuberculosis indicates an Asian ancestry 
for the species ..................................................................................................... 78 
 vii 
 
3.3.2. Phylogenetic clusters within Y. pseudotuberculosis associate with discrete CRISPR 
cassette patterns ................................................................................................. 80 
3.3.3. Cryptic ecology suggests that Y. pseudotuberculosis is a host generalist ........... 85 
3.3.4. Phylogenetic dating suggests recent geographical divergence .......................... 88 
3.3.5. CRISPR-associated phylogenetic clusters are associated with patterns of 
accessory gene conservation and core genome recombination ........................ 90 
3.4. Conclusions ................................................................................................................. 96 
4. Defining the population structure of Escherichia coli from non-human sources ......... 100 
4.1. Introduction .............................................................................................................. 101 
4.1.1. Aim and objectives ............................................................................................ 103 
4.2. Materials and Methods ............................................................................................. 105 
4.3. Results and Discussion .............................................................................................. 106 
4.3.1. Prevalence of E. coli isolated from river water and retail chicken meat .......... 106 
4.3.2. Molecular detection of β-lactamase genes in non-human E. coli .................... 109 
4.3.3. Whole-genome sequencing of non-human E. coli isolates ............................... 112 
4.3.4. Whole-genome-based multilocus sequence typing (MLST) analysis of the non-
human population of E. coli .............................................................................. 114 
4.3.5. Defining the phylogeny of the non-human population of E. coli ...................... 120 
4.3.6. Distribution of antimicrobial resistance genes among non-human E. coli ....... 124 
4.3.7. Determining the prevalence of ExPEC strains in the non-human population of E. 
coli ..................................................................................................................... 130 
4.4. Conclusions ............................................................................................................... 133 
5. Comparative population genomics of Escherichia coli from human-clinical and non-
human sources ........................................................................................................ 136 
5.1. Introduction .............................................................................................................. 137 
5.1.1. Objectives .......................................................................................................... 139 
5.2. Materials and Methods ............................................................................................. 141 
5.3. Results and Discussion .............................................................................................. 153 
5.3.1. Comparing the prevalence of STs between the human-clinical and non-human 
populations of E. coli ......................................................................................... 153 
 viii 
 
5.3.2. Comparative phylogenomic analysis of the human-clinical and non-human 
populations of E. coli ......................................................................................... 160 
5.3.3. Determining the prevalence of ExPEC strains in the human-clinical population of 
E. coli ................................................................................................................. 163 
5.3.4. Distribution of antimicrobial resistance genes among human-clinical E. coli .. 165 
5.3.5. Phylogenetic analyses of the E. coli lineages ST131 and ST648 ........................ 168 
5.3.5.1.  E. coli ST131.............................................................................................. 168 
5.3.5.2.  E. coli ST648.............................................................................................. 170 
5.3.6. Comparative genomic analyses ........................................................................ 173 
5.3.6.1. Pan-genome approach to compare human-clinical and non-human E. coli ... 
  ................................................................................................................... 173 
5.3.6.2. Comparisons of the accessory genomes of human-clinical and non-human 
E. coli ......................................................................................................... 175 
5.3.7. Pan-genome and recombination analysis of E. coli lineages ST69 and ST10 .... 184 
5.3.7.1. E. coli ST69 ................................................................................................ 184 
5.3.7.2. E. coli ST10 ................................................................................................ 188 
5.4. Conclusions ............................................................................................................... 192 
6. Conclusions and future directions ............................................................................ 198 
References ...................................................................................................................... 207 
Appendix ........................................................................................................................ 240 
 
 ix 
 
List of Tables 
  
Table Page 
Table 2.1: Numbers of whole chickens obtained from 6 major supermarket chains and a 
snapshot of chicken processing companies in the UK................................................................ 
 
52 
Table 2.2: Identification characteristics used to presumptively identify E. coli from other 
bacterial species present in environmental samples................................................................. 
 
55 
Table 2.3: Primer sequences used in this study......................................................................... 58 
Table 2.4: Illumina adapter sequences – index 1 (i7) adapters................................................ 62 
Table 2.5: Illumina adapter sequences – index 2 (i5) adapters................................................ 63 
Table 3.1: Yersinia pseudotuberculosis genomes used in this study.......................................... 72 
Table 3.2: CRISPR cluster-type Y. pseudotuberculosis strains with known isolation dates……… 84 
Table 4.1: E. coli reference genomes used for phylogrouping of non-human E. coli 
strains........................................................................................................................................ 
 
105 
Table 4.2: Total number of E. coli isolates identified from river water samples……………………… 107 
Table 4.3: Total number of E. coli isolates identified from retail chicken samples………………… 108 
Table 4.4: Sequence type designations for the 128 sequenced non-human E. coli 
genomes.................................................................................................................................... 
 
116 
Table 5.1: List of sequenced human-clinical E. coli genomes used for comparative genomic 
analyses in this study................................................................................................................. 
 
141 
Table 5.2: List of sequenced ST131 E. coli genomes used for comparative phylogenetic 
analysis in this study………………………………………………………………................................................ 
 
145 
Table 5.3: List of sequenced ST648 E. coli genomes used for comparative phylogenetic 
analysis in this study.................................................................................................................. 
 
151 
Table 5.4: Quantified recombinations between non-human and human-clinical genomes……. 191 
 x 
 
List of Figures 
Figure Page 
Figure 1.1: Routes of transmission and mechanisms of pathogenesis of the human 
pathogenic Yersinia species....................................................................................................... 
 
17 
Figure 1.2: Sites of colonisation by pathogenic E. coli................................................................ 29 
Figure 1.3: Potential ecological habitat and routes of transmission of E. coli in a global 
ecosystem.................................................................................................................................. 
 
34 
Figure 2.1: Map of Giltbrook sample site................................................................................... 50 
Figure 2.2: Map of Erewash Pinxton sample site........................................................................ 50 
Figure 2.3: Map of East Leake sample site.................................................................................. 51 
Figure 2.4: Map of Keyworth sample site................................................................................... 51 
Figure 3.1: Maximum-likelihood phylogenetic tree of 134 Y. pseudotuberculosis isolates 
annotated with continents of origin……………………………………………………………………………………… 
 
79 
Figure 3.2: Maximum-likelihood phylogenetic tree of 134 Y. pseudotuberculosis isolates 
annotated with the 33 identified CRISPR clusters...................................................................... 
 
82 
Figure 3.3: Global map showing sources of isolation of strains belonging to each of the 33 
identified CRISPR clusters.......................................................................................................... 
 
83 
Figure 3.4: Maximum-likelihood phylogenetic tree of 134 Y. pseudotuberculosis isolates 
annotated with all available metadata………………………………………………………………..................... 
 
87 
Figure 3.5A: Dated maximum clade credibility tree of 46 Y. pseudotuberculosis strains for 
which isolation dates were available......................................................................................... 
 
89 
Figure 3.5B: Bayesian Skyline reconstruction from BEAST 2 analysis......................................... 89 
Figure 3.6: Distribution of accessory gene profiles for 134 Y. pseudotuberculosis isolates........ 94 
Figure 3.7: BratNextGen analysis of core genome recombination events for 134 Y. 
pseudotuberculosis isolates....................................................................................................... 
 
95 
Figure 4.1: Electrophoresis gel showing PCR amplicons of β-lactamase genes detected in E. 
coli isolated from non-human samples...................................................................................... 
 
110 
Figure 4.2A: Percentage prevalence of β-lactamase genes blaTEM, blaSHV, blaCTX-M, and blaOXA 
in E. coli isolates from human-clinical samples.......................................................................... 
 
111 
 xi 
 
Figure 4.2B: Percentage prevalence of β-lactamase genes blaTEM, blaSHV, blaCTX-M, and blaOXA 
in E. coli isolates from non-human samples............................................................................... 
 
111 
Figure 4.3: Workflow indicating the numbers of E. coli isolates from river water and retail 
chicken samples consolidated at each stage of the investigation.............................................. 
 
113 
Figure 4.4: Minimum spanning tree illustrating STs of the non-human E. coli population 
isolated from river water and retail chicken samples................................................................. 
 
119 
Figure 4.5: Maximum-likelihood phylogenetic tree of 128 E. coli strains isolated from river 
water and retail chicken samples in Nottingham and 18 reference strains................................ 
 
123 
Figure 4.6: Distribution of antibiotic resistance gene profiles across 128 E. coli strains isolated 
from river water and retail chicken samples in Nottingham...................................................... 
 
129 
Figure 4.7: Distribution of ExPEC VAGs among 128 E. coli strains isolated from river water 
and retail chicken samples in Nottingham................................................................................. 
 
132 
Figure 5.1A: Prevalence of E. coli STs among E. coli strains isolated from human-clinical 
samples collected in Nottingham............................................................................................... 
 
156 
Figure 5.1B: Prevalence of E. coli STs among E. coli strains isolated from non-human samples 
collected in Nottingham............................................................................................................ 
 
156 
Figure 5.2: Prevalence of the most predominant E. coli STs associated with human 
extraintestinal infection in the human-clinical and non-human populations of E. coli in 
Nottingham............................................................................................................................... 
 
 
157 
Figure 5.3: Minimum spanning tree illustrating the E. coli STs isolated from human-clinical 
and non-human samples........................................................................................................... 
 
159 
Figure 5.4: Maximum-likelihood SNP-based phylogenetic tree of 264 E. coli strains isolated 
from human-clinical and non-human samples in Nottingham................................................... 
 
162 
Figure 5.5: Distribution of ExPEC VAGs among 136 E. coli strains isolated from human-clinical 
samples in Nottingham.............................................................................................................. 
 
164 
Figure 5.6: Distribution of antimicrobial resistance genes among 136 E. coli strains isolated 
from human-clinical samples in Nottingham............................................................................. 
 
167 
Figure 5.7: Maximum likelihood SNP-based phylogenetic tree of E. coli ST131 isolates............ 169 
Figure 5.8: Maximum likelihood SNP-based phylogenetic tree of E. coli ST648 isolates............ 172 
Figure 5.9: Core and pan-genome frequency plots of all 264 E. coli strains isolated from 
human-clinical and non-human samples in Nottingham............................................................ 
 
174 
 xii 
 
 
  
Figure 5.10: Functional categories of genes present in ≥ 85% of all 264 E. coli strains isolated 
from human-clinical and non-human samples in Nottingham................................................... 
 
176 
Figure 5.11: Comparison of population-unique accessory genes and shared accessory genes 
between the human-clinical and non-human populations of E. coli in Nottingham................... 
 
178 
Figure 5.12: Frequency of gene occurrence plots for population-unique and shared accessory 
genes for the human-clinical and non-human populations of E. coli in Nottingham.................. 
 
179 
Figure 5.13: Distribution of accessory genes in the human-clinical and non-human 
populations of E. coli in Nottingham.......................................................................................... 
 
183 
Figure 5.14: Distribution of gene profiles for ST69 E. coli strains isolated from human-clinical 
and non-human samples in Nottingham.................................................................................... 
 
187 
Figure 5.15: Distribution of core genome recombination events for ST69 E. coli strains 
isolated from human-clinical and non-human samples in Nottingham...................................... 
 
187 
Figure 5.16: Distribution of gene profiles for ST10 E. coli strains isolated from human-clinical 
and non-human samples in Nottingham.................................................................................... 
 
190 
Figure 5.17: Distribution of core genome recombination events for ST10 E. coli strains 
isolated from human-clinical and non-human samples in Nottingham...................................... 
 
190 
 xiii 
 
List of Abbreviations  
ABU  Asymptomatic bacteriuria 
A/E  Attaching and effacing 
APEC Avian pathogenic Escherichia coli 
API Analytical profile index 
ATM Amplicon Tagment Mix 
BBB  Blood-brain barrier 
BEAST Bayesian Evolutionary Analysis by Sampling Trees 
BLAST Basic Local Alignment Search Tool 
bp Base pair 
BTI Biliary tract infection 
BSAC British Society for Antimicrobial Chemotherapy 
Cas CRISPR-associated system (proteins) 
CDS Coding sequence 
CLED Cystine-, lactose-, and electrolyte-deficient  
CNS Central nervous system 
CRISPR Clustered regularly interspaced short palindromic repeat  
crRNA CRISPR ribonucleic acid 
CSV Comma-separated values (file) 
CTX-M Cefotaxime preferential extended-spectrum β-lactamase 
DA Domesticated animal 
DAEC Diffusely adherent Escherichia coli 
DNA Deoxyribonucleic acid 
dNTP Deoxyribonucleotide triphosphate 
DOI Digital object identifier 
DR Direct repeats 
EAEC Enteroaggregative Escherichia coli 
EAHEC Entero-aggregative-haemorrhagic Escherichia coli 
ECOR Escherichia coli Reference (collection) 
EHEC Enterohaemorrhagic Escherichia coli 
EIEC Enteroinvasive Escherichia coli 
EPEC Enteropathogenic Escherichia coli 
ESBL Extended-spectrum beta-lactamase 
ESS Effective sample size 
ETEC Enterotoxigenic Escherichia coli 
 xiv 
 
ExPEC Extraintestinal pathogenic Escherichia coli 
FIMM Institute for Molecular Medicine Finland 
GC Guanine and cytosine  
gDNA Genomic deoxyribonucleic acid 
GFF General feature format (file) 
HC Haemorrhagic colitis 
HCl Hydrochloric acid 
HPI High-pathogenicity island 
HT1 Hybridization Buffer 
HUS Haemolytic uraemic syndrome 
IPEC Intestinal pathogenic Escherichia coli 
iTOL Interactive Tree of Life 
Kbp Kilobase pairs 
LPS lipopolysaccharide 
LS-BSR Large-Scale Blast Score Ratio 
Mbp Megabase pairs 
MCC Maximum clade credibility (tree) 
MDR Multidrug resistance/multidrug-resistant  
MLEE Multilocus enzyme electrophoresis 
MLS Macrolide-lincosamide-streptogramins 
MLST Multilocus sequence typing 
MST Minimum spanning tree 
MSU Midstream sample of urine 
NaOH Sodium hydroxide 
NCBI National Centre for Biotechnology Information 
NGS Next-generation sequencing  
NMEC Neonatal meningitis Escherichia coli 
NPM Nextera PCR Master Mix 
NT Neutralize Tagment (buffer) 
OD Optical density 
OH Hydroxyl (group) 
ONT Oxford Nanopore Technologies 
OPS O-specific polysaccharide (O-antigen) 
ORF Open reading frame  
OXA Oxacillin preferential β-lactamase 
 xv 
 
PAI Pathogenicity island 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PFGE Pulsed field gel electrophoresis 
PG Phylogroup 
pH Potential hydrogen 
PSA Proportion of shared ancestry (tree) 
QUAST Quality Assessment Tool 
RNA Ribonucleic acid 
rRNA Ribosomal ribonucleic acid 
rpm Revolutions per minute 
RTI Respiratory tract infection 
SBS Sequencing by synthesis 
SHV Sulfhydryl-variable β-lactamase 
SNP Single nucleotide polymorphism 
ST Sequence type 
STC Sequence type complex 
STEC Shiga toxin-producing Escherichia coli 
Stx Shiga toxin 
SWI Surgical wound infection  
T3SS Type III secretion system 
TAE Tris-acetate-EDTA (buffer) 
TD Tagment DNA (buffer) 
TEM Temoneira β-lactamase 
TMRCA Time to most recent common ancestor  
UPEC Uropathogenic Escherichia coli 
UTI Urinary tract infection 
UV Ultraviolet 
VAG Virulence-associated gene 
VFDB Virulence Factors Database  
WGS Whole-genome sequencing 
YAPI Yersinia adhesion pathogenicity island  
 
 
  
 xvi 
 
List of Publications  
Conference presentations 
Seecharran T, Dickins B, Skurnik M, Corander J, McNally A. Phylogeographic separation and 
formation of sexually discrete lineages in a global population of Yersinia pseudotuberculosis. 5th 
Molecular Microbiology and 4th M4 Meeting 2017, Birmingham (poster). 
Seecharran T, Dickins B, Skurnik M, Corander J, McNally A. Phylogenetic and CRISPR analysis 
reveals ecological separation and restricted gene flow in a global population of Yersinia 
pseudotuberculosis. Microbiology Society Annual Conference 2017, Edinburgh (poster). 
Seecharran T, Winter J, Skurnik M, Corander J, McNally A. Elucidating the unknown ecology of 
bacterial pathogens from phylogenetic data. STAR Conference 2016, NTU (poster/oral 
presentation). Awarded first prize for best oral presentation. 
Seecharran T, Winter J, McNally A. Defining the population structure of Escherichia coli in the 
environment. Microbiology Society Annual Conference 2016, Liverpool (poster). 
Journal articles 
Seecharran T, Kalin-Manttari L, Koskela K, Nikkari S, Dickins B, Corander J, Skurnik M, McNally 
A. (2017) Phylogeographic separation and formation of sexually discrete lineages in a global 
population of Yersinia pseudotuberculosis. Microbial Genomics, 3 (10), e000133.  
http://doi.org/10.1099/mgen.0.000133. 
McNally A, Oren Y, Kelly D, Pascoe B, Dunn S, Seecharran T et al., (2016) Combined Analysis of 
Variation in Core, Accessory and Regulatory Genome Regions Provides a Super-Resolution View 
into the Evolution of Bacterial Populations. PLoS Genet 12 (9), e1006280.  
https://doi.org/10.1371/journal.pgen.1006280. 
 1 
 
 
 
 
 
CHAPTER 1 
Introduction 
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1. Introduction 
1.1. Unravelling microbial ecology  
Microbial ecology examines the diversity of microorganisms and how they maintain diversity 
through the interaction with each other, and with their environment. Microbial ecological 
studies have traditionally concentrated on two areas: (i) microbial diversity, which encompasses 
the isolation, identification, and quantification of different microorganisms in various habitats; 
and (ii) microbial activity, which pertains to what microorganisms do in their habitats and how 
this contributes to the observed microbial diversity (Xu, 2006). The study of microorganisms 
began in the late 17th century, through the work of Robert Hooke and Antonie van Leeuwenhoek, 
who individually published the first original observations of single-celled organisms (Gest, 2004). 
The diversity of microorganisms in the environment can be measured at various levels such as 
phylogenetic diversity, species diversity, genotypic diversity, and gene diversity (Xu, 2006). 
Microbial populations were traditionally understood at the species level and above solely 
through culture-based techniques, of which less than 1% of microbes are culturable (Amann et 
al., 1990), and typically require numerous physiological and biochemical tests for full 
characterisation. Classical microbiology primarily consisted of isolating microbes, growing them 
as pure cultures, and identifying biochemical properties of these organisms, such as cell wall 
structure by Gram staining, oxygen tolerance, and carbon or nitrogen sources that supported 
their growth. These techniques can be very time-consuming, laborious, and require prior 
knowledge of the organisms of interest to selectively and successfully culture from a complex 
microbial community. There are several limitations to culture-dependent methods, most 
important of which is a bias towards readily cultivable organisms, thus ignoring non-culturable 
bacteria, which comprise the largest proportion of microbes (Xu, 2006). Furthermore, even 
among culturable microorganisms, the true diversity found in nature may not be accurately 
represented by the observed diversity on standard microbiological media. This is because even 
though many different variants of media and growth conditions have been developed over the 
years to culture microorganisms, it is impossible to explore all of the conditions required to 
culture every microorganism. A more accurate estimation of microbial diversity has been 
achieved over the past two decades due to the application of culture-independent genomics 
tools. Immunological methods, such as enzyme-linked immunosorbent assay (ELISA) have been 
used to characterise and identify bacteria from a variety of ecosystems. However, these 
techniques are still limited in assessing functionality and have only been used sparingly due to 
the need for specific antigens/antibodies. Consequently, the focus of many recent microbial 
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ecological studies has turned towards development of molecular approaches for understanding 
these complex communities which, in some cases, eliminates the need for culturing beforehand. 
1.1.1. 16S ribosomal RNA sequencing  
Molecular techniques have superseded traditional microbiological methods due to the ease of 
use, reproducibility, sensitivity and speed of working with nucleic acids that these techniques 
provide. Culture-independent approaches such as DNA cloning and polymerase chain reaction 
(PCR) have been used to detect specific members as well as functional genes within a microbial 
community. Functional genes such as the 16S ribosomal RNA (rRNA) gene and 5S rRNA gene 
have been used as molecular markers for studying phylogenetic relationships. The rRNA gene 
consists of different regions, some of which are highly conserved across all phylogenetic 
domains of life (i.e. bacteria, eukarya, and archaea) and are more resistant to mutations, while 
other regions, called ‘hot spots’, are variable between closely related bacterial species. This 
variability allows for inferring phylogenetic information from microorganisms inhabiting 
different ecosystems (Clarridge, 2004). Another molecular marker would include the recA gene, 
which is essential for the repair and maintenance of DNA in all species, and has been used to 
define the phylogeny of Vibrio cholerae (Stine et al., 2000). In addition, the rpoA gene encodes 
the alpha subunit of RNA polymerase and has also proved useful in determining phylogenetic 
relationships (Fox and Sorhannus, 2003). A new era began with the innovation of Next-
Generation sequencing (NGS) technologies, which transformed the existing gold standard 
techniques of microbial community analysis. NGS allows large sets of sequence data to be 
generated in parallel, utilising phylogenetic markers such as the 16S rRNA gene, inexpensively 
and in considerably less time. The high-throughput (amount of DNA processed per unit time) 
results generated by 16S gene sequencing enables comprehensive analysis of community 
microbiota from various environments, as well as providing insights into the interactions with 
their ecosystems. In general, differentiation between organisms at the genus level across all 
major phyla of bacteria can be achieved through the comparison of 16S rRNA sequence data. 
Although 16S rRNA gene sequencing is highly useful with regards to bacterial classification, this 
technique does carry several limitations and sometimes exhibits low phylogenetic resolution at 
the species level, due to sequence similarities between species that exhibit different 
phenotypes, and in some cases, offers poor discriminatory power for some genera.  
1.1.2. Metagenomics 
A possible solution to these taxonomic problems is to utilise metagenomics, which is another 
high-throughput sequencing technology used to reveal microbial diversity in natural 
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environments. Metagenomics is the culture-independent analysis of the collective microbial 
genomes (termed the metagenome) in an environmental community, using an approach based 
either on expression or sequencing (Riesenfeld, Schloss and Handelsman, 2004). Such microbial 
communities may include a soil or water sample that contains substantially more genetic 
information than is available from the cultured subset. Metagenomic studies usually require the 
cloning of DNA fragments isolated directly from microbial samples, followed by sequencing and 
functional analysis of the cloned fragments, ultimately to make taxonomic assignments to 
characterise the microorganisms. Fully sequencing the DNA within a sample allows investigators 
to study the taxonomic diversity of all microbes within a sample and not just the culturable. 
However, one of the main issues presented by metagenomics is that functional genes are not 
usually analysed. Metagenomics is often limited to taxonomy – analysis of the 16S rRNA gene – 
which is used to identify organisms with the aim of determining the species present in an 
environmental sample. A specific function often cannot be reliably inferred from identification 
of the microorganism. Shotgun metagenomics studies are now starting to present opportunities 
for unravelling microbial community diversity, such as species sub-typing and strain-level 
profiling; however, the genomic resolution of single isolate sequencing is still higher than what 
can be achieved for single organisms in a metagenomics context (Quince et al., 2017). Increasing 
the profiling resolution to the level of single strains would be vital for in-depth population 
genomic analyses and the study of microbial ecology and epidemiology – something which 
currently can only be achieved at a high resolution when using a whole-genome sequencing-
based approach. 
1.1.3. Combining a culture-based approach with whole-genome sequencing 
Before the development of molecular techniques, microbial ecological studies were largely 
reliant upon traditional methods of isolation and identification to probe the structures of 
microbial populations. Culture-based approaches have not disappeared and indeed are still 
used, together with molecular analyses, to fully understand bacterial population dynamics. 
Advances in DNA sequencing technology, starting with the widespread implementation of 
automated DNA sequencing techniques in the 1990s, have revolutionised our understanding of 
microbial processes, from the physiology of single cells to large-scale population biology. The 
last two decades have seen an increase in the use of high-throughput or next-generation 
sequencing technologies, enabling investigations of microbial communities with unprecedented 
resolution, underpinning important research in pathogen epidemiology and evolution. To 
comprehensively characterise the complexity of a population of a particular bacterial species to 
the strain-level of classification, culture-based techniques must be complemented by the vast 
 5 
 
array of information obtained from culture-independent techniques, such as NGS technology. 
Whole-genome sequencing (WGS) provides more resolution through the generation of genome-
wide information for a cultured microbial population. WGS has emerged as the gold standard in 
bacterial typing, enabling successful tracking of worldwide epidemics, regional outbreaks, and 
foodborne outbreaks, and demonstrating that the fine-scale resolution provided by WGS 
facilitates our understanding of the structure of microbial populations and the spread of 
infectious agents. There are several WGS platforms available that have revolutionised the field 
of microbial ecology, ranging from traditional Sanger sequencing biochemistry to second-
generation (Illumina) and third-generation (single-molecule) sequencing technologies (Schadt, 
Turner and Kasarskis, 2010). 
1.1.4. Advancements in whole-genome sequencing technologies 
The first generation of whole-genome sequencing was initially developed by Sanger and 
colleagues (1975) and in parallel by Maxam and Gilbert (1977), which were termed the ‘chain-
termination method’ and the ‘chemical sequencing method’, respectively. Of the two methods, 
Sanger sequencing ultimately prevailed given that it was less complex and more favourable to 
being scaled up than the chemical sequencing method (Schadt, Turner and Kasarskis, 2010). 
Sanger sequencing typically results in a read length of ∼800 bases, which may be extended to 
above 1,000 bases (Schadt, Turner and Kasarskis, 2010). While fully automated implementations 
of this approach were the mainstay for original DNA sequencing technology, their main 
limitation was the low throughput results, as well as high cost, which resulted in a fundamental 
shift in methodology, leading to second-generation sequencing technologies, also generally 
known as next-generation sequencing (NGS) or high-throughput sequencing technologies.  
Second-generation sequencing technologies are known for extremely high throughput, resulting 
in an overall low cost per identified base. However, the time-to-result for these methods is 
generally long and can take up to several days to complete, due to the requirement of many 
scanning and washing cycles (Schadt, Turner and Kasarskis, 2010). Illumina NGS workflows 
include four basic steps: library preparation, cluster generation, sequencing, and data analysis. 
A sequencing library is prepared by random fragmentation of the DNA sample into short 
fragments, followed by ligation of 5’ and 3’ adaptor sequences to the ends of each fragment. 
For cluster generation, the library is loaded into a flow cell where the fragments attach to a lawn 
of surface-bound oligonucleotides complementary to the library adapter sequences. Each 
fragment is then amplified, using a bridge amplification technique, where copies are generated 
in situ, resulting in distinct clonal clusters of ∼1,000 amplicons of each fragment. Sequencing of 
the templates is carried out using Illumina’s sequencing-by-synthesis (SBS) technology, where 
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all four nucleotides are added to the flow cell simultaneously, along with DNA polymerase for 
the incorporation of bases into the DNA template strands. Each nucleotide is fluorescently 
labelled with a different colour, and each incorporation is a unique event due to the chemical 
blockage of the 3’-OH group after incorporation (Illumina, 2017). The flow cell is imaged after 
each incorporation step and the emission from each cluster is recorded. Each base is identified 
using the emission wavelength and intensity (Illumina, 2017). This cycle is repeated a specific 
number of times to create a read length of n number of bases. Integrated software checks the 
quality of each read and removes any poor-quality reads from the genome construct. 
Bioinformatics software can then align the newly identified sequence reads to a reference 
genome. Following alignment, many different forms of analysis are possible, such as 
identification of single nucleotide polymorphisms (SNPs) or insertions and deletions, read 
counting for RNA methods, phylogenetic analysis, and more. One of the limitations of second-
generation sequencing is the generation of short reads, which leads to highly-fragmented 
assemblies (Schatz, Delcher and Salzberg, 2010).  
The demand for technologies that can operate at higher speeds and produce longer reads 
resulted in the third-generation of sequencing. These sequencing technologies directly target 
single DNA molecules, enabling real-time sequencing where reads are available for analysis as 
and when they have passed through the sequencer (Schadt, Turner and Kasarskis, 2010). In 
2014, Oxford Nanopore Technologies (ONT) released a new third-generation sequencing 
platform, known as the MinION, which is a portable, real-time sequencing device. ONT platforms 
are capable of producing incredibly long reads, with a maximum read length up to a few hundred 
thousand base pairs (Laver et al., 2015). On the other hand, ONT reads have high error rates, 
with accuracy ranging from 65%−88% (Laver et al., 2015). However, due to its small size and low-
costing equipment, the MinION sequencer has attracted considerable interest in the genomics 
community, particularly for pathogen surveillance and clinical diagnostic applications, as these 
areas can best exploit the real-time nature of this sequencing platform. 
1.1.5. Using population genomics to uncover patterns of microbial ecology 
With the development and application of genomic tools, microbial ecology is undergoing a 
resurgence. Genomic tools, which now offer high-quality reads at decreasing costs and high 
throughput, have given us unprecedented access to microbial diversity. Whole-genome 
sequencing is increasingly being utilised as the gold standard approach to study the population 
structure of closely related microbes in place of more traditional molecular techniques such as 
pulsed-field gel electrophoresis (PFGE) and 16S rRNA sequencing. In the past, only single 'type 
strains' were sequenced to reveal information on the genome content of the species in question 
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due to the high costs of WGS (Avasthi et al., 2011). Recent advances have enabled large-scale 
sequencing projects to investigate variation within and between bacterial populations. 
Evolutionary forces of recombination and selection are responsible for shaping microbial 
genomes and maintaining diversity, leaving signatures that can be identified using comparative 
population genomics. Recently, studies have analysed genome sequences – for example to 
identify genes under positive selection – in order to discover ecologically distinct populations of 
bacteria and how they adapt to different niches. Whole-genome sequence data, when analysed 
with the appropriate statistical and computational methods, can provide insights into the 
structure and function of closely-related populations of microbes in their natural habitats. 
Ultimately, these analyses reveal that microbial evolution is usually driven by a divergence in 
populations that are adapted to distinct ecological niches. Lineage distinctness is then 
maintained by barriers to gene flow, which in some cases, are a consequence of ecological 
specialisation (Shapiro et al., 2012). 
The traditional niche theory of evolution would assume that organisms of different species 
occupy different ecological niches due to their species-specific properties and the niches are of 
limited similarities. In contrast to this, the neutral model of evolution assumes that microbial 
species are ecologically and functionally equivalent and that stochastic processes (random drift 
of mutant alleles that are selectively neutral or nearly neutral) are the main factors shaping 
species’ distributions and community structure (Hubbell, 2001). There are at least some 
examples where neutral models are able to reconstruct and predict relative species abundance 
in many environmental microbial communities (Woodcock et al., 2007; Sloan et al., 2006). More 
recent studies however, particularly those on the human and animal microbiome, seem to 
provide more negative cases than positive cases with regards to the neutral model (Nemergut 
et al., 2013). It is perhaps most likely that both niche and neutral mechanisms are in effect in 
microbial communities, but niche effect is often more prevalent than the neutral effect (Jeraldo 
et al., 2012; Dumbrell et al., 2010).Many bacterial lineages have a history of frequent and 
continuous horizontal gene transfer and loss, as evidenced by vast differences in genome 
content, even among isolates that are closely related. The evolution and maintenance of 
ecologically distinct populations of bacteria under such conditions of rapid gene exchange has 
been an area of investigation for many researchers. A review of recent population genomic data, 
by Polz, Alm and Hanage (2013), demonstrated the importance of habitat and niche in directing 
horizontal gene transfer and evolution. This led to a model of ecological speciation through a 
mechanism of gradual genetic isolation as a result of divergent niche-associated populations, 
where subpopulations can evolve through gene exchange within the local gene pool (Polz, Alm 
and Hanage, 2013). This insight provides an explanation for why, despite the potential for free 
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gene flow, bacteria remain genotypically and phenotypically clustered. A population genomics 
study by Shapiro et al. (2012) provides an example of how ecological divergence may drive 
genotypic differentiation of bacteria. Two populations of Vibrio cyclotrophicus, that are almost 
genetically indistinguishable but are ecologically divergent, were subjected to whole-genome 
sequencing to investigate how the populations had diversified. These populations coexist in 
coastal oceans but exhibit differential proclivity for occurring as free-living bacteria or attached 
to zoo- and phytoplankton. Analysis of whole-genome sequence data revealed that in these two 
recently diverged populations, ecological differentiation had occurred through a mechanism of 
gradual genetic isolation in which a few genomic regions, rather than whole genomes, have 
swept through subpopulations in a niche-specific manner (Shapiro et al., 2012). Furthermore, 
analysis of homologous recombination events within and between the populations 
demonstrated that both populations had been actively recombining in the past, however the 
most recent recombination events had become population-specific, suggesting gradual 
separation of the gene pools and independent evolutionary trajectory of these populations 
(Shapiro et al., 2012). These inferences would further support a model explaining genotypic 
cluster formation, in which the ancestral, ecologically uniform, and recombining population of 
bacteria diverges into unique, ecologically distinct subpopulations (Shapiro et al., 2012).  
Genome comparisons in another previous study have shown that several clades 
of Escherichia spp. isolated from predominantly non-host environments are more adapted to 
life outside of hosts, whilst gastrointestinal clades of E. coli possessed genomic features adapting 
them to the human gut environment (Luo et al., 2011). In an approach using the inventory of 
gene functions derived from the human microbiome project (Qin et al., 2010), the authors 
showed that genes that are common in other gut bacteria are also present in the gut-associated 
E. coli, but not in the environmental clades. Furthermore, genome-based analysis of 
recombination rates indicated that these environmental relatives of E. coli have historically not 
shared ecology with E. coli strains that classically inhabit the gastrointestinal tract of humans. 
The authors described frequent recombination among the environmental clades and among 
the intestinal E. coli clades, but not between the environmental and intestinal clades, providing 
evidence for an ecological barrier to recombination (Luo et al., 2011). Further phylogenetic 
analysis of the environmental clades by Cohan and Kopac (2011) confirmed each environmental 
clade to be distinguished as ecologically distinct from the human intestinal E. coli, and that finer 
divisions within each clade suggests that a greater extent of ecological diversity exists among 
these bacteria.  
Given that evidence of population divergence associated with ecological specialisation has been 
described in bacteria previously, it raises the question of whether we can use the same approach 
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to uncover novel information on the ecology of clinically important and well-studied bacterial 
pathogens. The current study proposes a similar whole-genome sequencing-based approach of 
single isolates to conduct population genomic analyses of closely related genomes obtained 
from various environments. Two particular species, Yersinia pseudotuberculosis and Escherichia 
coli, represent ‘model’ organisms for the study of microbial population genomics due to their 
environmental ubiquity and culturability under laboratory conditions. Both Yersinia 
pseudotuberculosis and Escherichia coli will be investigated in the present study to determine 
whether population genomics can provide valuable further insights into the ecological and 
genetic structures of these important human pathogens.  
 
1.2. Yersinia pseudotuberculosis 
1.2.1. The pathogenic Yersiniae 
The genus Yersinia belongs to the Enterobacteriaceae, a large and diverse group of Gram-
negative bacteria that includes many harmless commensals, along with pathogenic organisms 
such as those belonging to the genera Salmonella, Escherichia, Klebsiella, and Shigella. Definition 
of the genus Yersinia is based on classical systematics and biochemical species-classification 
methods, which resulted in the description of Yersinia being a highly diverse genus comprising 
18 distinct species (Savin et al., 2014; Hurst et al., 2011; Murros-Kontiainen et al., 2011a; 2011b; 
Merhej et al., 2008; Sprague et al., 2008; Sprague and Neubauer, 2005; Wren, 2003; Carniel, 
2003). Of these, Y. enterocolitica, Y. pseudotuberculosis, and Y. pestis are the most studied and 
are the only species that cause disease in mammals, including humans. Y. enterocolitica and Y. 
pseudotuberculosis are both zoonotic pathogens that cause self-limiting enteric infections in 
humans, whilst Y. pestis, the causative agent of plague, is a pathogen in fleas and rodents that 
can occasionally be transmitted to humans (McNally et al., 2016b). The further 15 known species 
of the genus are commonly isolated from soil and aquatic environments and are typically non-
pathogenic to mammals. Some Yersinia species however, are pathogenic in other hosts, such as 
Yersinia ruckeri (Sulakvelidze, 2000), which causes red mouth disease in Salmonidae, and 
Yersinia entomophaga, which has insecticidal activity (Hurst et al., 2011). With regards to the 
phylogenetic relation of the pathogenic Yersiniae, Y. enterocolitica represents a distant relative 
of Y. pseudotuberculosis and Y. pestis; their relatedness is often compared to that between 
Escherichia coli and Salmonella species (Achtman et al., 1999). Recent phylogenetic investigation 
based on whole-genome single-nucleotide-polymorphism (SNP)-based analysis of the entire 
Yersinia genus has allowed an accurate assessment of its population structure (Reuter et al., 
2014). This robust sequence-based taxonomy revealed that the genus contains 14 distinct 
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species clusters, which differed from the existing taxonomic description of the genus that was 
largely constructed on the basis of biochemical differences and 16S rRNA gene phylogeny 
(McNally et al., 2016b). The analysis also showed that the mammalian pathogens Y. 
enterocolitica and the Y. pseudotuberculosis–Y. pestis species complex form separate branches 
at opposite ends of the Yersinia phylogenetic tree and do not cluster together as was previously 
believed, and are thus genetically distinct (Reuter et al., 2014). The chromosomal DNA of Y. 
pestis and Y. pseudotuberculosis is extremely similar and global phylogenomic studies have 
identified recent evolution of Y. pestis from a clone of Y. pseudotuberculosis, as a result of gene 
loss and subsequent global dissemination (Reuter et al., 2014; Morelli et al., 2010; Achtman et 
al., 1999). The dispensability of metabolic functions in Y. pestis can be explained by adoption of 
a lifestyle which bypasses the gut infection phase. Proteins necessary for transmission by the 
faecal-oral route would therefore no longer be needed, resulting in the lack of selective pressure 
against mutations in genes such as ure (urease against gastric acid), inv, ail, and yadA (all 
essential for translocation across the intestinal barrier; Achtman et al., 1999). One commonality 
between the three pathogenic species is that they all share a ∼70 kb plasmid that encodes for 
various Yersinia outer proteins (Yops) that are key virulence factors for pathogenesis. The 
enteropathogenic Yersiniae are genetically more diverse than the more recently evolved plague 
bacterium Y. pestis. Y. enterocolitica demonstrates greater diversity and it is categorised into 6 
biogroups and more than 50 different serotypes, whilst Y. pseudotuberculosis has been 
classified into 21 distinct serotypes (Gage, 2012). 
1.2.2. Hidden ecological patterns in the pathogenic Yersiniae 
Large-scale population genomic analyses have previously been carried out for the human 
pathogenic Yersiniae, Y. pestis and Y. enterocolitica (Reuter et al., 2015; Reuter et al., 2014; 
Morelli et al., 2010), enabling a high-resolution understanding of the ecology, evolution, and 
population structure of these organisms. A population genomic investigation of Y. enterocolitica 
was performed in a recent study by our group, which involved carrying out pan-genome analysis 
to examine patterns of recombination in both the core and accessory genomes of the species 
(Reuter et al., 2015). This study highlights a restriction in genetic flow between phylogroups of 
Y. enterocolitica; when gene flow does occur, it is largely unidirectional with one phylogroup 
acting primarily as a reservoir for recombination with the rest of the species. Furthermore, the 
data uncovered hidden ecological patterns suggesting that the genetically distinct phylogroups 
of Y. enterocolitica may be ecologically separated, with phylogroup 1 (PG1) being ubiquitous and 
most commonly isolated from non-human environments, whilst PG2–5 are more commonly 
associated with human disease cases (Reuter et al., 2015). This parallels with a microbial 
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ecological study of the model bacterial species Escherichia coli, where whole-genome 
sequencing revealed that core genome recombination occurs between environmental isolates 
or between human/animal isolates, but never between environmental and human/animal 
isolates (Luo et al., 2011). Within the important multidrug-resistant nosocomial pathogen 
Enterococcus faecium, it has been suggested that subpopulations colonise distinct hospital 
niches, and once adapted to these new environments, these populations become isolated and 
recombination with other populations decline (Willems et al., 2012). The observation of host-
restricted lineages of Campylobacter jejuni in another study (Sheppard et al., 2014) provides 
further supportive evidence of ecological separation playing a major role in limiting genomic 
recombination, and thus shaping the evolution of an important bacterial species through the 
formation of distinct ecotypes. Given the observation of ecologically separated lineages in Y. 
enterocolitica, and considering that Y. pseudotuberculosis is also a member of the 
enteropathogenic Yersiniae and is heterogeneous and ubiquitous in nature, it would be 
reasonable to investigate whether the ecology of this species overlaps with genetic patterns. 
1.2.3. An introduction to the Y. pseudotuberculosis species 
First isolated in 1883 from tuberculosis-like lesions in guinea pigs (Paff, Triplett and Saari, 1976), 
Y. pseudotuberculosis are characterised by Gram-negative rods with rounded ends (coccobacilli) 
and are facultative anaerobes. As with the rest of the genus, they are catalase-positive but 
oxidase-negative, and are relatively slow growing in comparison to other members of the 
Enterobacteriaceae. Much like Y. enterocolitica, Y. pseudotuberculosis is a cold-tolerant species 
that is motile at temperatures below 30 °C but are non-motile at temperatures above 37 °C. One 
feature of the genus Yersinia is that its members are well-adapted to survive in the environment 
with an ability to grow in conditions of minimal nutrients and at temperatures ranging from 4–
43 °C (Brubaker, 1991). Y. pseudotuberculosis and Y. enterocolitica are the most divergent 
species of the genus, and are now thought to have gained pathogenicity independently, 
although they cause very similar gastrointestinal diseases in humans and animals. The two 
organisms also share pathogenicity islands and other virulence-associated genes, which are 
suggested to have been gained independently, perhaps initially from other genera, and then 
later via transfer within the genus (Reuter et al., 2014). As whole-genome sequence data for the 
genus became increasingly available, many strains of bacteria first typed as Y. 
pseudotuberculosis were consequently reclassified into other species that are now included in 
the phylogenetic group known as the ‘Y. pseudotuberculosis complex’ (Laukkanen-Ninios et al., 
2011). This species complex includes Y. pseudotuberculosis/Y. pestis, Y. similis (Sprague et al., 
2008), and the recently characterised Y. wautersii (previously referred to as the ‘Korean group’), 
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which is proposed to have pathogenic potential (Savin et al., 2014). Y. pseudotuberculosis and 
Y. pestis share ≥ 97% nucleotide sequence identity for most of their chromosomal genes (Koskela 
et al., 2015). Due to this close evolutionary relationship with Y. pestis, Y pseudotuberculosis is 
believed to have been the progenitor of the plague bacillus and is considered a model species 
for bacterial evolution (McNally et al., 2016b). Y. pestis is effectively a clone of Y. 
pseudotuberculosis, estimated to have evolved from its ancestor approximately 1,500–6,400 
years ago, in Asia (Achtman et al., 1999).  
1.2.4. Pathogenesis of Y. pseudotuberculosis 
1.2.4.1. Transmission of the bacteria to humans 
Y. pseudotuberculosis causes zoonoses in a wide range of hosts, including both wild and 
domesticated animals and birds (McNally et al., 2016b). With Y. pseudotuberculosis being a 
zoonotic pathogen, it can therefore be transmitted to humans through various routes. Y. 
pseudotuberculosis infection, though less common than those caused by Y. enterocolitica, has 
also been implicated in foodborne disease in humans, which is known as yersiniosis. 
Transmission of the bacterium is usually via the faecal–oral route, and human infection can 
result from ingestion of contaminated food products or water, or possibly through cross-
contamination during food preparation. Typical sources of infection include dairy products, 
inadequately cooked meat, and certain vegetables such as lettuce and raw carrots (Kangas et 
al., 2008; Nuorti et al., 2004). Both Y. pseudotuberculosis and Y. enterocolitica are cold-tolerant 
species that can survive and proliferate slowly at 4 °C, accounting for growth in cold-stored 
foodstuffs. Y. pseudotuberculosis is also found widely in the environment, including soil, and in 
animals it causes tuberculosis-like disease. Pigs, rodents, rabbits, sheep, goats, cattle, horses, 
dogs, cats, deer, and sometimes birds serve as reservoirs for Y. pseudotuberculosis. Person-to-
person transmission has also been reported, though less frequently, as has transmission via 
blood transfusion (Chiles et al., 2002). Most humans can serve as asymptomatic carriers of Y. 
pseudotuberculosis; however, several cases have been linked to handling and close-contact with 
infected animals. Patients exhibiting clear symptoms of infection tend to shed significant 
amounts of bacteria for up to 2–3 weeks. Infected individuals who are left untreated can become 
carriers and shed bacteria for as long as 2–3 months (Gage, 2012). Successful infection of the 
host requires a reasonably large dose of bacteria (median infective dose of 108–109 bacteria), 
and the incubation period is believed to be 3–7 days after ingestion. Although, incubation 
periods of 2–20 days have been seen in sporadic outbreaks, and symptoms typically appear at 
an average time of 4 days after exposure (Gage, 2012). 
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1.2.4.2. Epidemiology of Y. pseudotuberculosis-associated yersiniosis  
Human yersiniosis caused by Y. pseudotuberculosis is usually sporadic and such cases generally 
occur worldwide (Sunahara, Yamanaka and Yamanishi, 2000). The majority of nationwide 
gastrointestinal outbreaks of foodborne infection have been reported in countries of the 
Northern Hemisphere or countries of largely temperate climates. Most cases of Y. 
pseudotuberculosis infection occur in the winter and early spring, a trend which is likely related 
to the enhanced growth characteristics of this pathogen in cold temperatures that occurs during 
long-term storage of vegetables during the winter (Galindo et al., 2011). The first conclusive 
report of a community outbreak of Y. pseudotuberculosis was described in 1984 among 
schoolchildren in Kurashiki, Japan (Inoue et al., 1984). Y. pseudotuberculosis infection in Europe 
would appear to be highly prevalent in Germany, and there is some suggestion that higher meat 
consumption in this country, particularly pork, when compared to other European nations might 
correlate with the higher incidence of yersiniosis in Germany (Galindo et al., 2011). The 
prevalence of Y. pseudotuberculosis infection in the United States is currently unknown. 
Sporadic cases of Y. pseudotuberculosis infection are likely to be underreported because stool 
cultures are not routinely requested for patients presenting with mild, self-limiting clinical 
features, such as diarrhoea. Furthermore, the need for specific differential culture media for 
isolation has restricted the presence of active surveillance in many other countries, including 
those of Africa, Asia, the Middle East, Latin America, the Caribbean, and others.  
A report by Nuorti et al. (2004) at the National Public Health Institute of Finland provided solid 
documentation that Yersinia pseudotuberculosis can be transmitted through food, following a 
nationwide outbreak in 1998 that was detected by routine surveillance for Yersinia species. In 
this widespread outbreak, contaminated iceberg lettuce was strongly implicated as the vehicle 
of Y. pseudotuberculosis serotype O:3 infections, with 71% of case patients reported having 
eaten iceberg lettuce prior to hospitalisation. Prior to this study, Y. pseudotuberculosis was 
presumed to be a possible foodborne pathogen, by virtue of its similarity to Y. enterocolitica, 
but the evidence for this assumption was limited to a few suggestive clusters and to a large 
Canadian outbreak in 1998, which was epidemiologically linked to pasteurised homogenised 
milk and was the first recognised outbreak of Y. pseudotuberculosis serotype O:1b (Nowgesic et 
al., 1999). The investigation in Finland is the first to trace an outbreak of human illness to a likely 
environmental reservoir via contaminated food, and suggests that some cases of yersiniosis, 
which appear to be sporadic, may be part of unrecognised outbreaks caused by contaminated 
fresh produce (Nuorti et al., 2004). In 2004, an outbreak of several cases of gastroenteritis in 
schoolchildren in northern Finland was reported, and at the same time, an increase in Y. 
pseudotuberculosis cases was reported from other parts of the country. Kangas and co-workers 
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(2008) carried out an investigation which provided microbiologic and epidemiologic evidence 
that traced the school outbreak to consumption of raw carrots contaminated at the production 
farm. The long-term storage of raw carrots at cold temperatures would have favoured the 
growth of Y. pseudotuberculosis and thus result in human infection (Kangas et al., 2008). More 
recently, in 2014, a sustained outbreak of yersiniosis due to Y. pseudotuberculosis was reported 
in all of the major cities of New Zealand (Williamson et al., 2016). This study presented one of 
the largest globally reported outbreaks of human Y. pseudotuberculosis infection to date, with 
a total of over 200 laboratory-confirmed cases of infection reported. Prior to our study, the New 
Zealand study had provided the most inclusive genome-scale analysis of a Y. pseudotuberculosis 
population. Genomic and epidemiological analyses indicated a single point-source 
contamination of the food chain, with subsequent nationwide distribution of contaminated 
produce. Furthermore, the analysis carried out in this study involved incorporation of publicly 
available reference genomes within the context of a globally and taxonomically diverse dataset. 
This revealed that Y. pseudotuberculosis is a highly diverse species and that the New Zealand 
strains represented a geographically isolated clade of Y. pseudotuberculosis (Williamson et al., 
2016). This study serves as an example of the exploitation of pathogen genome sequence data 
and the contribution of population genomic analysis to understanding the epidemiology and 
spatiotemporal spread of clinically important bacterial pathogens. 
1.2.4.3. Virulence factors of Y. pseudotuberculosis  
The genomes of the pathogenic Yersiniae, Y. pseudotuberculosis, Y. enterocolitica, and Y. pestis, 
are 97% identical, however the three organisms cause different types of diseases in humans, 
despite sharing a tropism for lymph nodes (Fig. 1.1; Bergsbaken and Cookson, 2009). The 
different routes of infection, types of infections, and severity of disease in humans caused by 
the pathogenic Yersiniae are influenced by the distribution of shared and unique virulence-
associated genes (VAGs). Both chromosomal and plasmid-derived virulence-associated genes  
contribute to the pathogenesis of Yersinia species and the establishment and progression of 
yersiniosis. Recent work by our group, which delineated the phylogeny of the genus Yersinia, 
including 31 isolates of Y. pseudotuberculosis, revealed important information on the population 
structure and collection of virulence genes which define the genus (Reuter et al., 2014). Much 
like the other human pathogenic Yersiniae, the pathogenicity of Y. pseudotuberculosis is 
dependent on the presence of a ∼70 kb virulence plasmid associated with Yersinia virulence, 
pYV (Portnoy and Falkow, 1981). The pYV plasmid differentiates pathogenic strains from non-
pathogenic strains, because it is required for virulence. Although the pYV plasmid is commonly 
thought of as a single entity, it is highly variable between species and strains of species, 
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containing different origins of replication as well as exhibiting variable genetic architecture 
(Reuter et al., 2014; Portnoy and Falkow 1981). However, all pathogenic Yersinia strains harbour 
the large genetic locus encoding the Ysc type III secretion system (T3SS), located on the pYV 
plasmid (Reuter et al., 2014; Portnoy and Falkow, 1981). The Ysc T3SS, which was the first T3SS 
to be fully characterised, functions by mediating the targeted delivery of Yersinia outer protein 
(Yop) effector proteins into host cells. Yops are the key virulence factors in all pathogenic 
Yersiniae; injection of Yops and contact with host macrophages results in the inhibition of the 
pro-inflammatory cytokine response and ultimately, apoptotic death of the infected 
macrophages (Cornelis and Wolf-Watz, 1997). Additional virulence determinants that are 
variably present in Y. pseudotuberculosis include the chromosomal high-pathogenicity island 
(HPI), which is present in almost all European strains of Y. pseudotuberculosis serotype O:1 
(Carniel, 1999). HPI encodes proteins that are involved in the biosynthesis, regulation, and 
transport of the iron uptake system Yersiniabactin. Y. pseudotuberculosis also harbour the 
Yersinia adhesion pathogenicity island (YAPI), which includes a pilin gene cluster, the pil operon, 
encoding a type IV pilus that contributes to pathogenicity (Collyn et al., 2004). The vast majority 
of all Y. pseudotuberculosis strains originating from the Far East of Asia additionally produce one 
of three variants of a chromosomally-encoded novel superantigenic toxin YPM (the Y. 
pseudotuberculosis-derived mitogen), encoded by the ypm gene. The YPMa variant is encoded 
by the ypmA gene (Ramamurthy et al., 1997) and plays a more crucial role in systemic infections 
than in gastroenteritis. YPMb and YPMc are the other two variants of the superantigen, which 
are encoded by the ypmB and ypmC genes, respectively (Ramamurthy et al., 1997). A small 
conserved RNA chaperone protein, known as Hfq, is essential for the full spectrum of virulence 
in a variety of pathogenic bacteria, including both Y. pseudotuberculosis and Y. 
enterocolitica. The Hfq protein plays an important role in the regulation of motility, intracellular 
survival, and production of T3SS effectors in Y. pseudotuberculosis (Schiano, Bellows and 
Lathem, 2010). 
1.2.4.4. Pathophysiology of Y. pseudotuberculosis infection 
After ingestion by humans, Y. pseudotuberculosis pass into the small intestine and adhere to the 
mucosal lining of the ileum, where intracellular infections in Peyer’s patches, mucosal cells, and 
macrophages can occur (Fig. 1.1; Gage, 2012). Invasion of the ileal mucosa is favoured by the 
presence of numerous virulence-associated genes coding for fimbriae, flagellar proteins, and 
adhesins, such as invasin (Inv), YadA, and the attachment invasion locus protein (Ail) (Carniel, 
2003). The invasin protein prompts the internalisation of the bacteria, which translocate across 
the epithelium (Pepe and Miller, 1993). As a result, an inflammatory response occurs causing 
 16 
 
the characteristic symptoms of fever, abdominal pain, and diarrhoea, which are typical of acute 
gastroenteritis and mesenteric lymphadenitis. Ulcerative ileitis, and extraintestinal conditions 
such as mesenteric adenitis, erythema nodosum, and necrosis within Peyer’s patches can arise 
in more advanced cases (Jalava et al., 2006). If the regional defences of the ileum are broken, 
the bacteria can disseminate and cause sepsis, or even abscesses of the liver or spleen (Kaasch 
et al., 2012). Polyarthritis, a type of arthritis that involves five or more joints and usually 
associated with autoimmune conditions, may also occur at a later stage of illness, particularly in 
human leukocyte antigen (HLA)-B27-positive individuals (Gage, 2012). Bacterial cells that are 
replicating in the intestinal tract can also attack the host lymphoid tissues, much like Y. pestis. 
Invasion of these tissues and resistance against the host defences rely on the possession of the 
pYV plasmid which encodes genes for various Yops and the V antigen (LcrV) (Gage, 2012). The 
products of this plasmid work together to silence phagocytic immune cells as well as reduce 
inflammation, resulting in suppression of the host immune response. This favours persistence 
of these bacteria in the body, allowing them to replicate extracellularly and form aggregates in 
the mesenteric lymph nodes, which can lead to septicaemia (Gage, 2012). 
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Figure 1.1. Routes of transmission and mechanisms of pathogenesis of the human pathogenic Yersinia 
species.  
The routes of transmission for the enteropathogenic Yersinia species, Y. pseudotuberculosis and Y. 
enterocolitica, are usually associated with the consumption of contaminated raw vegetables 
(lettuce/carrots) and undercooked meat (mainly pork). They are ingested via the contaminated food and 
enter the lymphatic system through the M cells in the small intestine. They can then progress to cause a 
localised infection of the liver or spleen, or in rare cases, lead to systemic infection such as septicaemia. 
The main reservoirs of Y. pestis, on the other hand, are rodents and fleas. Transmission of the bacteria to 
humans occurs through the bite of an infected flea resulting in bubonic plague. Pneumonic plague can arise 
when Y. pestis reaches the lungs, via the bloodstream, and is transmitted to other individuals through the 
release and inhalation of respiratory droplets. Figure adapted from Heroven and Dersch (2014).  
M cell: microfold cell.   
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1.2.5. Clinical manifestations of Y. pseudotuberculosis infection 
After an incubation period of around 3 to 7 days, gastroenteritis usually develops, which can be 
difficult to distinguish from Salmonella- or Campylobacter-associated gastroenteritis. Patients 
with Y. pseudotuberculosis-associated infections typically present with clinical syndromes 
characterised by acute mesenteric adenitis with fever, diarrhoea, vomiting, and bloody stools 
(Gage, 2012). Young children are more likely to develop enterocolitis, whilst older children more 
commonly experience acute terminal ileitis, mesenteric adenitis, and systemic disease. Sepsis is 
generally uncommon and is most likely to occur in individuals with pre-existing conditions and 
risk factors such as diabetes mellitus, cirrhosis, immunosuppression, older age, and 
haemochromatosis. Splenic abscesses, meningitis, or endocarditis can develop in septic 
patients, and the mortality rate in these cases is close to 50%. Erythema nodosum is identified 
in about one-third of all patients and in approximately 10% of adults (Gage, 2012). Y 
pseudotuberculosis infections are more common in men than in women. However, post-
infection complications, such as erythema nodosum and reactive arthritis, are more common in 
women. Children aged 5 to 15 years comprise greater than 75% of patients with Y. 
pseudotuberculosis infection. Illness typically lasts 1 to 3 weeks, but symptoms may persist in 
some patients for several months (Gage, 2012). Although fever and self-limiting gastroenteric 
symptoms are the primary clinical manifestations of Y. pseudotuberculosis infection in Europe, 
those occurring in Japan, Korea, and the Far East of Russia include not only symptoms of 
gastroenteritis but also a variety of systemic manifestations such as scarletiniform rash, 
desquamation, and arthritis (Gage, 2012). This disease variant is called Far East scarlet-like fever, 
which is associated with specific superantigen-containing strains of Y. pseudotuberculosis. Two 
research groups have previously reported considerable geographical heterogeneity between 
the Far East of Asia and Europe regarding the prevalence of YPMa-producing strains (Ueshiba et 
al., 1998; Yoshino et al., 1995). The investigators reported an absence of the ypmA gene in 
strains belonging to serotypes O:1 and O:2 from Europe, however this gene was present in 
almost all strains belonging to serotypes O:1, O:2, O:4, and O:5 from Asia, indicating the 
importance of the ypmA gene in strains causing Far East scarlet-like fever (Ueshiba et al., 1998; 
Yoshino et al., 1995). In Russia and Japan, Y. pseudotuberculosis infection is regarded as a 
national health problem and was added to the national notification system in 1988 (Tseneva et 
al., 2012). 
1.2.6. Treatment and prevention 
Antibiotics generally do not improve the course of uncomplicated enterocolitis or mesenteric 
adenitis, and antibiotic treatment regimens are not recommended for intestinal forms of the 
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disease (Bottone, 1997). However, such therapy has been recommended for 
immunocompromised patients, individuals with septicaemia, and those with systemic disease 
or extraintestinal progression of disease. Broad-spectrum cephalosporins, sometimes 
accompanied by aminoglycosides, have resulted in successful outcomes in patients with 
extraintestinal forms of yersiniosis, including septicaemia (Bottone, 1997). Antimicrobial 
resistance is generally less common in Y. pseudotuberculosis than in Y. enterocolitica (Bonardi et 
al., 2016). Prevention of contracting Y. pseudotuberculosis infection relies on measures intended 
to protect individuals from direct contact with contaminated environments, foods, wastes, as 
well as other infected humans and animals. Some of these approaches include using proper 
sewage disposal methods, protecting water supplies from contamination, as well as using 
appropriate food hygiene, preparation, and storage measures (Bottone, 1997). 
1.2.7. Identification and typing of Y. pseudotuberculosis 
1.2.7.1. Serological characterisation of Y. pseudotuberculosis 
Diagnosis of yersiniosis begins with isolation of the causative organism, using selective media, 
from the human host’s stool, blood, or vomit, and sometimes at the time of appendectomy 
(surgical removal of the appendix). Biotyping and serotyping of Y. pseudotuberculosis can 
provide useful epidemiologic information when tracking the source of community outbreaks. 
Classically, identification and typing of Y. pseudotuberculosis is commonly based on the 
lipopolysaccharide (LPS) O-antigen, which is used for the serological characterisation of strains. 
The LPS is a lipoglycan present on the cell surface of most Gram-negative bacteria, and for many 
pathogens including Y. pseudotuberculosis, the LPS represents an important virulence factor (Ho 
et al., 2008). The structure of the LPS is comprised of three key components: lipid A, the core 
oligosaccharide, and O-specific polysaccharide (OPS; also termed the O-antigen). The O-antigen 
serotyping scheme used for Y. pseudotuberculosis involves differentiation of the variable OPS 
subunits (O units) using serology. It has been suggested that the same serotyping scheme can 
be implemented for the identification and typing of all members of the Y. pseudotuberculosis 
complex, which includes Y. pestis, Y. similis, and Y. wautersii (Savin et al., 2014; Laukkanen-
Ninios et al., 2011). Some of the 15 major serotypes (O:1 – O:15) of Y. pseudotuberculosis are 
divided into ten subtypes (O:1a, O:1b, O:1c, O:2a, O:2b, O:2c, O:4a, O:4b, O:5a, O:5b), thus 
resulting in a total of 21 known serotypes (Skurnik, Peippo and Ervela, 2000). The efficacy of 
serotyping in investigating potential outbreaks of Y. pseudotuberculosis in Europe is very limited, 
due to the vast majority of strains isolated from human cases belonging to serotypes O:1 and 
O:3, whereas serotypes O:2 and O:4–O:15 are primarily found in Asia (Fukushima et al., 2001). 
Previous studies have indicated that a large proportion of strains isolated from human cases 
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belong to serotypes O:1a, O:1b, and O:3 (Williamson et al., 2016; Laukkanen-Ninios et al., 2011). 
The application of serotyping methods to Y. pseudotuberculosis therefore provides only low-
level resolution when studying the ecology and diversity of this important human pathogen, 
thus suggesting the need for higher resolution typing methods.  
1.2.7.2. Y. pseudotuberculosis multilocus sequence typing (MLST) 
Population genomic analyses of Y. pseudotuberculosis have revealed greater details about the 
population structure of this species and its relationship to the other closely related species of 
the Y. pseudotuberculosis complex. Sequence-based analysis provides a more detailed 
classification system than biochemical characterisation to differentiate between phenotypically 
indistinguishable strains, as has been demonstrated with the recently described species Y. similis 
(Sprague et al., 2008), which is biochemically similar to Y. pseudotuberculosis. Multilocus 
sequence typing (MLST) is a molecular typing method, developed in 1998, with the aim of 
improving the portability and accuracy of epidemiological and molecular typing information. It 
was proposed to provide a highly discriminating typing system for the unambiguous 
characterisation of isolates of most bacteria and other organisms (Maiden et al., 1998). Soon 
after MLST analysis was first described, a research group led by Mark Achtman developed a new 
MLST scheme for Y. pseudotuberculosis (Laukkanen-Ninios et al., 2011). The MLST scheme was 
based on allele profiling of fragments of seven Y. pseudotuberculosis housekeeping genes: glnA, 
thrA, tmk, trpE, adk, argA, and aroA (Laukkanen-Ninios et al., 2011). The MLST scheme was 
applied to a diverse collection of 417 isolates from 29 countries representing all continents, in 
order to characterise the molecular epidemiology, population structure, and diversity of Y. 
pseudotuberculosis, adding further granularity to the serotype classification method. This 
analysis grouped serotype O:3 strains into a distinct clone designated ST19, which consists of 
single-locus variants ST50 and ST57. It has previously been suggested that these strains are 
associated with lowered pathogenicity (Fukushima et al., 2001); however, these strains harbour 
the pYV plasmid and the chromosomal inv gene and are sometimes responsible for fatal 
diarrhoea in cattle (Martins, Bauab and Falcao, 1998). It was revealed that serotype O:1 strains 
formed a distinct clade of strains which represented a large number of sequence type 
complexes. This indicated a genotypically diverse population of bacteria within the serotype O:1 
group and thus an overall high diversity among disease-causing Y. pseudotuberculosis strains 
(Laukkanen-Ninios et al., 2011).  
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1.3. Escherichia coli 
1.3.1. An introduction to the E. coli species 
The second model organism used in this study to investigate microbial ecology is Escherichia 
coli. The species was first discovered in the late nineteenth century by Theodor Escherich, a 
German-Austrian paediatrician who believed that intestinal diseases in infants were caused by 
the infant gut microbes. Escherich isolated E. coli from the faeces of infants and subsequently 
named the organism ‘Bacterium coli commune’, which was later renamed Escherichia coli after 
Escherich’s death (Hacker and Blum-Oehler, 2007). E. coli is a member of the 
Enterobacteriaceae, which are widespread in nature and are most commonly found in the 
intestinal tracts of mammals, but can also be isolated in high concentrations from soil, water, 
and agricultural land, due to faecal contamination (Winn et al., 2006). The genus Escherichia, 
which contains six distinct species (E. coli, E. albertii, E. fergusonii, E. vulneris, E. hermannii, and 
E. marmotae), is the most commonly encountered genus of the Enterobacteriaceae in the 
clinical setting. Within the genus Escherichia, E. coli is the only member to exhibit pathogenic 
traits, and due to its environmental ubiquity and ability to grow easily under laboratory 
conditions, it is also one of the most extensively studied model organisms in microbial genetics.  
The bacterium is a Gram-negative, rod-shaped, non-sporulating, facultatively anaerobic 
coliform, typically 2 µm in length and 0.5 µm in diameter (Winn et al., 2006). The bacterial cell 
characteristically has peritrichous flagella projecting in all directions, which enable a level of 
motility for the bacterium, a trait which is thought to contribute to bacterial fitness and virulence 
(Lane et al., 2005). Despite the metabolic complexity of E. coli, the species can be distinguished 
from other members of the Enterobacteriaceae based on distinct metabolic characteristics, 
which includes its ability to produce indole from the metabolism of the amino acid tryptophan. 
E. coli can also reduce nitrate to nitrite, and produce pyruvic acid from glucose, which can be 
demonstrated using the methyl-red indicator (Winn et al., 2006). Most strains of E. coli are also 
able to ferment lactose, which is often used as a feature to distinguish E. coli from the closely 
related species Shigella (Winn et al., 2006), and this can easily be demonstrated by a change in 
colour of the indicator on differential culture media, such as CLED (cysteine-, lactose-, and 
electrolyte-deficient) agar and MacConkey agar. The metabolic adaptability of E. coli may 
provide it with a fitness advantage over fastidious organisms, allowing it to survive and multiply 
in nutritionally poor microenvironments, such as the human bladder.  
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1.3.2. Commensal E. coli 
Commensal E. coli are strains which colonise humans and animals, but do not trigger an immune 
response or cause disease in the host. E. coli are one of the first bacteria to colonise the human 
intestine, with initial colonisation occurring during the early stages of infancy. This may be due 
to the transmission of E. coli from the mother to the neonate, or even through nursing staff in 
the hospital (Watt et al., 2003). E. coli are lifelong commensal colonisers of adults, where the 
species has adapted its metabolism very successfully to the nutritional ecological niche of the 
gut, withstanding competition from more than 500 other bacterial species (Tenaillon et al., 
2010). As a consequence of being a gut microbe, E. coli are regularly excreted into the wider 
environment, and despite being intricately adapted to life inside a host, E. coli must also be 
adapted to successfully acclimatise to harsher conditions outside of the host (Savageau, 1983). 
E. coli are able to persist in the environment until the next host consumes viable bacteria in 
contaminated food or water. One of the stress conditions faced by E. coli following ingestion is 
the acidic pH of the stomach, which it survives by evoking protective acid resistance systems 
(Foster, 2004). E. coli must then acquire the nutrients required to proliferate once reaching the 
colon. Successful colonisation of the colon by E. coli depends on competition for nutrients with 
an extremely large and diverse microbiota, penetration of the intestinal mucus layer, ability to 
avoid the host defences, and grow rapidly, beyond the turnover rate of the mucus layer (Conway 
and Cohen, 2015). E. coli persists in the mucus whilst some cells that are sloughed off into the 
lumen of the intestine are eliminated in the host faeces and the cycle repeats with a new host. 
This circle of colonisation and extraintestinal survival represents the life cycle for both 
commensal and pathogenic strains of E. coli. 
In addition to colonising the intestinal systems of humans, commensal E. coli also typically 
colonise the urinary tract and cause a condition known as asymptomatic bacteriuria (ABU), 
which is characterised by the presence of E. coli in urine but the host does not exhibit any of the 
classical symptoms associated with a urinary tract infection (UTI). It was traditionally thought 
that commensal E. coli strains simply did not possess virulence-associated genes in their genome 
and were therefore unable to cause disease (Mabbett et al., 2009). In fact, more recent studies 
of the ABU isolate E. coli 83972 have shown that this strain does possess virulence genes. Rather 
they have become attenuated due to deletion events and are no longer functional. It was 
postulated that this occurred through adaptation to the new environment of the bladder, giving 
avirulent strains the advantage of residing within the host without eliciting the lethal action of 
the immune response (Mabbett et al., 2009). 
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1.3.3. Intestinal pathogenic E. coli (IPEC) 
Despite the fact that E. coli exists as a commensal species in the intestinal microbiota of a variety 
of animals including humans, not all strains are harmless, and some can cause debilitating and 
sometimes life-threatening diseases in humans as well as mammals and birds (Belanger et al., 
2011). Pathogenic E. coli strains are classified into two groups: those that cause intestinal 
infection and those that cause extraintestinal infection. Unlike the intestinal commensal E. coli, 
intestinal pathogenic E. coli strains have acquired virulence-associated genes (VAGs), giving 
them the ability to cause many serious intestinal diseases (Kaper, Nataro and Mobley, 2004). 
Among the intestinal E. coli there are eight recognised pathotypes (Fig. 1.2): enteropathogenic 
E. coli (EPEC), enterotoxigenic E. coli (ETEC), enteroinvasive E. coli (EIEC), enteroaggregative E. 
coli (EHAC), enterohaemorrhagic (Shiga toxin-producing) E. coli (EHEC/STEC), diffusely adherent 
E. coli (DAEC), entero-aggregative-haemorrhagic E. coli (EAHEC), and adherent invasive E. coli 
(AIEC) (Clements et al., 2012). These pathotypes are capable of causing varying severities of 
disease ranging from mild, self-limiting diarrhoea to diseases such as haemolytic uraemic 
syndrome (HUS), which is characterised by haemolytic anaemia, acute kidney failure, and low 
platelet count. The type of disease caused by an intestinal pathogenic strain of E. coli is 
influenced by the types of virulence-associated genes that the strain possesses. The profile of 
VAGs and the type of disease caused by strains is used to broadly classify intestinal E. coli into 
one of the eight pathotypes, which are used to inform diagnosis and treatment of diseases. 
There is increasing crossover between E. coli strains of different pathotypes as a result of 
horizontal recombination, and thus new pathotypes are often proposed, increasing our 
understanding of the evolution of this important pathogen to humans. 
Enteropathogenic E. coli (EPEC) are pathogens that colonise the small intestines and are a 
common cause of severe, watery diarrhoea in infants of developing countries (Trabulsi, Keller 
and Tardelli Gomes, 2002). In industrialised countries, the prevalence of these organisms has 
decreased, but they continue to be an important cause of diarrhoea (Nataro and Kaper, 1998). 
The primary mechanism of EPEC pathogenesis involves attaching and effacing (A/E) lesions, 
which are characterised by microvilli destruction, adherence of the bacteria to the intestinal 
epithelium, pedestal formation, and aggregation of polarised actin and other elements of the 
cytoskeleton at sites of bacterial attachment (Nataro and Kaper, 1998).  
Enterotoxigenic E. coli (ETEC) are strains that colonise the mucosa of the small intestines of 
humans and cause a mild, self-limiting diarrhoeal disease. In immunocompromised hosts, the 
disease may progress to a more severe, longer lasting infection akin to that of cholera. ETEC is 
one of the leading causes of diarrhoea in the developing world, and it is the most common cause 
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of travellers’ diarrhoea, a significant disease in children estimated to be responsible for 
approximately 210 million cases and 380,000 deaths per year (Jelinek and Kollaritsch, 2008).  
Enteroinvasive E. coli (EIEC) is an intracellular E. coli pathotype which is genetically and 
biochemically very similar to Shigella, another genus of enteric pathogen within the 
Enterobacteriaceae. Both EIEC and Shigella possess the ipaH invasive gene (Kaper, Nataro and 
Mobley, 2004) and cause invasive disease which may lead to severe illness in otherwise healthy 
individuals. Since EIEC and Shigella are so closely related it has previously been suggested that 
they should be classified as a single pathotype of E. coli, however Shigella keeps its species 
designation due to the association with the disease shigellosis (Croxen and Finlay, 2010).  
Enteroaggregative E. coli (EAEC) was first described in 1987 in a child suffering from acute 
diarrhoea in Lima, Peru (Nataro et al., 1987). Since its discovery, EAEC have been associated with 
persistent diarrhoea in children living in EAEC-endemic areas (Nataro et al., 1987), individuals 
infected with the human immunodeficiency virus (HIV) (Mathewson et al., 1995), and as a cause 
of diarrhoea in travellers from industrialised countries visiting the developing world. The 
pathogenesis of EAEC is determined by its ability to adhere to intestinal cells, produce 
enterotoxins and cytotoxins, and induce inflammation of the intestinal wall. EAEC are 
characterised by the ability to colonise either the small or large intestinal mucosa, but primarily 
the colon, by aggregative adhesion.  
The diffusely adherent E. coli (DAEC) are considered a diarrhoeagenic class of organisms that 
colonise the small intestines, causing diarrhoea in children between the age of 18 months and 5 
years in developing countries (Mansan-Almeida, Pereira and Giugliano, 2013). These strains are 
characterised by the diffuse adherence pattern on cultured epithelial cells HeLa or Hep-2 
(Croxen and Finlay, 2010). DAEC strains are able to produce finger-like projections that extend 
from the surface of infected Caco-2 or HEp-2 cells (Cookson and Nataro, 1996). These 
projections supposedly “embed” the bacteria, providing some protection against gentamicin but 
without complete internalisation of the cell, however the role for this phenotype in 
pathogenesis has not yet been determined.  
The enterohaemorrhagic E. coli (EHEC) pathotype was first defined in 1983 after two outbreaks 
of gastrointestinal illness characterised by severe abdominal cramps, watery diarrhoea which 
progressed to extremely bloody diarrhoea, and was not accompanied by fever (Riley et al., 1983; 
Karmali et al., 1983). EHEC was defined based on the serological evidence and presence of a 
specific cytotoxin derived from these two outbreaks. EHEC strains comprise a subgroup of the 
Shiga toxin-producing E. coli (STEC), which encompasses EHEC and the lesser virulent/avirulent 
STEC. Owing to their human pathogenicity, some STEC strains are also designated as EHEC 
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(Nataro and Kaper, 1998). The major defining feature of EHEC is the production of phage-
encoded Shiga toxin, Stx1 and/or Stx2, which are responsible for serious disease in humans, such 
as HUS and HC.  
In 2011, an outbreak strain associated with haemolytic-uraemic syndrome and bloody diarrhoea 
in Europe, was identified as an EAEC strain that acquired the prophage-encoded Shiga toxin of 
EHEC, thus combining the virulence potentials of two different pathogens (Denamur, 2011). This 
combination of genomic features, associating characteristics from both EAEC and EHEC, gave 
rise to a new pathotype: the enteroaggregative-haemorrhagic E. coli (EAHEC). This outbreak 
highlighted the ability of E. coli to recombine and produce new combinations of genes, resulting 
in new lineages. The EAHEC outbreak also provided a good example of the application of modern 
sequencing technologies to rapidly and accurately identify causative strains, which in the past, 
relied heavily on low resolution methods such as serotyping of infectious organisms (Denamur, 
2011).  
The adherent-invasive E. coli (AIEC) are a pathotype of E. coli that have been implicated in the 
pathogenesis of Crohn’s disease (Darfeuille-Michaud, 2002). AIEC are unusual among intestinal 
E. coli pathotypes in that they are not associated with diarrhoea. The high prevalence of 
adherent E. coli isolated from the ileal mucosa of patients with Chron’s disease led to the 
characterisation of several strains, which failed to detect any virulence-associated genes that 
are traditionally present in typical pathogenic species. One characteristic of these strains is the 
ability to adhere to and invade intestinal epithelial cells, as well as the ability to replicate within 
macrophages, which discerns them from other varieties of E. coli, including commensals. These 
strains were therefore categorised as the specific pathogenic group known as AIEC (Darfeuille-
Michaud, 2002).  
1.3.4. Extraintestinal pathogenic E. coli (ExPEC) 
Extraintestinal pathogenic E. coli (ExPEC) are facultative pathogens which colonise the 
gastrointestinal tract of many healthy individuals, where they exist as commensals and do not 
cause enteric disease, contrary to the intestinal pathogenic E. coli (IPEC). ExPEC strains colonise 
sites outside of the intestinal tract, such as the urinary tract, bloodstream, and brain (Fig. 1.2). 
ExPEC are considered the primary aetiological agent of urinary tract infections (UTIs), as well as 
a common cause of bacteraemia and sepsis in the community. Other ExPEC strains are 
responsible for surgical wound infections, neonatal meningitis, and neonatal sepsis (Ron, 2010; 
Russo and Johnson, 2003). ExPEC strains which reside in the gastrointestinal tract differ from 
normal commensal strains, in that they possess virulence traits that allow them to colonise more 
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inhospitable environments, such as the urogenital tract (Smith, Fratamico and Gunther, 2007). 
In addition to these bacteria-specific traits, host-specific factors are also required in order to 
cause disease. ExPEC is therefore considered a necessary but not sufficient cause for 
extraintestinal E. coli infection, and as a result, additional factors are required for an infection 
to occur (Singer, 2015). Consequently, ExPEC are considered opportunistic pathogens for 
causing ExPEC-associated disease. When provided with an opportunity in individuals who might 
be susceptible in some way (e.g., compromised immune system), or through the influence of 
specific risk factors, the bacterium can be transferred to the urogenital tract where it can cause 
a UTI (Foxman, 2014). Similar to the intestinal pathogenic E. coli described earlier, ExPEC strains 
are also categorised into pathotypes as defined by the anatomical location of the disease they 
cause and the molecular virulence-associated genes that they carry, although few traits appear 
to be exclusive to one specific ExPEC subgroup. 
1.3.4.1. Avian pathogenic E. coli (APEC) 
Avian pathogenic E. coli (APEC) are responsible for causing systemic extraintestinal infections 
such as aerosacculitis, polyserositis, and septicaemia in avian hosts such as chickens, turkeys, 
and other wild and domesticated birds (Manges, 2016). APEC are typically part of the intestinal 
microbiota of healthy birds and infections typically result from environmental exposures and 
increased host susceptibility. More recently, APEC are also thought to be responsible for 
infections in humans, due to similarities in virulence determinants found in APEC and human 
ExPEC strains (Johnson et al., 2008). For instance, it has been demonstrated that genome 
content, virulence gene profiles, phylogeny, biofilm formation, and in vivo transcriptional 
activation are shared by APEC strains and the human ExPEC serotypes O18:K1:H7, O78, and 
O2:K1:H7 (Bauchart et al., 2010). Other studies of pathogenesis in vivo and in vitro have shown 
that APEC can cause disease in mammalian hosts and conversely, ExPEC isolated from human 
infections can cause disease in avian models (Jakobsen et al., 2012; Tivendale et al., 2010). These 
findings have led to the supposition that APEC is a zoonotic pathogen contributing to the weight 
of ExPEC infections in humans, particularly UTIs, and that consumption of retail poultry may be 
a source of infection (Platell et al., 2011b; Tivendale et al., 2010).  
1.3.4.2. Neonatal meningitis E. coli (NMEC) 
Neonatal meningitis E. coli (NMEC) have the ability to cross the blood-brain barrier (BBB) and 
are the second-leading cause of neonatal meningitis (Heath, Nik Yusoff and Baker, 2003), causing 
high mortality and neurologic sequelae in affected neonates. NMEC commonly inhabit the lower 
gastrointestinal tract, but become niche pathogens upon entry to the bloodstream and central 
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nervous system (CNS). NMEC are able to penetrate the BBB due to their ability to persist in the 
bloodstream by surviving engulfment by macrophages, multiplying in high numbers, and thus 
allowing successful invasion of the meninges of infants and causing meningitis (Kaper, Nataro 
and Mobley, 2004). NMEC are resistant to the host immune response, due to the possession of 
a KI capsule. This capsule is a thick polysialic acid layer that safeguards the bacterium from 
ingestion by phagocytic cells, and also from fusion with intracellular lytic vacuoles. As a 
consequence of the protection that the KI capsule provides, significant numbers of viable 
bacterial cells are transported across the BBB and into the CNS, where they can cause oedema 
and neural damage. It is most likely that these factors contribute to E. coli-associated neonatal 
meningitis carrying the significantly high mortality and morbidity rate (10–30%) associated with 
neonatal meningitis, caused by NMEC during the neonatal period (Kaper, Nataro and Mobley, 
2004).  
1.3.4.3. Uropathogenic E. coli (UPEC) 
The pathotype of E. coli responsible for causing urinary tract infections (UTIs) is referred to as 
uropathogenic E. coli (UPEC). Among the common urinary pathogens associated with the 
development of UTIs, UPEC are the primary cause (Terlizzi, Gribaudo and Maffei, 2017). UPEC 
are defined by their ability to cause extraintestinal infections of the urinary tract (bladder, 
kidneys, ureter, and urethra), and are characterised by a plethora of both structural (fimbriae, 
pili, flagella, capsules) and secreted (toxins, iron-acquisition systems, proteins) virulence factors 
that contribute to their capacity to cause disease. UTIs are globally widespread and affect a large 
proportion of the human population. Approximately 150 million people worldwide develop a 
UTI each year (Flores-Mireles et al., 2015) and roughly 11% of women suffer an episode of UTI 
per year (Foxman, 2014). UPEC are thought to be responsible for up to 80% of uncomplicated 
UTIs in females (Flores-Mireles et al., 2015). UPEC are particularly well-adapted to surviving in 
the urinary tract and possess VAGs enabling them to scavenge iron from the environment and 
catabolise the amino acid D-serine, which is present in urine (Flores-Mireles et al., 2015). 
Additionally, UPEC are also notable for their ability to adhere to host epithelial cells in the urinary 
tract, and this represents the most important determinant of pathogenicity for UPEC. In severe 
cases where a UTI is left untreated, UPEC can ascend the urinary tract to cause infection of the 
kidneys and bloodstream.  
UPEC strains that have invaded the bladder cells may be released and ascend to the kidneys via 
the ureters. Adherence to the kidney epithelial cells is mediated by binding of P-fimbriae to 
digalactoside receptors (Kaper, Nataro and Mobley, 2004). Upon colonisation of the kidney, 
UPEC virulence factors such as haemolysin and secreted autotransporter toxins (SAT) result in 
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damage to the renal epithelium, leading to pyelonephritis. Bacteria that have made it to this 
stage are then able to penetrate the endothelial cells of the proximal tubes and gain access to 
the bloodstream, resulting in bacteraemia (Kaper, Nataro and Mobley, 2004). The process of 
ascending infection from UTI to bacteraemia, involving the bladder, kidneys, and bloodstreams 
is known as urosepsis. The incidence of bloodstream infection is becoming more prevalent and 
is associated with higher rates of mortality. Bacteraemia caused by E. coli infection, which can 
be community or hospital-acquired, is reported with increasing frequency worldwide (Ron, 
2010), accounting for 17–37% of bacteraemia cases globally (Russo and Johnson, 2003). Studies 
have reported that E. coli is the most frequent organism isolated from septicaemia resulting 
from an initial UTI. A UK-based study revealed that E. coli accounts for ~75% of Gram-negative 
bacteraemia cases of urinary origin (Al-Hasan, Eckel-Passow and Baddour, 2010). The 
association of bacteraemia caused by E. coli and UTI origin is therefore significant in the UK. 
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Figure 1.2. Sites of colonisation of the human body by pathogenic strains of Escherichia coli. 
Pathogenic strains of E. coli are able to colonise various parts of the human body and cause subsequent 
disease, an ability that is attributed to the genome plasticity of the species and the carriage of specific 
virulence-associated genes (VAGs). The human extraintestinal pathogenic E. coli (ExPEC) develop infections 
at anatomical sites exterior to the gastrointestinal tract. Neonatal meningitis E. coli (NMEC) have the ability 
of crossing the blood-brain barrier (BBB) into the central nervous system and cause meningitis, whilst 
uropathogenic E. coli (UPEC) colonise and cause infection along various parts of the urinary tract, including 
the bladder and the kidneys, from which they can disseminate to the bloodstream and cause septicaemia. 
The intestinal pathogenic E. coli colonise various parts of the gastrointestinal tract. Enteroinvasive E. coli 
(EIEC), enteroaggregative E. coli (EAEC), and the particularly virulent entero-aggregative-haemorrhagic E. 
coli (EAHEC) and enterohaemorrhagic E. coli (EHEC) colonise the large intestines, whereas 
enteropathogenic E. coli (EPEC), enterotoxigenic E. coli (ETEC), diffusely adherent E. coli (DAEC), as well as 
adherent invasive E. coli (AIEC) colonise and cause infection in the small intestines. Enteroaggregative E. 
coli (EAEC) have the ability to cause disease in both the large and small intestines. Figure adapted from 
Croxen and Finlay (2010) to include the recently identified pathotypes, EAHEC and AIEC. 
Brain: NMEC 
Bladder: UPEC 
Kidneys: UPEC 
Small intestines: EPEC, ETEC, 
DAEC, EAEC, and AIEC 
Large intestines: EHEC, EIEC, 
EAEC, and EAHEC 
Bloodstream:  
NMEC and UPEC 
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1.3.5. Antibiotic resistance in extraintestinal pathogenic E. coli 
Antibiotic resistance in E. coli is a major problem facing today’s healthcare systems, as it is a 
common cause of nosocomial infection and the leading causative agent of urinary tract infection 
and bacteraemia. The prevalence of antimicrobial resistance has been increasing in 
uropathogenic bacteria in recent times and the management of infections caused by these 
strains has been hampered as a result. The cephalosporins, fluoroquinolones, and 
trimethoprim–sulphamethoxazole drug classes have often been used as first-line antibiotics to 
treat community and hospital-acquired infections caused by E. coli. Increasing resistance to 
these agents is responsible for impediments to the appropriate therapy, resulting in more 
frequent cases of morbidity and mortality (Tumbarello et al., 2007). Up until the late 1990s, 
ExPEC were known to be relatively susceptible to first-line antibiotics, but surveillance studies 
during the 2000s in Europe and North and South America have shown that 20–45% of ExPEC are 
resistant to multiple drug classes, including the cephalosporins, fluoroquinolones, and 
trimethoprim-sulfamethoxazole (Foxman, 2014). β-Lactam antibiotics, in particular the 
penicillins and third-generation cephalosporins, are a major drug class used to treat serious E. 
coli infections acquired in the community or the hospital setting (Livermore and Woodford, 
2006). Among E. coli, β-lactamase production remains the most important cause of β-lactam 
resistance. β-lactamases are usually plasmid-encoded enzymes produced by many Gram-
negative bacteria, that inactivate β-lactam antibiotics by hydrolysing the β-lactam ring of the 
basic penicillin structure, thus deactivating the molecule’s antibacterial properties (Livermore 
and Woodford, 2006). The first β-lactamases to be described were TEM (named after 
Temoneira, a patient in Greece from which TEM-1 was first isolated) in the 1960s, and later the 
SHV (SulfHydryl-Variable) β-lactamase. TEM and SHV β-lactamases are encoded by the blaTEM 
and blaSHV genes, respectively. These enzymes quickly became common in the hospital 
environment and allowed many genera of Gram-negative bacteria to become resistant to the 
commonly used antibiotics at the time.  
The TEM-1 enzyme is the most commonly encountered β-lactamase in Gram-negative bacteria. 
It is thought that up to 90% of ampicillin resistance in E. coli is attributed to the production of 
TEM-1 (Livermore, 1995). Although TEM-type β-lactamases are most often found in E. coli and K. 
pneumoniae, they are also found in other species of Gram-negative bacteria with increasing 
frequency. TEM-1 has the ability to hydrolyse penicillins and early cephalosporins, such as 
cephalothin and cephaloridine (Paterson and Bonomo, 2005). The TEM-3 derivative, originally 
reported in 1989, was the first TEM-type β-lactamase that displayed the ESBL phenotype, but in 
the years since the first report, over 100 derivatives of TEM have been described (Paterson and 
Bonomo, 2005). SHV-1 shares 68% amino acid homology with TEM-1 and has an overall similar 
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structure. The SHV-1 β-lactamase is most commonly found in K. pneumoniae and is responsible 
for approximately 20% of the plasmid-mediated ampicillin resistance in this species. A Klebsiella 
ozaenae isolate was identified in Germany in 1983, which possessed a β-lactamase which 
efficiently hydrolysed cefotaxime, and to a lesser extent ceftazidime (Knothe et al., 1983). 
Sequence analysis of this isolate revealed that the β-lactamase differed from SHV-1, by 
replacement of glycine by serine at position 238. This point mutation accounts for the extended-
spectrum properties of this β-lactamase, which was designated SHV-2 (Paterson and Bonomo, 
2005). Within just 15 years of the discovery of this enzyme, organisms possessing the SHV-2 β-
lactamase were found in every inhabited continent on Earth (Paterson et al., 2003). E. coli is also 
a typical clinical host of SHV-type enzymes, with previous studies reporting a high prevalence of 
E. coli producing SHV-type β-lactamases thought to be a significant cause of community-onset 
infections (Memariani et al., 2015). 
Of importance with regards to ExPEC infections in the community and hospital environment is 
the increasing numbers of isolates developing resistance against newly developed antibiotics. 
These include the plasmid-mediated AmpC β-lactamases (e.g., CMY types), carbapenemases, 
and extended-spectrum β-lactamases (ESBLs). ESBLs are able to hydrolyse third and fourth 
generation cephalosporins, but are catalytically less efficient than the parent enzymes and are 
therefore susceptible to β-lactamase inhibitors, such as clavulanic acid (Paterson and Bonomo, 
2005). To date, over 150 different types of ESBLs have been characterised, with a large 
proportion of ESBLs derived from point mutations in the parent β-lactamases, TEM-1, TEM-2, 
and SHV-1, which alter the amino acid configuration around the active site of these β-
lactamases. This extends the spectrum of β-lactam antibiotics that can be susceptible to 
hydrolysis by these enzymes (Paterson and Bonomo, 2005). An increasing number of ESBLs that 
are not of the TEM or SHV lineage have recently been described, which carry tremendous clinical 
significance. The CTX-M type ESBLs are so named as they preferentially hydrolyse CefoTaXime 
and were first discovered in Munich in 1986 (Pitout et al., 2005). These enzymes, encoded by 
blaCTX-M, are plasmid-mediated and are thought to have evolved separately from the TEM and 
SHV family, as they only have 40% sequence homology to these β-lactamases (Tzouvelekis et al., 
2000). When these enzymes were first discovered they were named TOHO-l, but this was later 
changed to CTX-M (Peirano and Pitout, 2010). CTX-M β-lactamases have mainly been found in 
strains of Salmonella enterica serovar Typhimurium and E. coli, but have also been described in 
other species of Enterobacteriaceae (Bradford, 2001). It is thought that the extended spectrum 
activity of the CTX-M-type β-lactamases is attributed to the serine residue at position 237, which 
is present in all of the CTX-M enzymes (Tzouvelekis et al., 2000). Strains expressing CTX-M-type 
β-lactamases have been isolated from multiple locations around the world, but have most often 
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been associated with focal outbreaks (Bradford, 2001). Since the emergence of the CTX-M family 
of ESBLs in the UK in 2001-02, they have become a major concern in the healthcare setting, 
particularly CTX-M-15 and -14, due to their highly transmissible nature. The production of CTX-
M-15 β-lactamases was first reported in an E. coli isolate in India in 2001 (Karim et al., 2001) and 
they have spread rapidly around the world, becoming an important cause of multidrug-resistant 
hospital- and community-acquired urinary tract infections (Peirano and Pitout, 2010). 
Consequently, CTX-M-15 is now the most globally widespread CTX-M enzyme, due to plasmid-
associated dissemination coinciding with the emergence of a particularly successful E. coli clone, 
O25b:H4 ST131 (Peirano and Pitout, 2010). The impact of ESBL-producing E. coli has spread 
beyond the human-clinical setting. A wide range of ESBL-producing ExPEC isolated from 
domesticated animals has been reported, primarily of CTX-M-1 in chicken and CTX-M-14 in 
cattle, while CTX-M-15 prevails among companion animals (Ewers et al., 2014). Furthermore, 
CTX-M-producing strains of clinically-associated clonal groups of E. coli have been identified in 
surface waters (Gomi et al., 2017b) and retail poultry (Johnson et al., 2017; Leverstein-van Hall 
et al., 2011), suggesting that potential non-human reservoirs of MDR ExPEC may exist. 
The OXA-type enzymes (oxacillinase, encoded by blaOXA) are another evolving family of ESBLs. 
These β-lactamases differ from the TEM, SHV, and CTX-M families (class A) in that they belong 
to molecular class D and functional group 2d (Bradford, 2001). OXA-type ESBLs confer resistance 
to multiple antibiotics, including ampicillin and cephalothin, and are characterised by increased 
hydrolytic activity against oxacillin and cloxacillin, whilst being poorly inhibited by clavulanic 
acid. While most ESBLs have been found in species such as E. coli, Klebsiella pneumoniae, and 
other members of the Enterobacteriaceae, the OXA-type ESBLs are more commonly found in 
Pseudomonas aeruginosa (Bradford, 2001). The most common OXA-type ESBL is OXA-1, which 
has been identified in roughly 1–10% of E. coli isolates. The blaOXA-48 gene encodes a 
carbapenemase class D β-lactamase that was first identified in K. pneumoniae from Turkey in 
2003 (Poirel et al., 2004), followed by subsequent reports of OXA-48 producers in E. coli from 
Israel, Senegal, and North Africa (Poirel et al., 2011a; Moquet et al., 2011; Cuzon et al., 2010). 
Further reports have indicated that OXA-48-producing E. coli have started to spread into the 
community in Europe (Poirel et al., 2011b), and can be an important cause of carbapenem 
resistance in extraintestinal infections. Aside from class D carbapenemases, there are also class 
A carbapenemases (mostly of the KPC type, produced by K. pneumoniae) and the metallo-β-
lactamases of class B (such as NDM). 
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1.3.6. Source attribution 
In nature, E. coli is principally a constituent of the gut microbiome of warm-blooded mammals, 
but it can also be found, albeit less frequently, in the gut microbiome of birds, reptiles and fish, 
as well as ubiquitously in the environment, in soil, water, plants and in food (Dublan Mde et al., 
2014; Berthe et al., 2013; Platell et al., 2011b; Brennan et al., 2010; Tenaillon et al., 2010). Due 
to its ubiquity in nature and agriculture, there is a significant risk associated with transmission 
to humans if the appropriate control measures are not considered. E. coli is a cause of zoonoses 
– infections that can be transferred from animals to humans through a variety of mechanisms. 
Most commonly, human infections with E. coli occur due to poor hygiene, close contact with 
infected animals, or the consumption of contaminated food products (Frank et al., 2011). 
Although not all E. coli strains isolated from the environment are capable of causing disease in 
humans, it is likely that some pathogenic strains can find their way into the food chain (Fig. 1.3). 
E. coli is shed in the faeces of natural hosts into the environment, where it can survive in soil, 
water or on food for several days. The successful habitation of E. coli in these secondary 
environments is reliant on several key factors, such as the availability of nutrients and water, 
temperature, and acidity (van Elsas et al., 2011). Considering that E. coli is a predominantly 
intestinal inhabitant, presence of E. coli in food or water is an indicator of faecal contamination 
or poor hygienic practices. 
Animals are a significant risk factor for the transmission of pathogenic E. coli to humans, due to 
the abundance of these microbes in the intestines of domesticated animals, such as sheep and 
ruminants. A previous study has shown that E. coli is well adapted to survive in the faeces of 
these animals, with an extinction range of 2–9 days, and has highlighted the potential risks 
associated with the contamination of food products by animal manure (Moriarty et al., 2010). 
Several outbreaks have been associated with contaminated or undercooked processed meat 
products such as beef burgers, sausages, and poultry (Vincent et al., 2010). Other studies have 
isolated E. coli from plants and seeds, suggesting that leaching from the soil leads to uptake of 
the organism into the roots where it can be disseminated to the leaves of plants such as lettuce 
and cabbage (Oliveira et al., 2012). Studies have suggested that the survival of E. coli in plants, 
which may be consumed raw or without the necessary washing or preparation, is of particular 
concern in the event of contamination with pathogenic E. coli capable of causing significant 
morbidity and mortality (Frank et al., 2011). Other studies have indicated E. coli outbreaks 
associated with contamination of animal-derived products such as unpasteurised milk and 
cheese (Gaulin et al., 2012). Studies have reported E. coli resembling the ExPEC strains 
responsible for human extraintestinal infection being recovered from waterways and retail 
poultry, leading to the suggestion that multiple non-human reservoirs for human ExPEC exist. 
 34 
 
 
Figure 1.3. Illustration depicting the potential ecological habitat and routes of transmission of 
Escherichia coli in a global ecosystem. 
E. coli is a natural constituent of the gut microbiome of warm-blooded mammals, including humans, but it 
can also be found in the gastrointestinal tracts of birds, reptiles, and fish. Non-pathogenic and pathogenic 
E. coli strains alike, when shed in the faeces of natural hosts into the environment, can survive in manure, 
soil, water, or on vegetation for several days. Furthermore, some E. coli in human faeces can survive the 
sewage treatment process and be discharged as effluents into natural waterways such as rivers and 
streams, and bodies of water such as lakes and the sea. If the appropriate control measures are not taken, 
there is a significant risk for transmission of E. coli to humans via the food chain, specifically through the 
consumption of contaminated water or food. The most common food sources for acquisition of E. coli 
would include fresh produce such as raw vegetables, dairy products such as unpasteurised milk, as well as 
undercooked ground beef and poultry that have become contaminated due to the slaughtering and food 
preparation processes. Furthermore, E. coli can be transmitted through direct contact with infected 
animals, as well as between humans, due to poor hygiene and sexual activity. 
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1.3.6.1. Surface waters as an environmental reservoir for ExPEC 
An inevitable consequence of being an intestinal or extraintestinal microbe is to be regularly 
excreted into external environments. Environmental and urban waterways act as a passive 
carrier for coliforms such as E. coli, which is often used as an indicator of faecal contamination 
by water quality testing procedures. The major sources of faecal contamination in various 
watersheds include humans, agricultural and domesticated animals, and wild animals. Surface 
waters across the globe are contaminated with bacteria carrying antimicrobial resistance genes 
(Gomi et al., 2017b; Muller, Stephan and Nuesch-Inderbinen, 2016; Chen et al., 2016; Su et al., 
2012; Dolejska et al., 2011b). Among these bacteria, E. coli are recognised as a contributor to 
the dissemination of antibiotic resistance genes in natural environments. Furthermore, 
freshwater environments are recognised as reactors for the evolution and dissemination of 
antibiotic resistance (Marti, Variatza and Balcazar, 2014). The major source of resistant bacteria 
and resistance genes is human sewage. Most developed countries around the world treat 
human sewage to reduce the bacterial load before releasing effluents into surrounding lakes, 
rivers, and oceans, or spreading it on land. However, previous studies indicate that treated 
sewage effluent, and the water into which it is released, remain heavily contaminated with 
antimicrobial-resistant bacteria (Gomi et al., 2017b; Dolejska et al., 2011b).  
Recent environmental studies, reporting the presence of MDR and pathogenic ExPEC strains of 
E. coli, indicate that surface water is considered to be one of the important non-human 
reservoirs of MDR ExPEC (Gomi et al., 2017b; Muller, Stephan and Nuesch-Inderbinen, 2016). It 
has been suggested that contamination of surface waters by clinically important pathogenic 
clones of E. coli may increase the risk of contracting waterborne diseases (Gomi et al., 2017b). 
One of the factors which link the occurrence of ExPEC in surface waters with an increased risk 
of waterborne disease is the capability of E. coli strains to survive in open environments. Every 
aspect of the external environment, whether it concerns nutrition, temperature, oxygen, 
moisture, pH, and/or the surrounding microbial community, can vary drastically (Savageau, 
1983). The ability to use nutrients and develop methods of overcoming these various stressors 
plays a crucial role in their survival in such environments. E. coli from livestock faeces is known 
to survive on grass pastures for 5 months or more, allowing the opportunity for pathogenic E. 
coli to be recycled by wild and domesticated animals (Avery, Moore and Hutchison, 2004), or to 
be introduced into aquatic environments following rainfall or irrigation. The presence of ExPEC 
in aquatic environments may appear to be a common denominator linking a diverse range of 
transitory habitats and transmission to animals and humans. 
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1.3.6.2. Retail poultry meat as a reservoir for ExPEC 
With the widespread prevalence of E. coli in the environment it is possible that pathogenic 
strains may be introduced into the food chain. Environmental E. coli that resemble the ExPEC 
strains responsible for human extraintestinal infections have been identified in environmental 
and urban waterways, sewage, domesticated and wild animals, soil and other environmental 
samples, suggesting that various non-human reservoirs for human ExPEC may exist (Platell et 
al., 2011a; Ewers et al., 2010). It has also been demonstrated that human-to-human 
transmission of genetically nearly indistinguishable ExPEC occurs between household members 
and sexual contacts (Johnson and Clabots, 2006), indicating that humans are definitely a 
reservoir for ExPEC. The magnitude of the contribution of these various routes to ExPEC 
infection, however, is not known. Given that the foodborne route is arguably the major 
contributor to the transmission of enteric E. coli pathotypes, multiple studies have conducted 
investigations into food-borne transmission routes for human ExPEC (Muller, Stephan and 
Nuesch-Inderbinen, 2016; Bergeron et al., 2012; Platell et al., 2011b; Vincent et al., 2010).  
A number of reports have suggested a high prevalence of ExPEC on retail chicken, beef, and pork 
meat, although recovery of ExPEC has evidently been highest from chicken meat (Jakobsen et 
al., 2010; Johnson et al., 2005a; 2005b). These studies have also suggested that consumption of 
contaminated poultry meat may play a role in human extraintestinal infections. The hypothesis 
that retail poultry meat products may provide a reservoir for human extraintestinal infection is 
based on several lines of evidence. Studies have identified genetic relationships between avian 
pathogenic E. coli (APEC) and human ExPEC (Zhao et al., 2009), and additionally, there are 
experimental studies showing the pathogenic potential of APEC in mammalian models and the 
pathogenic potential of human ExPEC in avian models (Jakobsen et al., 2012; Tivendale et al., 
2010). Furthermore, close genetic relationships between E. coli isolates recovered from human 
extraintestinal infections, poultry, and retail chicken meat have been shown through molecular 
epidemiological data (Johnson et al., 2008; Moulin-Schouleur et al., 2006). E. coli ST131 and 
other pandemic ExPEC lineages (ST69, ST394, ST95, ST10 and ST117) have previously been 
identified in both human extraintestinal infections and in poultry reared for consumption or 
retail meat sources (Bergeron et al., 2012; Vincent et al., 2010). A study in Sweden revealed that 
E. coli sequence types ST69, ST117, and ST10 comprised 50% of the extended-spectrum β-
lactamase (ESBL)-producing E. coli population recovered from domestic chicken meat. It was 
found that a substantial amount of chicken meat and chickens imported into Sweden, that were 
contaminated with ESBL-positive E. coli, had actually spread from imported parent broilers to 
broiler meat (Egervarn et al., 2014). This indicated that the occurrence of these antimicrobial-
resistant ExPEC lineages on chicken meat was due to faecal contamination at slaughter. A study 
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from the Netherlands described four sets of E. coli isolates originating from human and poultry 
or retail chicken meat with indistinguishable ESBL gene types (blaCTX-M-1 and blaTEM-
52), plasmids, and MLST genotypes (ST10, ST58, ST117 and ST10) (Leverstein-van Hall et al., 
2011). The Netherlands study however, much like many previous studies, focussed primarily on 
antimicrobial-resistant ExPEC, specifically ESBL-producing E. coli, and therefore studies of ESBL-
positive ExPEC lineages tend to be over-represented in the literature, and thus the true 
population structure of E. coli from non-human sources has not been accurately represented. 
1.3.7. Population structure of extraintestinal pathogenic E. coli 
1.3.7.1. E. coli phylo-typing  
The first bacterial species for which population genomic techniques were described was E. coli. 
Through a technique known as multilocus enzyme electrophoresis (MLEE), it was revealed that 
certain combinations of alleles had appeared on multiple occasions, leading to the 
interpretation that E. coli is characterised by a clonal population structure with infrequent 
recombination (Milkman, 1973). Further support for this conclusion was achieved through 
subsequent MLEE analyses of thousands of natural and clinical isolates from humans and other 
hosts; 72 of these isolates, known as the E. coli Reference (ECOR) collection, were chosen to 
represent the genetic diversity of the species known at that time (Ochman and Selander, 1984). 
Based on the analysis of the ECOR collection, the E. coli species was traditionally split into four 
main phylogenetic groups: A, B1, B2, and D. Phylogroups B2 and D are largely associated with E. 
coli strains causing extraintestinal infections in humans, including those responsible for UTIs, 
sepsis, and neonatal meningitis. In contrast, phylogroups A and B1 are mainly associated with 
commensal and non-pathogenic strains of E. coli (Clermont, Bonacorsi and Bingen, 2000). 
Phylogenetic analysis of housekeeping gene sequences from the ECOR collection indicated that 
phylogroup D had diverged first, with groups A and B1 being sister groups that separated later 
(Nelson et al., 1997). Subsequent analyses suggest that perhaps phylogroup B2, rather than D, 
is the ancestral group (Escobar-Paramo et al., 2004). In 2000, Clermont and colleagues described 
a phylogrouping technique based on triplex PCR (Clermont, Bonacorsi and Bingen, 2000), 
designed to be a simple and rapid alternative to the traditional phylogrouping methods of MLEE 
and ribotyping, which are both complex and time-consuming techniques. The triplex PCR 
method is of importance in bio-clinical practice and as a biotechnological screening tool for 
elimination of potentially pathogenic strains, given the established link between phylogeny and 
virulence. With the growing body of MLST and phylogenetic analyses based on whole-genome 
sequence data for E. coli, our understanding of the phylogroup structure for this species has 
been refined in recent years. An improved phylo-typing method based on quadruplex PCR was 
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developed by Clermont and colleagues (2013), who described a total of eight recognised E. coli 
phylogroups. Seven of these phylogroups (A, B1, B2, C, D, E, and F) belong to E. coli sensu stricto, 
whereas the Escherichia cryptic clade C-I is considered to be the eighth E. coli phylogroup. Four 
other cryptic lineages of the Escherichia genus (C-II, C-III, C-IV, and C-V) have also been 
described, which are phylogenetically distinct but phenotypically indistinguishable from typical 
E. coli (Clermont et al., 2013). The current generation of enhanced phylo-typing and sequence 
typing methods has revealed that E. coli strains, even within a single pathotype, can vary 
immensely in terms of their evolutionary trajectory, which in turn can affect pathogenic 
potential and fitness of E. coli strains associated with human infection (Wirth et al., 2006). 
1.3.7.2. ExPEC genotyping 
Due to its reproducibility and comparability between different laboratories, MLST is considered 
to be the gold standard for ExPEC genotyping (Tartof et al., 2005). The seven housekeeping 
genes for E. coli are adk, idh, fumC, mdh, purA, gyrB, and recA. The Achtman scheme is the 
established MLST typing scheme for E. coli and the database is available via a publicly accessible 
website (Wirth et al., 2006). Analysis of MLST data can be used to track dissemination of 
pathogenic variants in epidemiological studies. A recent retrospective study by Kallonen and co-
authors (Kallonen et al., 2017) analysed whole-genome sequence (WGS) data for 1509 E. coli 
isolates derived from the national British Society for Antimicrobial Chemotherapy (BSAC) 
collection (n = 1094) and a local collection from Cambridge University Hospital (n = 415). The 
combined collection comprised E. coli isolates associated with cases of bacteraemia between 
2001 and 2012. The 1509 E. coli isolates were resolved into 228 unique STs. The most prevalent 
STs detected in the population were ST73 (17.3%), ST131 (14.4%), ST95 (10.6%), ST69 (5.5%), 
ST12 (4.6%), and ST10 (2.7%) (Kallonen et al., 2017). This study confirmed the findings of several 
genetic studies of E. coli lineages associated with UTIs and/or bacteraemia in England and the 
US, which reported that the most prevalent sequences types are ST131, ST73, ST95, and ST69 
(Alhashash et al., 2013; Adams-Sapper et al., 2013; Gibreel et al., 2012). ST131, in particular, has 
received much scrutiny by investigators following its apparent emergence within the past two 
decades, due to its rapid dissemination across the globe and frequent multidrug-resistant 
phenotype.  
In the mid-2000s, pulsed-field gel electrophoresis (PFGE) analyses were performed on two CTX-
M-15 ESBL-producing E. coli strains that were associated with community- and hospital-onset 
UTI epidemics in the UK and Canada (Pitout et al., 2007; Woodford et al., 2004). Through the 
introduction of MLST typing methods, these strains were revealed to belong to a single sequence 
type, ST131, which were characterised as serotype O25b:H4 and phylogenetic group B2, as 
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determined by multilocus enzyme electrophoresis (MLEE) (Nicolas-Chanoine et al., 2008). 
Infections caused by ST131 are increasingly more frequent and are reported to be associated 
with increased morbidity and mortality (Johnson et al., 2010). Several studies have reported a 
high prevalence of ST131 isolates producing CTX-M-15 among ESBL producers and ST131 was 
significantly associated with fluoroquinolone resistance in a population of ESBL-negative strains 
(Johnson et al., 2010). ST131 is the leading E. coli sequence type causing antibiotic-resistant and 
MDR urinary tract infections in several countries in Europe and Asia, as well as Canada and 
Australia (Kallonen et al., 2017; Peirano and Pitout, 2010). E. coli ST131 are prevalent in both 
community- and hospital-acquired infections, but the source of infection is not well 
characterised. The potential of companion and domesticated animals to transmit this pathogen 
has previously been highlighted (McNally et al., 2016a), as has an association with the food chain 
(Platell et al., 2011b) and the environment (Gomi et al., 2017b).  
ST69 strains have been isolated worldwide from cases of UTI and bacteraemia from both 
community-onset and hospital-acquired infections (Kallonen et al., 2017; Alhashash et al., 2013; 
Croxall et al., 2011b). Most ST69 strains express an MDR phenotype, although they do not 
commonly produce ESBLs (Ajiboye et al., 2009). In a hospital-based study of E. coli bacteraemia 
isolates collected in San Francisco between 2007 and 2010, the ST69 complex was found to be 
the fourth most prevalent ExPEC ST after ST131, ST73, ST95 (Adams-Sapper et al., 2013), parallel 
to a recent UK-based study on E. coli bacteraemia isolates (Kallonen et al., 2017). ST69 strains 
were obtained less than 48 hours after admission from 83% of all cases, which may suggest that 
ST69 is a clonal ExPEC group circulating predominantly in the community as opposed to hospital 
settings. It is also thought that there may be a non-human reservoir for E. coli ST69, with isolates 
having been recovered from retail meats, domesticated animals, and the environment. 
E. coli ST95 strains belong to phylogenetic group B2 and comprise K1 capsular serotypes 
(O1:K1:H7, O2:K1:H7, and O18:K1:H7) that are traditionally linked to neonatal meningitis 
(Tivendale et al., 2010). The ST95 lineage also includes avian pathogenic E. coli strains which are 
responsible for colibacillosis in wild and domesticated birds (Mora et al., 2009). ST95 isolates 
were identified as the second most prevalent clonal group isolated from bacteraemia ExPEC 
infections in the United States (Adams-Sapper et al., 2013), and the third most common ST 
among bacteraemia isolates from UK-based studies (Kallonen et al., 2017; Alhashash et al., 
2013). In a French hospital-based study, the ST95 complex was the most common E. coli lineage 
isolated from blood and ascitic fluid cultures between 1997 and 2006 (Bert et al., 2010). One 
noticeable distinction of ST95 strains is that they are typically characterised by a low frequency 
of multidrug resistance. More than half of all ST95 isolates obtained from a San Francisco 
hospital-based study were susceptible to all antibiotics tested, demonstrating significantly less 
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resistance compared to ST131 isolates obtained from the same study. (Adams-Sapper et al., 
2013). In addition to animal hosts, E. coli ST95 is also commonly reported by environmental 
studies, and the ST95 complex was identified as the most prevalent clinically important clonal 
group (31%) among ExPEC isolates (n = 58) obtained from river water in Japan (Gomi et al., 
2017). 
E. coli ST73 strains belong to phylogenetic group B2 and are only associated with serotype O6:H1 
(Johnson et al., 2008). In the UK, ST73 was identified as the most commonly encountered ST 
among major ExPEC clonal groups isolated from cases of bacteraemia (Kallonen et al., 2017; 
Alhashash et al., 2013) and urinary tract infection (Gibreel et al., 2012), suggesting that the E. 
coli strain O6:H1-B2-ST73 is a leading cause of human extraintestinal infection in this country. 
Other UK-based studies have reported a high prevalence of ST73 strains associated with both 
community-onset and hospital-acquired infections (Croxall et al., 2011b). ST73 has also been 
reported to be one of the predominant ExPEC STs associated with expression of the CTX-M-15 
ESBL (Gibreel et al., 2012). ST73 strains with closely related PFGE types have been isolated from 
humans, dogs, and cats, suggesting cross-species transmission of this clone (Johnson et al., 
2008). It may be the case that ST73 represents a long-standing, human-adapted ExPEC clonal 
group as it has been responsible for causing UTIs in women from widely separated geographic 
locales over a considerable period of time (Manges et al., 2008). 
E. coli ST10 and closely related STs of the ST10 clonal complex belong to phylogenetic group A, 
which is typically associated with commensal colonisation of the human gastrointestinal tract. 
There are numerous serotypes associated with E. coli ST10. Although the ST10 clonal complex is 
commonly encountered as a human intestinal coloniser of low virulence and low antimicrobial 
resistance, it has also been associated with human infections and ESBL production (hospital- and 
community-acquired infections), meat products, and food animals (Peirano et al., 2012; Cohen 
Stuart et al., 2012). E. coli ST10 are also widespread in the environment and are commonly 
identified in surface waters (Gomi et al., 2017b; Jorgensen et al., 2017). In a study carried out in 
the Netherlands, CTX-M-producing ST10 strains were isolated from human blood cultures and 
poultry, and TEM-producing ST10 isolates were recovered from human urine samples as well as 
poultry (Leverstein-van Hall et al., 2011). Furthermore, a study from Canada identified 
multidrug-resistant E. coli ST10 strains from human-clinical samples, chicken faeces, retail 
chicken meat, pig faeces, and pork meat, indicating a strong association of this genotype with 
the food chain (Bergeron et al., 2012). 
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1.4. Aims and objectives 
The primary aim of this study was to carry out population genomic analyses to uncover novel 
information on the ecology of Y. pseudotuberculosis and E. coli. Comprehensive genome-scale 
analyses focussed on the enteric pathogen Y. enterocolitica suggested that distinct phylogroups 
of the species may be ecologically separated, through an exhibition of restricted genetic 
exchange between phylogroups. The dearth of such large-scale population genomic studies for 
Y. pseudotuberculosis means the ecology of this organism is not fully understood. To investigate 
whether similar hidden ecological patterns can be uncovered for this model organism, this study 
offers a high-resolution contribution to the understanding of the ecology, evolution, and 
dissemination of this important human pathogen. A large data set of globally and temporally 
distributed Y. pseudotuberculosis genomes from multiple ecosystems were analysed in this 
study. To identify any genomic signatures associated with the ecology of the Y. 
pseudotuberculosis population, core genome phylogenetic analysis was complemented with a 
pan-genome approach to effectively compare the entire gene contents of multiple genomes 
across the population.  
In addition to Y. pseudotuberculosis, E. coli was also investigated in this study. There are many 
reports in the literature of non-human E. coli resembling the ExPEC strains responsible for 
human extraintestinal infection that have been recovered from environmental and food 
sources, particularly river water and retail chicken meat. This has led to the suggestion that there 
may be several non-human reservoirs for human multidrug-resistant ExPEC. The majority of 
these studies, however, selectively enrich for antimicrobial-resistant isolates, and thus, reports 
of ESBL-producing E. coli tend to be overrepresented in the literature. The relative abundance 
of MDR E. coli and ExPEC strains in the wider non-human population of E. coli is therefore largely 
unknown. In this study, we sought to determine the true population structure of non-human E. 
coli from river water and retail chicken by taking an unbiased culture-based approach to 
sampling and not selectively cultivating resistant isolates. This strategy was combined with 
whole-genome sequencing of single isolates to allow comparative genomic analyses to be 
performed between the non-human population and human-clinical isolates of E. coli, previously 
obtained from the same region. A pan-genome approach was applied to the two populations, 
providing high-resolution genomic comparison to determine the extent of genetic overlap 
between the non-human and human-clinical populations and whether any genetic overlap exists 
between the non-human and human-clinical populations of E. coli in Nottingham, and whether 
non-human sources of E. coli are likely to contribute to the weight of extraintestinal infections 
in this region. 
 42 
 
The primary objectives of the study were to: 
• Reconstruct the phylogeny of a globally dispersed population of Y. pseudotuberculosis 
from multiple ecological niches and identify any genomic signatures associated with the 
ecology of the Y. pseudotuberculosis population. 
• Investigate the evolutionary history of Y. pseudotuberculosis by performing dating 
analysis to date the phylogeny of the species. 
• Determine whether any patterns of gene flow exist within the Y. pseudotuberculosis 
population by analysing the core and accessory genomes of these strains. 
• Isolate a population of E. coli from non-human (river water and retail chicken meat) 
samples and sequence the genomes of a non-biased representative proportion of the 
population, to generate a snapshot of the population structure of non-human E. coli, as 
determined by in silico multilocus sequence typing and phylogenetic analyses. 
• Detect antimicrobial resistance genes and virulence-associated genes in the non-human 
population of E. coli to create a snapshot of the prevalence of potentially multidrug-
resistant strains as well as human ExPEC strains. 
• Compare the population structures of non-human and human-clinical E. coli isolated 
from the same region, with regards to phylogeny and the prevalence of clinically 
important clonal groups, antimicrobial resistance determinants, and human ExPEC 
strains in both populations. 
• Use phylogenetic analysis to situate representative non-human strains of clinically 
important clonal groups within the wider populations of those clones obtained from 
multiple hosts. 
• Identify genomic signatures of ecological separation by performing comparative 
genomic analysis of all non-human and human-clinical strains of E. coli, using a pan-
genome approach. 
• Determine the extent of gene movement between closely related strains of the human-
clinical and non-human populations of E. coli, by comparing the pan-genomes and 
detected core genome recombination events between strains of clinically important 
clonal groups present in both populations. 
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CHAPTER 2 
Materials and methods 
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2.1. Media and reagents 
2.1.1. Growth and storage media 
Cystine Lactose Electrolyte Deficient (CLED, with Andrade’s indicator) agar was prepared with 
36.2 g of CLED agar powder (CM0423, Oxoid, Basingstoke, UK) per 1 L of distilled water.  
HiCrome™ UTI agar was prepared with 55.4 g of HiCrome™ UTI agar powder (16636, Sigma-
Aldrich, Dorset, UK) per 1 L of distilled water. 
LB agar was prepared with 40 g of LB agar powder, Miller (tryptone 10 g/L, yeast extract 5 g/L, 
sodium chloride 10 g/L; BP1425 Fisher BioReagents, Loughborough, UK) per 1 L of distilled water. 
Tryptone Soya agar (TSA) was prepared with 40 g of TSA powder (CM0131, Oxoid, Basingstoke, 
UK) per 1 L of distilled water. All agar solutions were sterilised by autoclaving at 121 °C for 15 
minutes and then cooled to 50 °C before pouring into sterile Petri dishes. 
Lysogeny broth (LB) was prepared with 40 g of LB broth powder (BP1426, Fisher BioReagents, 
Loughborough, UK) per 1 L of distilled water. 
Buffered peptone water, a broth used for the culture of organisms for detecting indole 
production with Kovac’s reagent, was prepared with 20 g of buffered peptone water powder 
(CM0509, Oxoid, Basingstoke, UK) per 1 L of distilled water. All broth solutions were sterilised 
by autoclaving at 121 °C for 15 minutes. 
A broth used for the storage of bacterial cultures at –80 °C was prepared in a 1 mL cryotube vial 
by suspending a single colony of bacterial culture from a CLED agar plate in 800 μL of LB broth 
with 200 μL (20% v/v) of glycerol (Sigma-Aldrich). 
2.1.2. API identification kit 
Identification of bacterial species was carried out using the API 20 E (20100, BioMérieux, Marcy-
l'Etoile, France) identification system for Enterobacteriaceae and other Gram-negative rods, by 
following the manufacturer's protocol. The API Reagent Kit (20120) was used for tests that 
require the addition of reagents when reading and interpreting the test strip. API Suspension 
Medium (20150) was used for the preparation of the inoculum for the API test strip. The 
McFarland Standard kit (70900) was used to produce a standard inoculum for API testing (0.5 
McFarland standard). Mineral oil (70100) was required to produce anaerobic test conditions for 
certain biochemical reactions within the API test strip. The apiweb identification database 
 45 
 
(40011, BioMérieux, Marcy-l'Etoile, France) was used to interpret the results and identify the 
species of the test organism. 
2.1.3. Molecular microbiology reagents 
Genomic DNA (gDNA) was prepared using the GenElute™ Bacterial Genomic DNA Kit (NA211O, 
Sigma Aldrich, Dorset, UK), as per the manufacturer's instructions. Polymerase chain reaction 
(PCR) amplification assays were performed using the GoTaq® Flexi DNA Polymerase kit (M8306, 
Promega, Southampton, UK). Agarose gels were prepared using Agarose Molecular Biology 
grade powder (10766834, Fisher Scientific, Loughborough, UK), 50x Tris-acetate-EDTA (TAE) 
buffer (EC-872, National Diagnostics supplied by Fisher Scientific, Loughborough, UK), and 
SYBR™ Safe DNA gel stain (S33102, Invitrogen, Renfrew, UK). PCR amplicons were 
electrophoresed on each gel with a 100 bp DNA Ladder (N3231, New England Biolabs, Hitchin, 
UK).  
2.1.4. NGS reagents and sequencing kits 
Qubit™ dsDNA BR Assay Kit 
Q32850, Invitrogen, Renfrew, UK 
Qubit™ dsDNA HS Assay Kit 
Q32854, Invitrogen, Renfrew, UK 
High Sensitivity D1000 ScreenTape 
5067-5584, Agilent Technologies, Stockport, UK 
High Sensitivity D1000 Reagents 
5067-5585, Agilent Technologies, Stockport, UK 
Agencourt AMPure XP 
A63881, Beckman Coulter, High Wycombe, UK 
Nextera XT DNA Library Prep Kit  
FC-131-1024, Illumina, Cambridge, UK 
Nextera XT DNA Library Index Kit v2 Set A 
FC-131-2001, Illumina, Cambridge, UK 
MiSeq Reagent Kit v2 (500 cycles) 
MS-102-2003, Illumina, Cambridge, UK 
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PhiX Control Kit v3 
FC-110-3001, Illumina, Cambridge, UK 
Sodium Hydroxide 10 M  
10488790, Fisher Scientific, Loughborough, UK 
2.1.5. Buffers and reagents   
0.85% saline solution was prepared by dissolving 1 saline tablet (BR0053, Oxoid, Basingstoke, 
UK) in 500 mL of distilled water. The solution was then sterilised by autoclaving at 121 °C for 15 
minutes to obtain 0.85% (’normal’, physiological, or isotonic) saline solution.  
1M Tris-HCI (pH 8.0) was prepared with 12.1 g of Tris base (BPE 152-1, Fisher Scientific, 
Loughborough, UK) per 80 mL of distilled water. The pH was adjusted to 8.0 using 1M HCl. The 
final volume of the solution was adjusted to 1 L using distilled water. The solution was sterilised 
by autoclaving at 121 °C for 15 minutes and any final pH adjustments were made once the 
solution cooled to room temperature. 
Oxidase discs (70439, Sigma-Aldrich, Dorset, UK) were used to detect oxidase-producing 
organisms. 
Kovac’s reagent for indoles (60983, Sigma-Aldrich, Dorset, UK) was used to detect indole-
producing organisms. 
 
2.2. Y. pseudotuberculosis phylogenomics  
2.2.1. Determining phylogenetic relationships  
A core genome alignment of the strains was constructed from localised co-linear blocks using 
the Parsnp tool (v1.2) from the Harvest suite (Treangen et al., 2014). Parsnp was run with default 
parameters, using the following command-line parsnp -r ! -d <genome_dir> -c where the 
(r)eference genome was set to ‘!’ to pick a random reference from the genome directory, the 
path was specified to the (d)irectory of genomes, and the (c)urated genome directory flag was 
used to force inclusion of all genomes in the directory. Parsnp takes the directory of FASTA files 
to be aligned and generates a maximum-likelihood phylogenetic tree, reconstructed from the 
alignment, based on core genome SNP analysis. Metadata encompassing information on 
isolation (continent, country and host), serotype, and CRISPR motif for each strain were 
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superimposed on the tree as coloured bars, using the Interactive Tree of Life (iTOL) web-based 
tool (Letunic and Bork, 2016). 
2.2.2. Analysis of CRISPR loci 
Katja Koskela (University of Helsinki) had searched the genome assemblies for CRISPR loci with 
BLASTN, using the Y. pseudotuberculosis–specific CRISPR direct repeat sequence (5’-
TTTCTAAGCTGCCTGTGCGGCAGTGAAC-3’), its complementary sequence, the 5’– and 3’–
flanking sequences of the YP1, YP2 and YP3 loci, and their complementary sequences (Koskela 
et al., 2015). Identified sequences were submitted to the CRISPRFinder tool on the CRISPRs Web 
Server (http://crispr.i2bc.paris-saclay.fr/Server/), together with the spacer dictionary compiled 
earlier (Koskela et al., 2015). This analysis increased the number of identified spacers in the Y. 
pseudotuberculosis spacer dictionary from 1902 to 2969. The complete list of strains and spacer 
arrays used for CRISPR spacer clustering is available from 
doi: http://dx.doi.org/10.1099/mgen.0.000133 as supplementary material (Seecharran et al., 
2017).  
2.2.3. Pan-genome and accessory genome analyses 
The Large-Scale Blast Score Ratio (LS-BSR) v3.0 pipeline (Sahl et al., 2014) was used to create 
pan-genomes from genome assemblies of all strains. The post-matrix script 
(filter_BSR_variome.py) was run to isolate the accessory genomes from the pan-genomes. The 
resulting accessory genome matrix was then transposed according to the order of the strains on 
the phylogenetic tree. The output was used to visualise the presence or absence of all accessory 
genes in each individual genome by generating a heat map using the ggplot2 package of the R 
statistical software v3.2.0 (http://www.r-project.org/; R Core Team, 2015; Wickham, 2016). 
Genes with > 90% prevalence, and also those found in fewer than 5 strains, were excluded from 
this analysis. The Python script compare_BSR.py from LS-BSR was used to look for unique coding 
sequences (CDSs) between two defined populations in the pan-genome matrix. Comparisons 
were made between the ‘European’ clade of strains and the ’Asian’ clade, as well as between 
each CRISPR cluster and the rest of the population. Any unique CDSs detected were compared 
to the non-redundant nucleotide database using nucleotide BLAST with default parameters 
(http://blast.ncbi.nlm.nih.gov/) to determine the genes they encode.  
The following analysis was performed by Jukka Corander (University of Oslo). KPAX2 software 
was used to cluster the strains based on their CRISPR spacer profiles (Pessia et al., 2015), 
resulting in 33 identified ‘CRISPR cluster’ labels. Input to the software was a binary matrix with 
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columns representing an absence/presence variable for each of the 2,969 spacers in each 
detected CRISPR cassette. KPAX2 was used with default prior hyperparameters and an upper 
bound for the number of clusters equal to 50. Five independent runs of the inference algorithm 
were performed and the clustering solution with the highest posterior probability was chosen. 
All estimation runs converged to a number of clusters well below the chosen upper bound, 
indicating that it was sufficiently large to accommodate the region of high posterior density. To 
analyse the association between CRISPR spacer patterns and the accessory genome content, an 
average accessory genome dissimilarity (Hamming distance normalised by the number of CRISPR 
spacers) matrix was calculated for all detected CRISPR clusters with > 1 strain (18 clusters).  
To assess the significance of the observed dissimilarity pattern, a standard permutation test was 
performed by Jukka Corander. Under the null hypothesis of no association between CRISPR 
clusters and accessory genome content, the cluster label of a strain can be permuted randomly. 
For each of 10,000 random permutations of the label, the average dissimilarity for each cluster 
was recalculated, and it was recorded how often the observed value is smaller than the observed 
dissimilarity in the original data matrix. Under the global significance level of 0.05, 12 out of 18 
CRISPR clusters had a significantly smaller average distance than expected under the null 
hypothesis.   
2.2.4. Detection of core genome recombination events 
Core genome alignments were constructed using Parsnp (Treangen et al., 2014), as previously 
described in section 2.2.1. Core genome recombination events were detected by running the 
software package BratNextGen (v1.0) (Marttinen et al., 2012) on the core genome alignment. 
BratNextGen was run by Alan McNally (University of Birmingham), using the default prior 
settings, 20 iterations of the HMM estimation algorithm and 100 runs executed in parallel for 
the permutation test of significance.  
2.2.5. Dating analysis 
Bayesian Evolutionary Analysis by Sampling Trees (BEAST 2, v2.4.0) (Bouckaert et al., 2014) was 
used to date the phylogeographic split within the species, and the formation of the distinct 
CRISPR clusters. Of the 134 genomes sequenced, isolation dates were available for 46 strains 
which represent the full diversity of the phylogeny. A core genome alignment of the 46 strains, 
constructed using Parsnp (Treangen et al., 2014), was stripped of recombination detected using 
BratNextGen (Marttinen et al., 2012), and the resulting alignment was used as input for BEAST 
2 with all known dates of isolation to date individual taxa. BEAST 2 was run by Alan McNally 
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(University of Birmingham). By assessing ESS (effective sample size) scores for priors, the 
following parameters were chosen for the best fitting model: HKY model of substitution with 
estimated base frequencies and a relaxed molecular clock. The analysis was run for a total of 50 
million iterations with the initial 5 million used as burn-in. From this, a maximum clade credibility 
tree was produced and visualised in Figtree (http://en.bio-soft.net/tree/figtree.html). For the 
Skyline analysis, a stepwise constant variant was selected with the age of youngest tip set to 
zero. 
 
2.3. Non-human E. coli strain collection 
2.3.1 River water sampling 
Nine water samples were collected by Jody Winter (Nottingham Trent University) in July 2015. 
These samples were taken from different sites along rivers/streams and wetlands at 4 
geographically distinct locations within the Trent River basin, in Nottinghamshire and 
Derbyshire: 
1. Giltbrook – Two samples were taken from the Gilt Brook near Giltbrook, 
Nottinghamshire (Fig. 2.1); one sample upstream and one sample downstream of 
Severn Trent Water Ltd waste water and sewage treatment plant.  
2. Erewash Pinxton – Two samples were obtained from the River Erewash near Pinxton, 
Derbyshire (Fig. 2.2); one sample upstream and one sample downstream of Amber 
Valley Water Services wastewater treatment plant. 
3. East Leake – Two samples were extracted from the Kingston Brook near East Leake, 
Nottinghamshire (Fig. 2.3); one sample upstream and one sample downstream of Brook 
Furlong Farm. 
4. Keyworth – Three samples were collected from a tributary of the Fairham Brook near 
Keyworth, Nottinghamshire (Fig. 2.4); one sample upstream and one sample 
downstream of Hillside Farm, and one sample from the wetland area near a cattle field. 
The samples were collected in sterile universal containers at a depth of 0.5 m and were 
transported to the laboratory on the day of collection. The samples were then stored at 4 °C and 
microbiological cultivation was carried out within 24 hours of collection.  
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Figure 2.1. Sample sites upstream and downstream of Severn Trent Water Ltd wastewater treatment 
plant, located on the Gilt Brook near Giltbrook, Nottinghamshire. 
 
 
Figure 2.2. Sample sites upstream and downstream of Amber Valley Water Services wastewater 
treatment plant, located on the River Erewash near Pinxton, Derbyshire. 
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Figure 2.3. Sample sites upstream and downstream of Brook Furlong Farm, located on the Kingston 
Brook near East Leake, Nottinghamshire. 
 
 
Figure 2.4. Sample sites upstream and downstream of Hillside Farm and sample site of wetland area 
near cattle field, located on the Fairham Brook near Keyworth, Nottinghamshire.  
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2.3.2. Retail poultry sampling 
A total of 20 whole chickens, weighing approximately 1.4–1.6 kg, were obtained from 6 major 
retail outlets in the Greater Nottingham area, in October 2015 (Table 2.1). All selected chickens 
were reared in the UK and represent both caged and free-range chickens. The chicken samples 
were kept in their original packaging and transported to the laboratory where they were stored 
at 4 °C and processed within 2 hours, following a previously published protocol (Asensi et al., 
2009). Each whole chicken was hand-rinsed, under aseptic conditions, with 100 mL of 0.85% 
saline solution (Oxoid) in a sterile plastic bag, for 3 minutes. The chicken rinse solution was then 
immediately subjected to microbiological cultivation.  
  
Table 2.1. Numbers of whole chickens obtained from 6 major supermarket chains and a 
snapshot of chicken processing companies in the UK. 
  Poultry processing companies 
Supermarket 
Number of 
chickens 
Faccenda 
Group 
Moy Park 
Ltd 
2 Sisters Food 
Group Ltd 
Cargill 
PLC 
Banham 
Poultry 
Ltd 
Tesco PLC 4  ✓ ✓ ✓ 
Sainsbury's 3  ✓ ✓   
Asda Stores Ltd 3 ✓     
Iceland Food Ltd 4    ✓ ✓
Morrisons 4   ✓  ✓
Aldi 2   ✓  ✓
 
The majority of all retailers source their fresh chicken from the same 4 processing companies that 
predominate the farming and abattoir business, which include the largest supplier in the UK, 2 Sisters Food 
Group Ltd. Asda Stores Ltd is the only major supermarket chain to source fresh chicken from Faccenda 
Group. 
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2.3.3. Isolation and identification of E. coli from non-human samples 
Bacteria were cultivated from river water and chicken rinse samples using standard 
microbiological techniques as follows. A total of 200 µL of each sample was transferred to CLED 
Agar with Andrade’s indicator (Oxoid) and inoculated using the spread plate technique. The 
plates were incubated at 37 °C for 18–24 hours. 
After incubation, the morphologies of single colonies present on CLED agar plates were recorded 
and an initial presumptive identification was made based on the characteristics described in 
Table 2.2. A control strain (E. coli UTI18, obtained from the NTU Pathogen Research Group 
culture collection) was used to test the performance of CLED agar to identify potential E. coli. All 
colonies that were presumptively identified as E. coli were subsequently sub-cultured onto 
HiCrome™ UTI Agar (Sigma-Aldrich), which is a chromogenic differential medium for 
identification and differentiation of microorganisms mainly causing urinary tract infections, 
including Enterobacteriaceae. The plates were then incubated at 37 °C for 18–24 hours and 
colony morphologies were recorded. This additional culture step allowed for purification to 
single colonies and, as a result, isolates that presented with two or more different morphologies 
were regarded as a ’mixed culture’ and were discarded from further testing.  
Pure colonies that exhibited characteristic E. coli morphology on HiCrome™ UTI Agar, as 
described in Table 2.2, were selected for further biochemical testing, which involved performing 
the oxidase test and the indole test. The oxidase test was performed to support the presumptive 
identification of E. coli, which are oxidase-negative organisms. A plastic inoculation loop was 
used to transfer a distinct colony from a fresh culture plate (less than 24 hours old) onto an 
oxidase test disc containing N′,N′-dimethyl-p-phenylenediamine (Sigma-Aldrich). A negative 
reaction was observed, indicated by an absence of colouration after the test was performed. For 
the indole test, a single colony was inoculated into 10 mL of Buffered Peptone Water (Oxoid) 
and incubated at 37 °C for 18–24 hours, with shaking (200 rpm). After incubation, 200 µL of 
Kovac’s reagent (Sigma-Aldrich) was added to the culture broth. If indole was present, the 
surface reagent layer turned red after 1–2 minutes, indicating an indole-positive organism, such 
as E. coli. A negative result was indicated by the surface reagent layer remaining yellow or 
yellow–orange in colour. E. coli strain UTI18 (NTU Pathogen Research Group strain collection) 
was used a control strain for both the oxidase and indole tests.  
Once oxidase-negative and indole-positive isolates had been ascertained, a single colony of each 
isolate was sub-cultured onto LB Agar (Fisher BioReagents) for purity and incubated at 37 °C for 
18–24 hours. Biochemical identification testing was performed from the purity plate using the 
Analytical Profile Index (API) 20 E identification system (BioMérieux, France). This system was 
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developed for the identification of members of the Enterobacteriaceae family of bacteria. 
Bacterial isolates can be identified to the species level based on a profile of 20 biochemical 
reactions, which can be compared to a vast number of taxa on the regularly updated API 
database. For the API 20 E protocol, a bacterial suspension was prepared from the pure culture 
plate by inoculating 5 mL of API Suspension Medium (BioMérieux) with a single colony. The 
bacterial suspension was standardised according to the turbidity of a 0.5 McFarland Standard 
(BioMérieux) and distributed into each cupule on the test strip, rehydrating the biochemical 
substrates that are freeze-dried at the bottom. Some biochemical tests required an overlay of 
mineral oil (BioMérieux) in the cupule to create anaerobiosis, before the test strip was incubated 
in an incubation box at 37 °C for 18–24 hours. The results of the test strip were interpreted by 
referring to the Reading Table provided with the API 20 E kit, which describes a colour or 
turbidity change for positive and negative tests. Some tests required the addition of reagents 
(API Reagent Kit, BioMérieux) to the cupule before a colour change could be revealed. Each 
biochemical test was determined as a positive or negative reaction, allowing a 7–digit numerical 
profile to be built for each bacterial isolate, based on the score for each set of 3 cupules. This 
numerical profile was compared against the apiweb database (BioMérieux, 
apiweb.biomerieux.com) and identification of the bacterial isolates were assigned to the species 
level, along with a confidence interval (%) for the identification. The confidence value for each 
species designation is based upon the percentage of biochemical tests for each strain that gave 
a positive result when the test strips were validated. In this study, identifications of 80% were 
considered as the minimum threshold for an acceptable identification. Strains identified as E. 
coli with confidence values below this threshold were discarded from further analysis. 
All bacterial isolates identified as E. coli, with ≥ 80% confidence, were stored at –80 oC in a 
storage medium of Lysogeny broth (LB, Oxoid) with 20% (v/v) glycerol (Fisher Scientific). Isolates 
were streaked to single colonies and incubated aerobically overnight at 37 °C on LB Agar plates, 
and checked for purity, before performing experiments. Broth cultures of isolates were grown 
in LB Broth (Sigma-Aldrich) with shaking (200 rpm) at 37 °C. 
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Table 2.2. Identification characteristics used to presumptively identify E. coli from other bacterial species present in non-human samples. 
 
 
Presumptive identifications of E. coli were made based on colony morphologies on a combination of agars: CLED with Andrade’s indicator and HiCrome™ UTI chromogenic agar. 
Presumptive identifications of E. coli were supported by an oxidase reaction and indole test results. These presumptive identifications helped eliminate any non-
Enterobacteriaceae and select for potential E. coli isolates in the original samples. The selected isolates were subjected to confirmatory testing and species designation using 
the API 20 E identification system.
 Colony morphology   
Species CLED with Andrade’s indicator  HiCrome™ UTI Oxidase Indole 
Escherichia coli 
Bright pink semi-translucent colonies with a 
surrounding pink halo in the medium 
Purple to magenta colonies - + 
Proteus mirabilis  Blue-green translucent colonies Light brown colonies - - 
Klebsiella spp. Grey-green mucoid colonies Blue to purple, mucoid colonies - - 
Pseudomonas aeruginosa Small, grey-green, translucent colonies 
Colourless colonies; greenish 
pigment may be observed  
+ - 
Staphylococcus aureus 
Smooth, entire, opaque; bright golden yellow 
colonies. Lactose fermenting 
Golden yellow colonies - - 
Enterococcus faecalis 
Similar to S. aureus but smaller and a much deeper 
orange yellow colour 
Blue-green, small colonies - - 
Streptococcus pyogenes Small opaque grey-green colonies Pale blue/purple, minute colonies - - 
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2.4. Molecular characterisation of non-human E. coli 
2.4.1. Preparation of genomic DNA 
Genomic DNA (gDNA) was prepared using the GenElute™ Bacterial Genomic DNA Kit (Sigma-
Aldrich), as per the manufacturer's instructions. Briefly, 1.5 mL of overnight culture grown in LB 
broth was centrifuged at 12,000 x g for 2 minutes. The resulting pellet was resuspended in 180 
μL of Lysis Solution T, containing 20 μL of RNase A solution. The solution was mixed and 
incubated for 2 minutes at room temperature before the addition of 20 μL of Proteinase K 
Solution and incubation at 55 °C for 30 minutes. 200 μL of Lysis Solution C was then added, 
mixed, and the solution was incubated for a further 10 minutes at 55 °C. The lysis solutions used 
in this extraction kit contain chaotropic salts which ensure the thorough denaturation of 
macromolecules. 200 μL of 100% ethanol was then added to the lysate, mixed, and vortexed 
thoroughly to precipitate the DNA and achieve a homogeneous mixture. The addition of ethanol 
enables the DNA to bind to a pre-prepared spin column as the contaminants are washed 
through. The lysate was transferred to a binding column and centrifuged at 6,500 x g for 1 
minute. The column was then washed twice to remove contaminants; firstly, with centrifugation 
at 6,500 x g for 1 minute, followed by a high-speed spin at 12,000 x g to dry the column and 
remove any excess wash solution. The DNA was then eluted into 50 μL of nuclease-free water 
by a final centrifugation at 6,500 x g for 1 minute. The quantity and quality of eluted gDNA was 
assessed using a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific). Only gDNA 
eluates with A260/A280 ratios of ~1.8 and A260/A230 ratios between 2.0 and 2.2 were used as 
templates in the following multiplex PCR protocol, as these values are indicative of 'pure' DNA 
without organic or inorganic contaminants. 
2.4.2. Detection of β-lactamase genes  
All E. coli isolated from non-human samples were tested for the presence of the β-lactamase 
genes blaTEM, blaSHV, blaCTX-M and blaOXA, using a previously published protocol and primer 
sequences (Fang et al., 2008). The primers used in the multiplex PCR assay were synthesised by 
Eurofins Genomics (Ebersberg, Germany). The PCR master mix contained 0.2 μM final 
concentrations of each primer, 2.5 mM MgCl2, 0.2 mM dNTPs (Promega), 1.25 U Taq polymerase 
(Promega), and 2 μL DNA template. The PCR reaction tubes were cycled with the following 
parameters: initial denaturation at 94 °C for 5 minutes, 30 cycles of denaturation at 94 °C for 30 
seconds, primer annealing at 62 °C for 90 seconds, elongation at 72 °C for 60 seconds, followed 
by a final elongation at 72 °C for 10 minutes. The reaction tubes were then put on hold at 4 °C. 
Primer sequences for each set of primers and amplicon size for each target gene are detailed in 
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Table 2.3. The Klebsiella pneumoniae strain UTI448 (NTU Pathogen Research Group culture 
collection), which contained known β-lactamase genes blaSHV, blaTEM, blaCTX-M and blaOXA, was 
included as a positive control, alongside a negative control containing no DNA, in order to 
monitor test performance. Amplification of DNA was performed using a Techne TC-4000 thermal 
cycler. PCR products were electrophoresed on 2% agarose gels, as described in section 2.4.3 
below.  
2.4.3. Agarose gel electrophoresis 
A 2% agarose gel (which was used in all protocols) was prepared with 1 g of agarose (Fisher 
Scientific) per 50 mL of 1 X Tris-acetate-EDTA (TAE) buffer. A concentration of 0.1 µL/mL of 
SYBR® Safe DNA Gel Stain (Invitrogen) was added to the gel solution. The gel solution was then 
poured into a gel casting tray and once set, it was placed into an electrophoresis tank of 1X TAE 
buffer. Aliquots of 5 µL of PCR product were loaded into each well along with 5 µL of the 
appropriate molecular weight marker (100 bp ladder, New England Biolabs) in a separate well. 
Electrophoresis was performed at 90 V for 90 minutes. The gel was then viewed under an 
ultraviolet (UV) light to observe the DNA bands, using the InGenius Gel Documentation System 
(Syngene). 
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Table 2.3. Primer sequences used in this study. 
 
Commonly used and referenced primers for β-lactamase genes were selected from the publication indicated in the reference column. The efficacy of the assay was tested 
using the positive control strain K. pneumoniae UTI448, which was run on each gel, where possible. 
The nucleotide ambiguity codes (IUPAC) are as follows: A, adenine; C, cytosine; G, guanine; T, thymine; K, keto (T or G); R, purine (A or G); S, strong (C or G); Y, pyrimidine (C 
or T). 
Primer 
name 
Primer sequence (5’ – 3’) Target Target gene 
function 
Annealing temperature 
(°C) 
Amplicon size 
(bp) 
Reference 
shvF CTTTATCGGCCCTCACTCAA 
blaSHV β-lactamase 62 237 
(Fang et al., 
2008) 
shvR AGGTGCTCATCATGGGAAAG 
temF CGCCGCATACACTATTCTCAGAATGA 
blaTEM β-lactamase 62 445 
temR ACGCTCACCGGCTCCAGATTTAT 
ctxmF ATGTGCAGYACCAGTAARGTKATGGC 
blaCTX-M ESBL 62 593 
ctxmR TGGGTRAARTARGTSACCAGAAYCAGCGG 
oxaF ACACAATACATATCAACTTCGC 
blaOXA ESBL 62 813 
oxaR AGTGTGTTTAGAATGGTGATC 
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2.5. Whole-genome sequencing  
2.5.1. Quality assessment of genomic DNA  
Genomic DNA samples with A260/A280 ratios of ~1.8 and A260/A230 ratios between 2.0 and 2.2 
were used in the following library preparation protocol for whole-genome sequencing. The 
concentration of double-stranded DNA was determined by using the Qubit™ 3.0 Fluorometer. 
The Qubit™ dsDNA HS Assay Kit (Invitrogen) was used first, as this assay is highly selective for 
double-stranded DNA within a range of 0.2–100 ng/µL. If DNA samples were out of range (i.e. 
too high), then the Qubit™ dsDNA BR Assay Kit (Invitrogen) was used, which can measure DNA 
within the broader range of 2–1000 ng/µL. The Qubit™ working solution was made to a ratio of 
1 µL dye:199 µL buffer for each sample. The Qubit™ 3.0 Fluorometer was calibrated using test 
standards for the specific kit, made to a ratio of 10 µL standard:190 µL Qubit™ solution. After 
calibration, the DNA samples were prepared using a ratio of 2 µL DNA sample:198 µL Qubit™ 
solution. The standards and samples were vortex-mixed in 0.5 mL Qubit™ Assay Tubes 
(Invitrogen), incubated at room temperature for 2 minutes, and then analysed on the Qubit™ 
3.0 Fluorometer. 
2.5.2. Illumina Nextera XT library preparation 
Indexed and paired-end libraries were prepared using the Nextera XT DNA Library Preparation 
Kit and Nextera XT v2 Index Kit set A (Illumina). In this protocol, a fresh hard-shell skirted PCR 
plate was used for each set of 24 libraries. A maximum total of 48 libraries were sequenced on 
a single reagent cartridge, to minimise the likelihood of a reduction in sequencing coverage. 
Before commencing library preparation, a sample sheet (comma-separated values [CSV] file) 
was created, which stores the necessary information required to set up, perform, and analyse a 
sequencing run. The parameters specified in the sample sheet included information on 
experiment name, analysis workflow, read length, and adapter trimming. The library 
preparation process consisted of the following 5 steps: 
Normalisation of gDNA concentrations across samples 
The goal of this step was to normalise the gDNA concentration across samples to achieve 
uniform reaction efficiency in the tagmentation step. Tagmentation is sensitive to the input 
gDNA concentration and the optimal concentration varies depending on the organism, DNA 
type, and the DNA extraction method used. For this protocol, all samples were normalised to an 
input gDNA concentration of 0.2 ng/μL. Quantification of gDNA was performed using the Qubit™ 
3.0 Fluorometer, as described in section 2.5.1. 
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Tagmentation of gDNA 
Input gDNA was tagmented (tagged and fragmented) by the Nextera XT transposome. The 
adaptor sequences tagged onto the ends of the fragmented DNA allow for indexing and PCR 
amplification in the next step. In a hard-shell skirted PCR plate, 10 μL of Tagment DNA (TD) Buffer 
and 5 μL of Amplicon Tagment Mix (ATM) were mixed with 5 μL of normalised gDNA. The plate 
was then sealed and run on a thermal cycler at 55 °C for 5 minutes, after which, 5 μL of Neutralize 
Tagment (NT) Buffer was added to each well before incubating at room temperature for 5 
minutes. 
PCR-mediated adapter ligation and library amplification 
PCR was used to incorporate the Illumina adaptor sequences (Table 2.4 and Table 2.5) to the 
tagmented DNA fragments, which are required for cluster formation on the flow cell. The Index 
1 (i7) and Index 2 (i5) adaptors bind fragments to the flow cell, and the barcodes (N7--, N5--) 
allow for multiplexed sequencing. In the plate containing the tagmented gDNA, 5 μL of each 
Index 1 (i7) adapter was added down each column (1-6) and 5 μL of each Index 2 (i5) adapter 
was added across each row (A-D). Nextera PCR Master Mix (NPM) was added in volumes of 15 
μL to each well containing index adaptors. The plate was sealed and subsequently run on the 
thermal cycler with the following parameters: 72 °C for 3 minutes; 95 °C for 30 seconds; 12 cycles 
of 95 °C for 10 seconds, 55 °C for 30 seconds and 72 °C for 30 seconds; 72 °C for 5 minutes and 
hold at 10 °C.  
Post-PCR clean-up of libraries 
The PCR products were purified with Agencourt AMPure XP magnetic beads (Beckman Coulter) 
to remove short library fragments. In this protocol, 30 μL of homogenised and room 
temperature beads were added to each well, mixed by pipetting, and incubated at room 
temperature for 5 minutes, before placing on a magnetic stand to pellet the beads. The 
supernatant was discarded and the beads were washed 2 times with 200 μL of freshly prepared 
80% ethanol, before air-drying the pellet on the magnetic stand for 5–10 minutes, or until the 
pellet appears “matte” in appearance. The pellet was then resuspended in 52.5 μL of Nextera 
Resuspension Buffer (RSB) and incubated on the magnetic stand for 2 minutes. 50 μL of the 
supernatant, which contained the purified libraries, was transferred to a new plate for the 
subsequent steps.  
Library quality control, normalisation, and pooling 
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Sample concentrations and fragment size distributions were estimated and the quantity of each 
library was normalised to ensure equal library representation in pooled samples. The DNA 
concentration of each sample was measured using the Qubit™ 3.0 Fluorometer as described in 
section 2.5.1 ‘Quality assessment of genomic DNA’. Fragment size (bp) distribution was 
measured for each library, using the Agilent 2200 TapeStation, by following the manufacturer’s 
instructions. Briefly, 2 μL of High Sensitivity D1000 sample buffer (Agilent Technologies) was 
aliquoted into sets of optical tube strips, followed by 2 μL of High Sensitivity D1000 ladder 
(Agilent Technologies) in the first tube, then 2 μL of gDNA library in the subsequent tubes. After 
vortex-mixing at 2,000 rpm for 1 minute, the samples were loaded into the 2200 TapeStation, 
along with the High Sensitivity D1000 ScreenTape and loading tips (Agilent Technologies). The 
analysis was then initiated by launching the Agilent 2200 TapeStation software, resulting in a 
rapid determination of the average fragment size for each gDNA sample. Based on individual 
sample concentrations and the common average fragment length, the DNA molarity of each 
sample was calculated using the following formula: 
𝑚 =
𝑐
𝑤 × 𝑠
 × 1,000,000 
Where 𝑚 = molarity (nM), 𝑐 = concentration of gDNA library (ng/μL), 𝑤 = average molecular 
weight of DNA (taken to be 660 g/mol), 𝑠 = average DNA fragment size of library. 
Each library was then normalised to 4 nM before pooling an equal 5 μL of each library into a 
single microcentrifuge tube.  
2.5.3. Sequencing on the MiSeq 
To prepare libraries for sequencing on the Illumina MiSeq, 5 μL of the 4 nM pooled libraries was 
denatured with 5 μL 0.2 N NaOH. Incubating for 5 minutes at room temperature enabled 
denaturation of the gDNA into single strands. The DNA was then diluted with 990 μL of pre-
chilled Hybridization Buffer (HT1), resulting in a 20 pM library. This was further diluted to 12 pM 
– the recommended concentration for the MiSeq Reagent Kit v2 (Illumina), which was used in 
this protocol. A PhiX control library was prepared by denaturing 2 μL of 10 nM PhiX with 3 μL 
Tris-HCI (pH 8.0) and 5 μL 0.2 N NaOH. The denatured PhiX library was then diluted to 20 pM 
using 990 μL HT1 buffer. This was then further diluted to 12.5 pM and combined with the diluted 
and denatured DNA library at a ratio of 6 μL PhiX:594 μL DNA library. The flow cell was cleaned 
using 80% ethanol and was loaded into the MiSeq along with Incorporation Buffer. The prepared 
libraries were loaded onto the reagent cartridge and sequenced on the MiSeq for 500 cycles, to 
generate 250 bp paired-end reads.  
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Table 2.4. Illumina adapter sequences for Nextera XT Index Kit v2 – index 1 (i7) adapters 
Bases in adapter 
i7 index 
name 
i7 bases for entry on 
sample sheet 
TCGCCTTA N701 TAAGGCGA 
CTAGTACG N702 CGTACTAG 
TTCTGCCT N703 AGGCAGAA 
GCTCAGGA N704 TCCTGAGC 
AGGAGTCC N705 GGACTCCT 
CATGCCTA N706 TAGGCATG 
GTAGAGAG N707 CTCTCTAC 
CAGCCTCG N710 CGAGGCTG 
TGCCTCTT N711 AAGAGGCA 
TCCTCTAC N712 GTAGAGGA 
TCATGAGC N714 GCTCATGA 
CCTGAGAT N715 ACTCGCTA 
CCTGAGAT N716 GGAGCTAC 
GTAGCTCC N718 GGAGCTAC 
TACTACGC N719 GCGTAGTA 
AGGCTCCG N720 CGGAGCCT 
GCAGCGTA N721 TACGCTGC 
CTGCGCAT N722 ATGCGCAG 
GAGCGCTA N723 TAGCGCTC 
CGCTCAGT N724 ACTGAGCG 
GTCTTAGG N726 CCTAAGAC 
ACTGATCG N727 CGATCAGT 
TAGCTGCA N728 TGCAGCTA 
GACGTCGA N729 TCGACGTC 
Oligonucleotide sequences © 2016 Illumina, Inc. All rights reserved. 
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Table 2.5. Illumina adapter sequences for Nextera XT Index Kit v2 – index 2 (i5) adapters 
Bases in adapter 
i5 index 
name 
i5 bases for entry on 
sample sheet 
CTCTCTAT S502 ATAGAGAG 
TATCCTCT S503 AGAGGATA 
GTAAGGAG S505 CTCCTTAC 
ACTGCATA S506 TATGCAGT 
AAGGAGTA S507 TACTCCTT 
CTAAGCCT S508 AGGCTTAG 
CGTCTAAT S510 ATTAGACG 
TCTCTCCG S511 CGGAGAGA 
TCGACTAG S513 CTAGTCGA 
TTCTAGCT S515 AGCTAGAA 
CCTAGAGT S516 ACTCTAGG 
GCGTAAGA S517 TCTTACGC 
CTATTAAG S518 CTTAATAG 
AAGGCTAT S520 ATAGCCTT 
GAGCCTTA S521 TAAGGCTC 
TTATGCGA S522 TCGCATAA 
Oligonucleotide sequences © 2016 Illumina, Inc. All rights reserved.  
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2.6. Analysis of E. coli sequence data 
2.6.1. Genome assembly, annotation, and quality assessment 
The Illumina software MiSeq Reporter performed secondary analysis which involved 
demultiplexing of all indexed reads – dividing all sequenced reads into separate files for each 
indexed tag/sample. The analysis also included generation of FASTQ files, which contained the 
non-indexed reads for each isolate, excluding reads identified as inline controls and reads that 
did not pass filter. FASTQ generation performed quality trimming of the 5’ portion of the adapter 
sequence for all reads, to prevent reporting sequence data beyond the sample DNA. De novo 
assemblies of raw reads into contigs and scaffolds were performed using SPAdes v3.9.0 
(Bankevich et al., 2012). The genome assemblies were annotated using Prokka v1.12 (Seemann, 
2014), by running the python script autoprokka.py 
(https://github.com/stevenjdunn/autoprokka) on the FASTA genome files. The quality of de 
novo assemblies was evaluated by running QUAST v3.2, a bioinformatics quality assessment tool 
for genome assemblies (Gurevich et al., 2013). Any incomplete assembled genomes, i.e. 
assemblies with N50 values < 1,900 bp and genome sizes < 4.3 Mbp were excluded from further 
analyses. The assembled genomes passing these criteria were analysed as described in sections 
2.6.2 – 2.6.7.  
2.6.2. Sequence-typing and clonal complex assignment  
Sequence typing of isolates was carried out by running the multilocus sequence typing (MLST) 
script (https://github.com/tseemann/mlst), which scans the assembled scaffolds against 
PubMLST databases and assigns a sequence type (ST) to each isolate. Closely related STs were 
grouped into ST complexes using the PHYLOViZ v3.0 platform (Francisco et al., 2012). PHYLOViZ 
uses the goeBURST algorithm, a refinement of eBURST (Feil et al., 2004), and its expansion to 
generate a complete minimum spanning tree (MST) of all STs. It achieves this by dividing an 
MLST data set into groups of related isolates and clonal complexes, predicting the ancestral 
genotype of each clonal complex, and computing the bootstrap support for the assignment. 
2.6.3. Detecting antibiotic resistance genes and ExPEC virulence determinants 
Genome sequence files were screened for the presence of acquired antibiotic resistance genes 
by running the bioinformatics tool ABRicate v2.0 (https://github.com/tseemann/abricate), 
which uses the ResFinder database to generate in silico antibiotic resistance profiles for each 
isolate. ABRicate was also run using VFDB – Virulence Factors Database (Chen et al., 2015) – to 
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mass screen contigs for the presence of virulence determinants that define ExPEC strains. All 
redundant isolates (i.e. isolates that were collected from the same sample source, assigned to 
the same ST, and exhibiting the same antibiotic resistance gene profiles) were excluded from 
further genomic analyses.  
2.6.4. Reconstructing phylogenetic trees  
Core genome alignments of strains were constructed from genome assemblies using Parsnp v1.2 
(Treangen et al., 2014), as described in section 2.2.1. One of the output files from Parsnp is a 
maximum-likelihood phylogenetic tree, reconstructed from the alignment, based on core 
genome SNP analysis. Phylogenetic trees were visualised using iTOL (http://itol.embl.de/) 
(Letunic and Bork, 2016) and trees were annotated with coloured bars to display metadata 
encompassing information on isolation source and presence of antibiotic resistance genes and 
virulence-associated genes. Reference genomes belonging to each of the following phylogroups 
(A, B1, B2, D, E, and F) or cryptic clades (clade I to V) were included in the initial phylogenetic 
tree. Reference genomes were selected from the genomes analysed in previous studies (Kaas et 
al., 2012; Luo et al., 2011). Each strain was then assigned to a phylogroup or a cryptic clade 
based on the position in the phylogeny. 
2.6.5. Pan-genome analysis 
Pan-genomes were constructed from the annotated genome assemblies produced by Prokka 
(GFF3 format) using Roary v3.8.2 (Page et al., 2015). Each input file should have a unique locus 
tag for the gene IDs to make it easier to identify where the genes came from. A gene presence 
and absence spreadsheet (CSV file) was produced as an output of Roary, which lists each gene 
and the strains they are present in. The accessory genomes of strains were analysed by excluding 
genes present in ≥ 85% of strains. The gene product functions of excluded genes were evaluated 
and were confirmed to be core genes of the E. coli genome. The query_pan_genome script, 
which takes the annotated GFF files and clustered_proteins output file from Roary, was run to 
identify genes that were either unique or shared between the human-clinical and non-human 
populations of E. coli. Any unique or shared genes were listed with strains in separate CSV files. 
Gene presence and absence matrices were annotated on core genome phylogenetic trees and 
visualised with associated metadata, using the interactive tool Phandango v1.1.0 (Hadfield et 
al., 2018; https://github.com/jameshadfield/phandango).  
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2.6.6. Detection of recombinant genomic regions 
Core genome alignments were constructed using Parsnp (Treangen et al., 2014), as described in 
section 2.2.1. Genomic recombination events between strains were detected by running the 
Gubbins v2.2.0 (Genealogies Unbiased By recomBinations In Nucleotide Sequences) (Croucher 
et al., 2015) algorithm on the core genome FASTA alignment, with default parameters. 
Recombination predictions were output in a GFF file and the recombination blocks were then 
visualised against the core phylogenetic Newick-formatted tree and associated metadata, using 
Phadango (Hadfield et al., 2018). 
2.6.7. Statistical analyses 
In this study, statistical analyses were performed to compare the prevalence of extended 
spectrum β-lactamase genes and sequence types between populations. p-values were 
calculated with two tails using the GraphPad QuickCalcs Fisher’s test calculator 
(https://www.graphpad.com). A p-value of p < 0.05 would indicate a statistically significant 
association. Moreover, p values of p < 0.001 and p < 0.0001 were considered very statistically 
significant, and highly statistically significant, respectively.  
Shannon diversity index values and the Hutcheson t-test were used to compare the diversity of 
the human-clinical and non-human populations of E. coli. These were calculated using a custom 
Excel spreadsheet. 
Comparisons between the observed and expected proportions of genes shared between the 
human-clinical and non-human populations were made by performing a permutation test with 
pseudo-random re-sampling of the population without replacement of genomes. This approach 
considered gene frequencies, and all strain-specific genes were excluded from the analysis. 
Permutations were carried out 1,000 times iterating for each gene category, and each 
permutation involved picking the same number of genomes as there are genes in that category. 
To test the significance of differences between expected and observed frequencies of gene 
sharing, one-tailed empirical p-values were calculated. The permutation script was written by 
Ben Dickins (NTU) and simulated proportions were plotted as histograms, with the observed 
proportions mapped on the graphs for comparison. Graphs were produced using the tidyverse 
package (Wickham, 2017) of the R statistical software v3.5.1 (http://www.r-project.org/; R Core 
Team, 2015). 
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CHAPTER 3 
Ecology and evolution of a global 
population of Yersinia pseudotuberculosis 
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3.1. Introduction 
The genus Yersinia belongs to the Gram-negative Enterobacteriaceae and it constitutes a model 
genus for studying bacterial pathogen ecology and evolution (McNally et al., 2016b). The 
majority of Yersinia species are found widely in the environment, including soil, and do not 
usually cause disease in mammals. There are three main species of Yersinia which are well-
recognised human pathogens: the plague bacillus Yersinia pestis, and the enteropathogenic 
Yersinia enterocolitica and Yersinia pseudotuberculosis (McNally et al., 2016b). Y. 
pseudotuberculosis, which causes infection in a wide range of hosts such as domesticated and 
wild animals, has also been implicated in foodborne infection in humans, which is known as 
yersiniosis. Transmission of the bacterium is usually via the faecal–oral route, and human 
infection can result from ingestion of contaminated food products or water, or alternatively by 
direct contact with an infected animal or human (Savin et al., 2014; Chiles et al., 2002). Although 
Y. pseudotuberculosis is not as frequently associated with human gastrointestinal yersiniosis as 
Y. enterocolitica, both are important pathogens with similar clinical manifestations associated 
with infection. These can include fever, abdominal pain, and diarrhoea. In some uncommon 
cases, extraintestinal symptoms such as reactive arthritis and erythema nodosum can occur 
(Jalava et al., 2006). Additionally, in more severe cases, infection can disseminate to the 
bloodstream and deep tissues (Kaasch et al., 2012).  
Classically, identification and typing of Y. pseudotuberculosis has been based on serotyping of 
the lipopolysaccharide O-antigen, with a total of 21 serotypes identified, including 6 originally 
classified as subtypes of either O:1, O:2, O:4 or O:5 (Skurnik, Peippo and Ervela, 2000). Previous 
studies have indicated that the majority of strains isolated from human cases belong to 
serotypes O:1a, O:1b, and O:3 (Williamson et al., 2016; Laukkanen-Ninios et al., 2011). The 
application of serotyping methods provides only a low-level resolution when investigating 
potential outbreaks of Y. pseudotuberculosis, suggesting the need for higher resolution typing 
methods. The population structure of Y. pseudotuberculosis has been defined by multilocus 
sequence typing (MLST) previously (Laukkanen-Ninios et al., 2011), adding detail to the serotype 
differentiation. It was revealed that serotype O:1 strains formed a distinct clade of strains which 
represented a large number of sequence type complexes, suggesting a highly diverse population 
of bacteria within the serotype O:1 group, and thus an overall high diversity of the Y. 
pseudotuberculosis species (Laukkanen-Ninios et al., 2011). In addition to MLST genotyping, a 
recent study has also analysed clustered regularly interspaced short palindromic repeat (CRISPR) 
loci of a large collection (n = 355) of Y. pseudotuberculosis isolates (Koskela et al., 2015). The 
CRISPR system is an adaptive RNA-based immune system that constitutes a bacterial defence 
against foreign nucleic acids derived from invading bacteriophages or plasmids. CRISPRs are 
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constructed from a chain of 21 to 47 bp repeated sequences called direct repeats (DR), and in 
between DRs are unique spacer sequences, which represent the acquired foreign DNA. One of 
the key findings from the study by Koskela and colleagues (2015) was that despite the genetic 
similarity between Y. pseudotuberculosis and Y. pestis, strains of these species shared very few 
CRISPR spacers, suggesting that CRISPR analysis can be used to inform bacterial evolution. 
Although most infections with Y. pseudotuberculosis are thought to be sporadic (Sunahara, 
Yamanaka and Yamanishi, 2000), this pathogen has been responsible for several nationwide 
gastrointestinal outbreaks of foodborne infection in countries of largely temperate climates, 
such as Finland, Russia, France and New Zealand (Williamson et al., 2016; Kangas et al., 2008; 
Jalava et al., 2006; Nuorti et al., 2004). More recently, in 2014, a sustained outbreak of 
yersiniosis caused by Y. pseudotuberculosis occurred in New Zealand, affecting all the major 
cities of the country (Williamson et al., 2016). With a total of 220 laboratory-confirmed cases of 
infection reported, this outbreak constitutes one of the largest globally reported outbreaks of 
human yersiniosis due to Y. pseudotuberculosis, to date. Prior to the present study, the most 
inclusive genome-scale analysis of Y. pseudotuberculosis focussed on the outbreak in New 
Zealand (Williamson et al., 2016). Genomic and epidemiological analyses in that study suggested 
a single point-source contamination of the food chain, with subsequent nationwide distribution 
of contaminated produce. Additionally, through incorporation of publicly available reference 
genomes within the context of a globally and taxonomically diverse dataset, the study indicates 
that Y. pseudotuberculosis is a highly diverse species and that the New Zealand strains 
represented a geographically isolated clade of Y. pseudotuberculosis. 
Large-scale population genomics studies have been performed on the two other human 
pathogenic Yersinia, Y. pestis and Y. enterocolitica (Reuter et al., 2015; Reuter et al., 2014; 
Morelli et al., 2010), allowing a high-resolution understanding of the ecology, evolution and 
dissemination of these pathogens. Global phylogenomic studies of Y. pestis have identified 
evolution from a clone of Y. pseudotuberculosis, as a result of gene loss and subsequent global 
dissemination (McNally et al., 2016b; Morelli et al., 2010). In contrast, similar global genomic 
studies of Y. enterocolitica have suggested an evolutionary path from a non-pathogenic ancestor 
through gene gain and loss, resulting in apparently ecologically separated clades within the 
species (Reuter et al., 2015; Reuter et al., 2014). A recent study by our group involved population 
genomic analysis of Y. enterocolitica, through means of examining patterns of recombination in 
both the core and accessory genome of the species  (Reuter et al., 2015). The study highlights 
that genetic flow in the species does not occur frequently between phylogroups of Y. 
enterocolitica, and when it does, it is primarily unidirectional with one phylogroup acting largely 
as a genetic reservoir for the rest of the species. Additionally, the data revealed hidden 
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ecological patterns and the analysis suggests that the distinct phylogroups of Y. enterocolitica 
may be ecologically separated, with phylogroup 1 (PG1) being ubiquitous and most commonly 
isolated from non-human environments, whilst PG2–5 are more commonly isolated from human 
disease cases (Reuter et al., 2015). The Y. enterocolitica study draws parallels with a study of 
Escherichia coli where core genome recombination was not observed between environmental 
and human/animal isolates; recombination was only detected between environmental isolates 
or between human and animal isolates (Luo et al., 2011). Furthermore, ecological separation 
within a hospital environment, leading to reduced recombination between isolated 
subpopulations of the nosocomial pathogen Enterococcus faecium has been reported previously 
(Willems et al., 2012). The observation of host-restricted lineages of Campylobacter jejuni 
(Sheppard et al., 2014) is further supportive of ecological barriers playing a major role in 
restricting genetic flow and recombination, and thus leading to the formation of distinct 
ecotypes within a bacterial species.  
3.1.1. Aim and objectives 
Given the observation of ecologically separated lineages in Y. enterocolitica, and considering 
that Y. pseudotuberculosis is a closely related species that is also heterogeneous and ubiquitous 
in nature, it would be beneficial for our understanding of microbial evolution to investigate 
whether similar ecological inferences can be made for Y. pseudotuberculosis. To contribute a 
high-resolution genomic view into the ecology, evolution and dissemination of this important 
human pathogen, a data set of globally and temporally distributed Y. pseudotuberculosis 
genomes, from multiple ecosystems, were analysed in this chapter. This was achieved by 
employing highly discriminatory comparative genomic techniques, such as pan-genome analysis 
and core genome recombination analysis. 
Specific objectives of this chapter were: 
• To reconstruct the phylogeny of a global population of Y. pseudotuberculosis and 
identify any genomic signatures correlated with the ecology of the Y. pseudotuberculosis 
population.  
• To investigate the evolutionary history of Y. pseudotuberculosis by performing dating 
analysis to date the phylogeny of the species. 
• To determine whether any patterns of gene flow exist within the Y. pseudotuberculosis 
population by analysing the core and accessory genomes of these strains.  
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3.2. Materials and Methods 
The key methods, bioinformatic tools and scripts used in this chapter were described previously 
in section 2.2. of chapter 2 ‘Materials and Methods’. A total of 134 Y. pseudotuberculosis 
genomes were analysed in this chapter (Table 3.1), of which 108 were recently sequenced and 
were provided as genome sequence (FASTA) files by Mikael Skurnik (University of Helsinki). 
These isolates were collected over a 46-year time frame from 19 different countries across 6 
continents, and represent the full spectrum of serotypes possible. Additionally, the strains were 
isolated from a wide range of hosts including livestock, wild animals and companion animals, 
human-clinical and environmental sources. Library preparation and sequencing of these isolates 
were performed using the Illumina Nextera kit and Genome Analyzer IIx instrument to create 
150 bp paired-end reads. This was carried out by Mikael Skurnik and Laura Kalin-Mӓnttӓri at the 
FIMM Sequencing unit (Helsinki, Finland). De novo assemblies were achieved using Velvet v1.2.1 
(Zerbino and Birney, 2008) and annotated using Prokka v1.12 (Seemann, 2014). The raw 
sequence reads were deposited to the European Nucleotide Archive (ENA) under project 
PRJEB14064. Additionally, de novo assemblies of all genomes used are available on Enterobase 
(https://enterobase.warwick.ac.uk/species/index/Yersinia), searchable by the strain names or 
ENA accession numbers listed in Table 3.1. Metadata regarding information on isolation 
(continent, country, host, and year), sequence type, serotype, and CRISPR spacer are available 
for the majority of strains. The CRISPR loci were identified by Katja Koskela (University of 
Helsinki) using BLASTN (Koskela et al., 2015). The full list of spacer arrays used for CRISPR spacer 
clustering for the strains analysed in this study are available from doi: 10.1099/mgen.0.000133 
as supplementary material (Seecharran et al., 2017). 
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Table 3.1. Y. pseudotuberculosis genomes used in this study. 
Strain Year ST* Serotype CRISPR cluster Host Continent Country Accession number 
1180/95 1995 - 1a 20 - - - ERR1448065 
2384 - 19 3 35 - - - ERR1448071 
CIP 55.85 1952 - 1 11 Turkey - - ERR1447956 
PST25 - 43 - 38 - - - ERR1447955 
2515 - - 2 32 - - - ERR1448073 
P 105 1990 14 - 9 Buffalo - - ERR1448074 
PST2660 - 14 3 9 - - - NC_010465 
PST1813 - 14 4 26 - - - ERR1448070 
YPIII - - 3 9 - - - ERR1448072 
IP32544 - 19 3 - Pig Africa South Africa ERR024924 
488 - - 1a - Salmon Asia Russia ERR024916 
514 - - 1a 20 Salmon Asia Russia ERR1448002 
RU496 - - 1a 20 Reindeer Asia Russia ERR1448001 
489 - - 1a 20 Reindeer Asia Russia ERR1447987 
RU488 - 42 1a 20 Salmon Asia Russia ERR1448003 
N912 - 14 2b - Rabbit Asia China ERR1447986 
H722-36/88 1986 11 6 8 Dog Asia Japan ERR024920 
IP33177 - 26 1 - Cabbage Asia Russia ERR1447974 
DC356 - 33 1b 6 Cat Asia Japan ERR1447962 
Pa3606 - 2 1b 40 Human Asia Japan ERR1447976 
H-1 - 2 1b 12 Human Asia Russia ERR1447977 
H-158 - - 1b 12 Human Asia Russia ERR1447978 
H-2212 - 2 1b 12 Human Asia Russia ERR1447979 
H1647 - - 1b 12 Human Asia Russia ERR1448019 
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H416 - 2 1b 12 Human Asia Russia ERR1448021 
Pa3597 - - 1b 40 Human Asia Japan ERR1448022 
8011-3 - 33 1b 15 Human Asia Japan ERR1448013 
IP31758 1966 37 1b 12 Human Asia Russia NC_009708 
Gifu-liver - 38 1b 13 Monkey Asia Japan ERR1448026 
MW145-2 - 89 1b 40 Freshwater Asia Japan ERR1448014 
H1746 - 2 1b 12 Small mammal Asia Russia ERR1447980 
H2517 - - 1b 12 Small mammal Asia Russia ERR1447981 
H404 - - 1b 12 Small mammal Asia Russia ERR1448020 
Wla352 - - 1b 37 Racoon dog Asia Japan ERR1447975 
1231 1985 2 4b - Small mammal Asia Russia ERR024910 
Soil-4 - 33 1b 15 Environment Asia Japan ERR1447973 
MW Taniguci - - 1b 37 Freshwater Asia Japan ERR1448015 
SP93422 1993 1 15 - Human Asia Korea ERR027412 
D1040 - 44 2b 25 Dog Asia Japan ERR1448036 
Wla708 - 33 1b 40 Duck Asia Japan ERR1447970 
K22 - 40 5a 23 Human Asia Japan ERR1447990 
79136 - 88 1b 16 Human Asia Korea ERR1448017 
Uematu289 - - 1b 2 Human Asia Japan ERR1448028 
Chigamatsu - - 1b 4 Human Asia Japan  ERR1448032 
GS95 - 43 3 1 Human Asia China ERR1448040 
IP33250 - 32 3 - Human Asia Russia ERR024921 
PC94-72 - 44 4a 25 Pig Asia Japan ERR1447989 
TP1039 - - 1b 3 Pig Asia Japan  ERR1448027 
PT682 1987 52 2b 37 Pig Asia Japan ERR024908 
PC504 - 44 2c 2 Pig Asia Japan ERR1448037 
S106 - - 1b 1 Rabbit Asia China ERR1447972 
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J51 - 47 13 31 Rabbit Asia China ERR1447991 
R103-2 - 45 5b 7 Rabbit Asia China ERR1448042 
R104-2 - 46 5b 14 Rabbit Asia China ERR1448043 
OK5586 1990 62 3 - Racoon dog Asia Japan ERR024907 
OK6088 1990 18 10 5 Racoon dog Asia Japan ERR027411 
CN2 - 49 1c 21 Small mammal Asia China ERR1447988 
DD362 - - 1b 29 Dog Asia Japan ERR1447984 
PC708 - 3 1b 6 Pig Asia Japan ERR1447985 
T-469-1 - - 1b 29 Pig Asia Japan ERR1448025 
RD20 - 31 1b 37 Racoon dog Asia Japan ERR1447971 
TE-93181 - 3 1b 29 Racoon dog Asia Japan ERR1448033 
2814/1998 1998 - 1a 20 Hare Europe Finland ERR1448038 
3822/2000 2000 - 1a 20 Hare Europe Finland ERR1448068 
IH111554 - 42 1a - Cat Europe Finland ERR1447982 
103 - 42 1a 20 Small mammal Europe Italy ERR1448016 
PB1 1960 68 1a 10 Small mammal Europe England ERR1448064 
2886 - 42 1a 10 Hare Europe Italy ERR1448029 
2809/1998 1998 - 1a 20 Small mammal Europe Finland ERR1448030 
15193/74 1974 - 1a 20 Human Europe Finland ERR1448031 
Rollier - 42 1a 20 Human Europe Belgium ERR024925 
H655-36/87 1987 42 1a 20 Human Europe Germany ERR1448048 
Y.PT/8 - 42 1a 20 Human Europe Belgium ERR1447966 
921/93 1993 - 1a 20 Human Europe Sweden ERR1448063 
11J - 42 - 20 Human Europe France ERR024923 
IP32953 - - 1b 42 Human Europe France ERR024927 
2800/1998 1998 - 1a 41 Jack daw Europe Finland ERR024926 
104 - 42 1a - Pigeon Europe Italy ERR024930 
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504/72 1972 42 1a 20 Duck Europe Italy ERR1448035 
Y722 1988 19 1 35 Human Europe Germany ERR1448060 
25418L - 9 1a 11 Canary Europe Denmark ERR1448057 
H943-36/89 1989 9 1a 11 Hare Europe Germany ERR1448010 
St.1 - - 1a 11 Human Europe Germany ERR1447963 
H892-36/87 1987 12 1a 39 Human Europe Italy ERR1448069 
H942-36/89 1989 9 1a 11 Human Europe Germany ERR1448062 
2895 - 43 1b 22 Bird Europe Italy ERR1448056 
2817/1998 1998 - 1b 22 Hare Europe Finland ERR1448061 
3858/2000 2000 - 1b 38 Hare Europe Finland ERR1448044 
H749-36/89 1989 43 1b 22 Duck Europe Germany ERR024903 
2887 - 43 1b 38 Hare Europe Italy ERR1448045 
H938-36/89 1989 43 1b 38 Hare Europe Germany ERR1448049 
2497 - 43 1b 38 Hare Europe Italy ERR1448052 
3876/2001 2001 - 1b 22 Hare Europe Finland ERR028208 
2812/79 1979 - 1b 38 Human Europe Finland ERR1447993 
866/81 1981 - 1b 38 Human Europe Finland NC_010634 
36/83 1984 - 1b 38 Human Europe Finland ERR1448008 
Tytgat - 43 1b 38 Human Europe Belgium ERR1448047 
Y.PT/7 - 43 1b 38 Human Europe Belgium ERR1447959 
42/00 2000 - 1b 22 Human Europe Sweden ERR1447996 
G2/77/2 1977 43 1b - Pet bird Europe Denmark ERR1447999 
G798/82/1 1982 43 1b 38 Pet bird Europe Denmark ERR1448004 
8597L - 43 1b 38 Pet bird Europe Denmark ERR1448066 
IP32670 - 43 1 - Pig Europe UK ERR1447954 
2812/1998 1998 - 1b 22 Pigeon Europe Finland NC_006155 
2889 - 43 1b 22 Turkey Europe Italy ERR1448046 
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IP33290 - - 1 38 - Europe France ERR1447992 
IP32463 - 16 5 - Small mammal Europe Switzerland ERR024894 
IP32921 - 16 2 - Hare Europe France ERR1448005 
IP32881 - 16 2 - Monkey Europe Switzerland ERR1447997 
IP33054 - 14 2 - Human Europe Spain ERR1447961 
2884 - 14 2a 2 Rabbit Europe Italy ERR1448000 
1435/8/2004 2004 - 1b 28 Carrot Europe Finland ERR1447998 
2161/13/2006 2006 - 1b 28 Environment Europe Finland ERR1448023 
Marsu 1980 14 3 9 Small mammal Europe Finland ERR1448050 
7616/84 1984 - 1a 9 Human Europe Finland ERR1448053 
2874/2003 2003 - 1b 28 Environment Europe Finland ERR1447983 
2484/2006 2006 - 1b 28 Environment Europe Finland ERR1447965 
3623/13/2004 2004 - 1b 28 Small mammal Europe Finland ERR1448011 
5456/85 1985 - 1b 12 Human Europe Finland ERR1448024 
Y718 1986 2 1b 15 Human Europe Germany ERR1448054 
677/82 1982 - 1b 12 Human  Europe Finland ERR1447957 
260 - 42 1a - Human North America Canada ERR024902 
Y716 - 19 1a 35 Small mammal North America USA ERR024914 
283 - 14 1b 28 Human North America Canada ERR1447968 
284 - 14 1b 4 Human North America Canada ERR1447969 
G5137 - 42 1a 20 Cow Oceania Australia ERR024929 
BB1152 - 42 1a 10 Deer Oceania New Zealand ERR024917 
No.93 - 42 1a 10 Goat Oceania New Zealand ERR1447995 
No.21 - 86 1a 11 Cattle Oceania New Zealand ERR1447994 
H305-36/89 1989 43 1b 22 Deer Oceania Australia ERR1448007 
IP33038 - 43 1 - Small Mammal Oceania Australia ERR1448006 
No.5 - 54 2b - Goat Oceania New Zealand ERR1448012 
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BF-1 - - 1a 35 Buffalo South America Brazil ERR1447967 
IP32938 - 19 3 - Cattle South America Argentina ERR024928 
 
Table 3.1. Y. pseudotuberculosis genomes used in this study. 
Strains underlined in the table were sequenced as part of a previously published study (Reuter et al., 2014). All other strains listed were isolated and sequenced as described in 
section 3.2 and were published recently (Seecharran et al., 2017).  
*ST: multilocus sequence type according to MLST databases at the University of Warwick, Warwick Medical School 
(http://mlst.ucc.ie/mlst/dbs/Ypseudotuberculosis/GetTableInfo_html) (Laukkanen-Ninios et al., 2011).  
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3.3. Results and Discussion 
3.3.1. Phylogeographic structure of Y. pseudotuberculosis indicates an Asian ancestry 
for the species 
A maximum-likelihood SNP-based phylogenetic tree was reconstructed from a core genome 
alignment of 134 Y. pseudotuberculosis genome sequences built using Parsnp (Treangen et al., 
2014). This analysis revealed that the phylogeny of the Y. pseudotuberculosis population is 
characterised by clades of varying genomic diversity (Fig. 3.1). There is a clade containing high 
levels of diversity, indicated by long branch lengths and a clade containing noticeably lower 
levels of diversity, as shown by much shorter branch lengths. Inclusion of a selection of Y. similis 
and Y. wautersii strains (Appendix 2) on the tree as an outgroup confirmed the highly diverse 
clade to be the ancestral clade for Y. pseudotuberculosis, as indicated by the tree topology 
(Appendix 3). Geographical source of isolation is available as part of the metadata for the 
majority of strains in the population. The phylogenetic tree was annotated with the continent 
of origin for each strain, where available, as illustrated by coloured bars at the branch tips in 
Figure 3.1. With regards to most of the strains isolated from Russia (Table 3.1), it was not entirely 
clear what specific geographical region these isolates were derived from. However, with the 
presence of Siberian isolates in the data set (e.g. strain IP33177), all strains obtained from Russia 
were accordingly categorised as being isolated from Asia. Annotation of continent of origin data 
revealed a very clear geographic split in the phylogeny, with the ancestral highly diverse clade 
containing predominantly Asian origin isolates and the second low diversity clade containing 
predominantly European origin isolates. A small transitional cluster of isolates originating from 
South Africa, North and South America, and Europe can be seen between the two distinct clades. 
The phylogenetic structure of globally dispersed isolates demonstrated in this chapter is 
consistent with an Asian origin for Y. pseudotuberculosis, with two separate migrations into 
Africa and the Americas, and more recently into Europe. An Asian ancestry of the Y. 
pseudotuberculosis species is in line with the postulated ancestry of Y. pestis (Morelli et al., 2010; 
Achtman et al., 1999), which is a clone that recently evolved from Y. pseudotuberculosis within 
the last 3,000 to 6,000 years, shortly before the first known human plague pandemics originating 
from central Asia. The data from the present study, however, appear to show that the greatest 
genetic variation occurs in Japan, not China. This does not appear to be an artefact of the 
geographical sampling in this chapter, however, it cannot be discounted that a more thorough 
and dense genomic sampling may provide a different result. Migration of isolates into Europe is 
consistent with a bottleneck event leading to the successful establishment of a small number of 
clones, as demonstrated by the low genetic diversity exhibited by the European clade of isolates.
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Fig. 3.1. Maximum-likelihood phylogenetic tree of 134 Y. pseudotuberculosis isolates. The phylogeny is derived from a core genome alignment (2,947,945 bp, 1,042,987 
SNPs) constructed using Parsnp and the tree was visualised using iTOL. The scale bar corresponds to the number of nucleotide substitutions per site. Continent of origin is 
superimposed on the tree as coloured bars. Geographic clades are defined by tree branch colouring. There is a clear phylogeographic split in the population, with the ancestral, 
highly diverse clade containing primarily Asian isolates and a second low diversity clade containing primarily European isolates. A small transitional cluster of African, American, 
and European isolates exists between the two clades. 
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3.3.2. Phylogenetic clusters within Y. pseudotuberculosis associate with discrete 
CRISPR cassette patterns 
CRISPR spacer data were available as part of the metadata for the majority of Y. 
pseudotuberculosis strains analysed in this chapter. The CRISPR loci for these strains were 
identified previously by Katja Koskela (University of Helsinki) using BLASTN (Koskela et al., 2015). 
Bayesian clustering of the presence/absence of all 2,969 known Y. pseudotuberculosis CRISPR 
spacers present in the data set (performed by Jukka Corander, University of Oslo) identified a 
total of 33 distinct sequence clusters of CRISPR cassettes (Table 3.1, section 3.2). The CRISPR 
cluster data were used initially to determine any obvious genotypic traits associated with the 
phylogeographic split observed in the Y. pseudotuberculosis population. Each identified CRISPR 
cluster was annotated on to the Y. pseudotuberculosis maximum-likelihood phylogenetic tree as 
coloured bars, using iTOL (Fig. 3.2).  
This analysis revealed the striking observation that CRISPR clusters form phylogenetically distinct 
groups within the Y. pseudotuberculosis population. The highest diversity of CRISPR clusters was 
found in the ‘Asian’ phylogenetic clade, with at least 23 of the 33 identified CRISPR clusters 
represented in this clade. Conversely, the ‘European’ clade exhibited the lowest diversity of 
CRISPR clusters, with isolates belonging primarily to clusters 10, 11, 20, 22, and 38. This 
observation indicates a correlation between diversity of CRISPR clusters and genomic diversity 
within each geographic clade. The phylogenetic distribution of CRISPR cluster cassettes 
observed here may suggest that this clustering could be a result of strains isolated in the same 
short time span or localised source. However, closer examination of the CRISPR cluster pattern 
to isolation year and geographical source of isolation (Table 3.2) suggests that this is not the 
case. For strains with isolation dates available, the temporal sampling indicates that strains of 
these CRISPR clusters were generally isolated in separate time periods. Furthermore, there are 
instances where strains from clusters 9, 11, 12, 20, 22, and 38 have a temporal separation of at 
least a decade or more (Table 3.2).  
To confirm the global geographical distribution of strains belonging to each of the 33 identified 
CRISPR clusters, prevalence of all CRISPR clusters were mapped to their respective countries of 
isolation (Fig. 3.3). The global map shows that CRISPR clusters are widely distributed across the 
world with some correlation to the phylogeographic split observed earlier in Figure 3.1. The 
highest diversity in CRISPR clusters occurs in the Far East of Asia, which is consistent with an 
Asian ancestry of Y. pseudotuberculosis (Achtman et al., 1999). The map also illustrates a clear 
coexistence of multiple CRISPR cluster-type strains in a number of different countries, suggesting 
that the formation of phylogenetically distinct CRISPR clades cannot be attributed to the 
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geographical separation of these strains. Given the previous observation that CRISPR evolution 
in the Enterobacteriaceae, in particular, is controlled by vertical and not horizontal evolution 
(Kupczok, Landan and Dagan, 2015), it is possible that the CRISPR-associated phylogenetic 
lineages observed in this study represent descent rather than due to CRISPRs restricting gene 
flow between strains. Some vertical descent may occur for independent reasons so, while 
CRISPR correlates with phylogeny, this does not necessarily mean that it is causal. This 
warranted further investigation into the formation of these CRISPR clades through phylogenetic 
dating and analysis of gene sharing in sections 3.3.4 and 3.3.5, respectively. 
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Figure 3.2. Maximum likelihood phylogenetic tree of 134 Y. pseudotuberculosis isolates annotated with 
the 33 identified CRISPR clusters. 
CRISPR clusters are determined by Bayesian clustering of concatenated CRISPR spacer sequence arrays and 
are annotated on the phylogenetic tree as coloured bars using iTOL. The tree is rooted by midpoint rooting.
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Figure 3.3. Global map showing the geographical sources of isolation of strains belonging to each of the 33 identified CRISPR clusters.  
Thirty-three unique CRISPR cluster types were identified in the population. The pie charts represent the proportions of each CRISPR cluster type prevalent in each country. The 
map demonstrates a clear coexistence of multiple CRISPR cluster-type strains in a number of countries.
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Table 3.2. CRISPR cluster-type Y. pseudotuberculosis strains with known isolation dates. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For strains with isolation dates available, strains belonging to the same CRISPR cluster were generally 
isolated across different time periods, and in some cases, from separate geographical locales.  
Strain name CRISPR cluster Country Year 
OK6088 5 Japan 1990 
H722-36/88 8 Belgium 1988 
7616/84 9 Finland 1984 
Marsu 9 Finland 1980 
P 105 9 - 1990 
PB1 10 England 1960 
H942-36/89 11 Germany 1989 
H943-36/89 11 Germany 1989 
CIP 55.85 11 - 1952 
677/82 12 Finland 1982 
5456/85 12 Finland 1985 
IP31758 12 Russia 1966 
Y718 15 Germany 1986 
2809/1998 20 Finland 1998 
3822/2000 20 Finland 2000 
2814/1998 20 Finland 1998 
15193/74 20 Finland 1974 
H655-36/87 20 Germany 1987 
504/72 20 Italy 1972 
921/93 20 Sweden 1993 
1180/95 20 - 1995 
H305-36/89 22 Australia 1989 
3876/2001 22 Finland 2001 
2817/1998 22 Finland 1998 
2812/1998 22 Finland 1998 
H749-36/89 22 Germany 1989 
42/00 22 Sweden 2000 
2874/2003 28 Finland 2003 
2161/13/2006 28 Finland 2006 
2484/2006 28 Finland 2006 
1435/8/2004 28 Finland 2004 
3623/13/2004 28 Finland 2004 
Y722 35 Germany 1988 
PT682 37 Japan 1987 
G798/82/1 38 Denmark 1982 
3858/2000 38 Finland 2000 
2812/79 38 Finland 1979 
866/81 38 Finland 1981 
36/83 38 Finland 1984 
H938-36/89 38 Germany 1989 
H892-36/87 39 Italy 1987 
2800/1998 41 Finland 1998 
 85 
 
3.3.3. Cryptic ecology suggests that Y. pseudotuberculosis is a host generalist 
In addition to the CRISPR cluster data, metadata concerning the serotype, country of origin, and 
host species/source of isolation were available for the majority of the Y. pseudotuberculosis 
population. With regards to O-antigen serotyping of these strains, a large proportion of the 
population comprise the O:1a, O:1b, and O:3 serotypes, which is consistent with previous 
studies indicating that the majority of Y. pseudotuberculosis strains isolated from human cases 
belong to these serotypes (Williamson et al., 2016; Laukkanen-Ninios et al., 2011). Other 
serotypes present in the population include serotypes O:2, O:4, O:5, and O:6, although these 
were lower in prevalence. All additional metadata were annotated onto the phylogenetic tree 
as coloured bars and the ‘Asian’ and ‘European’ clades were defined by tree branch colouring 
(Fig. 3.4). This analysis revealed that the ‘European’ clade is further split into distinct serotype 
O:1a and serotype O:1b phylogenetic clusters, further demonstrating the low diversity of this 
clade and indicating the predominance of these lineages among human-clinical and non-human 
environments in Europe. The ‘Asian’ clade is predominantly composed of strains belonging to 
serotype O:1b, whilst exhibiting the highest diversity of serotypes with O:2, O:4, O:5, and O:6 
also present in this clade. With regards to the geographical distribution of serotypes, this is 
parallel to a previous study that revealed geographic heterogeneity between East Asian and 
Western European strains of Y. pseudotuberculosis (Fukushima et al., 2001). It was observed 
that almost all human-clinical strains from Europe belonged exclusively to serotypes O:1a and 
O:1b, whilst those from the Far East of Asia belonged to serotypes O:1b and a variety of subtypes 
of O:2–6 (Fukushima et al., 2001). Skurnik and co-authors (2000) suggested that the cryptic O-
antigen gene cluster of Y. pestis biovar Orientalis showed that Y. pestis is most closely related 
to, and has evolved directly from, a Y. pseudotuberculosis serotype O:1b strain, isolated from a 
patient in Japan. This suggestion, in conjunction with the high diversity of O:1b strains 
originating from the Far East observed in this chapter (Fig. 3.4), would provide further evidence 
to support an ancestry of the Y. pseudotuberculosis species associated with Asia and the Far 
East, in particular. 
Annotation of host species/isolate source on the phylogenetic tree did not reveal any clustering 
of strains within specific host groups (Fig. 3.4). This is indicative of the widespread ecology of Y. 
pseudotuberculosis across the globe, with isolates obtained from various sources including 
livestock and domesticated animals, wild animals and birds, fish, vegetables, and the 
environment, in addition to human disease cases. Isolates from all non-human sources were 
distributed throughout the phylogenetic tree and did not cluster separately to the human 
isolates, and the human sourced isolates did not cluster either. Although enteropathogenic Y. 
pseudotuberculosis and the closely related Y. enterocolitica are both aetiological agents for 
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human yersiniosis, there are notable differences in the ecologies of both organisms. Infections 
caused by Y. enterocolitica mainly originate from swine (Virtanen et al., 2013), but fresh 
produce, such as iceberg lettuce and raw carrots, has been the primary source for widespread 
Y. pseudotuberculosis outbreaks within recent decades (Kangas et al., 2008; Jalava et al., 2006). 
Despite the frequent presence of Y. pseudotuberculosis in environmental samples, its reservoir 
is considered to be wildlife (Niskanen, Fredriksson-Ahomaa and Korkeala, 2002). This would 
suggest that while Y. enterocolitica is more adapted to its ecological niche of swine, Y. 
pseudotuberculosis is more of a host generalist pathogen and has an ability to thrive and 
multiply in habitats such as the environment, from which it could easily disseminate into the 
food chain as a contaminant. Additionally, it would suggest that Y. pseudotuberculosis is capable 
of frequent host switching, and this is demonstrated in Figure 3.4, by strains belonging to the 
same serotype and CRISPR cluster that are isolated from multiple host species. Y. 
pseudotuberculosis is also common in pork meat, and in this study, isolates from swine samples 
are also prevalent in the population. Several strains obtained from swine samples (PC94-72, T-
469-1, IP32544, and IP32670) have clustered together with strains from other domesticated and 
wild animal samples, in each of the ‘Asian’, ‘Transitional’, and ‘European’ clades of the 
population (Fig. 3.4). This is consistent with a recent study that has demonstrated through 
comparative genomic hybridisation analysis that European Y. pseudotuberculosis strains from 
swine cluster together with strains from human and wildlife samples (Jaakkola, Somervuo and 
Korkeala, 2015). This is further supported by a previous study by Niskanen et al. (2002), who 
reported on the homogeneity of Y. pseudotuberculosis strains isolated from swine samples 
based on pulsed-field gel electrophoresis analysis. Of importance in the population of the 
current study is perhaps the prevalence of human-clinical isolates from multiple countries 
among each geographic clade. This may suggest that human Y. pseudotuberculosis infection 
occurs sporadically, affecting multiple nations in different time periods. Given that Y. 
pseudotuberculosis is widespread among different ecological niches, the distribution of human 
strains across the phylogeny may suggest that human populations, through domestication of 
animals and movement across the globe, have provided a vector for dissemination allowing Y. 
pseudotuberculosis to reach new habitats in Europe and the West. Although the distribution of 
Y. pseudotuberculosis is worldwide, it is clear from the data set that most strains originate from 
regions of the Northern hemisphere, such as Europe, North America, Russia, China, and Japan. 
This may be indicative of under-sampling from countries of the Southern Hemisphere, but the 
emergence and dispersal of successful lineages in Europe and North America would have been 
dependent on the species’ ability to adapt to significantly different conditions compared to 
those of its Asian origin, implying that Y. pseudotuberculosis has evolved to become a cold-
tolerant species.  
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Figure 3.4. Maximum-likelihood phylogenetic tree of 134 Y. pseudotuberculosis isolates annotated with 
all available metadata. Additional metadata regarding host species/source, serotype, and country of origin 
were annotated on the tree as coloured bars using iTOL. No phylogenetic grouping is associated with 
ecological patterns (host species/isolate source). The ‘European’ clade is split into serotype 1a and serotype 
1b clusters. 
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3.3.4. Phylogenetic dating suggests recent geographical divergence 
Of the 134 Y. pseudotuberculosis genomes sequenced, isolation dates were available for 46 
isolates representing the full diversity of the phylogeny. To date the evolutionary split of the 
‘European’ clade of isolates from the ‘Asian’ clade, the BEAST 2 program (Bouckaert et al., 2014) 
was run by Alan McNally (University of Birmingham), analysing only the 46 strains for which 
isolation dates were available. The resulting dated maximum clade credibility (MCC) tree (Fig. 
3.5A) suggests a time to the most recent common ancestor (TMRCA) for the data set of 33,591 
years before the present. Error bars for each node, representing the upper and lower values 
within the 95% HPD (highest probability density) from the BEAST analysis, are displayed in the 
MCC tree of Appendix 4. The tree also suggests that the divergence of the ‘European’ and ‘Asian’ 
clades occurred approximately 12,500 years ago, which in the context of the TMRCA for the data 
set represents a recent phylogeographic split (Fig. 3.5A). With regards to human history, this 
period coincides with the end of the last ice age, during the transitionary period between the 
Neolithic and Mesolithic eras (Achtman, 2017). Migration of ancestral Y. pseudotuberculosis 
from Asia to Europe, and then further dissemination towards the West, would also appear to 
correlate with the beginning of livestock domestication and wheat and barley farming, as human 
populations migrated across the globe during this time period, generally favouring a system of 
nomadic agriculture. Running the BEAST 2 analysis also produced a Bayesian Skyline 
reconstruction of the Y. pseudotuberculosis population (Fig. 3.5B). The Skyline plot suggests that 
the population size remained stable over time but it also supports the possibility of a strong 
bottleneck occurring in the population within the ‘European clade’, in the very recent past (i.e. 
in the last few hundred years), owing to the estimated population size reduction indicated in the 
figure. This is consistent with the reduction in diversity and establishment of only a small number 
of clones in Europe. 
We also sought to determine a TMRCA for the CRISPR-associated clades with isolation dates 
available. The CRISPR cluster patterns identified in Figure 3.2 were annotated onto the dated 
MCC tree (Fig. 3.5A) allowing an estimation of the time for the emergence of these clusters. The 
most recent of these clusters has a TMRCA to the rest of the population of approximately 5,222 
years before present, suggesting that this clustering is not a recent phenomenon, nor is it due 
to any temporal artefacts of the sampling. This corroborates the comparison of the CRISPR 
cluster pattern to isolation years in Table 3.2, and it also indicates that these CRISPR-associated 
clades have existed over a considerable period of time, with the oldest of these clusters being 
of predominantly Asian origin and the more recently emerged clusters largely of European 
origin.  
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Figure 3.5. (A) Dated maximum clade credibility (MCC) tree produced from BEAST 2 analysis performed 
on the 46 Y. pseudotuberculosis strains for which isolation dates are available. (B) Bayesian Skyline 
reconstruction from BEAST 2 analysis. The dating analysis was performed by Alan McNally (University of 
Birmingham), using the BEAST 2 program with all known dates of isolation used to date individual taxa. The 
MCC tree (A) was produced and visualised using FigTree. The tree is annotated with CRISPR clusters as 
determined by Bayesian clustering of concatenated CRISPR sequence arrays. The Skyline plot (B) shows the 
estimated effective population size through time, as inferred by the Skyline demographic model. 
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3.3.5. CRISPR-associated phylogenetic clusters are associated with patterns of 
accessory gene conservation and core genome recombination 
Phylogenetic distinctions were observed between the CRISPR clusters of the Y. 
pseudotuberculosis population analysed in this chapter, based on core genome SNP analysis. 
Further comparative genomic analyses, taking consideration of the accessory and pan-genomes 
of these strains, would provide a high-resolution assessment of the extent of homogeneity 
between strains of the same CRISPR cluster. Considering the role of CRISPR in generating 
acquired immunity to foreign DNA across bacteria, an investigation was carried out to determine 
whether the CRISPR clusters within Y. pseudotuberculosis were associated with any signature of 
gene sharing. Firstly, a pan-genome matrix was created for all 134 genomes using the LS-BSR 
pipeline (Sahl et al., 2014), and then the accessory genomes were extracted from the pan-
genome matrix by running the post-matrix Python script filter_BSR_variome.py, which is 
provided by LS-BSR. Genes prevalent in > 90% of strains, and also those found in fewer than 5 
strains, were excluded as they were not of interest for this analysis. The resulting accessory 
genome matrix was visualised by generating a heat map using the ggplot2 package of the R 
statistical software (http://www.R-project.org/; R Core Team, 2015; Wickham, 2016), allowing 
the presence and absence of every distinct genetic locus in the Y. pseudotuberculosis accessory 
genome to be displayed. The accessory gene presence/absence matrix was then used to 
annotate the core phylogenetic tree alongside the CRISPR cluster patterns (Fig. 3.6). From this 
analysis, it is noticeable that there are clear patterns within the accessory genome profiles which 
are concordant with the pattern of CRISPR clusters on the phylogenetic tree. Some of the most 
discernible patterns are highlighted on the phylogenetic tree, which include CRISPRs 9, 10, 11, 
12, 20, 22, 28, and 35. This observation would suggest that for the majority of CRISPR clusters, 
Y. pseudotuberculosis strains have conserved unique combinations of accessory genes according 
to the CRISPR cluster they belong to. Despite coexisting with other CRISPR cluster-type strains 
in the same ecological niches and in close geographical proximity, where opportunities for gene 
sharing to occur would be frequent, it suggests that horizontal gene transfer between different 
CRISPR cluster-type strains is highly restricted. 
Another interesting observation was made in the accessory gene profiles with respect to the 
clusters of strains representing CRISPRs 22 and 35. These strains exhibit much smaller accessory 
genome profiles when compared to the rest of the population. This observation is exemplified 
by these clusters of strains lacking a number of genes that are present in the majority of the 
population, which can be seen from ~100–300 on the accessory loci index (𝑥–axis). Assembly 
quality analysis of these strains indicate that they are good quality and are complete sequenced 
genomes, with an average N50 of 116,376 bp and average genome size and GC content of 4.5 
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Mbp and 47.5%, respectively, which is within the range of what is expected for Y. 
pseudotuberculosis (genome sizes range from 4.3–4.8 Mbp and GC content ranges from 47–
48%). Furthermore, no genomes had dropped-out; all genomes were within the average range 
for genome size, N50 and GC content. The disparity in accessory genome content when 
compared to the rest of the population cannot therefore be due to poor assembly quality. 
Bacterial pathogens often have smaller genomes and fewer genes than their non- or less-
pathogenic relatives. The same pattern is seen within some bacterial species, with repeated 
transitions to higher virulence associated with reductive genome evolution (Weinert and Welch, 
2017). With this in mind, the smaller accessory genomes exhibited by the strains of CRISPR 
clusters 22 and 35 may suggest that these strains have undergone significant accessory gene-
loss events in comparison to the rest of the population, perhaps indicating an evolutionary shift 
to more pathogenic lineages. 
To further investigate the congruence between CRISPR cassette clusters and accessory gene 
patterns, the Python script compare_BSR.py, of LS-BSR (Sahl et al., 2014), was used to identify 
genes unique to any given CRISPR cluster, as well as genes unique to either the ‘European’ clade 
of strains or the ’Asian’ clade of strains. Attempts made to identify any unique genes in each 
CRISPR cluster and geographic clade were largely unsuccessful. Only one unique coding 
sequence (CDS) was detected in the ‘European’ clade of strains and no unique CDSs in the ‘Asian’ 
clade. Of CRISPR clusters that contained more than one representative strain, CRISPR 22 
contained nine unique CDSs relative to all other CRISPR clusters within the population. Other 
clusters include CRISPR 28, with two unique CDSs, and CRISPRs 1, 9, and 11 each with one unique 
CDS, when compared to the rest of the population. Unique genes could not be identified in the 
remainder of CRISPR clusters within the population. Overall, this analysis suggests that each 
distinct CRISPR cluster contains a combination of accessory genes that are unique to that cluster, 
rather than unique individual genes within each cluster. To confirm this, the average accessory 
genome dissimilarity matrix for all detected CRISPR clusters containing more than one strain (18 
out of 33 clusters) was calculated by Jukka Corander (University of Oslo). A standard 
permutation test was then performed to assess the significance of the observed dissimilarity 
pattern. This analysis confirmed that in 12 out of 18 CRISPR clusters, strains have significantly 
more similar gene profiles to strains in the same cluster than to strains in other clusters (p < 0.05 
based on 10,000 random permutations). Based on this evidence, it would suggest that gene 
sharing between strains in the Y. pseudotuberculosis population is largely restricted to within 
individual CRISPR clades.  
To investigate this further, BratNextGen analysis was run on core genome alignments of the Y. 
pseudotuberculosis population to detect recombination events between the core genomes of 
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all strains. The detected recombination events are displayed against the proportion of shared 
ancestry (PSA) tree annotated with CRISPR cluster patterns (Fig. 3.7). This analysis identified a 
distribution of core genome recombination events which is highly concordant with the pattern 
of CRISPR clustering. Despite very high levels of recombination being detected across the data 
set, the recombination occurring is not eroding the CRISPR cluster signal. This would suggest 
that inter-cluster horizontal transfer of genetic material is largely inhibited, or occurs at very low 
frequency compared to intra-cluster recombination events, consistent with the CRISPR cluster 
signature observed in the accessory gene profiles (Fig. 3.6). To support this, the amounts of 
intra-cluster and inter-cluster recombination detected from the BratNextGen analysis were 
quantified (Supplementary Data, doi: 10.1099/mgen.0.000133), and it was revealed that intra-
cluster recombination events generally outweigh the amount of recombination occurring 
between strains of different CRISPR clusters (Seecharran et al., 2017). For example, higher 
numbers of intra-cluster recombination events were detected for various CRISPR clusters when 
compared to the average inter-cluster recombination occurring for those clusters. This includes, 
but is not limited to, CRISPR clusters 12 (intra-cluster = 311, average inter-cluster = 18), 20 (intra-
cluster = 282, average inter-cluster = 14), and 28 (intra-cluster = 274, average inter-cluster = 16). 
Another interesting observation can be made from the BratNextGen analysis (Fig. 3.7), where 
no observable core genome recombination events were detected for a European cluster of 
strains represented by CRISPR clusters 22 and 38. This would suggest that strains of these 
clusters have perhaps ‘locked’ their genomes from transferring and receiving genetic material 
to/from other CRISPR cluster-type strains.  
Overall, determining the accessory gene profiles and core genome recombination events for this 
globally and temporally distributed population of Y. pseudotuberculosis has demonstrated a 
strong association between CRISPR and the restriction of both accessory and core gene 
exchange between different CRISPR clusters. The distinct phylogroup structure of Y. 
pseudotuberculosis is therefore maintained throughout the population over a considerable 
period of time. This is consistent with a previous study which demonstrated that CRISPR systems 
play an important role in shaping the accessory genomes of the model antibiotic-refractory 
pathogen Pseudomonas aeruginosa (van Belkum et al., 2015). Furthermore, phylogenetic 
analysis based on CRISPR sequences of Shigella genomes, carried out by Yang and co-workers 
(2015), revealed a correlation between CRISPR loci and phylogenetic structure, as CRISPR 
sequences were conserved among subtypes of this genus. This is parallel to the observation of 
CRISPR-associated phylogenetic clades of Y. pseudotuberculosis revealed in the present study. 
Additionally, homology analysis of spacers showed that CRISPR might be involved in the 
regulation of virulence transmission (Yang et al., 2015), which would suggest that CRISPR 
 93 
 
analysis is applicable for investigation of evolutionary relationships of bacterial pathogens and 
the formation of distinct microbial lineages, and this warrants further study across bacteria. 
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Figure 3.6. Distribution of accessory gene profiles for 134 isolates of Y. pseudotuberculosis. The genes (𝑥-axis) have been sorted by their presence/absence pattern (black, 
present; white, absent) across strains (𝑦-axis), which have been sorted according to the maximum likelihood phylogenetic tree, shown on the right. CRISPR clusters, continent 
of origin and serotype are annotated on the tree as coloured bars. The ‘Asian’ and ‘European’ clades are defined by tree branch colouring.
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Figure 3.7. BratNextGen analysis of core genome recombination events for 134 isolates of Y. pseudotuberculosis. BratNextGen was run by Alan McNally. The PSA tree of 134 
isolates is shown on the left. Horizontal coloured bars show the indicated recombination events for each strain (𝑦-axis), at the relative base pair positions (𝑥-axis). Where 
segments are the same colour in vertically overlapping positions, this indicates recombination events that are shared between those strains. The colours of the detected 
segments indicate the cluster in which the segment is most prevalent. CRISPR clusters and continent of origin are annotated on the tree as coloured bars.
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3.4. Conclusions 
The genus Yersinia has acted as a model for developing our understanding of microbial 
pathogenesis, molecular microbiology, and microbial ecology and evolution (McNally et al., 
2016b). Yersinia was the first bacterial genus to have all representative species sequenced, 
allowing fine-scale analysis of how pathogenesis evolved in the three human pathogenic 
members of the genus (Reuter et al., 2014). This analysis revealed a striking degree of 
parallelism in how human pathogenesis evolved in pathogenic Yersinia (Reuter et al., 2014). 
However, further fine-scale evolutionary genomic studies of Y. pestis and Y. enterocolitica have 
shown very distinct mechanisms of intra-species evolution. Y. pestis is a recently evolved clone 
of Y. pseudotuberculosis, which is globally disseminated and host-restricted with very low levels 
of diversity, allowing fine-scale transmission events to be successfully reconstructed (Morelli et 
al., 2010). In complete contrast to this, pathogenic Y. enterocolitica have evolved from a non-
pathogenic ancestor and have split into ecologically distinct clades, which move rapidly across 
host species (Reuter et al., 2015). To enhance our understanding of the population structure, 
ecological dissemination, and evolutionary events that define the model bacterial species Y. 
pseudotuberculosis, it was imperative to carry out purpose-designed, large-scale global 
population genomic analyses of Y. pseudotuberculosis in this study. 
By sequencing a globally and temporally distributed set of 134 Y. pseudotuberculosis genomes, 
isolated from a wide range of hosts and environments, it can be shown that evolution in this 
species is driven by completely different mechanisms from those seen in the other pathogenic 
Yersiniae. This study revealed that Y. pseudotuberculosis is the only pathogenic Yersinia species 
which shows a clear phylogeographic split in its population. This was once postulated to be the 
case for Y. enterocolitica (Wang et al., 2011) with Old World and New World strains, however, 
comprehensive population genomics have shown this is not the case (Reuter et al., 2015; Reuter 
et al., 2014). The indication of Asian ancestry for Y. pseudotuberculosis is consistent with an 
Asian ancestry of Y. pestis (Morelli et al., 2010; Achtman et al., 1999), though the greatest 
amount of genetic variation was found in Japan rather than China. This is interesting because 
of the fact that a sub-clade of Y. pseudotuberculosis exists which causes Far East scarlet-like 
fever and is associated with Japan and tropical South-East Asia (Eppinger et al., 2007), 
suggesting larger variation in this region and a potential focus of ancestry for the species. 
Although it is difficult to accurately date the phylogeny of a data set with only a relatively small 
number of isolation dates available, the TMRCA for the entire Y. pseudotuberculosis data set is 
in the same range (10,000 – 40,000 years before present) as that estimated for the emergence 
of Y. pestis (Achtman et al., 1999). Based on the evidence from this dating analysis, it is inviting 
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to speculate that the emergence of Y. pestis coincided with a larger population dispersal event 
across Y. pseudotuberculosis.  
Previous work by our research group analysed patterns of accessory gene sharing between 
serotype-specific clades of Y. enterocolitica, and concluded that the species is composed of 
ecologically distinct phylogroups (Reuter et al., 2015). This inference was made on the basis 
that the limited inter-clade sharing of genes could not be due to steric hindrance by the O-
antigens nor genetic exclusion, as no such mechanisms existed. Data from the present study 
also identify clearly distinct phylogenetic subgroups within the geographic clades of Y. 
pseudotuberculosis. These phylogroups have unique combinations of accessory genes with little 
variation in their accessory genomes, and a very similar pattern of core genome homologous 
recombination. Similar to Y. enterocolitica, it is highly unlikely that this might be a result of some 
factor which prevents physical contact between strains, given the limited variety of serotypes 
present in Y. pseudotuberculosis (Savin et al., 2014). Rather, analysis from this study presents a 
strong case for the role of CRISPR clusters in the formation of these phylogroups. The primary 
evidence for the active role of CRISPR in mediating this genetic restriction is the fact that 
different CRISPR cluster-type strains coexist in the same geographical locations. Given that Y. 
pseudotuberculosis is ubiquitous in nature, no active barrier precluding recombination would 
exist between strains occupying the same habitat. Therefore, it would be expected that the 
signal that identifies each CRISPR cluster to be eroded relatively quickly over time (Sheppard et 
al., 2008), resulting in a lack of clear phylogroup signatures (Dearlove et al., 2016; Sheppard et 
al., 2008). This would especially be the case given the high levels of recombination detected in 
the core genome of Y. pseudotuberculosis. However, as the CRISPR-associated phylogenetic 
clusters have coexisted in locations around the world, for approximately 5,000 years or more, 
and continue to display a clear signature of within-cluster similarity, the data suggest that the 
CRISPR system is strongly associated with restricting both accessory and core gene exchange 
between clusters and maintenance of the distinct Y. pseudotuberculosis phylogroups. 
CRISPR has been shown to play a role in shaping the accessory genomes of Pseudomonas 
aeruginosa (van Belkum et al., 2015), and CRISPR analysis correlated with phylogenetic 
structure in a study of Shigella genomes (Yang et al., 2015). However, it is likely that the present 
study provides the first evidence of a possible causative link between CRISPR cassettes and the 
evolution of distinct phylogroups in bacterial pathogens. Bayesian analysis of core genome 
recombination events suggests that the influence of CRISPR is exerted at the level of horizontal 
gene transfer. Data from a previous study have shown that CRISPR evolution in bacteria, 
particularly in the Enterobacteriaceae, is controlled by vertical and not horizontal evolution 
(Kupczok, Landan and Dagan, 2015). When taken together, the data from the current study 
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create a hypothesis for Y. pseudotuberculosis evolution, whereby large population 
perturbations lead to the emergence of geographically isolated clones. During the early 
formation of these clones, exposure to geographically localised exogenous DNA – such as 
genetic elements present in plasmids and phage – creates a CRISPR array of immunity, which 
then tightly regulates the repertoire of genetic material that can be transferred and acquired 
from the gene pool. This can be explained by the CRISPR mechanism, through which, new 
spacers derived from the genome of the invading virus are incorporated into the CRISPR array 
by an unknown mechanism (Barrangou et al., 2007). During the crRNA biogenesis stage, a 
CRISPR precursor transcript is processed by Cas endoribonucleases within repeat sequences to 
generate small crRNAs (Brouns et al., 2008). During the targeting/interference stage, the match 
between the crRNA spacer and target sequences (complementary protospacer) specifies the 
nucleolytic cleavage of the invading nucleic acid. As each of these nascent clones then globally 
disseminate, they encounter other clones of Y. pseudotuberculosis and coexist together in 
geographical isolation, but genetic transfer between different clones is restricted according to 
the CRISPR array of each clone. Clones comprising the same CRISPR array can acquire and 
transfer genes without any restriction. However, transfer of genetic material between different 
clones cannot occur at levels required to erode the clonal phylogenetic structure within the 
population, and consequently, distinct phylogroups of Y. pseudotuberculosis persist in the 
population.  
In reference to the phylogeographic split observed in the Y. pseudotuberculosis population, the 
highest diversity of serotypes and CRISPR clusters was detected among ‘Asian’ strains, in 
contrast to the noticeably lower levels of diversity observed among strains of the ‘European’ 
clade. This would suggest that as the species migrated towards Europe, from its Asian origin, a 
bottleneck event occurring in the recent past would have resulted in the successful 
establishment of a small number of clones in new ecosystems, and thus lead to subsequent 
dispersal of these clonal lineages into Europe and the rest of the world. Analysis of all metadata 
available for the Y. pseudotuberculosis population, indicated that clones which have 
successfully disseminated into Europe belong almost exclusively to serotypes O:1a and O:1b, 
consistent with a previous study (Fukushima et al., 2001), and in addition, these clones are 
largely associated with only a small number of CRISPR loci. A larger sample size of isolates would 
be required in future work, to determine whether similar levels of diversity in geographic clades 
are maintained in the wider population of Y. pseudotuberculosis. With regards to the ecology 
of Y. pseudotuberculosis, this study did not reveal any phylogenetic clustering of strains within 
specific host groups or sources. Isolates from all non-human sources were distributed 
throughout the phylogeny and did not cluster separately from human isolates. This is indicative 
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of the widespread ecology of Y. pseudotuberculosis and its ubiquitous nature in many different 
non-human hosts and environments. The absence of genetic patterns associated with the 
ecology of Y. pseudotuberculosis, revealed in this chapter, is in contrast to previous studies that 
have reported ecological barriers to gene flow and recombination, which exist within 
populations of important bacterial pathogens. Such examples would include Y. enterocolitica 
(Reuter et al., 2015), E. coli (McNally et al., 2013; Luo et al., 2011), and C. jejuni (Sheppard et 
al., 2014), for which, the formation of distinct, ecologically separated lineages have been 
demonstrated. Contrary to these species, which comprise ecotypes formed through restricted 
recombination due to ecological barriers, Y. pseudotuberculosis is a host generalist species, 
capable of frequent host switching and occupation of multiple ecological niches, from which it 
could easily become a contaminant of the food chain. The cryptic ecology of Y. 
pseudotuberculosis may explain the ability of this species to colonise multiple hosts, suggesting 
that host generalism can also be a successful ecological strategy for bacterial pathogens. By 
analysing a set of geographically and temporally dispersed Y. pseudotuberculosis genomes in 
this chapter, the results indicate that the observed phylogenetic structure of the Y. 
pseudotuberculosis population is driven by factors other than those that preclude physical 
contact. The data from this study highlight how CRISPR can be used to infer the evolutionary 
trajectory of bacterial lineages, and they show that the evolution and ecology of Y. 
pseudotuberculosis differs from that seen previously in the other two human pathogenic 
species of the genus Yersinia. 
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CHAPTER 4 
Defining the population structure of 
Escherichia coli from non-human sources 
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4.1. Introduction 
Although Escherichia coli were once thought of as clonal organisms, they are now recognised 
as a bacterial species of extreme heterogeneity – a result of very high levels of recombination 
within the accessory genome (Wirth et al., 2006). E. coli are generally categorised into three 
main groups: commensal E. coli, intestinal pathogenic E. coli, and extraintestinal pathogenic E. 
coli (ExPEC). From this level of classification, E. coli are traditionally further subdivided into 
pathotypes on the basis of their isolation source and the possession of certain ‘virulence-
associated genes’ (VAGs). Intestinal infections, characterised mainly by severe diarrhoea, are 
caused by pathotypes such as enteropathogenic E. coli (EPEC). Within ExPEC, the pathotype of 
E. coli which causes urinary tract infections (UTIs) are termed uropathogenic E. coli (UPEC) on 
the basis that they were isolated from the bladder and possess UPEC-specific VAGs (Janke et 
al., 2001). E. coli causing disease in birds are termed avian pathogenic E. coli (APEC), and those 
causing neonatal meningitis are termed ‘NMEC’. 
For many years, the accepted dogma for E. coli sub-classification was that the combination of 
virulence genes possessed by an organism influences pathogenic potential (Vejborg et al., 
2011). Some studies have shown that there is little correlation between the disease caused by 
E. coli and its genotype. Strains that belong to different phylogroups can occupy distinct 
ecological niches and display diverse properties or ability to cause infections (Clermont et al., 
2013).  Due to the era of enhanced phylo-typing and sequence-typing methods, we now know 
that E. coli strains, even within a single pathotype, can vary immensely in terms of their 
evolutionary descent, which in turn can affect pathogenic potential and fitness in an infection 
(Wirth et al., 2006; Picard et al., 1999). Extraintestinal pathogenic E. coli infections are the most 
common cause of hospital-acquired infections in the UK and also cause significant levels of 
community-acquired infections (Woodford et al., 2004). Human ExPEC strains have often been 
characterised at the sequence type (ST) level and a small number of STs, namely ST69, ST73, 
ST95, and ST131, were found to be the most predominant among cases of UTIs and bloodstream 
infections (Kallonen et al., 2017; Riley, 2014; Alhashash et al., 2013; Croxall et al., 2011b). These 
clonal groups are known to constitute highly antimicrobial-resistant strains. Multidrug 
resistance (MDR) mediated by ESBLs is of increasing global concern in E. coli, because strains 
tend to harbour various resistance genes, in particular CTX-M-15 and 14 (Nicolas-Chanoine et 
al., 2008). These genes are primarily plasmid-borne, which facilitates the transfer of resistance 
determinants to other strains, species, or genera (Woodford, Turton and Livermore, 2011). 
Moreover, infections caused by multidrug-resistant bacteria can lead to inadequate or delayed 
antimicrobial therapy and increased costs associated with treatment (Magiorakos et al., 2012). 
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Using both phenotypic and molecular methods, many previous studies have demonstrated that 
both ExPEC and MDR strains of E. coli can be detected in various environments other than the 
human intestinal tract. These would include rivers and other water sources, soils, various wild 
and domesticated animals, including food animals, as well as raw meat and poultry (Gomi et al., 
2017b; Johnson et al., 2017; Muller, Stephan and Nuesch-Inderbinen, 2016; Vincent et al., 2010; 
Jakobsen et al., 2010). Although most environmental and non-human E. coli strains are thought 
to be harmless, some strains have demonstrated pathogenic potential, and thus contamination 
of surface waters and retail meat by such strains can increase the risk of waterborne and 
foodborne diseases. Also of major concern is the prevalence of antimicrobial-resistant and MDR 
E. coli detected in these non-human reservoirs (Gomi et al., 2017b; Johnson et al., 2017). The 
hypothesis that human ExPEC and MDR E. coli strains may have a non-human reservoir in 
surface waters and food animals has been an area of study by various research groups 
worldwide (Kappell et al., 2015; Dolejska et al., 2011b; Dolejska et al., 2011a). Experimental 
studies reporting shared pathogenicity between human ExPEC and avian pathogenic E. coli 
(APEC) suggests that these extraintestinal E. coli strains may share a common ancestry and 
evolutionary roots with APEC (Logue et al., 2017). Several previous studies have consistently 
reported detection of specific human ExPEC strains in poultry or retail poultry meat products, 
but rarely in other meat products. This would appear to support the hypothesis that a poultry 
reservoir for human ExPEC may exist. These studies have regularly identified E. coli ST131 and 
other human-clinical associated ExPEC lineages, such as ST69, ST394, ST95, ST10 and ST117, in 
cases of human extraintestinal infection as well as in retail meat products and other food 
animals (Bergeron et al., 2012; Vincent et al., 2010). In Sweden, E. coli sequence types ST69, 
ST10, and ST117 represented half of the ESBL-producing E. coli isolated from retail chicken 
meat in this country. Moreover, there are several global environmental studies reporting the 
presence of MDR E. coli and potential pathogenic ExPEC strains in rivers and surface waters, 
which would support the hypothesis that water-related environments may be considered one 
of the important non-human reservoirs of human ExPEC (Gomi et al., 2017b; Muller, Stephan 
and Nuesch-Inderbinen 2016; Kappell et al., 2015). It has been suggested that contamination of 
surface waters by E. coli strains belonging to clinically important clonal groups may increase the 
risk of waterborne disease, because surface waters are used for sources of drinking water, 
irrigation, and recreational purposes (Gomi et al., 2017b). 
Despite evidence from previous studies suggesting that surface waters and retail poultry may 
provide a potential non-human reservoir for human ExPEC, few of these studies have been able 
to determine the prevalence of potential pathogenic human ExPEC and MDR E. coli, in the 
context of the wider population of E. coli found in these sources. Information regarding the fine-
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scale phylogeny, clonal composition and resistance determinant profiles of an unbiased sample 
of E. coli isolated from non-human environments, such as surface waters and retail poultry, is 
lacking in the current literature. The true population structure of the non-human population of 
E. coli in the wider environment has therefore not been adequately characterised. Several 
studies have been conducted addressing the potential for foodborne and waterborne 
transmission of ExPEC, but the majority of these studies are focussed on MDR E. coli, and more 
specifically, ESBL-producing ExPEC (Manges 2016; Lazarus et al., 2015; de Been et al., 2014). 
Numerous environmental studies enrich for antimicrobial-resistant isolates, using selective 
media prior to phenotypic and genotypic characterisation, thus their sampling strategies may 
bias towards MDR and ExPEC strains. Studies of ESBL-positive ExPEC lineages from surface 
waters and retail poultry therefore tend to be over-represented in the literature. To date, only 
one large-scale population study, based on whole-genome analysis of the prevalence of 
antimicrobial-resistant and extraintestinal pathogenic E. coli strains in river water, has been 
conducted (Gomi et al., 2017b). Similarly, a previous study by de Been and colleagues (de Been 
et al., 2014) implemented WGS analyses to study the relatedness of cephalosporin-resistant E. 
coli from humans, retail chicken meat, poultry and pigs. This study provided high resolution 
differentiation between human and poultry-associated isolates and suggested that there is little 
or no overlap between resistant E. coli isolates of human and poultry origin. A review of the 
current global evidence, implicating poultry meat as a potential reservoir for human ExPEC and 
MDR E. coli, has suggested the need for more whole-genome-based and comparative genomic 
analyses of E. coli populations recovered from food animals and retail meat products with 
human-clinical strains (Manges, 2016). 
4.1.1. Aim and objectives 
In order to infer ecological patterns of E. coli from non-host-associated habitats, such as the 
environment and food products, more phylogeny-based population genomic analyses must be 
conducted, similar to what was implemented recently in Y. pseudotuberculosis (Seecharran et 
al., 2017) and the E. coli ST131 lineage (McNally et al., 2016a). The current study employs an 
unbiased sampling procedure, by not selectively isolating antimicrobial-resistant strains. 
Coupling this strategy with whole-genome analysis of E. coli isolated from river water and retail 
chicken meat in the Nottingham area, it allows a snapshot to be constructed of the relative 
abundance of MDR E. coli and ExPEC strains in the wider non-human population of E. coli, which 
is largely unknown. This would provide great insight into determining the true population 
structure of non-human E. coli in aquatic environments and in the food chain. By determining 
the population structure of non-human E. coli isolated specifically from the Greater Nottingham 
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area in this chapter, it would allow for a geographically constrained comparison with the well-
characterised human-clinical population of E. coli, to be conducted in chapter 5. There are 
comprehensive phenotypic and genotypic data available for human-clinical E. coli isolates 
collected in this region over the past decade (Alhashash et al., 2016; Alhashash et al., 2013; 
Croxall et al., 2011b; Croxall et al., 2011a), and therefore, Nottingham provides the ideal 
ecosystem for generating a non-human E. coli data set for comparison with the human-clinical 
population of E. coli. 
Specific objectives of this chapter were: 
• To identify and isolate a population of E. coli from river water and retail chicken meat 
sampled in Nottingham and sequence the whole genomes of a non-biased 
representative proportion of the population. 
• To assess the level of diversity within the non-human population of E. coli, as 
determined by in silico multilocus sequence typing analysis of whole-genome sequence 
data. 
• To reconstruct the phylogeny of the non-human population of E. coli and determine the 
population structure and genotypic diversity, with regards to the prevalence of E. coli 
phylogroups. 
• To detect antimicrobial resistance determinants within bacterial strains isolated from 
river water and retail chicken samples, in order to create a snapshot of the prevalence 
of potential multidrug-resistant strains within the non-human population of E. coli. 
• To determine the prevalence of human ExPEC strains within the non-human population 
of E. coli, as defined by the presence of ExPEC-specific virulence-associated genes.  
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4.2. Materials and Methods 
The key methods, culture media, culturing conditions, and bioinformatics tools and scripts used 
in this chapter were described previously in sections 2.3 – 2.6 of chapter 2. The publicly available 
E. coli reference genomes used in this chapter are listed in Table 4.1.  
Table 4.1. E. coli reference genomes used for phylogrouping analysis of non-human E. coli 
strains. 
Strain Phylogroup ST Country Sample Reference 
TW10509 C-I 747 India Human (Kaas et al., 2012) 
TW15838 C-I - Australia Environment (Luo et al., 2011) 
B1147 C-II - Australia Bird (Walk et al., 2009) 
TW09276 C-III - United States Environment (Luo et al., 2011) 
TW11588 C-IV 2 Puerto Rico Environment (Luo et al., 2011) 
TW14182 C-IV - United States Environment (Luo et al., 2011) 
TW09308 C-V - United States Environment (Luo et al., 2011) 
P12b A 10 - - (Ratiner, 1985) 
DH1 A 1060 - - (Kaas et al., 2012) 
IAI1 B1 1128 France Human (Kaas et al., 2012) 
SE11 B1 156 Japan Human (Kaas et al., 2012) 
55989 B1 678 CAR* Human (Kaas et al., 2012) 
SE15 B2 131 Japan Human (Kaas et al., 2012) 
JJ1886 B2 131 United States Human (Owens et al., 2011) 
536 B2 127 - Human (Kaas et al., 2012) 
UTI89 B2 95 - Human (Kaas et al., 2012) 
MS_85-1 C 88 United States Human (Kaas et al., 2012) 
TW14425 C 23 United States Human (Kaas et al., 2012) 
042 D 414 Peru Human (Kaas et al., 2012) 
UMN026 D 597 United States Human (Kaas et al., 2012) 
EDL933 E 11 United States Food (Kaas et al., 2012) 
Sakai E 11 Japan Human (Kaas et al., 2012) 
IAI39 F 62 France Human (Kaas et al., 2012) 
  
Publicly available genomes were downloaded from the National Center for Biotechnology 
Information (NCBI) website (https://www.ncbi.nlm.nih.gov/genome/). These reference genomes 
belonging to known phylogenetic groups were used to assign E. coli strains from non-human 
samples to one of 7 E. coli phylogroups (A, B1, B2, C, D, E, F) or one of 5 Escherichia cryptic clades 
(C-I, C-II, C-III, C-IV, C-V). Reference strains were selected from the genomes analysed in previous 
studies, indicated in the ‘Reference’ column.  
*CAR: Central African Republic 
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4.3. Results and Discussion 
4.3.1. Prevalence of E. coli isolated from river water and retail chicken meat  
Nine river water samples were collected in July 2015 from 4 geographically separate locations 
within the Trent River basin (Nottinghamshire and Derbyshire) and were tested for the presence 
of E. coli. Samples were taken from upstream and downstream sites of waste water and sewage 
treatment plants as well as upstream and downstream sites of agricultural land – specifically 
cattle farms. A total of 20 British whole retail chickens, obtained from 6 major supermarket 
outlets in the Greater Nottingham area in October 2015, were also sampled for E. coli (detailed 
information on sampling is provided in sections 2.3.1 and 2.3.2 of chapter 2). E. coli present in 
the collected samples were identified via a process involving subculture onto differential 
chromogenic agar (CLED agar with Andrade’s indicator and HiCrome™ UTI agar) and 
biochemical identification tests (as described in section 2.3.3). E. coli were identified in 6 out of 
9 total river water samples and 11 out of 20 total retail chicken samples that were processed. 
Isolates were selected from the initial CLED plates based on colony morphology which 
resembled that of E. coli (as described in Table 2.3). From the 504 river water isolates that were 
selected from CLED plates, a total of 82 isolates (16%) were formally identified as E. coli. The 
majority of isolates from river water samples selected for identification testing (83%) were 
represented by other species of the Enterobacteriaceae, which were therefore excluded from 
further analyses in this study. Conversely, a high proportion (88%) of the 416 retail chicken 
isolates selected from CLED plates were confirmed as E. coli, and thus only a minority (12%) 
represented other species of Enterobacteriaceae. Because of the high prevalence of E. coli in 
retail chicken samples, the number of isolates to be included in the study population was limited 
to 148. This resulted in a study population of 230 isolates, across 29 river water and retail 
chicken samples, that were identified as E. coli with ≥ 80% confidence, according to the API 20E 
biochemical test system. Specific numbers of E. coli isolates identified from CLED plates for each 
respective sample of river water and retail chicken are given in Table 4.2 and Table 4.3, 
respectively.  
The presence of E. coli in freshwater, such as river water, can indicate contamination by animal 
or human faeces. This is because E. coli colonise the gastrointestinal tracts of a wide range of 
wild and domesticated animals, especially animals raised for human consumption, such as 
chickens. Contamination of retail chicken with pathogens such as E. coli can occur at multiple 
steps along the food chain, including production, processing, distribution, or packaging and 
retail marketing. A previous study had reported that a large proportion of chicken meat 
imported into Sweden that was contaminated with ESBL-producing E. coli, primarily ST10, 
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ST131, and ST69, was found to have spread from imported parent broilers to broiler meat 
(Egervarn et al., 2014). This indicates that the occurrence of these drug-resistant ExPEC lineages 
in chicken meat is likely due to faecal contamination at the slaughterhouse, which is at a very 
early stage of the retail meat production process. In terms of E. coli isolated from river water in 
this study, 70% of the population were obtained upstream and downstream of wastewater 
treatment plants at Giltbrook and Pinxton. This would indicate that treated effluents from 
sewage treatment plants would have a high influence on freshwater contamination by faecal 
pathogens, more so than rural runoff from farmland. A possible explanation for the difference 
in E. coli prevalence observed between retail chicken and river water samples could be due to 
the effectiveness of wastewater treatment processes, in Nottinghamshire and Derbyshire, to 
remove faecal contaminants before releasing effluents into streams and rivers. On the other 
hand, during the process of preparing British chickens for human consumption, from farm and 
abattoir to retail outlet, it would appear that contamination by faecal organisms is much harder 
to control. 
  
Table 4.2. Total number of E. coli isolates identified from river water samples. 
Sample name Number of E. coli isolates 
selected from CLED plates 
Giltbrook upstream 35 
Giltbrook downstream 14 
Erewash Pinxton downstream 2 
Erewash Pinxton upstream 6 
East Leake downstream 0 
East Leake upstream 24 
Keyworth upstream 0 
Keyworth downstream 0 
Keyworth cattle field puddle 1 
Total 82 
The numbers presented in the table correspond to the final count of E. coli isolates that were selected 
from CLED agar plates for each river water sample. A total of 82 E. coli isolates were obtained from river 
water samples. The majority of isolates were obtained from the Giltbrook and Erewash Pinxton samples. 
Giltbrook and Erewash Pinxton are sample sites near to wastewater treatment plants, whilst East Leake 
and Keyworth are sample sites near to cattle farms. 
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Table 4.3. Total number of E. coli isolates identified from retail chicken samples. 
Sample name Number of E. coli isolates 
selected from CLED plates 
Tesco sample 1 18 
Tesco sample 2 0 
Tesco sample 3 10 
Tesco free range sample 10 
Sainsbury's sample 1 0 
Sainsbury's sample 2 10 
Sainsbury's free-range sample 10 
Asda sample 1 0 
Asda free range sample 1 10 
Asda free range sample 2 10 
Aldi sample 1 0 
Aldi sample 2 0 
Iceland sample 1 20 
Iceland sample 2 20 
Iceland sample 3 0 
Iceland sample 4 0 
Morrisons sample 1 0 
Morrisons sample 2 15 
Morrisons sample 3 15 
Morrisons sample 4 0 
Total 148 
The numbers presented in the table correspond to the final count of E. coli isolates that were obtained 
from CLED agar plates for each retail chicken sample. Due to the large number of E. coli being obtained 
from retail chicken samples, a final reduced count of 148 isolates were selected for subsequent analyses. 
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4.3.2. Molecular detection of β-lactamase genes in non-human E. coli 
Due to the reported high prevalence of ESBL-producing E. coli in retail meat products and 
environmental waters, and the hypothesis that these sources could represent reservoirs for 
human ExPEC and MDR E. coli (Gomi et al., 2017b; Manges 2016; Vincent et al., 2010), 
preliminary work on prevalence of β-lactamase and ESBL genes among E. coli isolated from river 
water and retail chicken samples was carried out in this chapter. This involved performing 
multiplex PCR assays to screen for the presence of the β-lactamase genes blaTEM, blaSHV, blaCTX-
M and blaOXA (Fig. 4.1). To put the prevalence of β-lactamase genes in non-human E. coli in the 
context of human-clinical E. coli, percentage prevalence data for β-lactamase and ESBL gene 
carriage in 415 E. coli strains, isolated from human-clinical cases in Nottingham, were included 
in the analysis for comparison (Fig. 4.2). One hundred and fifty of these strains were isolated 
from cases of urinary tract infection and urosepsis in elderly patients (Croxall et al., 2011b); 140 
and 125 strains were isolated from bacteraemia patients and urinary samples, respectively, as 
part of a separate Nottingham-based study (Alhashash et al., 2013). The overall prevalence of 
the β-lactamase gene SHV (0.4%) and the ESBL gene CTX-M (5.2%), detected in E. coli from non-
human samples, was significantly lower than the prevalence of those genes in E. coli from 
human-clinical samples (8.9% and 19.5% respectively; p < 0.0001, two-tailed Fisher’s test). The 
most commonly detected gene in non-human E. coli was the TEM β-lactamase (38.7%), 
although prevalence of this gene is still significantly higher in human-clinical isolates of E. coli 
(52%; p < 0.001, two-tailed Fisher’s test). The high prevalence of the TEM β-lactamase gene in 
non-human and human clinical samples is in agreement with observations that TEM is the most 
frequently encountered β-lactamase in clinical Enterobacteriaceae, as it accounts for around 
80% of all plasmid-encoded β-lactamases (Bajpai et al., 2017; Paterson and Bonomo, 2005). The 
OXA ESBL gene went undetected in the non-human population, whereas this gene was detected 
in 9.9% of human-clinical E. coli isolates (p < 0.0001, two-tailed Fisher’s test). The rationale for 
carrying out molecular detection of β-lactamase and ESBL genes, prior to whole-genome 
sequencing, is that a preliminary snapshot of the prevalence of MDR E. coli in the non-human 
population could be compared to that of the well-characterised human-clinical population. In 
addition, this work gave an insight into the potential prevalence of MDR plasmids within the 
population, which would inform whether in silico analyses of plasmid DNA from WGS data 
should be carried out. Considering the very low prevalence of ESBL genes, particularly of the 
CTX-M type, it is likely that the prevalence of MDR plasmids circulating within the non-human 
population is also very low. Based on this observation, it was decided that comparative plasmid 
analyses for the human-clinical and non-human populations of E. coli would not be carried out 
in this study. 
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Figure 4.1. Electrophoresis gel showing PCR amplicons of β-lactamase genes detected in E. coli isolated 
from non-human samples.  
The genes encoding the SHV, TEM, CTX-M, and OXA β-lactamases were amplified from E. coli isolates from 
river water and retail chicken samples by multiplex PCR, using previously published primers (Table 2.4). 
PCR amplicons were electrophoresed on a 2% agarose gel and fragment sizes were checked against a 100 
bp DNA ladder (New England Biolabs). Lane 1 contains the positive control strain: Klebsiella pneumoniae 
UTI448, blaSHV+, blaTEM+, blaCTX-M+, blaOXA+. Lane 2 contains the negative control. Lanes 3–6 contain a 
selection of retail chicken isolates from this study: AFR-6 (lane 3), SFR-9 (lane 4), I2-20 (lane 5), and M3-22 
(lane 6). Lane 7 contains the 100 bp molecular weight marker.  
blaOXA  
813 bp 
blaCTX-M  
593 bp 
blaTEM  
445 bp 
blaSHV  
237 bp 
1,500 bp 
1,000 bp 
500 bp 
100 bp 
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Figure 4.2. Percentage prevalence of β-lactamase genes blaTEM, blaSHV, blaCTX-M, and blaOXA in E. coli 
isolates from human-clinical (A) and non-human (B) samples collected in Nottingham.  
The human-clinical population of E. coli presented here (n = 415) comprise 150 isolates from cases of UTIs 
in 150 elderly patients (Croxall et al., 2011b), as well as 140 isolates from cases of bacteraemia and 125 
isolates from urine samples across diverse patient groups (Alhashash et al., 2013). The non-human 
population (n = 230) represent 82 E. coli isolates from river water samples and 148 isolates from retail 
chicken samples obtained in this study. The prevalence of SHV, CTX-M, and OXA genes in E. coli isolated 
from human-clinical samples was significantly higher than the prevalence of those genes in E. coli from 
non-human samples (**human-clinical vs non-human; p < 0.0001, two-tailed Fisher’s test). Although TEM 
was the most commonly detected β-lactamase gene in non-human E. coli isolates, the prevalence of this 
gene is still significantly higher in human-clinical isolates of E. coli (*human-clinical vs non-human; p < 
0.001, two-tailed Fisher’s test).  
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4.3.3. Whole-genome sequencing of non-human E. coli isolates 
To provide insight into the previously undefined population structure of non-human E. coli, as 
well as confirm the presence of putative resistance genes and identify ExPEC-associated 
virulence determinants within the population, whole-genome sequencing was performed on E. 
coli isolated from non-human sources in this study. Due to budget constraints, 180 E. coli 
isolates were sequenced from the population of 230 E. coli sampled from non-human sources, 
so as to represent the full diversity of the study population with regards to sample source. 
Indexed and paired-end libraries were prepared using the Nextera XT DNA Library Preparation 
Kit and the libraries were sequenced using the Illumina MiSeq. De novo assemblies of raw reads 
into contigs and scaffolds were performed using the SPAdes assembler. Assembly statistics 
were obtained from running the QUAST quality assessment tool and details of N50 and L50 
values, genome size, GC content, and number of Ns per 100 kbp are provided in Appendix 5. 
N50 values indicate the length for which the collection of all contigs of that length or longer 
covers at least half an assembly. To eliminate any incomplete assemblies from further genomic 
analyses, N50 values of at least 1,900 bp and genome sizes of at least 4.3 Mbp were considered 
as the minimum criteria for assembled contigs to be used in genomic analyses. The first 12 
assemblies highlighted in red in Appendix 5 indicate genome assemblies that were excluded 
from the study population. In addition to excluding incomplete sequenced genomes, all 
redundant isolates (i.e. identical isolates of the same sequence type, from the same sample, 
with the same antimicrobial resistance gene profiles) were also excluded from further genomic 
analyses. To determine redundant isolates, a multilocus sequence typing (MLST) script 
(https://github.com/tseemann/mlst) and the bioinformatics tool ABRicate (Kleinheinz, Joensen 
and Larsen, 2014) were run on the assembled genomes to assign a sequence type (ST) and 
generate in silico antimicrobial resistance gene profiles for each isolate. The MLST script scans 
the assembled scaffolds against PubMLST databases and assigns an ST to each isolate. All 
isolates, barring one, obtained from the same sample source, assigned to the same ST, and 
defined by the same antimicrobial resistance gene profile were omitted from the study 
population, as these were multiple isolates of a single strain and were therefore considered 
redundant for further genome comparative analyses. The remaining isolates to be included in 
the study population were chosen at random. This resulted in a study population inclusive of 
128 non-redundant E. coli strains (Table 4.4), isolated from non-human sources, which were to 
be subjected to further genomic analyses. A summary of the number of E. coli isolates at each 
stage of the investigation is provided in Figure 4.3. 
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Figure 4.3. Workflow indicating the numbers of E. coli isolates from river water and retail chicken 
samples consolidated at each stage of the investigation. 
The flowchart illustrates the respective numbers of E. coli isolates from river water and retail chicken 
samples at the stages of formal identification of E. coli, multiplex PCR for β-lactamase genes, whole-
genome sequencing, and post-sequencing quality assessment of assemblies. The sample sizes were 
refined accordingly at each stage, resulting in a non-human E. coli study population of 128 strains.   
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4.3.4. Whole-genome-based multilocus sequence typing (MLST) analysis of the non-
human population of E. coli 
One method of determining the level of genetic heterogeneity within the non-human 
population of E. coli, isolated from river water and retail chicken samples in Nottingham, was 
to determine the prevalence of sequence types (STs). The study population was subjected to in 
silico MLST analysis and ST designations were obtained for all 128 strains, by running a MLST 
script which scans the genome assemblies against PubMLST databases, based on the seven E. 
coli housekeeping genes (adk, fumC, gyrB, icd, mdh, purA, recA), and assigns an ST to each 
strain. Closely related STs were then grouped into ST complexes using the PHYLOViZ platform, 
and a complete minimum spanning tree (MST) of all the STs in the population was constructed 
(Fig. 4.4). The sequence types were clustered based on sharing allele types rather than 
weighting SNPs; therefore, the MST illustrates clusters of ‘like-organisms' and does not attempt 
to infer phylogeny. 
Sequence typing analysis revealed that the E. coli population isolated from non-human samples 
in this study is genotypically diverse, with a total of 64 STs identified among all 128 strains (Table 
4.5). Considering the size of this study population, such a variety of different STs being identified 
from these samples would suggest considerable genotypic diversity among non-human E. coli, 
from river water and retail chicken samples. The ST designations are grouped into clonal 
complexes by their similarity to a central allelic profile (genotype). In the study population, 16 
different ST complexes were identified, with 50 strains being grouped into one of the known E. 
coli ST complexes. However, the majority of strains (n = 78) were designated STs which are not 
grouped into larger clonal complexes of closely related STs, further demonstrating the 
genotypic diversity within the population. Determining the sequence types of bacterial strains 
can assist in the production of a population map, which can be used to analyse the genetic 
relatedness of a population of bacteria. The MST (Fig. 4.4) reveals that the river water and retail 
chicken populations of E. coli demonstrate relatively similar levels of diversity with regards to 
ST prevalence, with 38 STs identified among strains isolated from river water samples and 31 
STs from retail chicken samples. Only 5 of the STs identified (ST10, ST93, ST746, ST752, and 
ST1551) were present in both river water and retail chicken samples, whereas 33 STs were 
exclusive to the river water population and 26 STs were exclusive to the retail chicken 
population. This illustrates a genotypic difference between E. coli strains isolated from the two 
sources, and it suggests that separate populations of E. coli exist in each environmental source 
(freshwater versus the food chain).  
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The population map (Fig. 4.4) also suggests that the non-human population of E. coli is not 
dominated by the major STs/ST complexes that are largely responsible for extraintestinal 
infections in human-clinical populations of E. coli (Kallonen et al., 2017; Alhashash et al., 2013; 
Croxall et al., 2011b; Lau et al., 2008). Rather, the non-human population of E. coli would appear 
to be composed largely of a wide variety of different STs, with the ST10 clonal complex emerging 
as the major central genotype, along with closely related STs such as ST93, ST746, ST752, and 
ST1551, which were identified in both types of non-human sources of E. coli analysed. This 
suggests a wider prevalence of these particular STs across the environment and in the food 
chain. The abundance of the ST10 clonal complex across river water and retail chicken samples 
observed in this study is expected as several previous studies have reported ST10 as the most 
prevalent genotype in retail chicken meat, other meat types, and environmental waters (Gomi 
et al., 2017b; Chen et al., 2016; Cohen Stuart et al., 2012; Overdevest et al., 2011). Only one 
instance of the important pathogenic ExPEC lineage, ST131, was observed in the non-human 
population of E. coli in this study. The dearth of this particular sequence type, as well as the lack 
of other well-known ExPEC sequence types, such as ST95, ST73, and ST69, provides an indication 
of the prevalence of human ExPEC strains in the non-human population of E. coli, which appears 
to be very low. It also gives an insight into the phylogenetic structure of the population and 
suggests that the non-human population of E. coli is perhaps predominated by strains that are 
characteristically commensal or non-pathogenic. 
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Table 4.4. Sequence type designations for the 128 sequenced non-human E. coli genomes. 
Strain 
name 
ST ST 
complex 
Sample source Sample name 
AFR-4 10 10 Retail chicken Asda free range 1 
AFR-6 10 10 Retail chicken Asda free range 1 
AFR-12 10 10 Retail chicken Asda free range 2 
AFR-22 10 10 Retail chicken Asda free range 2 
ELU39 10 10 River water East Leake upstream 
ELU103 10 10 River water East Leake upstream 
GU34 10 10 River water Giltbrook upstream 
I1-16 10 10 Retail chicken Iceland 1 
I1-17 10 10 Retail chicken Iceland 1 
I1-19 10 10 Retail chicken Iceland 1 
I1-24 10 10 Retail chicken Iceland 1 
M2-2 10 10 Retail chicken Morrisons 2 
M2-3 10 10 Retail chicken Morrisons 2 
M2-4 10 10 Retail chicken Morrisons 2 
M2-8 10 10 Retail chicken Morrisons 2 
T1-61 10 10 Retail chicken Tesco 1 
GU53 20 20 River water Giltbrook upstream 
I1-21 48 10 Retail chicken Iceland 1 
I2-1 48 10 Retail chicken Iceland 2 
ELU7 58 155 River water East Leake upstream 
ELU21 58 155 River water East Leake upstream 
EPU62 58 155 River water Erewash Pinxton upstream 
I2-20 69 69 Retail chicken Iceland 2 
M3-27 69 69 Retail chicken Morrisons 3 
T3-3 69 69 Retail chicken Tesco 3 
T3-14 69 69 Retail chicken Tesco 3 
EPU17 93 168 River water Erewash Pinxton upstream 
M3-18 93 168 Retail chicken Morrisons 3 
S2-4 93 168 Retail chicken Sainsbury’s 2 
S2-8 93 168 Retail chicken Sainsbury’s 2 
TFR-1 93 168 Retail chicken Tesco free range 
GU48 108 None River water Giltbrook upstream 
M3-24 115 None Retail chicken Morrisons 3 
M3-28 115 None Retail chicken Morrisons 3 
M3-30 115 None Retail chicken Morrisons 3 
M3-34 115 None Retail chicken Morrisons 3 
M3-36 115 None Retail chicken Morrisons 3 
SFR-11 117 None Retail chicken Sainsbury’s free range 
T1-27 117 None Retail chicken Tesco 1 
T1-30 117 None Retail chicken Tesco 1 
T1-39 117 None Retail chicken Tesco 1 
GD45 131 131 River water Giltbrook downstream 
GU50 135 None River water Giltbrook upstream 
GU87 141 None River water Giltbrook upstream 
T1-35 155 155 Retail chicken Tesco 1 
   
117 
 
GU51 201 469 River water Giltbrook upstream 
EPD30 218 10 River water Erewash Pinxton downstream 
I1-11 354 354 Retail chicken Iceland 1 
I1-25 354 354 Retail chicken Iceland 1 
I2-5 354 354 Retail chicken Iceland 2 
I2-6 354 354 Retail chicken Iceland 2 
S2-3 362 None Retail chicken Sainsbury’s 2 
GU15 394 394 River water Giltbrook upstream 
EPU5 399 399 River water Erewash Pinxton upstream 
EPU51 399 399 River water Erewash Pinxton upstream 
GD3 409 None River water Giltbrook downstream 
GD162 410 23 River water Giltbrook downstream 
GU35 446 446 River water Giltbrook upstream 
ELU87 537 14 River water East Leake upstream 
GU82 546 None River water Giltbrook upstream 
ELU65 635 399 River water East Leake upstream 
GU1 635 399 River water Giltbrook upstream 
GD46 642 278 River water Giltbrook downstream 
GD109 644 538 River water Giltbrook downstream 
GD49 648 648 River water Giltbrook downstream 
T1-11 665 None Retail chicken Tesco 1 
GU10 706 None River water Giltbrook upstream 
ELU122 746 None River water East Leake upstream 
SFR-6 746 None Retail chicken Sainsbury’s free range 
T1-1 746 None Retail chicken Tesco 1 
ELU98 752 None River water East Leake upstream 
T1-5 752 None Retail chicken Tesco 1 
T1-25 752 None Retail chicken Tesco 1 
T1-32 752 None Retail chicken Tesco 1 
T1-53 752 None Retail chicken Tesco 1 
T1-57 752 None Retail chicken Tesco 1 
T1-73 752 None Retail chicken Tesco 1 
T1-52 770 None Retail chicken Tesco 1 
GU43 906 None River water Giltbrook upstream 
GU6 929 None River water Giltbrook upstream 
GU77 929 None River water Giltbrook upstream 
EPD5 973 None River water Erewash Pinxton downstream 
I1-5 997 None Retail chicken Iceland 1 
I1-12 997 None Retail chicken Iceland 1 
T3-21 1011 None Retail chicken Tesco 3 
SFR-4 1112 None Retail chicken Sainsbury’s free range 
ELU28 1122 None River water East Leake upstream 
GU24 1125 None River water Giltbrook upstream 
ELU88 1276 None River water East Leake upstream 
SFR-15 1408 None Retail chicken Sainsbury’s free range 
AFR-16 1551 None Retail chicken Asda free range sample 2 
GU52 1551 None River water Giltbrook upstream 
M3-22 1551 None Retail chicken Morrisons 3 
S2-7 1551 None Retail chicken Sainsbury’s 2 
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T1-3 1551 None Retail chicken Tesco 1 
T3-1 1551 None Retail chicken Tesco 3 
T3-7 1594 None Retail chicken Tesco 3 
T3-18 1594 None Retail chicken Tesco 3 
TFR-2 1594 None Retail chicken Tesco free range 
TFR-15 1716 None Retail chicken Tesco free range 
T1-7 1800 None Retail chicken Tesco 1 
GU2 2136 None River water Giltbrook upstream 
GD93 2178 None River water Giltbrook downstream 
GU47 2178 None River water Giltbrook upstream 
M2-1 2309 None Retail chicken Morrisons 2 
M2-5 2309 None Retail chicken Morrisons 2 
I2-18 2459 None Retail chicken Iceland 2 
GU41 2521 None River water Giltbrook upstream 
GU45 2521 None River water Giltbrook upstream 
M3-29 2705 None Retail chicken Morrisons 3 
ELU29 2722 None River water East Leake upstream 
ELU34 3578 None River water East Leake upstream 
GU13 4105 None River water Giltbrook upstream 
GU27 4105 None River water Giltbrook upstream 
GU31 4105 None River water Giltbrook upstream 
GU70 4105 None River water Giltbrook upstream 
GU80 4105 None River water Giltbrook upstream 
S2-5 4243 None Retail chicken Sainsbury’s 2 
S2-10 4243 None Retail chicken Sainsbury’s 2 
T3-19 4243 None Retail chicken Tesco 3 
TFR-6 4937 None Retail chicken Tesco free range 
S2-2 4993 None Retail chicken Sainsbury’s 2 
T1-56 4994 None Retail chicken Tesco 1 
GD138 5236 None River water Giltbrook downstream 
TFR-13 5931 None Retail chicken Tesco free range 
GU5 5995 None River water Giltbrook upstream 
M2-7 6664 None Retail chicken Morrisons 2 
T1-49 6664 None Retail chicken Tesco 1 
 
Table 4.4. Sequence type designations for the 128 sequenced non-human E. coli genomes. 
Of the 180 sequenced E. coli genomes obtained from river water and retail chicken samples, 128 non-
redundant E. coli strains (i.e. strains meeting the minimum assembly quality criteria and are distinct in 
terms of ST or resistance gene profile, if isolated from the same sample) were included in the final study 
population of non-human E. coli. The population represents strains isolated from 5 different river water 
samples and 11 different retail chicken samples. Sequence types were determined for each strain by in 
silico MLST analysis. 
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Figure 4.4. Minimum spanning tree (MST) illustrating STs of the non-human E. coli population isolated from river water and retail chicken samples.  
The MST was produced using Phyloviz v3.0, which uses goeBURST to divide an MLST data set into groups of related isolates and clonal complexes. The size of the nodes reflects 
the number of strains belonging to each ST. Nodes outlined by a yellow-green ring represent ST complexes present in the population. The sample sources from which the strains 
were isolated are overlaid onto the diagram, which reveals a diversity of STs prevalent in both sample types. 
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4.3.5. Defining the phylogeny of the non-human population of E. coli 
To assign each strain to a phylogenetic group, the core genomes of the 128 strains from the 
study population were aligned with those of 23 publicly available reference strains (Table 4.1), 
representing the seven E. coli phylogroups (A, B1, B2, C, D, E, and F) and five cryptic Escherichia 
clades (C-I, C-II, C-III, C-IV, and C-V). The core genome SNP-based phylogenetic tree of the non-
human E. coli population was built using Parsnp, and phylogroup/cryptic clade assignment was 
made based on clustering with the reference strains on the phylogenetic tree (Fig. 4.5). From 
this analysis, it was revealed that 119 strains belonged to six of the seven E. coli phylogroups, 
with phylogroup C not being represented in the population. Furthermore, two strains were 
grouped with the sister Escherichia cryptic clade C-I, whereas the remainder of the strains 
belonged to the more distantly related cryptic clades, C-III (n = 1) and C-V (n = 6). These cryptic 
clades are novel lineages of the genus Escherichia, that are genetically distinct but 
phenotypically indistinguishable from E. coli. C-II and C-IV strains were not identified in the 
population, so the reference strains representing these clades, in addition to phylogroup C, were 
removed from the phylogenetic tree in an attempt to improve the resolution and interpretability 
of the tree. Cryptic clade C-I shares a recent common ancestor with the seven phylogroups 
comprising the majority of the population, illustrating the genetic similarity between this lineage 
and the E. coli phylogroups. In fact, according to the Clermont E. coli phylo-typing method, clade 
C-I is recognised as the eighth E. coli phylogroup (Clermont et al., 2013). This indicates how 
phylogenetically distinct the cryptic clades C-III and C-V are from the rest of the population, and 
they therefore serve as an outgroup for the population under investigation in this study, whilst 
allowing the tree to be rooted, as shown in Figure 4.5. Due to the presence of C-III and C-V strains 
in the population, a very small core genome alignment of 87,981 bp covering the 146 strains was 
achieved using Parsnp (≤ 5% of the reference genome covered by the alignment), however a 
total of 59,317 SNPs were identified across the alignment, further demonstrating the extreme 
genetic diversity that exists in the non-human population of E. coli. 
With regards to the E. coli phylogroups present in the non-human population, it was found that 
the most highly represented group was phylogroup A, with 49 (38%) out of 128 strains belonging 
to this group. This was followed by 27 strains (21%) being grouped in phylogroup D, 18 (14%) in 
phylogroup B1, 10 (8%) in phylogroup E, 9 (7%) in phylogroup B2, and 6 (5%) in phylogroup F. 
Phylogroup B2 strains generally carry more virulence-associated genes than strains belonging to 
the other groups do (Picard et al., 1999), and strains that cause extraintestinal infections are 
predominantly associated with phylogroup B2 and, to a lesser extent, phylogroup D (Picard et 
al., 1999). Several studies have reported phylogroups A and B1 as being chiefly composed of 
commensal strains of E. coli (Picard et al., 1999, Duriez et al., 2001). Based on the phylogroups 
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represented in the non-human population of E. coli in this study, it would appear that the 
majority of the population constitutes largely commensal and non-pathogenic strains, as 
illustrated by the higher prevalence of phylogroup A and B1 strains in the population. 
Phylogroup D was found to be the second-most prevalent group in the population, so the 
presence of extraintestinal pathogenic E. coli (ExPEC) cannot be ruled out; however, due to the 
lack of phylogroup B2 strains in the population, it would be expected that the prevalence of 
ExPEC is low among isolates from river water and retail chicken samples. While there was no 
discernible pattern of phylogenetic grouping associated with source of isolation (i.e. no clear 
phylogenetic split), it was noticeable that certain phylogroups appeared to be dominated by 
strains isolated from a particular source (Fig. 4.5). This would include phylogroups B1, B2, and 
cryptic clades C-III and C-V, which are dominated by river water isolates, and phylogroups D and 
E, which are largely composed of isolates from retail chicken samples. 
ST/ST complex designations representing three or more isolates (as typed by in silico MLST 
analysis) are overlaid onto the phylogenetic tree (Fig. 4.5), in addition to known representatives 
of ExPEC (ST131 and ST648) and EPEC (ST20) within the population, though these are 
represented only by a single isolate each. The distribution of STs across the non-human 
population of E. coli would suggest that phylogroup A comprises the highest diversity of strains, 
with 16 different STs identified within this group; the major sequence types being ST10, ST93, 
ST746, ST752, and ST1594 among them. Other sequence types of note in the population would 
include ST115 (n = 7) and ST117 (n = 4), of phylogroup D, which are both largely associated with 
wild birds and commercial poultry (Cristovao et al., 2017), and are commonly shared by APEC 
and human ExPEC strains (Maluta et al., 2014; Oteo et al., 2010). Close genetic relations have 
been detected in ST117 E. coli strains of animal and human origin, which have been identified in 
large poultry producing countries, such as Brazil (Maluta et al., 2014) and the USA (Danzeisen et 
al., 2013). Also of relevance in phylogroup D is ST69 (n = 5), which has been reported as a highly 
virulent strain in some animal models with a high content of resistance determinants (Cristovao 
et al., 2017; Tartof et al., 2005), and has also been associated with extraintestinal infections, 
such as UTIs and bacteraemia, in clinical case studies (Kallonen et al., 2017; Alhashash et al., 
2013; Croxall et al., 2011b; Lau et al., 2008). Phylogroup F strains are also prevalent within the 
population, which is a group closely related to the ExPEC-associated phylogroups B2 and D 
(Clermont et al., 2013). Prior to its recognition as a distinct phylogroup, its members were 
generally categorised under group D, based on a PCR-based phylo-typing assay that delineates 
only four major E. coli phylogroups (Clermont, Bonacorsi and Bingen, 2000). However, an 
enhanced version of this assay (Clermont et al., 2013), and whole-genome-based in silico MLST 
analysis, enable differentiation of phylogroup F from phylogroup D. Within this group, one 
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instance of ST648 has been identified in the non-human population of E. coli. This genotype is 
reported increasingly as an emerging resistance-associated lineage (Pitout, 2012) and is 
distributed worldwide, occurring as a pathogen and commensal of humans and animals 
(whether food-producing, domesticated, or wild), and in the environment (Muller, Stephan and 
Nuesch-Inderbinen, 2016; Goncalves et al., 2016; Sato et al., 2014; Kang et al., 2013). Though 
the phylogenetic structure of the non-human population of E. coli demonstrates a paucity of 
pathogenic strains, that are predominantly associated with extraintestinal infections in humans, 
the presence of lineages such as ST131, ST69, and ST648 in the non-human population would 
warrant further investigation into the profiles of resistance determinants and virulence-
associated genes that define each strain. This would allow for a determination of the prevalence 
of MDR and ExPEC strains among E. coli isolated from foodborne and environmental water 
sources, which will be compared with that of the human-clinical population of E. coli in chapter 
5.  
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Figure 4.5. Maximum-likelihood phylogenetic tree of 128 E. coli strains isolated from river water and 
retail chicken samples in Nottingham and 18 reference strains.  
The phylogeny was inferred from a core genome alignment of the population (87,981 bp, 59,317 SNPs, 146 
genomes) constructed using Parsnp. Publicly available reference genomes (Table 4.1 and strain names 
marked in red on the tree), belonging to the E. coli phylogroups (A, B1, B2, D, E, and F) and cryptic 
Escherichia clades (C-I, C-III, and C-V), were included in the alignment to assign strains to a phylogenetic 
group based on its position on the tree. The phylogenetic tree was visualised and edited using iTOL. Source 
of isolation is annotated on the tree as coloured bars, as well as STs/ST complexes which define three or 
more strains. ST20, ST131, and ST648, each represented by a single strain, are also indicated on the tree as 
shading behind the isolate’s name. The phylogenetic clades are defined by branch colouring according to 
each phylogroup. The tree reveals that six of the seven phylogroups are represented in the population, 
with the largest proportion of strains belonging to phylogroup A. Strains belonging to cryptic clades C-I, C-
III, and C-V were identified in the population. No strains belonged to phylogroup C or clades C-II or C-IV, so 
these reference strains were removed from the alignment. 
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4.3.6. Distribution of antimicrobial resistance genes among non-human E. coli 
All non-human E. coli genomes were screened for the presence of acquired antibiotic resistance 
genes, by running the bioinformatics pipeline ABRicate, which scans the ResFinder database to 
generate in silico antibiotic resistance gene profiles for each isolate (Fig. 4.6). A total of 46 
different resistance determinants were identified, corresponding to 8 different antibiotic 
classes: aminoglycosides, β-lactams, macrolide-lincosamide-streptogramins (MLS), phenicols, 
rifampicin, sulphonamides, tetracyclines, and trimethoprim. The phylogenetic distribution of 
resistance genes appears to be relatively consistent across the population, with the exception 
of a large proportion of phylogroup B1 represented by river water isolates, which demonstrate 
a clear lack of antimicrobial resistance genes compared to the rest of the population. Among 
these strains, only tet(34) encoding tetracycline resistance was identified, whereas aadA1 
(aminoglycoside), blaTEM-1B (β-lactamase), and sulphonamide resistance genes (sul), though 
possessed by the majority of the population, could not be detected. This is supported by low 
level antimicrobial resistance among phylogroup B1 E. coli isolated from cattle, which has been 
observed previously (Bok et al., 2014). Noticeably, there is also a lack of resistance determinants 
present in cryptic clades C-III and C-V, which is consistent with a previous study which reported 
a low frequency of resistance for the cryptic clades (Ingle et al., 2011), but is in contrast with a 
recent study which has reported antimicrobial resistance among cryptic clade isolates (Blyton et 
al., 2015). Acquired antibiotic resistance genes were most prevalent among strains belonging to 
phylogroup A and phylogroup D, which is in agreement with previous studies of antimicrobial 
resistance among E. coli phylogroups (Pavlickova, Dolezalova and Holko, 2015; Mosquito et al., 
2015). 
Aminoglycoside resistance genes 
Twelve distinct aminoglycoside resistance genes were detected, representing the largest group 
of antimicrobial resistance determinants in the population. The aadA1 gene, which confers 
resistance to streptomycin and spectinomycin, was the most prevalent aminoglycoside 
resistance gene and was detected in approximately 45% of the population, representing each 
phylogroup except for cryptic clades C-III and C-V. Other streptomycin resistance genes included 
strA and strB, which were also detected at relatively high frequencies, and these two genes were 
always detected together. Other than streptomycin resistance, the aac(3)-IId gene, which 
confers resistance to gentamycin and tobramycin, was detected in two isolates. Aminoglycoside 
resistance genes that were unique to retail chicken isolates 
included aadA2, aadA5, aadA12, aadA13, aac(3)-IId, aac(3)-Iva, aph(3’)-Ic, and aph(4)-
Ia, whereas the only unique gene to river water isolates was aph(3’)-Ia. The high prevalence of 
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streptomycin resistance genes in this population is consistent with a previous study, which found 
these genes to be widespread in environmental habitats and often occur on mobile genetic 
elements, which can easily be acquired by different strains and species of bacteria (van 
Overbeek et al., 2002). Notwithstanding this, resistance to streptomycin does not usually define 
multidrug resistance, so phenotypic testing for susceptibility to this agent is not essential 
(Magiorakos et al., 2012), and the prevalence of genes conferring resistance to this antibiotic 
cannot be used as a measure of multidrug resistance in the non-human population of E. coli. 
β-lactam resistance genes 
The in silico antibiotic resistance gene analysis of the 128 sequenced E. coli genomes of the study 
population indicated an even lower prevalence of ESBL genes in the population (Fig. 4.6) than 
what was suggested by the multiplex PCR assays, conducted in section 4.3.2. Among sequenced 
isolates, a total of 9 different genes encoding β-lactamases were identified, with the most 
common being blaTEM-1B (31.5%). The blaTEM family of β-lactamase genes, conferring resistance 
to the penicillin-like antibiotics such as ampicillin, were prevalent in 35.2% of isolates, 
representing 5 different variants of the gene (blaTEM-1A, blaTEM-1B, blaTEM-1C, blaTEM-1D, and blaTEM-
33). This is consistent with several previous studies that have also reported blaTEM as a commonly 
encountered class of antibiotic resistance genes (Bajpai et al., 2017; Jena et al., 2017). Regarding 
the β-lactamase gene blaSHV, and the ESBL genes blaCTX-M and blaOXA, a notable disparity was 
observed between the percentage prevalence data of the in silico antibiotic resistance gene 
analysis when compared to the multiplex PCRs. blaSHV and blaCTX-M could not be detected in the 
sequenced isolates, whereas these genes were amplified by PCR in 0.4% and 5.2% of the 
population, respectively, representing 13 isolates. However, it must be noted that 8 of these 13 
isolates were not included in the population of sequenced isolates, thus possibly contributing to 
the lack of blaSHV and blaCTX-M genes observed in the non-human E. coli population subjected to 
WGS. Furthermore, blaOXA genes, namely blaOXA-1 and blaOXA-10 encoding carbapenem-hydrolysing 
oxacillinases, were identified in 1.6% of sequenced isolates; however, no blaOXA genes could be 
detected by PCR. A possible reason for this disparity could be attributed to the methods used to 
detect antimicrobial resistance genes. Bioinformatic detection of resistance genes from WGS 
data is considered to be more effective in determining the full spectrum of antibiotic resistance 
genes in each isolate, and can generally detect more resistance genes than PCR (Moran et al., 
2017). In contrast to the low prevalence of ESBL-producing E. coli in the population, 5 instances 
of the AmpC-like β-lactamase gene blaCMY were observed. This gene encodes a cephalomycinase, 
which confers extended resistance to many β-lactams, including first-, second-, and third-
generation cephalosporins, as well as cephamycins such as cefoxitin and ceftriaxone (Zhao et 
al., 2001). The presence of variants of blaCMY in the population was unique to E. coli isolated from 
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retail chicken. This is consistent with previous studies that have reported that blaCMY genes are 
commonly present in E. coli and Salmonella isolated from food animals and retail chicken (Zhao 
et al., 2001; Winokur et al., 2001), which have also displayed decreased susceptibility to ceftiofur 
and ceftriaxone. It was noted that a relatively even distribution of β-lactamase genes was 
observed across river water and retail chicken isolates. 
Macrolide-lincosamide-streptogramin B (MLS) resistance genes 
Genes conferring resistance to macrolide, lincosamide, and streptogramin B (MLS) antibiotics 
are widespread in bacteria, including environmental isolates of E. coli (Gomi et al., 2017b). 
Several of these genes were identified in 34 isolates of the non-human population of E. coli, with 
the most prevalent being Inu(F) (11.7%), and others including Inu(B) (8.9%), mph(B) (4.7%), and 
mef(B) (3.1%). The erythromycin resistance gene erm(B) and Isa(A) gene were detected in one 
isolate, respectively, in addition to mph(A), which was identified in two isolates. Inu(B) and Inu(F) 
are recognised as members of the Inu gene family (Achard et al., 2005), which encode 
lincosamide nucleotidyltransferase enzymes responsible for the mediation of specific resistance 
to lincosamides, such as lincomycin and clindamycin. The mph(A) gene, which was also detected, 
encodes a macrolide phosphotransferase shown to confer azithromycin resistance in E. 
coli (Howie et al., 2010). Macrolide resistance genes were also detected in E. coli in a recent 
environmental study (Gomi et al., 2017b). The results of these studies suggest that E. coli may 
represent a major reservoir for macrolide resistance genes which could then be horizontally 
transferred to other bacteria. 
Chloramphenicol resistance genes 
Four different chloramphenicol resistance genes (cmlA1, catA1, catB3, and floR) were detected 
in the population. These same four genes were also detected in chloramphenicol-resistant E. 
coli in two previous studies, which also reported floR as the most prevalent chloramphenicol 
resistance gene (Gomi et al., 2017b). This would suggest that chloramphenicol resistance in E. 
coli is typically encoded by these four main genes. 
Sulphonamide resistance genes 
Resistance to sulphonamides in E. coli results from the acquisition of an alternative 
dihydropteroate synthase gene (sul) (Perreten and Boerlin, 2003). There are three known types 
of sul genes (sul1, sul2, and sul3) described in the literature (Zankari et al., 2012), and all three 
were detected in the present study. These genes were identified in roughly 40% of the 
population of non-human E. coli, and thus a higher reported prevalence of sulphonamide 
resistance genes when compared to the β-lactamase genes. sul1 and sul2 were reported with 
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relatively similar prevalence (25.8% and 21.1%, respectively), whereas sul3 was detected in only 
four isolates. While the detection frequency of these three sul genes is in agreement with some 
previous studies (Gomi et al., 2017b; Kaper, Nataro and Mobley, 2004), it would seem to differ 
among other studies (Su et al., 2012; Hu et al., 2008), demonstrating the diversity of sul gene 
distribution profiles among various regions. 
Tetracycline resistance genes 
Of the 46 distinct tet alleles described to date, three types of tetracycline resistance genes 
[tet(A), tet(B), and tet(34)] were detected in 113 isolates (88.3% of the population). The tet(34) 
gene was the most prevalent tetracycline resistance determinant in the population (78.9%), 
followed by tet(A) (28.1%) and tet(B) (11.7%). A similar observation of higher tet(A) prevalence 
compared to tet(B) prevalence in E. coli recovered from surface waters was reported in a 
previous study (Hu et al., 2008). In the present study, tet(A) was associated with retail chicken 
isolates more so than river water isolates of E. coli, and the tet(B) gene was not detected at all 
in E. coli isolated from river water. Although tetracycline is not used to treat E. coli infections in 
humans, resistance to tetracycline is still common among E. coli (Dominguez et al., 2002). This 
would also appear to be the case in non-human E. coli, as suggested by the high prevalence of 
tetracycline resistance genes reported in this study. 
Trimethoprim resistance genes 
Trimethoprim resistance is mainly attributed to the acquisition of a trimethoprim-insensitive 
dihydrofolate reductase, which is the target enzyme of this agent (Seputiene et al., 2010). More 
than 30 different dihydrofolate reductase (dfr) genes have been identified (Zankari et al., 2012). 
Seven of these dfr genes were detected in the non-human E. coli population of the present 
study, with the dfrA1 resistance gene being the most prevalent variant (16.4%). The prevalence 
of other dfr alleles in the population is low, with the dfrA5 allele detected in only 3 isolates and 
dfrA7, dfrA16, dfrA17, dfrB1, and dfrB4 present in only single isolates, respectively. dfrA17 has 
frequently been found in clinical E. coli isolates (Seputiene et al., 2010), which correlates well 
with the high level of resistance against trimethoprim observed for E. coli isolates of human-
clinical origin in a previous Nottingham-based study (Croxall et al., 2011b). In contrast, the lower 
prevalence of dfr genes identified in non-human E. coli would suggest much lower levels of 
resistance to trimethoprim. This demonstrates the inefficacy of trimethoprim in clinical cases, 
which has traditionally been described for prophylaxis in UTIs. 
Although a diverse range of resistance determinants were detected in the population, 
corresponding to 8 different antibiotic classes, it was not completely determined what 
proportion of the population explicitly expressed a multidrug-resistance phenotype (non-
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susceptibility to antimicrobial drugs belonging to 3 or more classes). Carriage of certain 
antimicrobial resistance genes does not necessarily mean that isolates in possession of those 
genes would express the corresponding resistance phenotype. It is suggested that phenotypic 
antimicrobial susceptibility testing should be performed as part of future work on this study 
population, as such testing was not carried out in this study due to time constraints. The low 
prevalence of ESBL genes detected in the population would indicate that expression of multidrug 
resistance to the extended spectrum of β-lactam antibiotics likely occurs at a very low frequency, 
if at all. Producing an antibiogram for the entire population would provide further insight into 
whether a correlation exists between resistance genotypes and resistance phenotypes, and 
would further our understanding of the prevalence of multidrug resistance in the wider non-
human population of E. coli. Comparisons between the antibiotic resistance gene profiles that 
characterise non-human and human-clinical E. coli will be made in chapter 5. 
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Figure 4.6. Distribution of antibiotic resistance gene profiles across the population of 128 E. coli strains isolated 
from river water and retail chicken samples in Nottingham.  
The genomes of 128 E. coli strains were mass screened for antibiotic resistance gene carriage, by running the ABRicate 
bioinformatics tool against the ResFinder database. Presence of resistance determinants are shown on the 
phylogenetic tree as purple-coloured bars and are grouped by antibiotic class. ST designations, as determined by in 
silico MLST, are also indicated on the tree. The most prevalent antimicrobial resistance genes in the population were 
identified as tet(34), aadA1, blaTEM-1B, and the sul genes. Isolates belonging to cryptic clades C-I and C-V, as well as a 
number of isolates of phylogroup B1, revealed much lower carriage of these genes in comparison to the rest of the 
population. 
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4.3.7. Determining the prevalence of ExPEC strains in the non-human population of 
E. coli  
Multiple research groups around the world have reported a consistent observation of specific 
human ExPEC lineages in poultry or poultry products (Johnson et al., 2017; Jakobsen et al., 2010), 
as well as in river and surface waters (Gomi et al., 2017b; Muller, Stephan and Nuesch-
Inderbinen, 2016). This would apparently provide evidence to support the hypothesis that there 
may be a poultry and environmental reservoir for human ExPEC. For this reason, an investigation 
was carried out to determine the prevalence of ExPEC strains among E. coli isolated from retail 
chicken and river water samples in this study. This involved screening all genomes of the study 
population for the presence of specific virulence-associated genes (VAGs), by running the 
bioinformatics pipeline ABRicate, which scans the Virulence Factors Database (VFDB) to 
generate in silico VAG profiles for each isolate (Fig. 4.7). The definition of ExPEC used in this 
study is based on the presence of five virulence markers, as implemented in previous studies 
(Gomi et al., 2017b; Johnson and Stell, 2000). The ExPEC pathotype was defined by the presence 
of two or more of papA and/or papC, afa/dra, kpsMT II, iutA, and sfa/foc, so therefore only these 
VAGs were considered in the analysis. The most frequently detected ExPEC virulence marker in 
the population (Fig. 4.7) was the iron acquisition gene iutA (61/128), which was more commonly 
detected in retail chicken isolates (90.2%) than in river water isolates of E. coli (9.8%). 
Gene clusters for the S fimbrial adhesin (sfa) and F1C fimbriae (foc) were less frequently 
detected in the population (9/128). Similarly, subunits of the pap operon papA and papC, which 
are associated with adhesion to the upper urinary tract, were detected together in 8 strains, 
with the exception of one strain (AFR-12) which possessed only papC. The afa/dra operons were 
present in only one isolate, whilst the type II capsule marker kpsMT II was not detected at all.  
Contrary to previous studies, the ExPEC virulence gene profiles generated in this study indicate 
that the prevalence of ExPEC strains in the non-human population of E. coli is very low; only 11 
of the 128 non-human E. coli isolates (8.6%) were classified as ExPEC, based on their VAG 
profiles. These ExPEC strains are phylogenetically distinct and are distributed across four 
different phylogroups, with 2 strains belonging to phylogroup D and 3 strains belonging to each 
of phylogroups A, B1, and B2, respectively. Additionally, ExPEC strains were identified in both 
river water (n = 7) and retail chicken (n = 4), indicating a presence of potentially pathogenic 
strains in the environment as well as the food chain. Consistent with a recent environmental 
study by Gomi et al. (2017b), non-human isolates of ExPEC exhibited clonal distribution with 
ST10, STC14, ST69, STC168, ST115, ST131, ST141, STC155 and ST4937 prevalent among these 
isolates. Clinically important clonal groups among these isolates would include ST10, STC14, 
ST69, and ST131. Although the sample size of ST131 isolates found and analysed in the present 
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study is very small (exactly one isolate), this strain did not carry any CTX-M-type ESBLs, which 
may be an early indication that environmental ST131 and human-clinical ST131 strains may be 
different in terms of their phylogenetic distribution, as suggested by a previous study using a 
similar study setting (Gomi et al., 2017b). Further genomic analyses between clinically important 
strains of non-human and human origin will be carried out in chapter 5. It was found that ST58 
isolates, belonging to the ST155 complex of phylogroup B1, were the most commonly 
encountered of all ExPEC isolates detected (27.3%). These isolates were positive for the VAGs 
pacA, papC, iutA, and sfa/foc, exhibiting a similar virulence gene profile to the ST131 strain. STC-
(sequence type complex)-155 was recently reported as a clonal group of animal origin that is 
spreading in humans and is highly drug-resistant (Skurnik et al., 2016). It is therefore interesting 
to note in the present study that STC155 isolates were prevalent in river water as well as retail 
chicken samples, with ExPEC strains of STC155 being exclusive to river water. This is supported 
by previous studies which have also reported STC155 strains in surface waters (Gomi et al., 
2017b; Muller, Stephan and Nuesch-Inderbinen, 2016). Noticeably, however, genes encoding 
multidrug resistance were not identified in STC155 strains isolated in the current study, 
suggesting little clinical relevance. Contamination of surface waters with ExPEC strains belonging 
to clinically important STs would therefore be of little or no concern to human health due to the 
occurrence of these strains at such low frequencies in the environment.  
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Figure 4.7. Distribution of ExPEC virulence-associated genes among the population of 128 E. coli strains 
isolated from river water and retail chicken samples in Nottingham. The genomes were mass screened 
for VAG carriage, by running the ABRicate bioinformatics tool to scan the Virulence Factors Database 
(VFDB). The presence of two or more of the following VAGs were used to define the ExPEC pathotype: papA 
and/or papC; afa/dra; kpsMT II; iutA; and sfa/foc. Presence of VAGs is annotated onto the maximum-
likelihood phylogenetic tree as red-coloured bars and the strains identified as ExPEC are highlighted in 
green. ST designations, as determined by in silico MLST, and isolate sample source are also indicated on 
the tree. The prevalence of ExPEC strains among river water and retail chicken samples is low (8.6%) and 
these pathotypes are distributed among phylogroups B2 and D, as well as phylogroups B1 and A. 
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4.4. Conclusions 
In the present study, E. coli obtained from river water and retail chicken samples in the Greater 
Nottingham area, were successfully characterised by whole-genome sequencing. From the 
initial sampling, E. coli were identified in 6 out of the total 9 river water samples collected, and 
82 of all isolates selected from CLED plates (16%) were formally identified as E. coli, through a 
combination of microbial culture on chromogenic media, biochemical testing, and confirmation 
with the API 20E test system. E. coli were also isolated from 11 out of 20 retail chicken samples 
processed. A markedly higher prevalence of E. coli (88%) was observed from the 416 isolates 
selected from retail chicken sample plates. The presence of E. coli in freshwater and surface 
waters is a strong indication of recent human sewage or animal waste contamination. E. coli is 
a natural coloniser of the gastrointestinal tracts of a wide range of wild and domesticated 
animals, particularly those raised for human consumption, such as chickens. The retail chickens 
sampled in this study may have been contaminated at any of the multiple steps along the food 
chain, from production and processing at the abattoir to distribution and retail marketing in 
Nottingham. The presence of ExPEC lineages in retail chicken samples may indicate some early 
faecal contamination of the chicken meat occurred at the slaughterhouse. The difference in E. 
coli prevalence observed between retail chicken and river water samples in this study could be 
attributed to the wastewater treatment processes within the Trent River basin, which would 
appear to keep the release of effluents under relative control, and thus reducing the 
contamination of streams and rivers by faecal pathogens. Conversely, the numbers of E. coli 
isolated in this study would suggest that contamination of British retail chicken by faecal 
organisms is much harder to control, during the process of preparing chicken for human 
consumption. 
Whole-genome sequences for the study population of 128 non-human E. coli strains were 
analysed by in silico multilocus sequence typing (MLST), and the population was found to be 
extremely clonally diverse, consisting of 64 different sequence types. It was evident from this 
analysis that the non-human population of E. coli is not dominated by the ST complexes that are 
commonly associated with urinary tract and bloodstream infections, such as the ST131, ST95, 
ST73, and ST69 complexes (Kallonen et al., 2017; Alhashash et al., 2013; Croxall et al., 2011b; 
Lau et al., 2008). The non-human population of E. coli analysed in this study comprised a wide 
variety of different STs, with the majority of strains not grouping into larger clonal complexes, 
demonstrating the genotypic diversity within the population. The ST10 clonal complex was the 
most frequently encountered clonal group, representing approximately 15% of the Nottingham 
non-human E. coli population analysed in this study, and was prevalent in both river water and 
retail chicken samples. This is an indication that the ST10 complex is widespread across the 
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environment and in the food chain, consistent with the findings of several previous studies 
(Gomi et al., 2017b; Chen et al., 2016; Cohen Stuart et al., 2012; Overdevest et al., 2011). 
Although current literature has reported the presence of well-known ExPEC sequence types in 
environmental waters and retail poultry, this study pinpoints a lack of such strains in the 
Nottingham population of non-human E. coli, suggesting the overall prevalence of human ExPEC 
strains in populations of non-human and commensal E. coli is very low.  
Whole-genome analysis enabled the detection of 46 different resistance determinants among 
all isolates of the study population. The most frequently encountered resistance determinants 
in the non-human population of E. coli were tet(34), aadA1, sul, and blaTEM-1B, which confer 
resistance to tetracycline, streptomycin/spectinomycin, the sulphonamides and penicillin-like 
antibiotics, respectively. The high prevalence of these resistance genes noted in the current 
study is in agreement with the current literature, which suggests that resistance conferred by 
these genes is widespread among E. coli isolated from environmental habitats (Gomi et al., 
2017b; Bajpai et al., 2017; Kaper, Nataro and Mobley, 2004). Many previous studies have 
reported the presence of MDR E. coli strains in surface waters and water-related environments, 
as well as in retail poultry and food animals, on the basis of phenotypic resistance testing and 
detection of several resistance determinants (Gomi et al., 2017b; Johnson et al., 2017; Muller, 
Stephan and Nuesch-Inderbinen, 2016; Vincent et al., 2010; Jakobsen et al., 2010; Johnson et 
al., 2005a). Multidrug resistance in E. coli is mediated by extended-spectrum β-lactamases 
(ESBLs), mainly of the CTX-M family, particularly CTX-M-15 and 14, and less frequently of the 
SHV and OXA families (Nicolas-Chanoine et al., 2008; Lau et al., 2008). Considering that 
antimicrobial susceptibility testing was not performed in this study, it could not be determined 
what proportion of the population explicitly expressed a multidrug-resistance phenotype (non-
susceptibility to antimicrobial drugs belonging to 3 or more classes). However, in silico antibiotic 
resistance gene analysis enabled a determination of the prevalence of the β-lactamase genes 
blaSHV, blaTEM, blaCTX-M, and blaOXA, more accurately than through multiplex PCR assays. Many 
environmental studies reporting isolates that carry ESBL genes often target resistant isolates in 
their sampling procedures, and therefore do not report an accurate representation of ESBL 
prevalence with regard to the wider non-human and environmental population of E. coli. In this 
study, however, an unbiased sampling strategy was employed, in combination with whole-
genome sequencing of isolates, to reveal that a paucity of ESBL genes exists in the non-human 
population of E. coli, suggesting that multidrug resistance occurs at levels much lower than 
described in human-clinical populations of E. coli. 
Reconstruction of the phylogenetic structure of the population revealed that six of the seven 
known E. coli phylogroups were represented in the population, as well the cryptic Escherichia 
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clades C-I, C-III, and C-V, demonstrating the full spectrum of genomic diversity of E. coli in the 
non-human E. coli study population. The majority of strains (approximately 52%) belonged to 
phylogroups A and B1, which are usually dominated by commensal and non-pathogenic strains 
(Duriez et al., 2001; Picard et al., 1999), whereas roughly 28% of the population were assigned 
to phylogroups B2 and D, which are typically associated with strains that cause extraintestinal 
infections (Johnson and Stell 2000; Picard et al., 1999). This suggests that the non-human 
population of E. coli constitutes a high proportion of commensal strains, with a much lower 
prevalence of ExPEC strains. This was confirmed by in silico VAG profiling of each strain for genes 
that are used to define ExPEC. This analysis revealed that only 8.6% of the non-human E. coli 
population could be classified as ExPEC. Moreover, these strains exhibited clonal diversity and 
only a small number of clinically important clonal groups were identified among these isolates, 
with very low prevalence. Although a small-scale representation of human ExPEC lineages, such 
as ST131, ST69, and ST648, has been determined through phylogenetic analysis in the present 
study, it cannot be overlooked that previous studies consistently reporting the presence of such 
clonal groups in the environment and the food chain would appear to support the hypothesis 
that these sources may serve as reservoirs for human ExPEC infection. However, further 
investigation using methods with higher resolving power would be required to determine the 
genomic relatedness between clinically important E. coli STs, isolated from non-human and 
human-clinical sources, as MLST and phylogenetic analyses only take into account variation 
within sections of the core genome. Any variations within the accessory genome that may 
contribute to virulence would not be detected. This will be addressed in chapter 5, through 
comprehensive comparative genomics, which may offer the discrimination necessary to 
determine if a non-human reservoir of human ExPEC exists and address whether it contributes 
to the burden of human extraintestinal infections. 
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CHAPTER 5 
Comparative population genomics of 
Escherichia coli from human-clinical and 
non-human sources 
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5.1. Introduction 
Multilocus sequence typing (MLST) analysis in chapter 4 demonstrated that the non-human 
population of E. coli in Nottingham is clonally diverse. A very low prevalence of ExPEC strains 
was identified in this population, and additionally, the occurrence of extended-spectrum β-
lactamase (ESBL) genes (and thus potential for multidrug resistance) was negligible. These 
results contrasted with previous studies reporting the presence of specific human extraintestinal 
pathogenic E. coli (ExPEC), and multidrug-resistant (MDR) lineages, in poultry (Johnson et al., 
2017; Jakobsen et al., 2010) and surface waters (Gomi et al., 2017b; Coleman et al., 2013). 
Several previous studies have attempted to attribute transmission of ExPEC in humans to poultry 
or other environmental sources, but the majority of these studies usually selectively culture for 
antimicrobial-resistant bacteria, rather than culturing all bacteria and then quantifying resistant 
strains within that population. These studies, therefore, do not present an accurate snapshot of 
the prevalence of multidrug-resistant E. coli in the environment and food-chain (Manges 2016; 
Lazarus et al., 2015). Many of these studies have used traditional, low-resolution typing methods 
to deduce that these E. coli strains, and genes such as those encoding antibiotic resistance and 
virulence factors, can spread from food-producing animals, via the food-chain, to humans 
(Platell et al., 2011b; Dolejska et al., 2011a), and additionally from environmental sources (Jang 
et al., 2013; Dolejska et al., 2011b). However, these methods may not have provided sufficient 
resolution to reliably assess the relatedness of these strains isolated from non-human and 
human-clinical sources. This highlights the importance of applying whole-genome comparative 
analysis, with the aim of distinguishing between seemingly related strains of bacteria. 
E. coli isolated from different geographical regions and ecosystems have highly heterogeneous 
genomes and may vary in size by up to 1 Mbp (Bergthorsson and Ochman, 1998). The diversity 
between E. coli genomes can be attributed to the deletion or acquisition of mobile genetic 
elements by horizontal gene transfer. In a previous study by Lawrence and Ochman (1998), it 
was found that ~18% of all open reading frames (ORFs) of the E. coli strain MG1655 are 
horizontally acquired, which have conferred properties permitting E. coli to colonise otherwise 
unreachable ecological niches. Horizontal gene transfer is largely responsible for the evolution 
of different E. coli pathotypes, as many virulence-associated genes (adhesins, toxins, invasins, 
and others) and antibiotic resistance genes may be encoded on mobile genetic elements, such 
as pathogenicity islands, plasmids, and transposons. Genes conferring other selective 
advantages, such as niche adaptation and fitness, also make up part of the dispensable 
(accessory) genome and can be readily transferred between strains via methods of horizontal 
gene transfer, such as conjugation and transduction. Whole-genome sequencing has provided a 
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method by which to comprehensively characterise the genetic diversity and evolution of large 
populations of related strains, which had proven very difficult prior to the advent of whole-
genome analysis (Metzker, 2010). The E. coli species, which can range from harmless commensal 
to versatile pathogen, is a model organism for such whole-genome based studies (Tenaillon et 
al., 2010). An application of the comparative genomics approach would include the investigation 
of disease outbreaks and diagnosis of infectious disease agents. One example is the use of 
genome sequencing of environmental E. coli to expand the understanding of the ecology and 
speciation of this model organism, which was achieved in a study by Luo and co-authors (2011). 
Genomic comparisons were conducted between pathogenic/commensal E. coli and 
environmental strains that are phenotypically and taxonomically indistinguishable from 
typical E. coli (commensal or pathogenic). It was found that the commensal genomes, which 
encode for more functions that are important for fitness in the human gut, do not exchange 
genetic material with their environmental counterparts. Due to the high discriminatory ability 
of comparative genomics, it was revealed that genetic exchange between emergent ecologically 
distinct phylogenetic clades of E. coli may not be as pronounced or prolonged as would be 
expected (Luo et al., 2011). 
Phylogenetic analysis of whole-genome sequence data has transformed our understanding of 
the evolution and expansion of many important bacterial lineages, due to the high-resolution 
view it provides. However, many of these analyses do not consider the potential role of the 
accessory genome when inferring evolutionary paths. To be able to accurately determine and 
compare the entire gene contents of multiple genomes, the pan-genome approach was 
developed (Tettelin et al., 2008). The pan-genome is the entire gene set of all strains of a species. 
It consists of a core genome, which represents the genes present in all strains of the species, 
and also a dispensable or variable (accessory) genome, which refers to genes that are not 
present in all of the strains; these include genes present in two or more strains, or even genes 
unique to only single strains (Tettelin et al., 2008). Therefore, on inclusion of every new genome 
in a pan-genome analysis, new strain-specific genes are added and thus, the size of the pan-
genome increases. The core genome typically includes housekeeping genes for cell envelope or 
regulatory functions, while the accessory genome comprises genes which encode for the species 
diversity and provides selective advantages for strains, such as niche adaptation, antibiotic 
resistance, and virulence factors. Pan-genome analysis is therefore beneficial for comparing the 
population structures and mechanisms of adaptation and evolution for different bacterial 
populations, as well as providing targets for vaccines and antibiotic treatment (Tettelin et al., 
2008). Pan-genome analysis can also be used to determine the gene pool of a given species 
(Tettelin et al., 2005), as well as from different species (Gordienko, Kazanov and Gelfand, 2013). 
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The pan-genome approach can also provide a method with which to contrast the gene content 
of strains from the same species, but of different pathotypes or clonal groups.  
A recent study by de Been and colleagues (2014) implemented whole-genome sequencing 
(WGS) analyses to study the relatedness of cephalosporin-resistant E. coli from humans, retail 
chicken meat, poultry and pigs. This analysis demonstrated significant heterogeneity between 
human and poultry-associated isolates and the study failed to provide evidence for recent clonal 
transmission of cephalosporin-resistant E. coli strains from poultry to humans, as had been 
suggested previously based on traditional, low-resolution typing methods. Although this study 
suggested that there is little or no overlap between E. coli isolates of human and poultry origin, 
the study had focussed primarily on ESBL-producing E. coli. Similarly, several previous studies 
have been conducted attempting to address the question of potential for waterborne 
transmission of E. coli to humans from freshwater sources (Ojer-Usoz, Gonzãlez and Vitas, 2017; 
Zhang, Gao and Chang, 2016). However, these studies are usually biased towards ESBL-
producing and MDR E. coli because of selectively culturing for resistant isolates in their sampling 
procedure, and thus the relative abundance of these isolates is largely unknown.  
5.1.1. Aim and objectives 
There is a need for whole-genome-based comparative analyses of E. coli populations from 
poultry and the environment and humans, in which ESBL-producing E. coli are not the sole focus, 
but instead investigated in proportion to their frequency. To address this, comparative genomic 
analysis of WGS data for non-human and human-clinical populations of E. coli, obtained from 
the same geographical region, is performed in this chapter, in order to provide sufficient 
resolution to determine the level of genetic heterogeneity between these populations. The two 
populations compared in this chapter include an unbiased sample of isolates, with regards to 
antimicrobial resistance, obtained from river water and retail chicken meat in the Nottingham 
area (i.e. the non-human population of E. coli defined in chapter 4). Representing the human-
clinical population of Nottingham is a collection of blood and urine-derived isolates of E. coli, 
obtained from hospital- and community-acquired extraintestinal infections. Nottingham 
provides the ideal regional ecosystem for comparison of such populations of E. coli, because of 
the comprehensive phenotypic and genotypic data available for human-clinical ExPEC strains, 
collected by the NTU Pathogen Research Group over the past decade (Alhashash et al., 2016; 
Alhashash et al., 2013; Croxall et al., 2011b; Croxall et al., 2011a). Inclusion of human-clinical 
strains isolated from these Nottingham-based studies allows for a geographically constrained 
comparison between the two populations. By applying a pan-genome approach, in conjunction 
with core genome phylogenetic analyses, this chapter aims to provide high-resolution genomic 
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comparison to determine the extent of genetic overlap between the non-human and human-
clinical populations of E. coli in Nottingham. These comprehensive comparative genomic 
analyses aim to provide sufficient discrimination, to address whether the non-human reservoir 
of E. coli contributes to the burden of hospital- and community-acquired human extraintestinal 
infections in this region. 
Specific objectives of this chapter were: 
• To compare the population structures of human-clinical and non-human E. coli, with 
regards to the prevalence of clinically important STs, as determined by in silico 
multilocus sequence typing. 
• To determine the relatedness of strains from the human-clinical and non-human 
populations of E. coli, by constructing a SNP-based core genome phylogenetic tree. 
• To compare the prevalence of antimicrobial resistance determinants and the prevalence 
of human ExPEC strains between the human-clinical and non-human populations of E. 
coli. 
• To construct phylogenetic trees from core genome alignments, in order to determine 
the relatedness of two non-human representative strains of clinically important STs, 
ST131 (GD45) and ST648 (GD49), to the wider populations of the ST131 and ST648 
lineages, obtained from multiple hosts. 
• To perform comparative genomic analysis of all non-human and human-clinical strains 
of E. coli, using a pan-genome approach to identify the proportions of genomic loci that 
are unique to either population or present in both populations. 
• To determine the extent of gene movement between closely related strains of the 
human-clinical and non-human populations of E. coli, by comparing the pan-genomes 
and detected core genome recombination events between strains of ST69 and ST10 
from both populations.   
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5.2. Materials and Methods 
The key bioinformatics tools, scripts, and methods used in this chapter were described 
previously in sections 2.6.2 – 2.6.7 of chapter 2. The E. coli strains listed in Table 5.1 represent 
the human-clinical population in Nottingham, which were used for comparative genomic 
analyses with the non-human population of E. coli. The E. coli strains used for comparative 
phylogenetic analyses of ST131 and ST648 populations are detailed in Table 5.2 and Table 5.3, 
respectively. 
Table 5.1. One hundred and thirty-six sequenced human-clinical E. coli genomes isolated from 
Nottingham. 
Strain name ST ST 
complex 
Sample 
source 
Disease type Year of 
isolation 
B3 131 131 Blood Bacteraemia 2011 
B5 131 131 Blood Bacteraemia 2011 
B9 10 10 Blood Bacteraemia 2011 
B10 73 73 Blood Bacteraemia 2011 
B14 73 73 Blood Bacteraemia 2011 
B16 131 131 Blood Bacteraemia 2011 
B18 73 73 Blood Bacteraemia 2011 
B20 10 10 Blood Bacteraemia 2011 
B22 131 131 Blood Bacteraemia 2011 
B26 131 131 Blood Bacteraemia 2011 
B29 73 73 Blood Bacteraemia 2011 
B31 69 69 Blood Bacteraemia 2011 
B33 69 69 Blood Bacteraemia 2011 
B34 95 95 Blood Bacteraemia 2011 
B36 73 73 Blood Bacteraemia 2011 
B37 131 131 Blood Bacteraemia 2011 
B38 95 95 Blood Bacteraemia 2011 
B40 73 73 Blood Bacteraemia 2011 
B44 131 131 Blood Bacteraemia 2011 
B46 131 131 Blood Bacteraemia 2011 
B47 131 131 Blood Bacteraemia 2011 
B48 131 131 Blood Bacteraemia 2011 
B51 131 131 Blood Bacteraemia 2011 
B54 131 131 Blood Bacteraemia 2011 
B58 131 131 Blood Bacteraemia 2011 
B65 131 131 Blood Bacteraemia 2011 
B71 131 131 Blood Bacteraemia 2011 
B72 73 73 Blood Bacteraemia 2011 
B73 73 73 Blood Bacteraemia 2011 
B75 131 131 Blood Bacteraemia 2011 
B77 131 131 Blood Bacteraemia 2011 
B83 196 None Blood Bacteraemia 2011 
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B84 73 73 Blood Bacteraemia 2011 
B87 58 155 Blood Bacteraemia 2011 
B89 131 131 Blood Bacteraemia 2011 
B91 73 73 Blood Bacteraemia 2011 
B94 131 131 Blood Bacteraemia 2011 
B95 131 131 Blood Bacteraemia 2011 
B102 73 73 Blood Bacteraemia 2011 
B104 131 131 Blood Bacteraemia 2011 
B107 38 38 Blood Bacteraemia 2011 
B116 133 None Blood Bacteraemia 2011 
B125 131 131 Blood Bacteraemia 2011 
B132 131 131 Blood Bacteraemia 2011 
B133 131 131 Blood Bacteraemia 2011 
B134 73 73 Blood Bacteraemia 2011 
B150 131 131 Blood Bacteraemia 2011 
U1 73 73 Urine UTI 2011 
U2 131 131 Urine UTI 2011 
U5 131 131 Urine UTI 2011 
U7 73 73 Urine UTI 2011 
U12 131 131 Urine UTI 2011 
U18 3451 None Urine UTI 2011 
U19 10 10 Urine UTI 2011 
U21 73 73 Urine UTI 2011 
U22 95 95 Urine UTI 2011 
U24 73 73 Urine UTI 2011 
U30 73 73 Urine UTI 2011 
U36 73 73 Urine UTI 2011 
U42 73 73 Urine UTI 2011 
U44 131 131 Urine UTI 2011 
U48 73 73 Urine UTI 2011 
U50 73 73 Urine UTI 2011 
U58 91 None Urine UTI 2011 
U60 95 95 Urine UTI 2011 
U64 69 69 Urine UTI 2011 
U67 69 69 Urine UTI 2011 
U76 73 73 Urine UTI 2011 
U79 131 131 Urine UTI 2011 
U80 131 131 Urine UTI 2011 
U92 131 131 Urine UTI 2011 
U102 38 38 Urine UTI 2011 
U104 3452 None Urine UTI 2009 
UTI18 131 131 Urine UTI 2009 
UTI24 131 131 Urine UTI 2009 
UTI32 131 131 Urine UTI 2009 
UTI62 131 131 Urine UTI 2009 
UTI188 131 131 Urine UTI 2009 
UTI226 131 131 Urine UTI 2009 
UTI306 131 131 Urine UTI 2009 
UTI423 131 131 Urine UTI 2009 
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UTI587 131 131 Urine UTI 2009 
F14W091968 10 10 MSU UTI 2014 
F14W127020-13 10 10 MSU UTI 2014 
F14W127020-20 10 10 MSU UTI 2014 
F14W131166-20 10 10 MSU UTI 2014 
M14W080122 12 12 MSU UTI 2014 
M14W098595-18 12 12 MSU UTI 2014 
M14W098595-31 12 12 MSU UTI 2014 
M14W101150 12 12 MSU UTI 2014 
M14W102050 12 12 MSU UTI 2014 
M14W107589 12 12 MSU UTI 2014 
F14W098435 58 155 MSU UTI 2014 
F14W125408 69 69 MSU UTI 2014 
F14W138284 69 69 MSU UTI 2014 
M14W071194-25 69 69 MSU UTI 2014 
M14W071194-2 69 69 MSU UTI 2014 
F14W108540 73 73 MSU UTI 2014 
F14W113875-18 73 73 MSU UTI 2014 
M14W127066 73 73 MSU UTI 2014 
M14W118794 80 568 MSU UTI 2014 
F14W114148-3 88 23 MSU UTI 2014 
F14W114148-7 88 23 MSU UTI 2014 
F14W131166-2 95 95 MSU UTI 2014 
M14W138421 95 95 MSU UTI 2014 
F13W143423 131 131 MSU UTI 2014 
F14W104167-24 131 131 MSU UTI 2014 
F14W104167-30 131 131 MSU UTI 2014 
F14W104167-31 131 131 MSU UTI 2014 
F14W104462-19 131 131 MSU UTI 2014 
F14W104462-28 131 131 MSU UTI 2014 
F14W118623 131 131 MSU UTI 2014 
F14W141832 131 131 MSU UTI 2014 
M14W073874 131 131 MSU UTI 2014 
M14W108795 131 131 MSU UTI 2014 
M14W113876 131 131 MSU UTI 2014 
M14W125435 131 131 MSU UTI 2014 
M14W131103-35 131 131 MSU UTI 2014 
M14W131103-5 131 131 MSU UTI 2014 
F14W071693 355 None MSU UTI 2014 
F14W080037 404 14 MSU UTI 2014 
F14W108313 404 14 MSU UTI 2014 
F14W113464-2 648 648 MSU UTI 2014 
F14W113464-40 648 648 MSU UTI 2014 
M14W114085 648 648 MSU UTI 2014 
M14W140076 681 None MSU UTI 2014 
1980_EC 95 95 Blood Neonatal sepsis 2015 
1982_EC 2622 None Blood Neonatal sepsis 2015 
1983_EC 538 538 Blood Neonatal sepsis 2015 
1984_EC 73 73 Blood Neonatal sepsis 2015 
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1985_EC 73 73 Blood Neonatal sepsis 2015 
2113_EC 95 95 Blood Neonatal sepsis 2015 
2114_EC 95 95 Blood Neonatal sepsis 2015 
2286_EC 69 69 Blood Neonatal sepsis 2015 
2297_EC 120 None Blood Neonatal sepsis 2015 
2300_EC 458 73 Blood Neonatal sepsis 2015 
 
Table 5.1. One hundred and thirty-six sequenced human-clinical E. coli genomes isolated from 
Nottingham. 
One hundred and thirty-six E. coli genomes, from the Nottingham Trent University (NTU) Pathogen 
Research Group strain collection, were included in this chapter for comparative genomic analyses with the 
Nottingham non-human population of E. coli, isolated in chapter 4. These strains were previously isolated 
from human-clinical samples (blood and urine cultures), obtained from the QMC hospital in Nottingham. 
Genome sequences and annotations were provided as FASTA files and GFF files from separate PhD studies 
at NTU: Gemma Clark, 2009; Fahad Alhashash, 2011; Ruqaiah Bedawai, 2014; Mohamed Saad, 2015.  
ST: sequence type as confirmed by in silico multilocus sequence typing analysis; MSU: midstream sample 
of urine; UTI: urinary tract infection. 
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Table 5.2. Two hundred and forty-two sequenced ST131 E. coli genomes used for comparative 
phylogenetic analysis in this chapter. 
Strain name Source Sample Year Country 
Reference/ 
Accession number 
JIE186 Human UTI 2005 Australia ERR537636 
B36EC_81 Human UTI 2007 Australia (Petty et al., 2014) 
MS2481_77 Human Bacteraemia 2007 Australia (Petty et al., 2014) 
MS2493_59 Human Bacteraemia 2007 Australia (Petty et al., 2014) 
S104EC_75 Human UTI 2008 Australia (Petty et al., 2014) 
S105EC_73 Human UTI 2008 Australia (Petty et al., 2014) 
S98EC_75 Human Asymptomatic 2008 Australia (Petty et al., 2014) 
S100EC_53 Human Unknown 2009 Australia (Petty et al., 2014) 
S101EC_81 Human Unknown 2009 Australia (Petty et al., 2014) 
S108EC_61 Human Neutropenia 2009 Australia (Petty et al., 2014) 
S109EC_69 Human Asymptomatic 2009 Australia (Petty et al., 2014) 
S110EC_77 Human UTI 2009 Australia (Petty et al., 2014) 
S111EC_69 Human UTI  2009 Australia (Petty et al., 2014) 
S112EC_73 Human UTI 2009 Australia (Petty et al., 2014) 
S113EC_75 Human Unknown 2009 Australia (Petty et al., 2014) 
S65EC_79 Human Unknown 2009 Australia (Petty et al., 2014) 
S79EC_75 Human Unknown 2009 Australia (Petty et al., 2014) 
S99EC_49 Human Asymptomatic 2009 Australia (Petty et al., 2014) 
S102EC_51 Human Unknown 2010 Australia (Petty et al., 2014) 
S103EC_73 Human Pyuria 2010 Australia (Petty et al., 2014) 
S107EC_75 Human Bacteraemia 2010 Australia (Petty et al., 2014) 
S77EC_77 Human UTI 2010 Australia (Petty et al., 2014) 
S114EC_77 Human UTI 2011 Australia (Petty et al., 2014) 
S115EC_75 Human UTI 2011 Australia (Petty et al., 2014) 
19770 DA Cat 2009 Austria ERR264251 
S121EC_81 Human UTI 2000 Canada (Petty et al., 2014) 
S123EC_81 Human UTI 2001 Canada (Petty et al., 2014) 
S125EC_83 Human SWI 2002 Canada (Petty et al., 2014) 
S126EC_79 Human UTI 2002 Canada (Petty et al., 2014) 
S127EC_59 Human UTI 2002 Canada (Petty et al., 2014) 
S131EC_75 Human UTI 2002 Canada (Petty et al., 2014) 
S122EC_81 Human UTI 2003 Canada (Petty et al., 2014) 
S124EC_77 Human UTI 2003 Canada (Petty et al., 2014) 
S128EC_79 Human Primary sepsis 2004 Canada (Petty et al., 2014) 
S129EC_79 Human UTI 2004 Canada (Petty et al., 2014) 
S130EC_83 Human UTI 2004 Canada (Petty et al., 2014) 
S132EC_77 Human UTI 2005 Canada (Petty et al., 2014) 
S133EC_73 Human UTI  2005 Canada (Petty et al., 2014) 
S134EC_81 Human UTI 2005 Canada (Petty et al., 2014) 
S135EC_77 Human BTI  2005 Canada (Petty et al., 2014) 
S120EC_63 Human BTI  2009 Canada (Petty et al., 2014) 
WCE266 Human Ascites fluid 2005 China LSFO00000000 
WCE296 Human Pleural effusion 2005 China LSEZ00000000 
WCE307 Human Bacteraemia 2005 China LSGU00000000 
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WCE208 Human UTI 2006 China LSEX00000000 
WCE233 Human Bacteraemia 2006 China LSEY00000000 
E4 Human Asymptomatic  2011 China LRXB00000000 
J09 Human UTI 2011 China LSEG00000000 
J21 Human Asymptomatic  2011 China LSEH00000000 
M8 Human Asymptomatic  2011 China LSEK00000000 
K0178B Avian Cormorant  2007 CZR LSEI00000000 
HP47 Avian Rook 2010 CZR LRXE00000000 
27678 Avian Rook 2011 CZR ERR264279 
27679 Avian Rook 2011 CZR ERR264280 
27683 Avian Rook 2011 CZR ERR264281 
27684 Avian Rook 2011 CZR ERR264282 
27685 Avian Rook 2011 CZR ERR264283 
27686 Avian Rook 2011 CZR ERR264284 
27690 Avian Rook 2011 CZR ERR264285 
17530 DA Dog 2008 Denmark ERR264240 
18582 DA Dog 2009 Denmark ERR264245 
22233 DA Dog 2010 Denmark ERR264266 
18572 DA Dog 2009 France ERR264244 
23942 DA Dog 2010 France ERR264273 
12520 Avian Chicken 2007 Germany ERR264278 
12556 DA Dog 2008 Germany ERR264289 
18342 DA Dog 2009 Germany ERR264242 
18982 DA Dog 2009 Germany ERR264246 
19001 DA Dog 2009 Germany ERR264247 
19336 DA Dog 2009 Germany ERR264249 
19529 DA Dog 2009 Germany ERR264250 
21176 Human Unknown 2010 Germany ERR264257 
21177 Human Unknown 2010 Germany ERR264258 
21178 Human Unknown 2010 Germany ERR264259 
21181 Human Unknown 2010 Germany ERR264260 
21182 Human Unknown 2010 Germany ERR264261 
21201 Human Unknown 2010 Germany ERR264262 
21514 DA Dog 2010 Germany ERR264263 
22022 Avian Bird 2010 Germany ERR264264 
22186 DA Cat 2010 Germany ERR264265 
22239 DA Dog 2010 Germany ERR264267 
22372 DA Cat 2010 Germany ERR264268 
23511 DA Dog 2010 Germany ERR264269 
23778 DA Dog 2010 Germany ERR264271 
23927 DA Cat 2010 Germany ERR264272 
24089 DA Dog 2010 Germany ERR264274 
24510 DA Dog 2010 Germany ERR264275 
852 Human UTI 2011 Germany LNPW00000000 
972 Human UTI 2011 Germany LNOM00000000 
1011 Human UTI 2011 Germany LRHP00000000 
1019 Human UTI 2011 Germany LRHQ00000000 
1039 Human UTI 2011 Germany LRHR00000000 
1087 Human UTI 2011 Germany LRHS00000000 
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1223 Human UTI 2011 Germany LRHT00000000 
1351 Human UTI 2011 Germany LRHU00000000 
1366 Human UTI 2011 Germany LRVN00000000 
1369 Human UTI 2011 Germany LRVO00000000 
1380 Human UTI 2011 Germany LRVP00000000 
1389 Human UTI 2011 Germany LRVQ00000000 
1402 Human UTI 2011 Germany LRVR00000000 
2963 Human Asymptomatic 2011 Germany LRVS00000000 
2999 Human UTI 2011 Germany LRVU00000000 
3019 Human UTI 2011 Germany LRVT00000000 
3020 Human UTI 2011 Germany LRVV00000000 
3134 Human UTI 2011 Germany LRVW00000000 
3140 Human UTI 2011 Germany LRVX00000000 
24790 DA Dog 2011 Germany ERR264276 
24839 DA Dog 2011 Germany ERR264277 
26368 Livestock Cattle 2011 Germany ERR264288 
IR18E_63 Human UTI 2009 India (Petty et al., 2014) 
IR49_69 Human UTI 2009 India (Petty et al., 2014) 
IR65_69 Human UTI 2009 India (Petty et al., 2014) 
IR68_79 Human UTI 2009 India (Petty et al., 2014) 
MB1074 Human Asymptomatic  2012 Ireland LSEL00000000 
MB14972 Human Asymptomatic  2012 Ireland LSEM00000000 
MB17684 Human Asymptomatic  2012 Ireland LSEN00000000 
MB3298 Human Asymptomatic  2012 Ireland LSEO00000000 
MB3323 Human Asymptomatic  2012 Ireland LSEP00000000 
19017 DA Dog 2009 Italy ERR264248 
19801 DA Dog 2009 Italy ERR264252 
20130 DA Dog 2009 Italy ERR264253 
20441 DA Cat 2010 Italy ERR264255 
20936 DA Dog 2010 Italy ERR264256 
18570 DA Dog 2009 NDL ERR264243 
20402 DA Cat 2010 NDL ERR264254 
23736 DA Dog 2010 NDL ERR264270 
S92EC_51 Human Bacteraemia 2009 NZ (Petty et al., 2014) 
S93EC_79 Human Bacteraemia 2009 NZ (Petty et al., 2014) 
S94EC_63 Human Bacteraemia 2009 NZ (Petty et al., 2014) 
S95EC_75 Human Bacteraemia 2009 NZ (Petty et al., 2014) 
S96EC_53 Human Bacteraemia 2010 NZ (Petty et al., 2014) 
S97EC_73 Human Bacteraemia 2010 NZ (Petty et al., 2014) 
K0198B Avian Cormorant 2007 Serbia LSEJ00000000 
HS115 Avian Rook 2010 Serbia LRXF00000000 
27702 Avian Rook 2011 Serbia ERR264286 
27703 Avian Rook 2011 Serbia ERR264287 
17898 DA Dog 2008 Spain ERR264241 
HVM1147_73 Human Abscess 2010 Spain (Petty et al., 2014) 
HVM1299_69 Human Abscess 2010 Spain (Petty et al., 2014) 
HVM1619_79 Human SWI 2010 Spain (Petty et al., 2014) 
HVM1997_61 Human UTI  2010 Spain (Petty et al., 2014) 
HVM2044_75 Human UTI 2010 Spain (Petty et al., 2014) 
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HVM2289_73 Human UTI  2010 Spain (Petty et al., 2014) 
HVM277_81 Human UTI  2010 Spain (Petty et al., 2014) 
HVM3017_57 Human UTI 2010 Spain (Petty et al., 2014) 
HVM3189_79 Human UTI  2010 Spain (Petty et al., 2014) 
HVM5_47 Human UTI  2010 Spain (Petty et al., 2014) 
HVM52_83 Human UTI  2010 Spain (Petty et al., 2014) 
HVM826_63 Human RTI  2010 Spain (Petty et al., 2014) 
HVM834_75 Human UTI 2010 Spain (Petty et al., 2014) 
HVR2496_77 Human UTI 2010 Spain (Petty et al., 2014) 
HVR83_61 Human UTI 2010 Spain (Petty et al., 2014) 
P53EC_53 Human Asymptomatic 2011 Spain (Petty et al., 2014) 
P56EC_47 Human Asymptomatic 2011 Spain (Petty et al., 2014) 
P146EC_71 Human Asymptomatic 2011 Spain (Petty et al., 2014) 
P189EC_55 Human Asymptomatic 2011 Spain (Petty et al., 2014) 
P50EC_77 Human Asymptomatic 2011 Spain (Petty et al., 2014) 
EC958 Human UTI 2001 UK CAFL01000001 
S39EC_79 Human Unknown 2004 UK (Petty et al., 2014) 
S43EC_81 Human Unknown 2004 UK (Petty et al., 2014) 
S47EC_79 Human Unknown 2004 UK (Petty et al., 2014) 
S53EC_79 Human Unknown 2004 UK (Petty et al., 2014) 
S1EC_81 Human UTI 2007 UK (Petty et al., 2014) 
S2EC_61 Human UTI 2007 UK (Petty et al., 2014) 
S30EC_81 Human UTI 2007 UK (Petty et al., 2014) 
S31EC_81 Human UTI 2007 UK (Petty et al., 2014) 
S32EC_79 Human UTI 2007 UK (Petty et al., 2014) 
S5EC_75 Human UTI 2007 UK (Petty et al., 2014) 
S6EC_73 Human UTI 2007 UK (Petty et al., 2014) 
UTI18 Human UTI 2008 UK ERR062284 
UTI188 Human UTI 2008 UK ERR062289 
UTI226 Human UTI 2008 UK ERR062293 
UTI24 Human UTI 2008 UK ERR062292 
UTI306 Human UTI 2008 UK ERR062295 
UTI32 Human UTI 2008 UK ERR062294 
UTI423 Human UTI 2008 UK ERR062296 
UTI587 Human UTI 2008 UK ERR062291 
UTI62 Human UTI 2008 UK ERR062297 
S10EC_77 Human UTI 2009 UK (Petty et al., 2014) 
S11EC_83 Human UTI 2009 UK (Petty et al., 2014) 
S12EC_79 Human UTI 2009 UK (Petty et al., 2014) 
S15EC_83 Human UTI 2009 UK (Petty et al., 2014) 
S19EC_73 Human UTI 2009 UK (Petty et al., 2014) 
S21EC_59 Human UTI 2009 UK (Petty et al., 2014) 
S22EC_83 Human UTI 2009 UK (Petty et al., 2014) 
S24EC_75 Human UTI 2009 UK (Petty et al., 2014) 
S26EC_69 Human UTI 2009 UK (Petty et al., 2014) 
S34EC_75 Human UTI 2009 UK (Petty et al., 2014) 
S37EC_83 Human UTI 2009 UK (Petty et al., 2014) 
S116EC_77 Human BTI  2011 UK (Petty et al., 2014) 
S117EC_49 Human BTI  2011 UK (Petty et al., 2014) 
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S118EC_69 Human UTI 2011 UK (Petty et al., 2014) 
S119EC_71 Human Bacteraemia 2011 UK (Petty et al., 2014) 
B104 Human Bacteraemia 2012 UK LRWU00000000 
B125 Human Bacteraemia 2012 UK LRWX00000000 
B132 Human Bacteraemia 2012 UK LRWY00000000 
B133 Human Bacteraemia 2012 UK LRWZ00000000 
B150 Human Bacteraemia 2012 UK LRXA00000000 
B16 Human Bacteraemia 2012 UK LRWA00000000 
B22 Human Bacteraemia 2012 UK LRWB00000000 
B26 Human Bacteraemia 2012 UK LRWC00000000 
B3 Human Bacteraemia 2012 UK LRVY00000000 
B37 Human Bacteraemia 2012 UK LRWD00000000 
B44 Human Bacteraemia 2012 UK LRWE00000000 
B46 Human Bacteraemia 2012 UK LRWF00000000 
B47 Human Bacteraemia 2012 UK LRWG00000000 
B48 Human Bacteraemia 2012 UK LRWH00000000 
B5 Human Bacteraemia 2012 UK LRVZ00000000 
B51 Human Bacteraemia 2012 UK LRWI00000000 
B54 Human Bacteraemia 2012 UK LRWJ00000000 
B58 Human Bacteraemia 2012 UK LRWK00000000 
B65 Human Bacteraemia 2012 UK LRWL00000000 
B71 Human Bacteraemia 2012 UK LRWM00000000 
B75 Human Bacteraemia 2012 UK LRWN00000000 
B77 Human Bacteraemia 2012 UK LRWO00000000 
B89 Human Bacteraemia 2012 UK LRWR00000000 
B94 Human Bacteraemia 2012 UK LRWS00000000 
B95 Human Bacteraemia 2012 UK LRWT00000000 
U12 Human UTI 2012 UK LSEQ00000000 
U2 Human UTI 2012 UK LSER00000000 
U44 Human UTI 2012 UK LSES00000000 
U5 Human UTI 2012 UK LSET00000000 
U79 Human UTI 2012 UK LSGT00000000 
U80 Human UTI 2012 UK LSEU00000000 
U92 Human UTI 2012 UK LSEV00000000 
F13W143423 Human UTI 2014 UK Unpublished  
F14W118623 Human UTI 2014 UK Unpublished  
F14W141832 Human UTI 2014 UK Unpublished  
M14W073874 Human UTI 2014 UK Unpublished  
M14W108795 Human UTI 2014 UK Unpublished  
M14W113876 Human UTI 2014 UK Unpublished  
M14W125435 Human UTI 2014 UK Unpublished  
M14W131103-35 Human UTI 2014 UK Unpublished  
F14W104167-31 Human UTI 2014 UK Unpublished  
F14W104167-30 Human UTI 2014 UK Unpublished  
F14W104462-28 Human UTI 2014 UK Unpublished  
F14W104167-24 Human UTI 2014 UK Unpublished  
F14W104462-19 Human UTI 2014 UK Unpublished  
M14W131103-5 Human UTI 2014 UK Unpublished  
GD45 Environment River water 2015 UK Unpublished  
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F283 Avian Crow 2012 USA LRXD00000000 
JJ1886 Human UTI 2012 USA CP006784.1 
 
Table 5.2. Two hundred and forty-two sequenced ST131 E. coli genomes used for comparative 
phylogenetic analysis in this chapter. 
Two hundred and forty-one ST131 E. coli genomes were included in this chapter for comparative 
phylogenetic analysis with the single Nottingham E. coli ST131 strain (GD45), isolated from river water in 
chapter 4. These strains were isolated from various hosts across multiple geographical locations and time 
periods. The ST131 population includes 125 avian (wild birds), domesticated animal (cats and dogs), 
livestock (cattle), and human-clinical isolates, sequenced as part of a recent study by McNally et al. (2016a); 
102 human isolates (clinical and asymptomatic) from a previous phylogenomic study (Petty et al., 2014); 
and 14 human-clinical isolates obtained from the NTU Pathogen Research Group strain collection 
(unpublished). The genomes were provided by Alan McNally as FASTA files and the accession numbers (or 
citation) for these genomes are shown in the table.  
DA: domesticated animal; SWI: surgical wound infection; UTI: urinary tract infection; RTI: respiratory tract 
infection; BTI: biliary tract infection; NDL: The Netherlands; UK: United Kingdom; USA: United States of 
America; CZR: Czech Republic; NZ: New Zealand. 
  
   
151 
 
Table 5.3. Eighty-nine sequenced ST648 E. coli genomes used for comparative phylogenetic 
analysis in this chapter. 
Strain name CTX-M carriage 
F_12_GNB_311 blaCTX-M-15 
F_30_1_R8 ND 
F_GNB_2781 blaCTX-M-14 
F_GNB_2809 ND 
F_GNB_2838 blaCTX-M-15 
F_GNB_3697 blaCTX-M-15 
F_N13_1_3 blaCTX-M-3 
F_QUC093 blaCTX-M-15 
GD49 ND 
IHIT22921 blaCTX-M-15 
IHIT22927 blaCTX-M-15 
IHIT22988 blaCTX-M-15 
IHIT22990 blaCTX-M-15 
IHIT23010 blaCTX-M-15 
IHIT23044 blaCTX-M-15 
IHIT23167 blaCTX-M-15 
IHIT23176 blaCTX-M-15 
IHIT23177 blaCTX-M-15 
IHIT25637 blaCTX-M-15 
IHIT25686 blaCTX-M-15 
IHIT27893 ND 
IMT12298 ND 
IMT12560 blaCTX-M-1 
IMT13211 blaCTX-M-3 
IMT16316 blaCTX-M-15 
IMT16343 blaCTX-M-15 
IMT16352 blaCTX-M-15 
IMT17438 blaCTX-M-15 
IMT17486 blaCTX-M-14b 
IMT17507 blaCTX-M-15 
IMT17539 blaCTX-M-15 
IMT17576 blaCTX-M-15 
IMT17887 blaCTX-M-15 
IMT17908 blaCTX-M-3 
IMT18337 blaCTX-M-15 
IMT18340 blaCTX-M-15 
IMT18351 blaCTX-M-14 
IMT18984 blaCTX-M-15 
IMT19322 blaCTX-M-15 
IMT20000 blaCTX-M-15 
IMT20607 blaCTX-M-14 
IMT20610 blaCTX-M-14 
IMT21183 blaCTX-M-15 
IMT21409 blaCTX-M-15 
IMT21500 blaCTX-M-15 
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Table 5.3. Eighty-nine sequenced ST648 E. coli genomes used for comparative phylogenetic analysis in 
this chapter. 
  
  
IMT21502 blaCTX-M-15 
IMT21509 blaCTX-M-15 
IMT21529 blaCTX-M-14 
IMT21531 blaCTX-M-15 
IMT22074 blaCTX-M-15 
IMT23463 blaCTX-M-14 
IMT23464 blaCTX-M-14 
IMT23760 blaCTX-M-15 
IMT23775 blaCTX-M-15 
IMT24056 blaCTX-M-15 
IMT24058 blaCTX-M-15 
IMT24081 blaCTX-M-15 
IMT24488 blaCTX-M-15 
IMT24490 blaCTX-M-15 
IMT24495 ND 
IMT24616 blaCTX-M-15 
IMT24817 blaCTX-M-15 
IMT24818 blaCTX-M-15 
IMT24834 blaCTX-M-15 
IMT24837 blaCTX-M-15 
IMT24849 blaCTX-M-15 
IMT26356 blaCTX-M-15 
IMT27014 blaCTX-M-15 
IMT33120 ND 
IMT33123 blaCTX-M-15 
IMT33127 blaCTX-M-15 
IMT33136 blaCTX-M-15 
IMT33143 blaCTX-M-15 
IMT33148 blaCTX-M-15 
IMT33149 blaCTX-M-14 
IMT33150 blaCTX-M-15 
IMT33151 blaCTX-M-15 
IMT33152 blaCTX-M-15 
IMT33159 blaCTX-M-15 
IMT33167 blaCTX-M-15 
IMT33170 blaCTX-M-15 
IMT33171 blaCTX-M-15 
IMT33601 ND 
IMT33602 ND 
IMT33608 blaCTX-M-32 
IMT33613 blaCTX-M-15 
IMT34407 ND 
IMT34408 ND 
NA023 blaCTX-M-15 
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Table 5.3. Eighty-nine sequenced ST648 E. coli genomes used for comparative phylogenetic analysis in 
this chapter.  
The genomes of 88 ESBL-producing ST648 E. coli strains were included in this chapter, for comparative 
phylogenetic analysis with the single Nottingham E. coli ST648 strain (GD49), isolated from river water in 
chapter 4. These strains originated from different hosts including humans, companion animals (cats, dogs, 
and horses), and wild birds, across Western Europe. The genomes were previously sequenced by Sebastian 
Guenther and colleagues (University of Greifswald) and were provided as FASTA files for this study. The 
CTX-M types identified for each strain, as determined by in silico resistance gene screening using ABRicate, 
are provided in the table.  
ND: not detected. 
 
5.3. Results and Discussion 
5.3.1. Comparing the prevalence of STs between the human-clinical and non-human 
populations of E. coli 
In silico MLST analysis in chapter 4 revealed that the Nottingham population of E. coli isolated 
from non-human samples in this study is clonally diverse, with a total of 64 different sequence 
types (STs) identified among 128 strains (section 4.3.4, Table 4.4). The population structure of 
non-human E. coli was comprised largely of a wide variety of different STs, with the ST10 clonal 
complex representing the most predominant central genotype, along with closely related STs 
such as ST93, ST746, ST752, and ST1551, which were prevalent in both retail chicken and river 
water samples. To put the prevalence of sequence types in the non-human E. coli population 
into the context of the human-clinical E. coli population, MLST data for a large collection of E. 
coli strains isolated from human-clinical cases in Nottingham were included in the analysis for 
comparison. Sequence type designations were obtained for 399 human-clinical E. coli strains 
isolated from two previous Nottingham-based studies; 134 of these strains were isolated from 
cases of urinary tract infection and urosepsis in elderly patients (Croxall et al., 2011b); 140 and 
125 strains were isolated from bacteraemia patients and urinary samples, respectively, as part 
of a separate Nottingham-based study (Alhashash et al., 2013). Sequence types were 
determined in these studies by PCR-based MLST and using the typing scheme developed and 
hosted by Mark Achtman and colleagues (Wirth et al., 2006).  
Percentage prevalence data for STs with ≥ 3 representative isolates identified among the 
human-clinical population and ≥ 3 isolates among the non-human population of E. coli, are 
presented in Figure 5.1A and 5.1B, respectively. Considering the larger sample size of isolates 
analysed for the human-clinical population of E. coli, this may explain why a greater number of 
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unique STs (n = 138) were identified. The most prevalent STs identified in the human-clinical 
population were ST131 (17.0%), ST73 (14.3%), ST69 (7.0%), and ST95 (5.8%), which are all largely 
associated with ExPEC infections in humans (Fig. 5.1A). In the non-human population of E. coli, 
on the other hand, the most prevalent STs were ST10 (12.5%), and closely related STs of the 
ST10 clonal complex, ST752 (5.5%), ST1551 (4.7%), and ST93 (3.9%). The ‘other STs’ category 
comprised all STs represented by ≤ 2 isolates in the human-clinical population (Fig. 5.1A) and ≤ 
2 isolates in the non-human population (Fig. 5.1B). This category constituted 30.8% of human-
clinical isolates and 44.5% of non-human isolates. Although more unique STs were detected in 
the human-clinical population, the level of genotypic heterogeneity would appear to be similar 
to that of the non-human population, which revealed a high proportion of isolates belonging to 
the ‘other STs’ category within a comparatively small sample size. This was confirmed by 
calculating the Shannon diversity indices for the abundance of STs in both the human-clinical 
(3.81) and non-human (3.79) populations of E. coli. The Hutcheson t-test was then used to 
compare the diversity of the two populations. The calculated t-value of 0.11 does not exceed 
the critical value of 1.96, indicating that the difference between the calculated diversities of both 
populations is not statistically significant (p < 0.05; 95% confidence interval). In comparison, the 
two populations would appear to differ in terms of population structure, as illustrated by the 
prevalence of STs in Figure. 5.1. The human-clinical population of E. coli is dominated by the four 
main ExPEC-associated STs, ST69, ST73, ST95, and ST131, which together represent around 44% 
of this population. It is well documented in the literature that these four sequence types are 
collectively responsible for a large proportion of E. coli urinary tract and bloodstream infections 
(Kallonen et al., 2017; Doumith et al., 2015; Alhashash et al., 2013; Croxall et al., 2011b; Lau et 
al., 2008). The ST95 complex, which is a prominent ExPEC sequence type complex associated 
with extraintestinal infections in humans and poultry (Vincent et al., 2010), was 
underrepresented in this strain set (5.8% of isolates) in comparison to the other major ExPEC 
STs reported. The relatively low proportion of ST95 strains compared to the overrepresentation 
of ST131 in the Nottingham human-clinical population of E. coli highlights the recent emergence 
of a new dominant clone (Johnson et al., 2017; Kallonen et al., 2017; Clark et al., 2012). The non-
human population of E. coli isolated from this study is not highly represented by the four major 
STs identified in the human-clinical population, and instead the analysis reveals that the ST10 
clonal complex is the most predominant genotype.  
Comparison of the prevalence of the most predominant STs of both populations (ST131, ST73, 
ST69, ST95, and ST10) further demonstrates the disparity in the population structures of human-
clinical and non-human E. coli (Fig. 5.2). While the important multidrug-resistant (MDR) ExPEC 
lineage ST131 was the most commonly encountered ST among human-clinical isolates analysed 
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in this study, only one instance of the same genotype was observed in the non-human 
population of E. coli, indicating a significantly low prevalence in comparison (p < 0.0001, two-
tailed Fisher’s test). Additionally, the well-known human ExPEC sequence types ST73 and ST95 
were prevalent in the human-clinical population, but could not be detected among non-human 
isolates of E. coli. ST69, which is a highly virulent strain associated with human extraintestinal 
infections (Kallonen et al., 2017; Alhashash et al., 2013; Croxall et al., 2011b; Lau et al., 2008), 
as well as some animal models (Cristovao et al., 2017; Tartof et al., 2005), was identified among 
human-clinical E. coli isolates in addition to non-human (retail chicken) isolates (Fig. 5.2). This ST 
represented a higher proportion of human-clinical isolates (7.0%) than non-human isolates 
(3.1%), however, this difference may not be considered to be significant (p = 0.137, two-tailed 
Fisher’s test). ST10 is a common human ExPEC ST that is also associated with food animals and 
retail poultry meat (Aslam et al., 2014; Bergeron et al., 2012; Vincent et al., 2010). It was 
revealed in this study that ST10 dominates in the non-human population of E. coli (prevalent 
among 12.5% of isolates), but comprised a significantly lower proportion (1.5%) of the human-
clinical population of E. coli (p < 0.0001, two-tailed Fisher’s test). This suggests a more 
widespread prevalence of this ST in the environment and food chain than in human-clinical cases 
of extraintestinal infection. The paucity of human ExPEC STs 131, 73, 69, and 95 in the non-
human population of E. coli would suggest that the non-human reservoir of human ExPEC is 
negligible, at least in so far as it has been sampled in this study, and it is unlikely to be responsible 
for the majority of human ExPEC infections in Nottingham. 
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Figure 5.1. Percentage prevalence of E. coli sequence types (STs) among E. coli strains isolated from (A) 
human-clinical and (B) non-human samples collected in Nottingham.  
The human-clinical population of E. coli (n = 399) comprise 259 isolates from cases of UTI and urosepsis in 
elderly patients, and 140 from bacteraemia patients. STs were determined by PCR-based MLST as part of 
previous studies (Alhashash et al., 2013; Croxall et al., 2011b). The non-human population comprises 128 
sequenced strains from retail chicken and river water samples. ST designations were made by in silico MLST 
analysis of WGS data. Percentage prevalence is presented for all STs with ≥ 3 representative isolates, whilst 
the ‘other STs’ category constitutes all STs represented by ≤ 2 isolates, except for STs 20, 131, and 648, 
which are presented independently in chart B. 
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Figure 5.2. Percentage prevalence of the most predominant E. coli sequence types (STs) associated with 
human ExPEC infection in the human-clinical and non-human populations of E. coli in Nottingham.  
Percentage prevalence comparison is presented for STs 131, 73, 69, 95, and 10, detected in the human-
clinical population (n = 399) and non-human population (n = 128) of E. coli. ST131 was the dominant clone 
of the human-clinical population (17.0%), but only one ST131 strain (0.78%) was detected in the non-
human population of E. coli, indicating a statistically significant difference between the two populations 
(**human-clinical ST131 vs non-human ST131; p < 0.0001, two-tailed Fisher’s test). The well-known human 
ExPEC sequence types ST73 and ST95, which were also prevalent in the human-clinical population, were 
not identified among non-human isolates of E. coli (**human-clinical ST73 vs non-human ST73, p < 0.0001, 
two-tailed Fisher’s test; *human-clinical ST95 vs non-human ST95, p < 0.001, two-tailed Fisher’s test). ST69, 
on the other hand, was prevalent in both populations and whilst this genotype represented a higher 
proportion of human-clinical isolates (7.0%) than non-human isolates (3.1%), this may not be considered a 
statistically significant difference (human-clinical ST69 vs non-human ST69; p = 0.137, two-tailed Fisher’s 
test). The prevalence of ST10 was significantly higher in the non-human population (12.5%) than that of 
the human-clinical (1.5%) population (**human-clinical ST10 vs non-human ST10; p < 0.0001, two-tailed 
Fisher’s test). The asterisks represent comparisons made between human-clinical and non-human isolates. 
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The MLST data for both populations were combined and divided into groups of closely related 
isolates and clonal complexes, using the PHYLOViZ platform to construct a complete minimum 
spanning tree (MST) of all the STs in the analysed E. coli population (Fig. 5.3). When comparing 
E. coli isolates from human-clinical and non-human samples, the analysis revealed that the 
majority of these isolates clustered into different sequence types or clonal groups, based on 
their source of isolation. The MST illustrates a noticeable separation in the population structures 
of human-clinical and non-human E. coli. This is demonstrated by a large proportion of roughly 
90% (124/138) of the STs identified among human-clinical E. coli isolates being unique to this 
population (i.e. not found in the non-human population). Similarly, a relatively large proportion 
of around 78% (50/64) of the STs identified among non-human E. coli isolates were unique to 
this population. This meant that out of the total 186 E. coli STs identified among all isolates, only 
14 STs (7.5%) were prevalent in both the human-clinical and non-human populations. This would 
indicate that considerable genotypic differences exist between E. coli strains isolated from the 
two populations, and it suggests that the population of E. coli that exists in the environment and 
food chain is largely distinct from the human-clinical population of E. coli associated with human 
ExPEC infections. Of the 14 STs prevalent in both the human-clinical and non-human 
populations, clinically important ExPEC strains were identified among ST69, ST131, ST141, ST58, 
ST93, and ST10 in the non-human population of E. coli analysed. ST648 is a highly multidrug-
resistant clone observed in human patients globally, and more incidentally in companion 
animals and wild birds (Guenther, Ewers and Wieler, 2011). This ST was also prevalent in the 
human-clinical and non-human populations presented in this study. Other STs present in both 
populations include ST48, ST394, ST409, ST644, ST929, ST1011, and ST2459. The presence of 
sequence types such as ST131, ST141, ST58, ST93, and ST648 in river water samples would 
indicate a relatively small level of contamination of surface waters by E. coli strains belonging to 
clinically important clonal groups, due to direct discharge from wastewater treatment plants 
and agricultural runoff. Human ExPEC strains belonging to ST69 and ST10 were isolated from 
retail chicken meat in this study, which may suggest a link between contaminated food products 
and E. coli strains that cause extraintestinal infection. Overall, the MST (Fig. 5.3) illustrates two 
populations of E. coli in Nottingham which appear to be distinct in terms of population structure 
and do not frequently come into contact with each other. Further genomic analyses would be 
able to determine whether strains of clinically important clonal groups isolated from the non-
human population are the same strains implicated in community-acquired and hospital-
acquired extraintestinal infections.  
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Figure 5.3. Minimum spanning tree (MST) illustrating the E. coli STs isolated from human-clinical and non-human samples.  
The MST was produced using Phyloviz v3. The size of the nodes reflects the number of strains belonging to each ST. Nodes outlined by a yellow-green ring represent ST 
complexes. The sample types (human-clinical, red; non-human, blue) are overlaid onto the diagram, which confirms the predominance of ST131, ST73, ST65, and ST95 among 
human-clinical isolates and the ST10 clonal group among non-human isolates, with a limited number of STs shared between the two populations.
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5.3.2. Comparative phylogenomic analysis of the human-clinical and non-human 
populations of E. coli 
The collection of sequenced isolates from Nottingham-based studies includes the 128 E. coli 
genomes isolated from river water and retail chicken samples in chapter 4, representing the 
Nottingham non-human population of E. coli in this study. Also included are 136 E. coli genomes 
previously isolated from human-clinical samples, collected from the Queen’s Medical Centre 
(QMC) hospital in Nottingham. The human-clinical population encompasses 47 isolates from 
cases of bacteraemia, 79 isolates from cases of UTIs, and 10 isolates from cases of neonatal 
sepsis, obtained from the NTU Pathogen Research Group strain collection (metadata for strains 
are provided in Table 5.1). It should be noted that these sequenced strains do not represent the 
true population structure of human-clinical E. coli in Nottingham, due to a large proportion of 
these genomes being selectively sequenced based on their ST designation and association with 
extraintestinal infections. This would explain the overrepresentation of ST131 and ST73 strains 
in the human-clinical population of E. coli.  
A maximum-likelihood SNP-based phylogenetic tree was constructed using Parsnp (Fig. 5.4), 
which was derived from a core genome alignment, obtained from localised co-linear blocks 
(length = 62,825 bp, total SNPs = 55,677), of all non-human and human-clinical E. coli genomes 
(n = 264). The population included cryptic clade E. coli isolates, which served as the outgroup for 
the tree. With source of isolation annotated on the tree as coloured bars and phylogenetic 
clades defined by coloured branches according to phylogroup, the analysis revealed an 
observable phylogenetic divide between the human-clinical and non-human populations of E. 
coli. There is a clear clustering of isolates according to ST, and due to the overrepresentation of 
ST131, ST73, ST95, and ST12 strains, the human-clinical population is dominated by phylogroup 
B2, with 80.1% (109/136) of the population belonging to this phylogenetic group. In contrast, 
only 7% of the non-human population (9/128) were classified as phylogroup B2, demonstrating 
the lack of classically pathogenic strains in this population. The difference in population 
structures between the two populations is therefore quite evident. Other phylogroups present 
in the human-clinical population of E. coli would include phylogroups F (n = 3), D (n = 10), E (n = 
2), B2 (n = 4), A (n = 7), and additionally, one strain belonging to cryptic clade C-V was also 
identified. Non-human E. coli isolates outnumber the human-clinical isolates present in these 
phylogroups, further illustrating the difference in the two population structures.  
Although there is a bias towards ST131 and ST73 among the sequenced human-clinical E. coli 
genomes included in this analysis, the distribution of STs and clonal complexes demonstrated in 
Figure 5.3 indicates a prevalence of STs which are closely related to the larger clonal groups of 
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ST131, ST73, ST95, and ST69. When this is taken into consideration with the clustering of these 
ST complexes on the phylogenetic tree (Fig. 5.4), it strongly suggests that the wider human-
clinical population of E. coli is largely represented by phylogroups B2 and D. This is consistent 
with previous studies which have indicated that Phylogroup B2 strains are generally more 
virulent than strains belonging to the other groups (Picard et al., 1999; Boyd and Hartl, 1998). 
Additionally, phylogroup B2 and, to a lesser extent, phylogroup D are predominantly associated 
with strains that cause extraintestinal infections (Johnson and Stell, 2000; Picard et al., 1999). 
Conversely, most of the non-human population belong to phylogroups A and B1, suggesting a 
high proportion of largely commensal strains of E. coli, as described by previous studies (Duriez 
et al., 2001; Picard et al., 1999). 
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Figure 5.4. Maximum-likelihood SNP-based phylogenetic tree of 264 E. coli strains isolated from human-
clinical and non-human samples in Nottingham.  
The 128 E. coli genomes isolated from river water and retail chicken samples in chapter 4, representing the 
Nottingham non-human population of E. coli, are presented on the tree in addition to 136 E. coli genomes 
previously isolated from human-clinical samples. The human-clinical population encompasses 47 isolates 
from cases of bacteraemia, 79 isolates from cases of UTIs, and 10 isolates from cases of neonatal sepsis 
(details of strains are provided in section 5.2, Table 5.1). The phylogeny was inferred from a core genome 
alignment of the combined populations (62,825 bp, 55,677 SNPs, 264 genomes) constructed using Parsnp. 
The phylogenetic tree was visualised and edited using iTOL (Letunic and Bork, 2016). Source of isolation is 
annotated on the tree as coloured bars and STs/ST complexes are indicated on the tree as coloured 
segments behind the strain names. The phylogenetic clades are defined by branch colouring according to 
each phylogroup/cryptic clade. 
  
   
163 
 
5.3.3. Determining the prevalence of ExPEC strains in the human-clinical population 
of E. coli 
The high prevalence of phylogroup B2 strains in the human-clinical population of E. coli would 
be suggestive of a high prevalence of virulence-associated genes (VAGs) (Picard et al., 1999; 
Boyd and Hartl 1998). The population is therefore likely to consist of a high proportion of ExPEC 
strains, due to this phylogroup being predominantly associated with strains that cause 
extraintestinal infections (Johnson and Stell 2000; Picard et al., 1999). In chapter 4, analysis of 
ExPEC VAG profiles indicated that the prevalence of ExPEC strains in the non-human population 
of E. coli is very low, which is in contrast to previous studies that have reported a consistent 
observation of specific human ExPEC lineages in poultry (Johnson et al., 2017; Jakobsen et al., 
2010) and surface waters (Gomi et al., 2017b; Coleman et al., 2013). Only 11 of the 128 non-
human E. coli isolates (8.6%) were classified as ExPEC, based on the possession of two or more 
of the following VAGs: papA and/or papC; afa/dra; kpsMT II; iutA; and sfa/foc. 
In silico ExPEC VAG profiling was also carried out for the 136 sequenced E. coli isolates of the 
human-clinical population (Fig. 5.5). The genomes were screened for the presence of the above-
mentioned VAGs by running the bioinformatics pipeline ABRicate, which scans the Virulence 
Factors Database (VFDB) to generate VAG profiles for each isolate. This allowed the prevalence 
of ExPEC strains in the human-clinical population to be determined and compared with that of 
the non-human population of E. coli. It was found that the pap operons papA and papC, as well 
as the iron acquisition gene iutA, are widespread throughout the human-clinical population, 
whilst the afa/dra operons and S fimbrial adhesin and F1C fimbriae cluster (sfa/foc) were 
detected in a number of phylogroup B2, F, and D strains (Fig. 5.5). Similar to the non-human 
population, the type II capsule marker kpsMT II was not detected in human-clinical isolates. 
Roughly 67% of the human-clinical population (91/136) were defined as ExPEC, representing the 
majority of the population. ExPEC strains were identified predominantly in phylogroup B2, 
however 9 ExPEC strains were also detected within phylogroups D, E, and F. ExPEC strains were 
prevalent among several different sequence types, including STs 131, 73, 95, 12, 404, 648, 88, 
69, and 38, indicating the clonal distribution of ExPEC within the human-clinical population of E. 
coli. The difference between the prevalence of ExPEC in the Nottingham human-clinical and non-
human populations of E. coli revealed in this study is statistically significant (66.9% prevalence 
in human-clinical vs 8.6% prevalence in non-human; p < 0.0001, two tailed Fisher’s test). This 
highlights the possibility that an obvious non-human reservoir of human ExPEC does not exist 
and therefore, the non-human population of E. coli is unlikely to contribute significantly to the 
weight of human ExPEC infections, in comparison to the human-clinical population E. coli. 
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Figure 5.5. Distribution of ExPEC virulence-associated genes among the population of 136 E. coli strains 
isolated from human-clinical samples in Nottingham. Human-clinical E. coli genomes (Table 5.1) were 
mass screened for VAG carriage, by running the ABRicate bioinformatics tool to scan the Virulence Factors 
Database. The presence of two or more of the following VAGs were used to define the ExPEC pathotype: 
papA and/or papC; afa/dra; kpsMT II; iutA; and sfa/foc. VAGs are mapped onto the maximum-likelihood 
phylogenetic tree as red-coloured bars and strains identified as ExPEC are shown in green. ST designations, 
as determined by in silico MLST, are also indicated on the tree. The difference in ExPEC prevalence between 
human-clinical and non-human E. coli is statistically significant (66.9%, human-clinical vs 8.6%, non-human; 
p < 0.0001, two-tailed Fisher’s test). 
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5.3.4. Distribution of antimicrobial resistance genes among human-clinical E. coli  
In chapter 4, in silico antimicrobial resistance gene profiling revealed a diverse range of 
resistance determinants detected in the Nottingham non-human population of E. coli, which 
corresponded to 8 different antibiotic classes (Fig. 4.6; section 4.3.6). However, contrary to 
previous reports of MDR E. coli consistently being reported from the environment and food 
sources, a very low prevalence of ESBL genes was observed in the non-human population of E. 
coli. This suggests that multidrug resistance to the extended spectrum of β-lactam antibiotics 
likely occurs at a very low frequency. To compare the prevalence of antimicrobial resistance 
genes in the human-clinical population with that of the non-human population, all 136 human-
clinical E. coli genomes were also screened for the presence of acquired antimicrobial resistance 
genes. This was achieved in silico, by running the bioinformatics pipeline ABRicate, which scans 
the ResFinder database to generate antibiotic resistance gene profiles for each isolate (Fig. 5.6).  
With regards to the human-clinical population of E. coli, a total of 51 different resistance 
determinants were identified, compared to 46 genes identified in the non-human population. 
These genes corresponded to 11 different antibiotic classes, 8 of which were identified in the 
non-human population, and 3 additional classes: polymyxins, quinolones, and glycopeptides 
(vancomycin). Noticeable similarities between the two populations would include the high 
prevalence of aminoglycoside resistance genes. The streptomycin resistance genes strA, strB, 
aadA1, and aadA5 were detected at high frequencies throughout the human-clinical population. 
Additionally, a high prevalence of β-lactam (blaTEM-1B), sulphonamide (sul1 and sul2), and 
tetracycline (tet(A), tet(B), and tet(34)) resistance genes were reported among human-clinical 
isolates, similar to the non-human population of E. coli. On the other hand, some observable 
differences were also noted between the acquired resistance gene profiles of both populations. 
The human-clinical population revealed a higher prevalence of chloramphenicol resistance 
genes, particularly catA1 and catB3, which were identified in 26.5% of all human-clinical isolates, 
compared to the lower prevalence (3.9%) among non-human E. coli isolates. Furthermore, there 
is a clear contrast between the frequencies of trimethoprim resistance genes observed for both 
populations. The prevalence of dfr alleles, which confer resistance to trimethoprim, was 
generally low for the non-human population, whilst a high prevalence of dfr gene types was 
identified among human-clinical isolates, in particular dfrA17 (33% prevalence), which has 
frequently been reported in clinical E. coli isolates (Seputiene et al., 2010). This correlates well 
with the high level of phenotypic trimethoprim resistance observed for human-clinical isolates 
of E. coli in a previous NTU-based study (Croxall et al., 2011b). Additionally, the macrolide 
resistance gene mph(A), which was detected in only two isolates of the non-human population, 
was considerably more prevalent in the human-clinical population (29.4% of isolates). However, 
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additional macrolide resistance genes (mph(B), Inu(F), Inu(B), and Isa(A)) present in the non-
human population were not detected in the human-clinical population. This may suggest that 
although E. coli are intrinsically resistant to macrolide antibiotics (Gomi et al., 2017b), there is a 
disparity in the type of macrolide resistance genes that are acquired and conserved in both 
populations, perhaps due to the selective pressures that they encounter. A noticeable pattern 
that can be observed from the antimicrobial resistance gene profiles of the human-clinical 
population is the concentration of genes in the ST131 clade of phylogroup B2 (Fig. 5.6). These 
isolates demonstrate a high prevalence of all the major resistance determinants associated with 
this population, in particular aadA1 and aadA5, blaCTX-M-15, blaOXA-1, mph(A), sul1, and dfrA17. 
This may suggest that human-clinical ST131 in this population is likely to be comprised of mainly 
ST131 clade C isolates, which is the most dominant lineage (currently up to 80% of global ST131 
belong to clade C) (Nicolas-Chanoine, Bertrand and Madec, 2014) and is often associated with 
blaCTX-M-15 carriage.  
One of the significant observations made between the two populations is the appreciable 
difference in prevalence of ESBL genes. Results from this study have revealed a very low 
prevalence of ESBL genes in the non-human population of E. coli, through molecular detection 
by multiplex PCR assays of 230 isolates (in section 4.3.2 of chapter 4), and confirmed by in silico 
antimicrobial resistance gene profiling of the 128 sequenced non-human E. coli genomes (in 
section 4.3.6 of chapter 4). While the emergence and dissemination of the CTX-M family of ESBLs 
among E. coli within the community is of particular concern, the blaCTX-M family of genes could 
not be detected in the non-human population of E. coli. By contrast, however, blaCTX-M type ESBL 
genes were identified in 21.3% of all human-clinical E. coli isolates (Fig. 5.6), with blaCTX-M-15 being 
the most prevalent ESBL gene (present in 20.6% of all isolates). Furthermore, blaOXA genes, 
namely blaOXA-1 and blaOXA-10, were identified in only 1.6% of non-human E. coli isolates analysed, 
whereas blaOXA-1 predominated in 21.3% of all human-clinical isolates analysed, indicating a 
significant difference between the two populations (1.6% vs 21.3%; p < 0.0001, two tailed 
Fisher’s test). SHV-type ESBLs, which were not detected in the non-human population, were less 
prevalent than the other ESBLs and were identified in only 2.9% of all human-clinical isolates. 
However, the high prevalence of blaCTX-M and blaOXA genes in the Nottingham human-clinical 
population of E. coli is consistent with previous reports of ESBLs being commonly detected in 
human-clinical isolates (Kallonen et al., 2017; Alhashash et al., 2013; Croxall et al., 2011b; Lau et 
al., 2008), suggesting that these isolates may act as reservoirs for ESBLs. The absence of blaCTX-
M-carrying plasmids in the non-human population of E. coli analysed would indicate that 
horizontal transfer of such genetic elements between isolates from non-human sources occurs 
at low frequencies. This would suggest that non-human isolates of the Nottingham E. coli 
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population do not readily encounter ESBL-producing strains of the human-clinical population, 
and horizontal gene transfer and recombination between the two populations are likely to be 
limited. 
 
 
Figure 5.6. Distribution of antibiotic resistance gene profiles across the population of 136 E. coli strains 
isolated from human-clinical samples in Nottingham.  
The genomes of the 136 human-clinical E. coli strains included in the study population were mass screened 
for antibiotic resistance gene carriage, by running the ABRicate bioinformatics tool using the ResFinder 
database. Presence of resistance determinants are shown on the phylogenetic tree as purple-coloured bars 
and are grouped by antibiotic class. ST designations, as determined by in silico MLST, are also indicated 
next to the taxa on the tree. The human-clinical population showed higher prevalence of chloramphenicol 
and trimethoprim resistance genes, in addition to ESBLs (blaCTX-M and blaOXA), when compared to the non-
human population (section 4.3.6, Fig. 4.5).  
Tree scale: 0.1
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5.3.5. Phylogenetic analyses of the E. coli lineages ST131 and ST648 
5.3.5.1.  E. coli ST131  
Of the limited number of clinically significant sequence types identified in the non-human 
population of E. coli, only a single strain belonging to the ST131 clonal group was isolated from 
river water samples. The ST131 lineage of extraintestinal pathogenic E. coli has been rapidly 
globally disseminated to become the dominant MDR strain of E. coli from urinary tract and 
bloodstream infections, across the globe (Banerjee and Johnson, 2014). The phylogenetic 
structure of the ST131 lineage consists of three distinct clades (Petty et al., 2014). These are 
defined as clades A, B, and C, of which clade C, also known as H30Rx, is associated with the rapid 
expansion and global dissemination of MDR isolates carrying the blaCTX-M-15 ESBL gene. Core 
genome phylogenetic analysis of the human-clinical and non-human populations of E. coli (Fig. 
5.4) did not provide significant genomic distinction between strains belonging to the same clonal 
group. To gain further resolution between closely related strains found in both human-clinical 
and non-human sources, these strains must be analysed in a wider context of strains within the 
same clonal group.  
To determine the position of the single non-human ST131 isolate from this study in a wider 
population of the ST131 lineage, it was included in a global collection of 242 E. coli ST131 
genome sequences, from multiple ecosystems (Table 5.2). In addition to the river water isolate, 
125 were avian (wild birds), domesticated animal (cats and dogs), livestock (cattle), and human-
clinical isolates, sequenced as part of a recent study by McNally et al. (2016a); 102 were human-
clinical isolates from a previous phylogenomic study (Petty et al., 2014); and the remaining 14 
were human-clinical isolates obtained from the NTU Pathogen Research Group strain collection 
(unpublished). A core genome alignment and maximum likelihood phylogeny was obtained from 
localised co-linear blocks (length = 3,727,932 bp, total SNPs = 287,012) for all 242 genomes, 
which confirmed the 3-clade structure of E. coli ST131, as previously described (Fig. 5.7). This 
analysis revealed that the river water strain (GD45) had clustered with clade B, which appears 
to be the most genetically diverse clade, as indicated by longer branch lengths and all isolate 
sources are represented in this clade (Fig. 5.7). It is therefore important to note that GD45 is not 
a clade C strain, which is the most globally dominant lineage. Global longitudinal studies 
revealed that clade B was predominant among ST131 before the 1990s, however, since the 
2000s clade C has become the most dominant lineage with up to 80% of global ST131 belonging 
to clade C (Nicolas-Chanoine, Bertrand and Madec, 2014). Clade C is mostly fluoroquinolone-
resistant and is often associated with carrying the ESBL gene blaCTX-M-15, whilst clade B is most 
often fluoroquinolone-susceptible and rarely carries plasmids with blaCTX-M-15. This is consistent 
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with the GD45 strain isolated in this study, which is ESBL-negative. Given the position of GD45 
within clade B, it can be deduced that this isolate is not associated with the lineage of ST131 that 
is currently responsible for the majority of extraintestinal infections in humans and is therefore 
unlikely to be of significant concern to human health.  
 
 
 
Figure 5.7. Maximum likelihood SNP-based phylogenetic tree of 242 E. coli ST131 isolates.  
A global collection of ST131 strains isolated from humans, wild birds (avian), dogs and cats (domesticated 
animals), cattle (livestock), and river water are indicated by coloured bars at the tips of the tree. The 
phylogeny was inferred from a core genome alignment of all strains (length = 3,727,932 bp, total SNPs = 
287,012, 242 genomes) constructed using Parsnp. The phylogenetic tree was visualised and edited using 
iTOL. The names of the taxa correspond to those listed in Table 5.2. The phylogenetic clades A, B, and C are 
indicated by colour coding of the branches and the ST131 strain isolated from river water in this study 
(GD45) is highlighted in blue within clade B.  
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5.3.5.2.  E. coli ST648 
ST648 is another ExPEC-associated sequence type, in addition to ST131, which is associated with 
worldwide dissemination of E. coli producing the CTX-M β-lactamase (Pitout, 2012). ST648, 
which belongs to phylogroup F, has been identified previously in livestock and companion 
animals (Ewers et al., 2012). Of particular concern, are ST648 strains with an ESBL phenotype 
which have been observed globally in human patients, and more incidentally from domesticated 
and wild animals in Europe and Asia (Guenther, Ewers and Wieler 2011; Guenther et al., 2010; 
Zong and Yu, 2010; Cortes et al., 2010). The frequent occurrence of CTX-M-15-type ESBLs in 
ST648 isolates, among samples from predominantly companion animals and horses, highlights 
the widespread dissemination of this ESBL-producing genotype, which has been detected in 
livestock, wildlife, and humans. A previous study by Ewers and co-authors (2014) suggested that 
the prevalence of CTX-M-15 – a predominantly human-linked β-lactamase type – among 
companion animal ST648 isolates indicates that a mutual exchange of such strains between 
clinical, community, and environmental surroundings is likely.  
In the present study, only a single isolate of ST648 was identified among the non-human 
population of E. coli analysed. To determine the phylogenetic relation of this strain within the 
context of a wider population of the ST648 lineage, it was included in a European collection of 
89 E. coli ST648 genome sequences, from multiple host sources (Table 5.3). In addition to the 
river water isolate, 88 strains were isolated from different hosts including humans, companion 
animals (cats, dogs, and horses), and wild birds, across Western Europe. A core genome 
alignment and maximum likelihood phylogeny was obtained from localised co-linear blocks 
(length = 4,002,826 bp, total SNPs = 208,172) for all 89 genomes (Fig. 5.8). The phylogeny reveals 
three predominant clades that are observable in the population, with the Nottingham river-
water isolate (GD49) positioned within the population of European isolates (not forming a 
separate branch). Annotation of identified CTX-M types onto the tree exposes a predominance 
of the blaCTX-M-15 ESBL type in the population. An overwhelming majority of approximately 88% 
(78/89) of the population were found to harbour a CTX-M ESBL gene, with blaCTX-M-15 being 
detected in roughly 72% (64/89) of the population. The 14 other CTX-M-positive isolates were 
found to carry blaCTX-M-1, blaCTX-M-3, blaCTX-M-14, and blaCTX-M-32. There were only 11 isolates in the 
population in which CTX-M type ESBLs could not be detected, including GD49 isolated from the 
current study. Interestingly, GD49 clusters with the clade of primarily CTX-M-negative isolates, 
and isolates carrying blaCTX-M-3, blaCTX-M-14, and blaCTX-M-32 were also present, whilst only two 
carriers of blaCTX-M-15 were identified within this clade. The majority of CTX-M-15-producing 
isolates therefore constitute the other two clades within the population. This suggests that a 
level of genetic diversity exists within this population of ST648, where strains have lost their CTX-
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M-associated plasmid or acquired different CTX-M-associated plasmids, perhaps due to 
ecological separation and encountering a change in environment.  
It is also interesting to note that despite the geographical separation between the ESBL-negative 
GD49 strain (isolated from Nottingham) and the rest of the population, consisting of primarily 
MDR isolates from animals (isolated from mainland Western Europe), GD49 still falls within the 
tree indicating its phylogenetic relation to the European population of ST648. This would 
support a widespread dispersion of this sequence type, as has been reported globally (Guenther 
et al., 2012; Cortes et al., 2010; Sidjabat et al., 2009), and it may also imply that the ST648 strain 
isolated from the environment could originate from humans, companion animals, or livestock. 
Based on the association of the blaCTX-M-15 ESBL type in ST648 isolates with human-clinical cases 
observed in previous studies (Zong and Yu 2010; Cortes et al., 2010; Nicolas-Chanoine et al., 
2008), it would seem unlikely that ST648 isolates that do not possess a CTX-M-carrying plasmid, 
in particular blaCTX-M-15, can be attributed to the global expansion of ST648 in humans. Having 
identified an ESBL-negative ST648 strain in the non-human (river water) population of E. coli in 
this study, it may suggest that ST648 strains in this population pose little clinical significance to 
humans. 
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Figure 5.8. Maximum likelihood SNP-based phylogenetic tree of 89 E. coli ST648 isolates.  
A European collection of ST648 strains isolated from humans, companion animals (cats, dogs, and horses), 
wild birds, and river water are included in the phylogenetic tree. The phylogeny was inferred from a core 
genome alignment of all strains (length = 4,002,826 bp, 89 genomes) constructed using Parsnp. The 
phylogenetic tree was visualised and edited using iTOL. blaCTX-M carriage, as determined by in silico 
resistance gene screening using ABRicate, is annotated on the tips of the tree as coloured bars. The names 
of the taxa correspond to the strains listed in Table 5.3. The single ST648 strain isolated from river water in 
this study (GD49) is highlighted in blue on the tree. Five different CTX-M types were identified in the 
population: blaCTX-M-1, blaCTX-M-3, blaCTX-M-14, blaCTX-M-15, and blaCTX-M-32. blaCTX-M-15 was found to be the most 
frequently detected CTX-M type, whilst GD49 was one of the few strains that did not possess a CTX-M-
carrying plasmid. 
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5.3.6. Comparative genomic analyses  
5.3.6.1. Pan-genome approach to compare human-clinical and non-human E. coli 
Comparative analyses between the non-human and human-clinical populations of E. coli in this 
study has thus far suggested two distinct populations of E. coli in Nottingham. If this is the case, 
then significant levels of genetic exchange would not be expected between the two populations. 
To be able to accurately determine and compare the entire gene contents of multiple genomes, 
a pan-genome approach was applied when comparing the human-clinical and non-human 
populations of E. coli in this study. Pan-genome analysis offers a higher resolution than core 
genome phylogeny and MLST typing methods, as it analyses the entire bacterial genome (Hall, 
Ehrlich and Hu, 2010). Since there are only a limited number of clinically relevant STs present in 
the non-human population, all strains were included in the pan-genome to look for any patterns 
of gene flow between the two populations. Determination of the core and pan-genomes of all 
264 human-clinical and non-human E. coli strains of the Nottingham study population was 
achieved using the Roary pan-genome bioinformatics pipeline (Page et al., 2015). 
Overall, the pan-genome of the Nottingham E. coli population was composed of 69,645 genes, 
of which, only 596 genes were represented at least once in ≥ 95% of strains (Fig. 5.9A). Despite 
the presence of 10 cryptic clade Escherichia strains in the population, this would indicate a 
species with a large dispensable/accessory genome, reflecting the diversity of E. coli, with only 
a small proportion of core genes conserved for basic biological and phenotypic functions. This 
was confirmed by re-running the pan-genome analysis on all E. coli sensu stricto strains (n = 254) 
by excluding the 10 cryptic Escherichia strains (Fig. 5.9B). The analysis revealed that the number 
of core genes represented at least once in ≥ 95% of strains remained unchanged (596 core 
genes), suggesting a very small core genome for the species. A large number of strain-specific 
genes are therefore present in the E. coli pan-genome, as well as genes encoding species 
diversity and providing selective advantages such as niche adaptation, antibiotic resistance, and 
virulence factors. Of the total number of genes which make up the pan-genome of the study 
population, 29,139 genes were found to be unique strain-specific genes (a gene possessed by 
exactly one isolate), and the frequency of gene occurrence plot for the pan-genome of all 264 
strains (Fig. 5.9A) indicates that a minimal number of core genes are shared by all strains of the 
study population. Determining the level of horizontal gene transfer of dispensable accessory 
genes between the two populations would provide an insight into the frequency of strain 
movement, and thus, whether the human-clinical and non-human populations of E. coli overlap. 
To investigate this, analysis of the accessory genomes of all strains is required. 
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Figure 5.9. (A) Core and pan-genome frequency plots of all 264 E. coli and cryptic clade Escherichia 
strains isolated from human-clinical and non-human samples in Nottingham. (B) Core and pan-genome 
frequency plots of all 254 sensu stricto E. coli strains isolated from human-clinical and non-human 
samples in Nottingham. 
The box and whisker plots display the number of genes on the 𝑦-axis against the number of genomes on 
the 𝑥-axis. The pan-genome was determined using the Roary pan-genome bioinformatics pipeline and the 
plots were generated using the R plots (ggplot2) flag. As the number of genomes increases, the total 
number of genes in the pan-genome increases (shown in red). The pan-genome analysis was first run on 
all 264 E. coli genomes, inclusive of 10 cryptic clade Escherichia strains (A). A total of 69,645 genes were 
identified in the pan-genome of all 264 strains, of which, only 596 genes were represented at least once in 
≥ 95% of strains (shown in blue as ‘conserved genes’). The pan-genome analysis was re-run on the E. coli 
population, excluding the 10 cryptic clade Escherichia strains (B). A total of 66,477 genes were identified in 
the pan-genome of 254 strains, while the number of core genes represented at least once in ≥ 95% of 
strains remained unchanged (596 core genes). 
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5.3.6.2. Comparisons of the accessory genomes of human-clinical and non-human E. coli 
Comparisons between the accessory genomes of all 264 human-clinical and non-human E. coli 
strains would allow for a determination of the proportion of accessory gene clusters or loci 
unique to either population, as well as the proportion that is shared between both populations. 
Comparing the accessory genomes of human-clinical and non-human E. coli isolates would 
provide an insight into whether gene sharing occurs frequently or is restricted between the two 
populations. Additionally, accessory gene sharing between strains of the two populations may 
provide some indication of whether strain movement occurs readily between the two 
populations. For this purpose, genes considered to be core for all strains were excluded from 
this analysis to allow for accessory genome comparisons. Genes present in at least 85% of strains 
conforms to the definition of “soft core” genes (Gordienko, Kazanov and Gelfand, 2013), and it 
was therefore decided to use this as exclusion criteria for this particular analysis. The accessory 
genomes of all strains were obtained by excluding genes present in ≥ 85% of strains from the 
pan-genome matrix, which would result in the removal of primarily core genes from the pan-
genome. To confirm that the excluded genes represent predominantly core/soft core genes of 
the E. coli genome, the gene product functions of these genes were evaluated and their 
proportions are presented in Figure 5.10. It was revealed that the majority of these genes 
encode for basic biological and phenotypic functions, such as DNA replication, lipid biosynthesis, 
cell wall and plasma membrane maintenance, motility, respiration, cell division, hydrolase 
activity, and stress response. The most common gene functions encoded by these genes 
included transport, protein biosynthesis and general metabolism of the cell. Gene functions for 
cell adhesion (1.32%), antibiotic resistance (0.74%), enzyme inhibitors (0.37%), and antibiotic 
biosynthesis (0.16%) were also reported, however these are negligible in comparison to the 
major gene functions identified. This analysis confirmed that the excluded genes predominantly 
encode for the basic biochemical and phenotypic functions associated with the core genome of 
E. coli, justifying the exclusion of these genes from further analysis.  
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Figure 5.10. Functional categories of genes present in ≥ 85% of all 264 E. coli strains isolated from 
human-clinical and non-human samples in Nottingham.  
The graph shows the distribution of functional categories for genes present in ≥ 85% of the 264 genomes 
included in the pan-genome analysis (section 5.3.6.1), with percentage prevalence of genes in each 
category shown on the 𝑥-axis. Genes were identified by creating a pan-genome of all genomes, using the 
Roary bioinformatics pipeline. The graph confirms that these genes predominantly encode for the basic 
biochemical and phenotypic functions associated with core/soft core genes of E. coli, thus justifying the 
exclusion of these genes for accessory genome analyses.  
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The resulting accessory gene presence/absence matrix was analysed using the Roary 
query_pan_genome script, to identify the genetic loci uniquely associated with the human-
clinical population or the non-human population, as well as genes that are associated with both 
populations of strains. The total number of genes unique to either population and the total 
number of shared genes between the two populations are presented in the Venn diagram (Fig. 
5.11). The analysis revealed that removal of “soft” core genes (present in ≥ 85% of strains) 
resulted in an accessory genome comprising 64,835 genes, representing a large proportion of 
the total pan-genome. Of the total number of accessory genes detected, 12,311 genes were 
unique to human-clinical strains and 31,468 genes were identified among non-human E. coli 
strains exclusively, whilst a total 21,056 accessory genes were present in both populations. This 
corresponded to ~40% of genes identified in non-human E. coli and ~63% of genes identified in 
human-clinical E. coli being shared between the two populations. Scanning the gene functions 
of the 21,056 accessory genes shared between the two populations revealed that 150 
antimicrobial resistance genes and 785 phage-associated elements were identified. In the 
context of shared accessory genes, these numbers are relatively high indicating that there is 
likely a high number of mobile genetic elements present in both populations. This suggests that 
gene exchange between the two populations does occur and the extent of this should be 
investigated further. Although numerous accessory genes were identified as being unique to 
either population, the frequency of gene occurrence plots for genes unique to the human-
clinical (Fig. 5.12A) and non-human (Fig. 5.12B) populations indicate a large proportion of strain-
specific genes for each population. Of the 12,311 genes unique to the human-clinical population, 
8,879 genes were strain-specific genes, whilst 20,039 of the 31,468 genes unique to the non-
human population were also strain-specific genes. This equates to 72% and 63% of unique genes 
being strain-specific genes in the human-clinical and non-human populations, respectively. The 
frequency of gene occurrence plot for the 21,056 genes present in both populations (Fig. 5.12C) 
reveals a more even distribution of accessory genes, with the number of shared genes 
decreasing as the number of genomes included increases. This was expected given that these 
genes are, by definition, not strain-specific. The majority of the shared genes would appear to 
be ST- or clade-specific genes, while only 17 common genes are prevalent in a maximum of 209 
out of 264 genomes across the two populations. Due to the high genomic diversity of strains 
included in the study population, the number of unique genes detected in each population is 
skewed towards strain-specific genes, which does not provide a good indicator of how 
genetically distinct human-clinical and non-human E. coli are as populations. On the other hand, 
these observations would suggest that examining the gene set of shared accessory genes 
between the two populations in further detail would provide a higher resolution for genomic 
comparison of strains isolated from human-clinical and non-human sources.  
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Figure 5.11 Comparison of population-unique accessory genes and shared accessory genes between the 
human-clinical and non-human populations of E. coli in Nottingham. 
The Venn diagram displays the number of genes unique to the non-human population of E. coli (left, blue), 
unique to the human-clinical population of E. coli (right, red), and shared between the two populations 
(centre, mauve). The total number of accessory genes comprising the two populations is shown in green. 
The accessory genome was determined by generating a pan-genome matrix using the Roary pipeline and 
excluding genes present in ≥ 85% of all 264 genomes included in the analysis. Unique and shared genes 
were identified by running the Roary query_pan_genome script on the accessory gene presence/absence 
matrix. Of the total 64,835 accessory genes detected, 12,311 genes were unique to human-clinical strains 
and 31,468 genes were identified among non-human E. coli strains exclusively, whilst 21,056 genes were 
identified in both populations. This corresponded to ~40% of genes identified in non-human E. coli and 
~63% of genes identified in human-clinical E. coli being shared between the two populations. 
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Figure 5.12. Frequency of gene occurrence plots for population-unique and shared accessory genes for 
the human-clinical and non-human populations of E. coli in Nottingham. 
The graphs plot the number of genes on the 𝑦-axis against the number of genomes on the 𝑥-axis for 
accessory genes unique to the human-clinical population of E. coli (A), unique to the non-human population 
of E. coli (B), and shared between the two populations (C). The graphs indicate a large proportion of unique 
genes being specific to one or a few genomes in each population. The majority of shared genes may 
represent ST or clade-specific genes, while only 17 genes are prevalent in a maximum of 209 of the 264 
genomes across the two populations. 
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The number of accessory genes identified as present in both populations (21,056) may be 
considered high relative to the numbers of unique genes reported (Fig. 5.11), particularly for the 
human-clinical population, so statistical analysis was performed to investigate this further. The 
probability of a gene being identified from the non-human population is the proportion of 
shared and non-human-unique genes out of the total, which is 81% ([21,056 + 31,468 / 64,835] 
× 100). On the other hand, the probability of a gene being identified from the human-clinical 
population is 51.5% ([21,056 + 12,311 / 64,835] × 100), which corresponds to the proportion of 
shared and human-clinical unique genes out of the total accessory genome. Assuming that these 
two probabilities are independent of one another, the expected probability of encountering a 
gene identified in both populations can be derived by multiplying the two proportions ([81% × 
51.5%] / 100), which gives an expected probability of 41.7% of identifying a gene present in both 
populations. However, the observed frequency of genes shared between the human-clinical and 
non-human populations reported here is 32.5% ([21,056 / 64,835] × 100). Therefore, it can be 
deduced that the observed frequency of shared genes equates to approximately 78% of the 
expected frequency, and the probability of encountering a gene that is present in both 
populations is 9.2% lower than the expected probability.  
The chance of a gene being identified in multiple groups is not independent of the number of 
genomes the gene is in. Therefore, to provide a statistically robust comparison between the 
observed and expected proportions of genes shared between the human-clinical and non-
human populations, a permutation test was carried out with pseudo-random re-sampling of the 
population without replacement of genomes. This approach took into account gene frequencies, 
and all genes that were only present once in each population (i.e. strain-specific genes) were 
excluded from the analysis. Permutations were carried out 1,000 times iterating for each gene 
category, and each permutation involved picking the same number of genomes as there are 
genes in that category. One-tailed empirical p-values were calculated to compare the expected 
frequencies of gene sharing to those of the observed data set. The simulated proportions are 
plotted as histograms on the graphs of Appendix 6, with the observed proportions mapped on 
the graphs for comparison. It is clear from the graphs that the observed data shows far less gene 
sharing than is expected by chance. The majority of gene categories for genes present in up to 
80 genomes show significantly less gene sharing than expected (p = 0). Only when the number 
of genomes is quite high (> 80) does this situation change and the observed proportions 
correlate with those of the simulated data. 
Statistical analysis of the observed data suggests that there is perhaps a restriction in the 
amount of gene sharing that takes place between the human-clinical and non-human 
populations, presumably because of the ecological barriers that exist between the two 
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populations. Environmental selection pressures are likely to play a part in the differences in gene 
content observed between the two populations. Infectious human ExPEC strains that have 
infiltrated the urinary tract and bloodstream are generally believed to originate from the faecal 
flora (Smith, Fratamico and Gunther, 2007). The environmental conditions of the human 
intestines, urinary tract, and bloodstream are considerably different from those encountered by 
E. coli that inhabit the wider environment, such as river and surface waters. These conditions 
would impose different selection pressures on the bacteria and therefore the evolution of E. coli 
in non-human environments is likely to be driven by a need to survive and proliferate under 
extreme environmental stresses, such as desiccation, temperature variation, and osmotic 
pressure, in addition to surviving transit in food and water (Boor, 2006). E. coli strains of the 
non-human population may have acquired many new advantageous genes, via horizontal gene 
transfer, from the large genepool of Enterobacteriaceae in the wider environment, which may 
explain the genetic differences observed between the non-human and human-clinical 
populations of E. coli. Considering that the accessory genome also encodes for the strain 
diversity within a population of bacteria, the observation of non-human E. coli genomes 
possessing more accessory genes than human-clinical strains is consistent with the high level of 
genomic variation of these strains, as revealed through phylogenetic analyses in this study.  
To explore in more detail the distribution of accessory genes detected in both populations, the 
accessory gene presence/absence matrix of shared genes was used to annotate the core 
genome phylogenetic tree, which was visualised with associated metadata using Phandango 
(Hadfield et al., 2018), as shown in Figure 5.13. It is noticeable that there are patterns within the 
accessory gene profiles which appear to correlate with the ST clusters on the phylogenetic tree. 
The patterns are not entirely clear-cut for all STs in the population but are most apparent for STs 
with multiple representative isolates, such as STs 131, 95, 73, 69, 115, 117, 1551, 12, 354, and 
648. On closer inspection of the accessory gene profiles for certain STs, some observable 
differences between strains isolated from human-clinical and non-human samples were noted. 
One example would include ST69, represented by both human-clinical and non-human strains, 
in which three strains isolated from non-human samples (I2-18, M3-27, and I2-20) appear to be 
distinct from the human-clinical strains in this clonal group, as they share fewer accessory genes 
with the human-clinical population. This is demonstrated to a greater extent in the ST10 cluster, 
which not only exhibits the highest diversity of strains among all STs, but also reveals a difference 
in the accessory gene profiles between human-clinical and non-human strains. The majority of 
non-human strains in this clonal group (AFR-12, AFR-22, AFR-6, AFR-4, M2-3, M2-2, M2-8, M2-
4, and I1-24) share fewer genes with the human-clinical population, which may suggest limited 
gene flow due to ecological barriers between the human-clinical and non-human population of 
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E. coli in Nottingham. Lineage-specific pan-genome and recombination analyses of human-
clinical and non-human ST69 and ST10 strains is required to assess the extent of gene sharing 
between the two populations in greater detail. This was undertaken in section 5.3.7.  
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Figure 5.13. Distribution of accessory genes in the human-clinical and non-human populations of E. coli in Nottingham.  
The heat map shows the presence or absence of accessory loci from the pan-genome of all 264 sequenced E. coli strains. The genomes are arranged on the 𝑦-axis, according to 
the maximum-likelihood phylogenetic tree shown on the left, with individual loci on the 𝑥-axis. Blue indicates presence of the locus in a strain and white indicates absence. The 
phylogenetic clades are defined by tree branch colouring and STs and sources of isolation are annotated on the tree as coloured bars.
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5.3.7. Pan-genome and recombination analysis of E. coli lineages ST69 and ST10 
Although there are only a limited number clinically relevant STs that are represented in both the 
human-clinical and non-human populations in this study, multiple representative strains of ST69 
and ST10 have been identified among both populations. E. coli ST10 strains are natural 
colonisers of the human gastrointestinal tract and are widespread in the environment. They are 
usually associated with low virulence and antibiotic susceptibility (Manges and Johnson, 2012), 
however, several recent case studies have identified an association of ST10 isolates with human 
disease, ESBL carriage, and livestock (Peirano et al., 2012; Leverstein-van Hall et al., 2011; Cortes 
et al., 2010). The ST69 clonal group, on other hand, is well established among human ExPEC 
infections and ST69 strains have been isolated worldwide from cases of UTI and bacteraemia, 
from both hospital- and community-acquired infections (Kallonen et al., 2017; Dias et al., 2009). 
The presence of these STs in both the human-clinical and non-human populations of E. coli 
analysed in this study warranted further investigation. Pan-genome analysis and detection of 
core genome recombination events was performed exclusively for ST69 and ST10 strains, to 
further compare the gene content of human-clinical and non-human strains, and assess the level 
of genetic exchange occurring between related strains isolated from the two different 
environments.  
5.3.7.1. E. coli ST69 
The pan-genomes of all 14 ST69 strains, identified among the Nottingham human-clinical and 
non-human E. coli populations analysed in this study, were determined using Roary. The 
resulting gene presence/absence matrix was used to annotate the core genome phylogenetic 
tree of ST69, which was visualised with isolate source data (Fig. 5.14). The pan-genome of this 
clonal group comprised 10,673 genes, 3,299 of which were core genes represented at least once 
in all strains. The number of genes identified for the ST69 population in this study represents a 
strikingly large pan-genome for this clonal group. With less than one-third of the pan-genome 
corresponding to core genes, this would indicate a large accessory or variable genome and thus 
highly diversity among the clonal group. Running the Roary query_pan_genome script on the 
pan-genome matrix had identified 2,957 genes unique to non-human strains, 2,194 genes 
unique to human-clinical strains, and 2,223 accessory (non-core) genes shared between ST69 
strains of both populations. The independent probability expectation for shared genes was 
calculated to test the significance of these numbers. The probability of an accessory gene being 
identified from the non-human population is 70.2%, whilst the probability of a gene being 
identified from the human-clinical population is 59.9%. Assuming that these two probabilities 
are independent of one another, the expected probability of encountering an accessory gene 
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identified in both populations is 42%. However, the observed frequency of accessory genes 
shared between the human-clinical and non-human populations of ST69 is 30.1%. It can 
therefore be inferred that the observed frequency of shared genes equates to approximately 
71.7% of the expected frequency, and the probability of encountering a gene that is present in 
both populations is 11.9% lower than the expected probability. The pan-genome 
presence/absence matrix (Fig. 5.14) confirms the findings of the accessory genome analysis 
(section 5.3.6.2) that outside of the core genome, there are noticeable differences in the gene 
profiles that characterise human-clinical and non-human strains of ST69. Most striking are 
strains M3-27, I2-18, and I2-20 isolated from non-human sources, which possess more accessory 
genes than the human-clinical ST69 strains. Interestingly, gene clusters which are circled in green 
in Figure 5.14 are unique to strains I2-18 and I2-20, and additionally, gene clusters circled in 
orange are unique to strain M3-27, which further demonstrates the disparity between these 
strains and the rest of the ST69 population. The fact that these non-human E. coli strains possess 
more accessory genes, as well as many unique genes, would suggest a high frequency of 
acquisition of advantageous genes, possibly from other environmental/non-human strains of 
the Escherichia genus, or other species of Enterobacteriaceae, which may prove to be beneficial 
for the bacteria to survive and proliferate in different environmental conditions.   
The difference in gene profiles observed between human-clinical and non-human ST69 strains 
may also suggest low levels of homologous recombination, due to ecological barriers between 
the two populations. To investigate this notion, regions of genomic recombination were 
detected by running the Gubbins algorithm (Croucher et al., 2015) on a core genome alignment 
of all ST69 genomes (length = 4,069,033 bp; 14 genomes). Any regions of recombination 
detected were visualised as coloured blocks against the phylogenetic tree constructed by 
Gubbins (Fig. 5.15). Blue blocks indicate recombination events that have occurred in a single 
isolate, while red blocks indicate signatures of recombination shared between multiple isolates. 
The horizontal position of the blocks represents their position in the alignment. It is evident from 
this analysis that recombination events unique to individual ST69 isolates are more prevalent 
than recombination events between multiple isolates across the alignment. Recombination 
between ST69 isolates of the human-clinical and non-human populations is rare, as indicated by 
the red blocks (Fig. 5.15). A cluster of human-clinical isolates (U67, B33, B31, and 2286_EC) 
which exhibit the lowest levels of recombination, shared only a single recombination event with 
non-human isolates (I2-18, T3-14, and T3-3), suggesting that these isolates do not inhabit the 
same place at the same time. Another example of limited gene flow between non-human and 
human-clinical strains would include I2-20 and I2-18, isolated from the same retail chicken 
sample, which do not recombine readily with other ST69 isolates in the strain set. Given the 
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suggestion that human-clinical ST69 may have non-human origins, due to reports of ST69 being 
isolated from pork, chicken, and beef (Vincent et al., 2010; Jakobsen et al., 2010), it would be 
reasonable to expect that opportunities for recombination to occur between non-human ST69 
and human-clinical ST69 isolates would be more frequent. However, from the evidence of the 
current study, it can be inferred that only negligible levels of recombination occur between 
human-clinical and non-human E. coli ST69 strains, which would indicate limited gene flow 
between strains of the two populations. This suggests that chance encounters between ST69 
strains of human and non-human origins in the same habitat do not occur frequently, indicating 
that ecological barriers may play a role in limiting the amount of gene sharing that takes place 
between ST69 strains of the two populations. 
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Figure 5.14. Distribution of gene profiles for ST69 E. coli strains isolated from human-clinical and non-
human samples in Nottingham. The heat map shows the presence or absence of every genetic locus from 
the E. coli ST69 pan-genome of 14 sequenced strains (human-clinical, n = 9; non-human, n = 5). The 
genomes are arranged on the 𝑦-axis according to the maximum-likelihood phylogenetic tree shown on the 
left, with individual loci on the 𝑥-axis. Blue indicates presence of the locus in a strain and white indicates 
absence. Sources of isolation are annotated on the tree as coloured bars. The pan-genome matrix appears 
to be totally concordant with the phylogenetic tree, where similar strains have more similar gene profiles. 
It is noticeable that non-human strains generally share fewer accessory genes with human-clinical strains. 
 
 
Figure 5.15. Distribution of core genome recombination events for ST69 E. coli strains isolated from 
human-clinical and non-human samples in Nottingham. Recombination events were predicted by running 
the Gubbins algorithm on a core genome alignment of all 14 human-clinical and non-human ST69 genomes 
(length = 4,069,033 bp). The phylogeny of ST69, as constructed by Gubbins, is shown on the left with source 
of isolation annotated on the tree. For each isolate, blocks representing the regions identified as 
recombination events by Gubbins are indicated by coloured blocks; blue blocks are unique to a single 
isolate while red blocks are shared by multiple isolates. The horizontal position of the blocks represents 
their position in the alignment. The number of genomes for which each recombination event is detected is 
indicated on the graph at the bottom. 
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5.3.7.2. E. coli ST10  
The pan-genomes of all 27 ST10 strains, identified among the Nottingham human-clinical and 
non-human E. coli populations analysed in this study, were constructed. The resulting gene 
presence/absence matrix was annotated on the core genome phylogenetic tree of ST10 with 
isolate source data (Fig. 5.16). It was found that the ST10 clonal group is composed of 19,642 
genes, of which, 882 were core genes represented at least once in all strains. Quite striking is 
the size of the pan-genome of this clonal group, which is noticeably larger than the ST69 pan-
genome (10,673 genes). While only a small proportion (4.5%) of the ST10 pan-genome 
corresponds to core genes, the vast majority would represent accessory genes, some of which 
may play a role in adaptation to special growth conditions, such as those involved in the 
colonisation of new ecological niches. The large gene repertoire of E. coli ST10 would suggest 
that these strains are widespread in nature and have greater access to the global microbial gene 
pool. Roary query_pan_genome analysis identified 13,092 genes unique to non-human strains, 
while only 978 genes were unique to human-clinical strains, and 4,690 accessory (non-core) 
genes were shared between ST10 strains of both populations. The independent probability 
expectation for shared genes was calculated to test the significance of these numbers. The 
probability of an accessory gene being identified from the non-human population is very high at 
94.8%, whilst the probability of a gene being identified from the human-clinical population is 
only 30.2%. If these two probabilities are independent of one another, the expected probability 
of encountering a gene identified in both populations is 28.6%. However, the observed 
frequency of genes shared between the human-clinical and non-human populations of ST10 is 
25%. Therefore, it can be interpreted that the observed frequency of shared genes equates to 
only 87.4% of the expected frequency, and the probability of encountering a gene that is present 
in both populations is 3.6% lower than the expected probability. The pan-genome 
presence/absence matrix (Fig. 5.16) reveals noticeable patterns in the gene profiles for human-
clinical and non-human ST10 strains, which corroborate the findings for ST69 (section 5.3.7.1) 
that genetic differences exist between human-clinical and non-human strains, perhaps due to 
niche adaptation. This pattern is even more prominent for ST10 where the human-clinical strains 
F14W131166-20, B20, B9, U19, F14W091968, F14W127020-13, and F14W127020-20 all possess 
highly diminished accessory genomes in comparison to the non-human strains of the ST10 strain 
set. This is also demonstrated by non-human ST10 strains possessing more unique genes when 
compared to the human-clinical strains. This would indicate that E. coli ST10 is a genetically 
diverse clonal group, and the larger gene pool of non-human E. coli ST10 would suggest that 
these strains typically comprise more genes encoding niche-specific fitness factors, whereas 
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human-clinical ExPEC strains may have undergone several gene loss events as a trade-off for 
enhanced fitness and survival in the bladder and bloodstream. 
Recombination events were also determined to assess the amount of gene flow that occurs 
between human-clinical and non-human ST10 strains. The Gubbins algorithm was run on a core 
genome alignment of all ST10 genomes (length = 2,049,758 bp; 23 genomes), and any regions 
of recombination detected are shown in Figure 5.17. Overall, significantly more recombination 
events were detected between E. coli ST10 strains when compared to ST69, which would be 
expected considering the genetic diversity of the ST10 clonal group. Most of the recombination 
events shared between multiple isolates were detected between non-human strains, 
particularly in two clusters. On the other hand, recombination events unique to the human-
clinical strains appears at much lower levels, and the overall level of detected recombination is 
lower in ST69 and ST10 strains of human-clinical origin. This was confirmed by quantifying the 
number of bases in the detected recombination events for each strain (Table 5.4). Interestingly, 
a cluster of non-human strains (AFR-12, AFR-6, AFR-22, M2-3, and AFR-4) do not recombine at 
all with the rest of the population, and only a limited amount of recombination occurs between 
these strains, in addition to these strains being more distantly related to the other ST10 strains, 
which may suggest that they form part of a subclade of the ST10 clonal complex. Furthermore, 
the number of SNPs falling within predicted recombination events were quantified (Table 5.4), 
and for the majority of non-human strains, these were generally lower than the number of base 
substitutions falling outside of predicted recombination events (i.e. those arising by point 
mutation), which would perhaps suggest lowered recombination levels between these strains 
and the rest of the population. Considering the high levels of recombination detected within the 
non-human E. coli population of ST10 strains, the amount of recombination observed between 
non-human and human-clinical strains would appear to be reduced. This is most noticeable for 
human-clinical strains F14W091968, F14W127020-13, and F14W127020-20, which exhibited 
much lower levels of shared recombination events with the rest of the strain set (Fig. 5.17; Table 
5.4). Given the common reporting of E. coli ST10 in both community and hospital settings, as 
well as in non-human sources such as food animals and the environment, it would be reasonable 
to expect that human-clinical and non-human strains of this ST may come into close contact by 
chance occurrence, and therefore opportunities for recombination would be more frequent.  
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Figure 5.16. Distribution of gene profiles for ST10 E. coli strains isolated from human-clinical and non-
human samples in Nottingham. The heat map shows the presence (blue) or absence (white) of every 
genetic locus from the pan-genome of 23 E. coli ST10 strains (human-clinical, n = 7; non-human, n = 16). 
The genomes are arranged on the 𝑦-axis according to the phylogenetic tree shown on the left, with 
individual loci on the 𝑥-axis. Sources of isolation are annotated on the tree as coloured bars. Human-clinical 
strains share noticeably fewer accessory genes with the non-human strains of the ST10 strain set. 
 
 
Figure 5.17. Distribution of genomic recombination events for ST10 E. coli strains isolated from human-
clinical and non-human samples in Nottingham. Recombination events were predicted by running 
Gubbins on a core genome alignment of all 23 ST10 genomes (length = 2,049,758 bp). The phylogeny 
constructed by Gubbins is shown on the left, with isolate source annotated on the tree. Regions of 
recombination are indicated by horizontal coloured blocks for each genome. Blue blocks are unique to a 
single isolate, while red blocks are shared by multiple isolates. The number of genomes for which 
recombination events are detected is indicated on the graph at the bottom. 
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Table 5.4. Length of genome of recombinant origin within ST10 E. coli strains isolated from 
human-clinical and non-human samples in Nottingham. 
 
Recombination events were predicted by running Gubbins on a core genome alignment of all 23 ST10 
genomes (length = 2,049,758 bp). The number of bases in recombination blocks is shown for each node, 
which represents the total length of all recombination events, as quantified by the Gubbins algorithm (Fig. 
5.17). The total number of recombination blocks reconstructed onto each branch was also quantified, as 
well as the number of base substitutions reconstructed onto the branch that fall within a predicted 
recombination. For the majority of non-human strains, the number of base substitutions identified within 
recombination events is generally lower than those falling outside of predicted recombination events (i.e. 
those arising by point mutation), which may suggest lowered recombination levels between these strains 
and the rest of the population.  
  
Node 
Bases identified within 
recombination events (bp) 
No. of recombination 
blocks 
No. of SNPs inside 
recombinations 
(out of total SNPs) 
F14W091968 94,307 9 598 (814) 
F14W127020-13 94,795 0 0 (0) 
F14W127020-20 94,795 0 0 (75) 
ELU39 149,857 9 427 (677) 
EPD30 897,655 119 5,942 (10,316) 
I2-1 813,606 0 0 (81) 
I1-21 813,606 0 0 (0) 
T1-61 682,182 46 4,227 (4,806) 
GU34 524,200 0 0 (0) 
F14W131166-20 403,350 25 1,385 (1,637) 
I1-24 441,277 14 355 (857) 
I1-17 422,806 0 0 (0) 
I1-19 422,806 1 4 (46) 
I1-16 422,816 1 7 (46) 
M2-2 454,752 3 73 (713) 
M2-8 477,053 9 204 (1,384) 
M2-4 451,121 0 0 (0) 
ELU103 422,797 0 0 (0) 
U19 241,201 9 1,136 (1,387) 
T1-73 180,500 0 0 (0) 
B20 182,187 0 0 (0) 
B9 182,187 0 0 (0) 
AFR-12 45,881 16 514 (3,517) 
AFR-6 6,264 0 0 (0) 
AFR-22 24,198 11 283 (712) 
M2-3 37,391 0 0 (0) 
AFR-4 59,365 12 266 (1,646) 
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5.4. Conclusions 
What we currently know about the ecology of E. coli is based on data from studies of 
representative isolates. A large amount of data has been collected for antimicrobial-resistant E. 
coli isolated from human-clinical cases. In chapter 4, genomic analyses of a large, unbiased 
population of E. coli isolated from non-human sources revealed a population of significant 
genomic diversity, with a low prevalence of specific human ExPEC and multidrug-resistant 
lineages. The population structure of E. coli responsible for human extraintestinal infection is 
well-described in the current literature. Human-clinical ExPEC strains have often been 
characterised at the sequence type level by MLST, and a small number of STs, namely ST69, 
ST73, ST95, and ST131, were found to predominate among cases of UTIs and bloodstream 
infections (Kallonen et al., 2017; Riley, 2014; Alhashash et al., 2013; Croxall et al., 2011b). 
Previous studies that have attempted to attribute transmission of ExPEC in human infections to 
poultry or environmental sources, have largely focussed on MDR E. coli and ESBL-producing 
strains, using traditional typing methods. These studies are not likely to provide sufficient 
resolution to assess the relatedness of strains isolated from non-human and human-clinical 
sources (Jang et al., 2013; Platell et al., 2011b; Dolejska et al., 2011b; Dolejska et al., 2011a). To 
address this, comparative genomic analyses of WGS data for geographically-constrained non-
human and human-clinical populations of E. coli were carried out, to provide a higher level of 
resolution to determine the extent of genetic overlap that may between these two populations. 
The ST-designations of a collection of 399 human-clinical strains, previously isolated from cases 
of bacteraemia and UTIs in Nottingham (Alhashash et al., 2013; Croxall et al., 2011b), confirmed 
a clonally diverse population dominated by the four major ST complexes: ST131, ST73, ST69, and 
ST95, and an observable presence of the ST10 complex. Comparison of the prevalence of these 
clinically-dominant STs between the human-clinical population and the non-human population 
of E. coli, characterised in chapter 4, further demonstrates a clear disparity in the population 
structures of human-clinical and non-human E. coli. Whilst the important MDR ExPEC lineage, 
ST131, was the most commonly encountered ST among human-clinical isolates analysed in this 
study, only one instance of this genotype was observed in the non-human population of E. coli. 
Additionally, STs 73 and 95, which were prevalent in the human-clinical population analysed in 
this study, could not be detected among non-human isolates of E. coli. ST69 was identified in 
both the human-clinical and non-human populations, and although this ST represented a higher 
proportion of human-clinical isolates (7.0%) than non-human isolates (3.1%), this difference was 
not considered to be statistically significant (p = 0.137, two-tailed Fisher’s test). ST10 is a 
common human ExPEC ST that is also associated with food animals and retail poultry meat 
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(Manges 2016; Aslam et al., 2014; Bergeron et al., 2012; Vincent et al., 2010). It was revealed in 
this study that ST10 was the dominant lineage in the non-human population of E. coli (12.5%) 
and was significantly more prevalent than human-clinical ST10 isolates (1.5%; p < 0.0001, two-
tailed Fisher’s test). This suggests a more widespread prevalence of this ST in the environment 
and the food chain than in human-clinical cases of ExPEC. The paucity of human ExPEC STs 131, 
73, 69, and 95 in the non-human population of E. coli would indicate that the non-human 
reservoir of human ExPEC is negligible and is unlikely to be responsible for the majority of human 
ExPEC infections. The distinct nature of the population structures that define human-clinical and 
non-human E. coli in Nottingham, in addition to the lack of shared STs, would suggest that the 
two populations do not frequently encounter each other despite existing within a 
geographically-constrained ecosystem.  
A core genome phylogenetic tree, encompassing 136 whole-genome sequenced human-clinical 
strains (isolated from cases of bacteraemia, UTI, and neonatal sepsis in Nottingham) and the 128 
non-human E. coli genomes from chapter 4, provided an insight into the phylogroup 
composition of the two populations. Due to the overrepresentation of ST131 and ST73 strains, 
the human-clinical population was dominated by phylogroup B2 (80.1%), while in contrast, only 
7% of the non-human population were classified as phylogroup B2. This would demonstrate a 
lack of classically pathogenic strains in the non-human population, according to previous 
observations that phylogroup B2 strains are generally more virulent than strains belonging to 
the other phylogroups (Picard et al., 1999; Boyd and Hartl, 1998). On the contrary, the non-
human population of E. coli is largely composed of phylogroup A and B1, indicating a high 
proportion of largely commensal strains of E. coli, as reported by previous studies (Duriez et al., 
2001; Picard et al., 1999). Considering that the human-clinical E. coli study population consisted 
of isolates primarily from elderly patients and neonates with suspected urinary and bloodstream 
infections, the lack of human-clinical isolates from classical commensal phylogroups suggests 
that pathogenic E. coli may be more likely to opportunistically colonise patients with 
compromised immune systems. This is supported by the significantly higher prevalence of ExPEC 
strains identified in the human-clinical population when compared to the non-human 
population of E. coli, as determined by in silico VAG profiling (human-clinical, 66.9% vs non-
human 8.6%; p < 0.0001, two tailed Fisher’s test). Another disparity noted between the two 
populations is the prevalence of potentially MDR strains of E. coli. In silico antimicrobial 
resistance gene profiling of all strains revealed a higher prevalence of ciprofloxacin, 
trimethoprim, and macrolide resistance genes among human-clinical isolates when compared 
to non-human isolates of E. coli, corroborating the levels of phenotypic resistance observed for 
these antibiotic classes in human-clinical E. coli previously (Kallonen et al., 2017; Alhashash et 
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al., 2013; Croxall et al., 2011b). More importantly, however, was the appreciable difference in 
prevalence of ESBL genes observed between the two populations. The blaCTX-M family of ESBL 
genes, responsible for the majority of MDR infections worldwide (Nicolas-Chanoine et al., 2008; 
Lau et al., 2008), were identified in 21.3% of all human-clinical E. coli isolates, while such genes 
could not be detected in the non-human population. Furthermore, a significantly higher 
prevalence of blaOXA genes were detected in human-clinical isolates (21.3%), when compared to 
non-human E. coli isolates (1.6%; p < 0.0001, two tailed Fisher’s test). When taken together, the 
low prevalence of human ExPEC and MDR strains in the non-human population of E. coli may 
suggest that strains of the non-human population of E. coli in Nottingham do not readily 
encounter strains of the human-clinical population, thereby lowering the frequency of 
horizontal transfer of ESBL and virulence-associated genes between the two populations.  
Of the limited number of clinically important sequence types identified in the non-human 
population of E. coli analysed in this study, only a single ST131 strain (GD45) and a single ST648 
strain (GD49) were isolated from river water samples. GD45 was included in a core genome 
phylogenetic tree of a global collection of 242 E. coli ST131 genomes, obtained from multiple 
ecosystems, to determine the relatedness of the non-human ST131 strain to a wider population 
of the ST131 lineage. Of the three known E. coli ST131 subclades, GD45 was revealed to be a 
clade B strain, and is therefore not related to the clade C lineage of ST131, which is often 
associated with carrying the ESBL gene blaCTX-M-15 and is currently responsible for the majority of 
extraintestinal infections in humans (Nicolas-Chanoine, Bertrand and Madec, 2014). Given the 
position of GD45 in clade B and its lack of a CTX-M-carrying plasmid, it would suggest that this 
particular non-human ST131 strain is unlikely to be implicated in human ExPEC infections, and 
perhaps indicates limited overlap between non-human and human-clinical populations of E. coli. 
However, to determine whether a low prevalence of clade C ST131 strains is true for the majority 
of non-human populations of E. coli, deeper genomic sampling from additional non-human and 
environmental sources would be required in future work. Similar phylogenetic analysis was 
performed for the non-human ST648 strain (GD49), which was included in a core genome 
phylogenetic tree of 89 European E. coli ST648 genomes, from multiple host sources. Despite 
the geographical and ecological separation between GD49 (isolated from river water in 
Nottingham) and the rest of the population (isolated largely from companion animals in 
mainland Western Europe), GD49 still falls within the phylogenetic tree, indicating its relation to 
the European population of ST648. This would support a widespread dispersion of this ST as 
previously reported globally (Guenther et al., 2012; Cortes et al., 2010), and it may also suggest 
that environmental ST648 strains originate from humans, companion animals, or livestock. 
However, of importance is the fact that GD49 lacks a CTX-M-carrying plasmid, which is contrary 
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to the overwhelming majority of the ST648 population (88%), which were found to harbour a 
CTX-M gene. Based on the association of blaCTX-M-15 in ST648 isolates with human-clinical cases 
observed in previous studies (Zong and Yu, 2010; Cortes et al., 2010; Nicolas-Chanoine et al., 
2008), it would seem unlikely that ST648 isolates lacking this ESBL type can be attributed to the 
global expansion of ST648 and ExPEC infections in humans. A broader sample size of ST648 
isolates from environmental and foodborne sources should be studied in future work to 
determine whether these isolates follow a general trend of lacking the blaCTX-M-15 ESBL. The 
Nottingham E. coli study population includes other instances of STs prevalent in both 
populations, such as ST10 (human-clinical, n = 7; non-human, n = 16) and ST69 (human-clinical, 
n = 9; non-human, n = 5). However, it was decided that phylogenetic comparative analysis would 
not be carried out for the non-human E. coli ST10 strains within the wider population of ST10, 
because aside from a small clade that are largely CTX-M-1 producers (Leverstein-van Hall et al., 
2011), ST10 is a very diverse clonal complex associated with low virulence and antibiotic 
susceptibility (Manges and Johnson, 2012). Pan-genome analysis would therefore provide the 
appropriate method to distinguish between non-human and human-clinical strains. Regarding 
ST69, there was simply not a large enough genome collection from multiple sources to carry out 
a substantial phylogenetic reconstruction of the wider ST69 population.  
A pan-genome approach was taken in this study, as it offers a much higher resolution than core 
genome phylogenetic and MLST analyses, because it takes into consideration the entire bacterial 
genome (Hall, Ehrlich and Hu, 2010). The pan-genome analysis of all 264 human-clinical and non-
human E. coli strains of the Nottingham study population revealed a highly heterogeneous 
genomic data set, where only 596 of the total 69,645 genes were represented at least once in ≥ 
95% of strains. The analysis also indicated a vast number of strain-specific genes (29,139) 
present in the pan-genome, suggesting a large accessory genome which encodes for the strain 
diversity and selective advantages for virulence, antibiotic resistance and niche adaptation 
(Tettelin et al., 2008). This prompted further analysis of the accessory genomes to determine 
proportions of accessory gene clusters or loci that are unique to either the human-clinical or 
non-human population, as well as the proportion of genes shared between both populations. It 
was found that 12,311 genes and 31,468 genes were unique to the human-clinical and non-
human populations, respectively, however the majority of these genes corresponded to strain-
specific genes. It was therefore the number of genes shared between the two populations (n = 
21,056) which was of interest for comparing the two populations. Statistical analysis revealed 
that the probability of encountering a gene that is present in both the human-clinical and non-
human populations of Nottingham is 9.2% lower than expected. This would perhaps be 
indicative of a restriction in the amount of gene sharing that takes place between the human-
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clinical and non-human populations of E. coli, presumably because of the ecological barriers and 
difference in environmental selection pressures that exist between the two populations.  
Pan-genome analysis and detection of core genome recombination events were also carried out 
specifically for strains of ST69 and ST10, as multiple representative strains were identified for 
these STs in both the human-clinical and non-human populations. ST10 is a diverse lineage and 
several recent studies have reported an association of ST10 isolates with human disease, ESBL 
carriage, and livestock (Bergeron et al., 2012; Peirano et al., 2012; Leverstein-van Hall et al., 
2011; Cortes et al., 2010). ST69 is one of the more recognised clonal groups implicated in human 
ExPEC infection worldwide (Kallonen et al., 2017; Dias et al., 2009; Johnson et al., 2009). 
Identification of these clinically relevant STs in both the human-clinical and non-human 
populations of E. coli therefore warranted further genomic comparisons to assess the level of 
genetic flow between closely related strains of the two populations. Noticeable differences in 
the gene profiles of human-clinical strains compared to non-human strains were observed for 
both the ST69 and ST10 strain sets, though these were more prominent for ST10. The non-
human strains shared few accessory genes with the human-clinical strains, and the non-human 
strains possessed more accessory genes, perhaps due to these strains requiring more genes 
encoding niche-specific fitness factors for adaptation and survival in the environment. Lowered 
levels of recombination events were detected between human-clinical and non-human strains 
of ST69, which is concordant with the divergent gene profiles of human-clinical and non-human 
strains. This observation is consistent with previous studies reporting reduced genetic flow 
between environmental and enteric E. coli (Luo et al., 2011), and additionally between poultry 
and human-clinical isolates of E. coli (de Been et al., 2014), suggesting that human-clinical and 
non-human E. coli form two distinct populations. To further investigate the level of genetic 
overlap between human-clinical and non-human strains, additional sequence type-specific pan-
genome and recombination analyses should be carried out in future work. 
Overall, the results of this investigation revealed that there are clear differences in the 
population structures of E. coli isolated from human-clinical and non-human sources, with 
regards to the major STs that comprise these populations. At the phylogenetic level, a small 
number of clinically important, clonally-related strains such as ST131, ST648, ST69, and ST10 
were identified in both populations. However, comparative analyses at the whole genome level 
revealed a low prevalence of potential MDR and ExPEC strains in the non-human population 
compared to the human-clinical population. Furthermore, gene sharing between E. coli ST69 
strains of the human-clinical and non-human populations is limited, suggesting that ecological 
barriers may contribute to reduced levels of recombination between the two populations. 
Further lineage-specific specific analyses, encompassing additional non-human sources of E. coli 
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would be required to confirm this. Collectively, these results lead to the conclusion that an 
obvious non-human reservoir of human MDR E. coli and ExPEC strains does not exist, and 
therefore, it is unlikely that the non-human population of E. coli contributes significantly to the 
burden of hospital- and community-acquired extraintestinal infections. 
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CHAPTER 6 
Conclusions and future directions 
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6. Conclusions and future directions 
Accessing information on the full ecology of bacterial pathogens has previously been a 
deficiency of many microbial ecological studies, and consequently, has hindered our 
understanding of the evolution and dissemination of these organisms, which cause many 
debilitating and life-threatening diseases in humans. Before the advent of whole-genome 
sequence-based analysis, the study of microbial ecology was largely restricted to low-resolution 
and subjective molecular and biochemical techniques. To effectively probe the structures of 
microbial populations and fully appreciate species diversity, sequencing of single isolates must 
be employed to achieve the genomic resolution required (Quince et al., 2017). Using this 
approach, the current study aimed to elucidate the unknown ecology of two important 
pathogens to humans, Y. pseudotuberculosis and E. coli. Previous genome-scale analyses 
revealed hidden ecological inferences for the enteric pathogen Y. enterocolitica (Reuter et al., 
2015; Reuter et al., 2014), which warranted further investigation to determine whether similar 
hidden patterns may exist in Y. pseudotuberculosis.  
Phylogenetic analysis of globally and temporally distributed Y. pseudotuberculosis genomes 
from multiple ecosystems identified a clear phylogeographic split in the population, which was 
previously undetected for pathogenic Yersinia species. This was characterised by an ancestral 
clade of strains of primarily Asian origin and a second low diversity clade of mainly European 
strains. This phenomenon was once postulated for Y. enterocolitica with Old World and New 
World strains (Wang et al., 2011), however, recent population genomics studies by our group 
have shown this is not the case (Reuter et al., 2015; Reuter et al., 2014). The Asian ancestry of 
Y. pseudotuberculosis is consistent with the estimated ancestry of Y. pestis (Morelli et al., 2010; 
Achtman et al., 1999). Phylogenetic dating provided an estimated TMRCA for the entire Y. 
pseudotuberculosis data set, which is in the same range (10,000–40,000 years before present) 
as that estimated for the emergence of Y. pestis (Achtman et al., 1999). Based on this evidence, 
we could argue that the emergence of Y. pestis coincided with a larger population dispersal 
event across Y. pseudotuberculosis. Additionally, the dating analysis indicated a recent 
geographical divergence of the European and Asian clades occurring ~12,500 years before 
present. It would be tempting to suggest that a bottleneck event occurring in the recent past 
may have resulted in the establishment of a small number of successful clones in new 
ecosystems, leading to subsequent dissemination of these clonal lineages into Europe and the 
rest of the world. Mapping serotype designations onto the Y. pseudotuberculosis phylogeny 
indicated that successfully established clones in Europe belong almost exclusively to serotypes 
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O:1a and O:1b, consistent with previous studies reporting a predominance of these serotypes in 
Europe, whilst greater serotype diversity exists in Asia (Fukushima et al., 2001).  
One of the limitations of the phylogenetic dating analysis was the availability of only a relatively 
small number of isolation dates (n = 46) representing the full diversity of the phylogeny. This 
made it difficult to accurately date the phylogeny of the entire data set. A greater accuracy of 
dating would have been achieved had there been more isolation dates available. Furthermore, 
it would be suggested that a more thorough and dense genomic sampling should be considered 
for further analysis of Y. pseudotuberculosis. This would reveal whether the levels of diversity 
observed in geographic clades in this study are maintained in the broader population of Y. 
pseudotuberculosis. Significantly more isolates from Africa and the Americas should be included 
in further analyses, as these isolates were noticeably underrepresented in the population 
analysed in this study. This should provide stronger evidence to support a separate migration of 
the species into Africa and the Americas, as evidenced by the small transitional cluster of strains 
between the Asian and European clades. 
Further genomic analysis of the Y. pseudotuberculosis population identified clearly distinct 
phylogenetic subgroups within each clade. These phylogroups have unique combinations of 
accessory genes, with little variation in their accessory genomes, and they share very similar 
patterns of core genome homologous recombination. Similar phylogroup signatures were 
identified from analysis of accessory gene sharing between serotype-specific clades of Y. 
enterocolitica, in a previous study by our group (Reuter et al., 2015). It was concluded that the 
restricted gene sharing between clades was due to ecological separation. In Y. 
pseudotuberculosis, however, the observation of phylogenetic subgroups, which are intimately 
connected to the CRISPR spacer designations, presents a strong case for the role of the CRISPR 
system in the formation of these phylogroups. The inference of CRISPR playing a role in 
mediating this genetic restriction is supported by the observation that different CRISPR cluster-
type strains coexist in the same geographical habitat, and several clusters appear in samples 
separated by at least a decade. Moreover, it would be expected that the CRISPR cluster signature 
would be gradually eroded over time (Dearlove et al., 2016), especially considering that Y. 
pseudotuberculosis is widespread in nature, and no active barrier would prevent recombination 
between strains coexisting in the same ecological niche. As a result, clear phylogroup signatures 
should not be observed within the population (Sheppard et al., 2008), given the high levels of 
core genome recombination detected for Y. pseudotuberculosis. However, it can be concluded 
from the data that the CRISPR system is strongly associated with restriction of both accessory 
and core gene exchange between tightly maintained Y. pseudotuberculosis phylogroups. To our 
knowledge, this study provides the first evidence of a possible causative link between CRISPRs 
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and the evolution of distinct phylogroups in a bacterial species. The data suggest that large 
population perturbations led to the emergence of geographically isolated clones. These clones 
encounter geographically localised exogenous DNA, creating a CRISPR array of immunity which 
controls the range of genetic material that can be exchanged with other clones of Y. 
pseudotuberculosis. Clones comprising the same CRISPR array can freely exchange genes 
without any restriction; however, horizontal gene transfer between different clones is not 
sufficient to erode the clonal phylogenetic structure, and thus distinct phylogroups of Y. 
pseudotuberculosis persist within the population. 
Whilst a strong correlation between CRISPRs and restriction of genetic flow exists in the Y. 
pseudotuberculosis population, this study did not reveal any phylogenetic signature associated 
with the ecology of the species. Isolates from different hosts/ecosystems were distributed 
throughout the phylogeny and did not cluster separately from each other. This is indicative of 
the ability of Y. pseudotuberculosis to colonise many different non-human hosts and 
environments, suggesting a broad and widespread ecology for the species. Although several 
previous studies have reported a role for ecological barriers, in shaping distinct ecotypes within 
populations of important bacterial pathogens (Reuter et al., 2015; Sheppard et al., 2014; 
McNally et al., 2013; Luo et al., 2011), the present study has demonstrated that Y. 
pseudotuberculosis is a host generalist species with an ability to occupy multiple ecological 
niches, from where pathogenic lineages can easily be transferred to humans. Our findings 
indicate that evolution of Y. pseudotuberculosis is driven by factors other than those that 
prevent physical contact. The study therefore creates a new window of research for microbial 
ecology and evolution where CRISPR can be used to investigate how distinct ecotypes may 
emerge for important human pathogens. 
Comprehensive population genomic analyses were also performed on E. coli, another model 
organism used to investigate microbial ecology in this study. Multiple reports exist of E. coli, 
isolated from environmental waters and retail chicken meat, that resemble strains responsible 
for human extraintestinal infections. This has led to the suggestion that there may be a non-
human reservoir for human multidrug-resistant ExPEC. Many of these environmental 
microbiological studies tend to bias towards resistant isolates in their sampling procedure, thus 
leading to an overrepresentation of MDR – specifically ESBL-producing – E. coli strains in the 
literature (Hussain et al., 2017; Manges, 2016; Lazarus et al., 2015; de Been et al., 2014). Given 
the shortcoming of past studies, it was imperative to determine the population structure of non-
human E. coli from river water and retail chicken samples in this study. This was achieved using 
an unbiased culture-based approach, to sample all isolates in order to achieve a more accurate 
snapshot of the prevalence of MDR and pathogenic E. coli. An E. coli population, consisting of 
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128 sequenced genomes, was obtained from river water and retail chicken samples in 
Nottingham and subjected to whole-genome analysis. To put this population in the context of 
E. coli causing human extraintestinal infection, comparative population genomics was 
performed with previously isolated human-clinical E. coli strains from urinary and bloodstream 
infection cases in Nottingham, allowing for high-resolution examination of any genetic overlap 
between the two populations.  
In silico MLST analysis revealed that the non-human E. coli population is not dominated by the 
STs that are frequently associated with urinary tract and bloodstream infections; ST131, ST73, 
ST69, and ST95. Rather, the non-human population of E. coli is comprised of a wide variety of 
different STs, with most strains not grouping into larger clonal complexes, demonstrating the 
genetic diversity within the population. The ST10 clonal complex emerged as the most 
frequently encountered clonal group, representing approximately 15% of the non-human E. coli 
population analysed in this study. These findings represent a clear disparity in the population 
structures of non-human and human-clinical E. coli. The lack of STs associated with human 
extraintestinal infection in the non-human population would suggest that the environmental 
and foodborne risk for human extraintestinal infection, specifically through contaminated water 
and retail chicken meat, is very low. The limited number of clinically associated STs identified 
may also be indicative of a limitation in the non-human sampling. Isolates were only obtained 
from river water and retail chicken samples in this study. To access the full diversity of E. coli in 
the environment and food chain, future work should consider a much deeper sampling of non-
human sources, such as slurry, plants, wild and domesticated animals, other retail meats, and 
dairy products. 
Phylogenetic analysis of the non-human and human-clinical populations of E. coli provided an 
insight into the phylogroup composition of the two populations. An overrepresentation of 
human-clinical E. coli genomes belonging to ST131 and ST73 meant that this population was 
dominated by phylogroup B2 strains (~80%), while by contrast, only 7% of the non-human 
population were classified as phylogroup B2. This demonstrated a lack of classically pathogenic 
strains in the non-human population, according to previous reports that phylogroup B2 strains 
are generally more virulent than strains belonging to other phylogroups (Picard et al., 1999; 
Boyd and Hartl, 1998). On the other hand, the non-human population of E. coli was largely 
composed of phylogroup A and B1 strains, indicating a predominance of largely commensal and 
non-pathogenic strains of E. coli (Duriez et al., 2001; Picard et al., 1999). To confirm the 
distribution of pathogenic strains between the human-clinical and non-human populations of E. 
coli, in silico VAG profiling was performed for all strains to identify the virulence factors 
associated with ExPEC. A significantly higher prevalence of ExPEC strains in the human-clinical 
   
203 
 
population (66.9%) was revealed when compared to the non-human population of E. coli (8.6%). 
Given that the human-clinical E. coli population analysed in this study was largely derived from 
elderly patients and neonates diagnosed with urinary and bloodstream infections, the high 
prevalence of ExPEC would indicate that pathogenic E. coli strains are more likely to cause 
opportunistic infection in immunocompromised hosts. Therefore, the non-human population, 
with a very low prevalence of ExPEC, presents little or no significance to cases of human 
extraintestinal infection in Nottingham. It must be noted that the definition of ExPEC used in this 
study is based on the presence of five virulence markers, but that the actual pathogenicity of 
strains cannot be determined just by the presence/absence of these five markers. Furthermore, 
the human-clinical genomic data set analysed in this study does not reflect an accurate 
representation of the prevalence of pathogenic strains in the population. The genomic data set 
consists of sequenced E. coli genomes from human-clinical samples, from Nottingham, that were 
available at the time of this study; however, the population is largely overrepresented by ST131 
and ST73 strains, which were selectively sequenced as part of previous projects by our group 
(Alhashash et al., 2016; Clark et al., 2012). To accurately compare the phylogroup structure and 
prevalence of ExPEC in non-human and human-clinical populations of E. coli in future work, a 
similar approach should be taken with human-clinical samples, where isolates are sequenced to 
represent the full spectrum of diversity in the population. Another important difference noted 
between the two populations would be the prevalence of potential MDR strains of E. coli. The 
blaCTX-M family of ESBL genes, which is associated with the majority of MDR infections worldwide 
(Nicolas-Chanoine et al., 2008; Lau et al., 2008), was identified in 21.3% of all human-clinical E. 
coli isolates, while these genes were not present among non-human E. coli strains. The low 
incidence of ESBL gene carriers and ExPEC strains, in the non-human population of E. coli, 
reflects a genuine representation of the prevalence of potential MDR and/or pathogenic strains, 
in the natural environment and in food products. This contrasts with previous studies that have 
selectively enriched for antimicrobial-resistant isolates and have reported an increasing 
occurrence of ESBL producers (Hussain et al., 2017; Manges, 2016; Lazarus et al., 2015; de Been 
et al., 2014). The lack of phenotypic characterisation of the non-human E. coli isolates in this 
study is noted. Future work may consider performing antimicrobial susceptibility testing on 
these isolates, as well as assays for physiological virulence factors such as adhesins, capsule 
production, flagella, and toxins, to assess the virulence potential of these isolates in vitro. 
Given the paucity of E. coli sequence types associated with human extraintestinal infection in 
the non-human population (namely ST131, ST73, ST95, and ST648), producing pan-genomes 
specific to these STs was not feasible. Therefore, a pan-genome of all 264 human-clinical and 
non-human E. coli strains of the Nottingham study population was constructed, which revealed 
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a highly heterogeneous genomic data set sharing only a small proportion of core genes; a result 
of the inclusion of distantly related strains representing the full spectrum of phylogenetic 
diversity across the species (Rasko et al., 2008). The analysis also revealed a vast number of 
strain-specific genes present in the pan-genome, indicating the high level of genome plasticity 
in the E. coli accessory genome, which encodes for the strain diversity and selective advantages 
for virulence, antibiotic resistance, and niche adaptation (Tettelin et al., 2008). This led to 
subsequent investigation of the accessory genome, to determine the number of accessory genes 
that are unique to either the human-clinical or non-human population, as well as the number of 
genes shared between both populations. This uncovered a noticeable difference in the number 
of accessory genes unique to either population, though these numbers largely represented 
strain-specific genes. Closer scrutiny of the number of genes shared between the two 
populations revealed that the probability of encountering a gene that is present in both the 
human-clinical and non-human populations is 9.2% lower than expected. This indicates that 
there could be ecological barriers limiting the amount of gene sharing that takes place between 
the two populations. A restriction in genetic flow may also indicate limited movement of MDR 
plasmids between strains of the two populations. Given the very low prevalence of ESBL-carrying 
plasmids in the non-human population, it was decided that comparative analyses of plasmid 
DNA with human-clinical strains would not be carried out in this study, and thus, the pan-
genome approach was employed to provide an indication of gene flow. The limitation of 
constructing a pan-genome of both combined populations is that the reported number of genes 
unique to either population may be misleading, due to the overrepresentation of strain-specific 
genes. Constructing pan-genomes specific to each of the dominant E. coli STs responsible for 
human extraintestinal infection would perhaps give a clearer indication of movement of mobile 
genetic elements between the two populations. Genome sequencing of additional non-human 
E. coli ST131, ST73, ST95, and ST648 strains, from the same geographical region, would therefore 
be required for further genomic comparison with human-clinical strains of the same STs. 
Only single representative isolates of the clinically important ST131 (GU45) and ST648 (GD49) 
strains were detected in the non-human population of E. coli. SNP-based core genome 
phylogenetic trees were constructed to situate the ST131 and ST648 strains within wider 
populations of their respective STs. The ST131 isolate obtained from this study was situated 
within clade B of the ST131 phylogeny, comprising globally dispersed ST131 genomes from 
multiple ecosystems. The clade C lineage of ST131 is most often associated with carriage of the 
ESBL gene blaCTX-M-15 and is currently recognised as the major cause of human extraintestinal 
infections (Nicolas-Chanoine, Bertrand and Madec, 2014). The absence of clade C, CTX-M-15-
producing E. coli ST131 strains in the non-human population analysed in this study would 
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suggest that ST131 in the environment poses very little concern to human health. Subclones of 
ST131 clade C have recently been identified among ESBL-producing E. coli, in wastewater from 
treatment plants and hospitals in Japan (Gomi et al., 2017a), suggesting dissemination of 
clinically important lineages into the environment. However, to determine the prevalence of 
clade C ST131 clones within the context of the non-human E. coli population of Nottingham, a 
much more thorough and dense genomic sampling of isolates from additional non-human 
sources in this region, would be required in future genomic analyses. The single non-human E. 
coli ST648 strain recovered from this study was situated phylogenetically within a European 
population of ST648, isolated mainly from companion animals. Despite the phylogenetic 
relatedness of GD49 to the rest of the population, this strain did not harbour the blaCTX-M-15 ESBL 
gene, whilst the vast majority (88%) of the ST648 population was associated with blaCTX-M 
carriage. Given the worldwide prevalence of ST648 strains possessing the blaCTX-M-15 ESBL gene, 
and the implication of these strains in human-clinical cases (Zong and Yu 2010; Cortes et al., 
2010; Nicolas-Chanoine et al., 2008), it would be reasonable to suggest that ST648 strains lacking 
a CTX-M-carrying plasmid, from non-human sources, are unlikely to contribute to the global 
expansion of ST648 in human extraintestinal infections. A broader collection of non-human 
ST648 isolates would be required in future genomic studies, to determine whether ST648 from 
the wider non-human/environmental population in Nottingham generally lack the blaCTX-M-15 
ESBL gene.  
Pan-genome analysis was also performed specifically for ST69 and ST10, owing to multiple 
representative strains of these STs in both the human-clinical and non-human populations of E. 
coli. The non-human strains possessed more unique genes than those shared with human-
clinical strains, suggesting a greater repertoire of genetic material acquired from the gene pool, 
such as those encoding niche-specific fitness factors for adaptation and survival in the 
environment. Recombinant regions within the core genomes of ST69 and ST10 strains were 
detected to assess the extent of genetic exchange between non-human and human-clinical E. 
coli. Negligible levels of recombination were detected between human-clinical and non-human 
ST69 strains, suggesting limited opportunity for genetic exchange, likely due to these strains not 
coexisting in the same space at the same time. Significantly more recombination events were 
shared between human-clinical and non-human ST10 strains, however, indicating genetic 
exchange between these strains. Given the widespread, diverse nature and frequent isolation 
of E. coli ST10 in community, hospital, and environmental locales, it would be expected that 
opportunities for recombination would be more frequent due to chance encounters. While 
strains of the same ST from human-clinical and non-human sources are phylogenetically related, 
there is a clear difference in gene content between non-human and human-clinical strains. This 
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would suggest that these strains once shared a recent common source, but have since diversified 
and become more adapted to the surrounding environment they presently inhabit. Further 
sequence type-specific investigations into the pan-genomes and core genome recombination 
events between non-human and human-clinical strains are required, to confirm the level of 
genetic overlap between clinically associated lineages of the two populations.  
In summary, the work detailed in this thesis was achieved through whole-genome sequence 
analyses, providing a high-resolution view of the population structures, ecology, and evolution 
of Y. pseudotuberculosis and E. coli. Through in-depth phylogenetic analysis, this study yielded 
definitive evidence of a phylogeographic split of a globally dispersed population of Y. 
pseudotuberculosis with an Asian ancestry, and subsequent dissemination of successful clonal 
lineages into Europe and the rest of the world. This study provides the first evidence of a possible 
causative link between CRISPR cassettes and the evolution of these distinct lineages in Y. 
pseudotuberculosis. Bayesian analysis of core genome recombination revealed that restriction 
of genetic exchange maintains the discrete lineage structure in the population, despite 
coexistence of lineages for thousands of years. The study did not identify a role for ecological 
barriers in defining the distinct lineage structure of this species, suggesting that Y. 
pseudotuberculosis is a host generalist pathogen with an ability to persist in multiple niches. The 
use of CRISPR in providing evolutionary insights into the emergence of bacterial lineages 
warrants further investigation in other important human pathogens. Comparative population 
genomics of E. coli uncovered clear differences in the population structures of E. coli isolated 
from human-clinical and non-human sources. A snapshot revealing a low prevalence of clinically-
associated sequence types, multidrug resistance, and potential ExPEC strains among non-human 
E. coli when compared to human-clinical E. coli would suggest two distinct populations within 
the region. This was supported by a clear difference in accessory genome content between the 
two populations and only minimal levels of genetic exchange between closely related strains, 
such as ST69, suggesting ecological barriers to recombination may play a role in driving evolution 
within E. coli. The evidence gathered from this study led to the conclusion that the non-human 
population of E. coli is unlikely to contribute significantly to the burden of hospital- and 
community-acquired extraintestinal infections in humans. 
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Appendix 
Appendix 1. Full printed copy of the published journal article containing information and data 
from chapter 3 (provided in pocket at the end of the thesis): 
Title:  
Phylogeographic separation of sexually discrete lineages in a global population of Yersinia 
pseudotuberculosis 
Authors:  
Seecharran T., Kalin-Manttari L., Koskela K., Nikkari S., Dickins B., Corander J., Skurnik M., 
McNally A. 
Journal: 
Microbial Genomics. 2017;3 (10): e000133. http://doi.org/10.1099/mgen.0.000133 
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Appendix 2. Y. similis and Y. wautersii genomes used for the outgroup in Appendix 3. 
Strain 
name 
Species Year ST Host Continent Country Accession 
number 
R819 Y. similis 1988 75 Mouse Asia Japan ERR024895 
Y233 Y. similis 1991 75 Mole Asia Japan ERR024899 
Y719 Y. similis 1991 75 Human Europe Germany ERR024904 
OK3108 Y. similis - - River Asia Japan ERR1448034 
Y228 Y. similis 1990 92 Rabbit Europe Germany ERR024898 
MW109-2 Y. similis 1990 71 Water Asia Japan ERR024915 
N916Ysi Y. similis - - Animal Europe Finland ERR027410 
Y252 Y. similis 1990 71 Mole Asia Japan ERR024900 
WP-931201 Y. wautersii 1993 21 Water Asia Korea ERR024893 
4008/2002 Y. wautersii 2002 - Hare Europe Finland ERR1448055 
Y428 Y. wautersii - 96 Badger Europe Germany ERR024901 
 
Eight Y. similis and three Y. wautersii genomes were included as an outgroup on the phylogenetic tree of 
the Y. pseudotuberculosis study population (Appendix 3). De novo assemblies of Y. similis and Y. wautersii 
genomes are available on Enterobase (https://enterobase.warwick.ac.uk/species/index/yersinia), 
searchable by the strain name or accession number indicated in the table. 
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Appendix 3. Maximum-likelihood phylogenetic tree of 134 Y. pseudotuberculosis, 3 Y. wautersii, and 8 
Y. similis isolates annotated with all available metadata. Y. wautersii and Y. similis are separate species 
of the Y. pseudotuberculosis complex and were included in the phylogenetic tree as an outgroup. Inclusion 
of these genomes (accession numbers shown in Appendix 2) indicated that the “Asian” clade represents 
the ancestral clade for the study population. 
   
 
 
2
4
3 
 
Appendix 4. Dated maximum clade credibility (MCC) tree produced from BEAST 2 analysis performed on the 46 Y. pseudotuberculosis strains for which isolation dates are 
available. The tree was visualised and manipulated using FigTree. Error bars are displayed at each node representing the upper and lower values within the 95% HPD (highest 
probability density) from the BEAST analysis.
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Appendix 5. Assembly statistics for the 180 sequenced non-human E. coli genomes. 
Strain N50 (bp) L50 (bp) Genome size 
(bp) 
GC content 
(%) 
Number of N's per 
100 kbp 
I2-15 1,107 951 3,359,765 50.28 8.04 
I2-8 1,135 894 3,276,310 50.51 15.26 
AFR-38 1,226 819 3,334,302 50.49 15.9 
I1-29 1,263 829 3,311,016 50.09 25.67 
I2-7 1,367 895 3,884,517 50.36 18.74 
AFR-26 1,426 826 3,801,326 50.53 18.41 
M3-26 1,462 821 3,930,731 50.86 32.49 
TFR-7 1,528 722 3,690,087 50.81 25.47 
AFR-36 1,555 733 3,827,893 51.31 19.04 
I1-6 1,640 726 3,743,495 50.5 28.05 
AFR-28 1,814 779 4,627,632 50.32 23.9 
AFR-34 1,863 654 4,241,859 50.4 30.36 
M3-24 1,939 712 4,514,416 50.91 31.45 
M2-8 2,163 610 4,349,702 51.48 33.54 
I2-6 2,188 632 4,804,256 50.48 16.86 
AFR-4 2,206 625 4,722,035 51.07 35.66 
I1-33 2,285 601 4,399,093 50.77 32.05 
AFR-12 2,309 599 4,741,109 50.77 27.21 
AFR-20 2,403 486 4,467,222 51.03 25.07 
M3-31 2,458 500 4,631,908 51 7.77 
T3-18 2,512 543 4,616,073 50.92 21.01 
AFR-16 2,532 588 4,854,746 50.85 36.97 
M3-30 2,628 560 4,902,181 51.18 35.07 
AFR-18 2,790 528 4,941,315 50.86 57.84 
TFR-6 2,993 454 4,624,797 51.04 30.68 
GU1 3,207 394 4,433,701 50.83 2.26 
I1-11 3,326 450 5,181,407 50.16 21.62 
AFR-22 3,346 465 5,200,256 50.7 50.42 
M2-6 3,647 434 5,111,765 50.93 40.59 
M2-2 3,696 402 4,905,557 51.02 27.52 
AFR-14 3,755 421 5,235,395 50.70 33.73 
M3-36 4,047 385 5,328,946 50.85 26.27 
M2-3 4,080 398 5,334,950 51.03 41.26 
T1-53 4,149 371 5,525,329 50.87 31.4 
M3-23 4,231 394 5,697,090 50.42 33.96 
AFR-30 4,480 338 5,164,501 50.68 20.14 
M2-9 4,785 316 4,990,196 51.37 14.83 
T3-21 4,819 317 5,435,770 50.34 25.13 
I2-18 5,422 318 5,610,195 50.55 19.59 
GU2 6,468 219 4,898,346 50.60 3.06 
AFR-10 6,675 254 5,756,792 50.52 20.06 
M2-7 6,694 263 5,466,211 50.76 16.28 
GD138 7,567 189 4,785,679 50.67 2.93 
M2-5 7,946 218 5,606,004 50.60 16.05 
I1-5 8,208 196 5,038,692 50.37 13.61 
T3-1 8,235 194 5,569,609 50.78 20.47 
M3-21 8,262 214 5,808,794 50.75 27.17 
I1-24 8,272 201 5,238,932 50.80 13.93 
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M2-1 8,539 199 5,474,492 50.61 15.11 
M3-27 8,644 198 5,585,928 50.77 7.88 
I2-20 8,857 201 5,781,737 50.46 13.3 
TFR-2 8,869 160 5,265,664 50.72 5.32 
M3-29 8,894 158 4,797,545 50.71 13.34 
AFR-40 9,378 181 5,598,833 50.87 48.62 
M3-22 9,745 175 5,457,271 50.84 16.68 
T1-7 10,079 154 4,995,381 50.76 13.41 
AFR-32 10,583 151 5,365,379 50.76 15.66 
M3-25 10,645 157 5,634,273 50.71 10.65 
M3-20 11,200 141 5,593,407 50.59 19.31 
I1-25 11,346 160 5,913,968 50.34 41.28 
M3-34 11,788 148 5,689,566 50.60 7.73 
AFR-8 12,613 131 5,396,156 50.71 8.9 
I1-15 12,990 117 5,018,581 50.57 11.34 
AFR-24 13,191 121 5,370,200 50.85 10.8 
T3-7 13,614 114 5,151,232 50.61 10.72 
T1-11 14,911 101 5,015,163 50.65 13.06 
I2-5 14,954 117 5,588,523 50.30 9.3 
M2-4 14,989 107 5,521,688 51.01 44.03 
S2-5 17,101 102 5,585,248 50.56 4.83 
M3-28 18,091 97 5,754,056 50.55 9.54 
T3-19 19,015 95 5,856,858 50.62 12.96 
T1-52 20,742 84 5,700,106 50.31 24.61 
AFR-2 20,861 85 5,752,069 50.69 41.95 
M2-10 22,332 75 5,582,390 50.93 35.4 
GD109 22,711 67 4,905,714 50.47 1.2 
I2-1 23,125 68 5,632,497 50.89 65.64 
S2-10 25,291 63 6,002,178 50.66 12.1 
M3-18 27,148 47 4,800,461 50.77 9.73 
S2-7 27,148 64 5,852,125 50.75 37.63 
T1-49 28,588 57 6,028,358 50.78 1.82 
AFR-6 28,746 58 5,636,541 50.57 10.88 
S2-8 29,947 56 6,014,939 50.5 25.7 
T1-9 35,181 44 5,123,419 50.69 12.49 
SFR-6 36,805 44 5,024,664 50.65 16.54 
TFR-15 39,555 40 4,704,649 50.89 19.7 
M3-32 39,818 45 5,995,208 50.44 18.35 
ELU65 46,408 35 4,893,644 50.65 10.3 
T1-27 48,560 32 5,339,120 50.97 8.52 
GU77 50,825 34 5,600,130 51.21 31.55 
ELU103 51,772 34 5,629,601 50.78 19.18 
I1-21 52,253 29 5,664,842 50.92 36.19 
T1-32 52,361 33 5,362,438 50.47 9.75 
T1-73 55,462 29 5,089,386 50.58 27.96 
M3-19 56,424 28 4,866,004 50.56 11.04 
EPU5 56,609 30 4,875,919 50.83 30 
T1-56 57,551 30 5,761,442 50.4 17.32 
I1-16 57,612 32 5,404,494 50.72 18.65 
EPU62 58,039 27 4,979,186 50.73 0.8 
GU15 59,632 31 5,437,433 50.56 16.53 
GU41 60,562 26 5,019,387 50.75 14.56 
ELU7 63,109 25 4,972,394 50.73 1.41 
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GU13 65,278 23 4,777,286 50.47 3.24 
I1-28 66,591 26 5,420,730 50.76 33.21 
GD3 69,188 25 5,096,017 50.85 22.27 
T1-30 70,461 22 5,423,956 50.63 23.27 
I1-12 70,756 26 5,170,047 50.44 15.40 
SFR-11 76,811 22 5,227,403 50.66 31.99 
T3-6 80,594 22 5,433,335 50.7 27.00 
GU27 80,995 19 4,913,402 50.51 28.09 
ELU71 82,060 20 4,979,055 50.74 0.4 
TFR-1 82,704 23 5,629,233 50.67 65.6 
I1-19 84,958 22 5,385,365 50.73 15.39 
ELU98 85,575 21 5,411,422 50.39 9.68 
T3-3 87,089 19 5,186,480 50.65 26.61 
EPD5 87,284 21 5,404,635 50.56 28.46 
ELU17 87,482 19 4,978,547 50.74 0.4 
ELU67 87,606 19 4,977,900 50.74 0.8 
EPU22 88,228 20 5,156,329 50.76 18.71 
EPU51 90,598 18 4,964,100 50.69 11.18 
GD131 91,113 15 5,230,245 50.57 90.38 
T3-4 91,242 22 5,708,849 50.62 39.52 
GU53 92,610 19 5,406,222 50.48 9.53 
S2-4 96,735 20 5,519,072 50.43 19.99 
T1-57 100,004 18 5,415,934 50.37 19.33 
I1-17 100,097 20 5,392,204 50.74 18.69 
ELU122 100,420 17 4,967,713 50.69 28.26 
T1-25 102,293 18 5,408,044 50.35 26.65 
T1-3 103,224 17 5,858,729 50.65 42.94 
ELU88 103,785 17 4,976,742 50.59 10.13 
T1-1 103,939 16 4,946,744 50.68 28.46 
T1-61 104,032 18 5,121,170 50.67 8.98 
ELU21 104,242 18 4,974,449 50.73 0.2 
EPD30 104,925 15 4,787,052 50.75 0.21 
ELU24 105,056 14 4,981,484 50.72 15.38 
GU80 106,390 16 5,211,996 50.37 67.15 
EPU17 106,671 15 4,923,598 50.68 9.22 
ELU39 107,069 14 4,730,043 50.62 9.01 
ELU72 107,272 17 4,858,247 50.69 10.27 
GU34 107,488 15 4,846,293 50.78 0.41 
T1-39 107,683 16 5,400,960 50.62 7.54 
ELU28 108,043 14 4,745,339 50.89 2.84 
T3-14 109,000 12 5,199,403 50.63 23.75 
ELU22 109,377 15 4,979,149 50.72 0 
T1-5 109,634 13 4,748,761 50.68 9.6 
I1-32 110,485 16 5,190,226 50.37 13.64 
ELU20 111,954 16 4,980,229 50.73 0 
S2-2 112,253 15 5,289,074 50.25 0.19 
GU47 114,419 12 4,846,073 50.7 14.84 
SFR-4 114,470 15 4,975,197 50.78 0.20 
SFR-15 114,554 14 4,754,370 50.58 12.85 
GU45 117,001 16 5,319,647 50.79 20.7 
ELU16 119,583 13 4,980,732 50.72 0 
S2-3 122,183 16 5,236,836 50.72 8.13 
T1-35 123,140 14 4,908,868 50.63 11.53 
   
247 
 
GU39 124,074 12 4,948,309 50.33 11.24 
TFR-13 126,831 16 5,742,821 50.67 34.48 
GU49 128,774 13 5,219,251 50.77 21.02 
GU51 135,819 11 5,057,578 50.66 0 
GU24 142,610 12 5,004,195 50.71 20.48 
ELU87 152,411 11 5,253,977 50.45 20.61 
GU35 154,804 10 5,063,753 50.61 10.64 
GU46 163,299 12 5,218,231 50.72 53.03 
GD46 179,117 10 5,154,659 50.66 0 
GU48 180,109 12 5,334,803 50.5 23.45 
ELU29 188,138 10 4,861,206 50.69 9.94 
GU70 189,883 9 5,009,043 50.26 10.62 
GU10 200,504 8 4,931,939 50.62 8.23 
GU5 203,129 9 4,673,999 50.86 10.38 
GD49 209,107 8 5,154,459 50.63 26.21 
GU82 220,014 7 4,482,513 50.38 21.37 
GD93 227,685 7 4,784,503 50.67 0 
GU6 234,263 8 5,218,733 50.49 26.88 
GU43 243,045 7 4,856,399 50.58 0 
GU52 248,372 9 5,236,603 50.72 24.58 
GU31 252,882 8 4,950,178 50.27 20.10 
GD162 257,260 7 4,788,765 50.64 0 
GD45 340,187 5 5,097,407 50.6 12.34 
GU87 348,597 6 5,115,851 50.5 21.03 
GU50 367,693 4 4,869,944 50.61 9.26 
ELU34 401,570 5 4,991,917 50.55 9.76 
 
Appendix 5. Assembly statistics for the 180 sequenced non-human E. coli genomes. 
One hundred and eighty E. coli isolates were selected for sequencing, so as to represent the full diversity 
of sampled isolates. Assembly statistics were obtained from running the QUAST quality assessment tool 
(Gurevich et al., 2013). N50 values indicate the length for which the collection of all contigs of that length 
or longer covers at least half an assembly; L50 is the minimal number of contigs that cover half of the 
assembly; GC content refers to the total number of G and C nucleotides in the assembly, divided by the 
total length of the assembly; number of N’s per 100 kb is the total number of uncalled bases per 100,000 
assembled bases. The first 12 strains highlighted in red in the table, with N50 values < 1,900 bp and genome 
sizes < 4.3 Mbp, were excluded from further genomic analyses as they represent incomplete assembled 
genomes. Genome sizes ranging from ∼4.4 Mbp to ∼6.0 Mbp within the study population represent the 
average E. coli genome size of 5.19 Mbp and an average GC content of ∼50% would be within the narrow 
range that is normal an Escherichia genome (Mann and Chen, 2010). 
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human populations of E. coli. 
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Appendix 6. Observed and expected proportions of genes shared between the human-clinical and non-
human populations of E. coli. The expected proportions were determined by carrying out a permutation 
test with random re-sampling of the population without replacement of genomes. Strain-specific genes 
were excluded from the data set. Permutations were run 1,000 times repeating for each gene category. 
The simulated proportions are plotted as histograms and the observed proportions are mapped onto the 
graphs for comparison. The permutation script was written by Ben Dickins (NTU) and the graphs were 
generated using the tidyverse package of the R statistical software. 
